*********** PTASSAMj00 ******** FILEIN user.vek ../../CSA/PIK_SPRITE/ ULMN 5 2dln_c00 D-ALANINE--D-ALANINE LIGASE user 1 5 # 1 15 GLU A 333 GLU~? 2.48 ZN ZN A 401s 150 SER A 332 SER~? 10.92 ZN ZN A 402 216 TYR A 331 TYR~? 10.26 ZN ZN A 402 255 ARG A 271 ARG^? 13.44 ZN ZN B 401 276 GLY A 308 GLY.? 7.69 O1 B3P A 371 coo 18.72 1.95 50.27 17.22 2.99 49.29 -35.80 114.74 -10.32 -37.65 115.72 -10.06 coo 20.89 3.58 46.02 20.41 4.18 48.30 -31.12 112.57 -9.16 -30.10 110.35 -8.93 coo 25.64 7.68 49.08 22.95 7.02 48.68 -30.16 115.06 -4.86 -28.37 117.16 -5.34 coo 15.80 13.82 43.70 16.77 10.99 44.40 -33.34 101.75 -1.66 -34.94 103.58 0.21 coo 18.03 11.13 50.74 17.53 11.78 50.39 -36.78 108.02 -6.71 -37.57 107.80 -6.86 2dln_c00 source 2dln D-ALANINE--D-ALANINE LIGASE : 1 hits 2dln_c00 naa= 5 ULMN 4 1a4l_c03 ADENOSINE DEAMINASE user 1 4 # 1 D1717 GLU B 333 GLU~? 2.50 ZN ZN B 402s D1738 HIS B 330 HIS~? -3.52 ZN ZN B 401s D1740 TYR B 331 TYR~? 10.21 ZN ZN B 401 D1795 ASP B 309 ASP.? 7.61 ZN ZN B 401 coo 79.46 66.71 96.16 78.02 67.53 97.49 -40.33 98.40 11.28 -42.37 98.54 11.02 coo 77.62 63.23 97.06 75.99 64.55 97.16 -40.87 100.43 6.30 -42.90 100.10 6.71 coo 79.86 61.53 92.34 77.28 61.88 93.36 -35.74 95.21 5.65 -35.48 92.47 6.11 coo 70.75 65.08 97.32 72.46 65.59 98.49 -40.43 105.08 4.20 -40.75 103.07 3.51 1a4l_c03 source 1a4l ADENOSINE DEAMINASE : 1 hits 1a4l_c03 naa= 4 ULMN 4 1aj8_c02 CITRATE SYNTHASE user 1 4 # 1 A 193 SER A 289 SER.? -5.35 O1 B3P A 371s A 223 HIS A 330 HIS~? -3.46 ZN ZN A 402s A 262 HIS A 68 HIS.? -3.48 ZN ZN A 401s A 312 ASP A 48 ASP.? 7.07 ZN ZN A 402 coo 28.44 32.05 73.53 28.64 31.12 71.24 -41.15 110.32 -7.28 -42.46 109.97 -5.25 coo 29.33 36.13 69.70 30.07 34.20 70.11 -37.28 113.42 -5.32 -38.81 114.77 -5.81 coo 38.54 36.60 66.38 37.88 34.77 67.15 -37.46 120.39 -11.50 -38.87 119.03 -12.26 coo 30.62 37.23 61.07 30.08 35.73 62.49 -34.00 122.50 -3.86 -35.34 120.86 -3.93 ULMN 4 1aj8_c02 CITRATE SYNTHASE user 2 4 # 2 A 193 SER A 289 SER.? -5.35 O1 B3P A 371s A 223 HIS A 330 HIS~? -3.46 ZN ZN A 402s A 262 HIS A 102 HIS~? 4.84 O2 B3P A 371 A 312 ASP A 48 ASP.? 7.07 ZN ZN A 402 coo 28.44 32.05 73.53 28.64 31.12 71.24 -41.15 110.32 -7.28 -42.46 109.97 -5.25 coo 29.33 36.13 69.70 30.07 34.20 70.11 -37.28 113.42 -5.32 -38.81 114.77 -5.81 coo 38.54 36.60 66.38 37.88 34.77 67.15 -42.24 121.28 -10.34 -42.29 119.63 -9.04 coo 30.62 37.23 61.07 30.08 35.73 62.49 -34.00 122.50 -3.86 -35.34 120.86 -3.93 ULMN 4 1aj8_c02 CITRATE SYNTHASE user 3 4 # 3 A 193 SER B 289 SER.? -5.32 O1 B3P B 371s A 223 HIS B 330 HIS~? -3.52 ZN ZN B 401s A 262 HIS B 68 HIS.? -3.46 ZN ZN B 402s A 312 ASP B 48 ASP.? 7.12 ZN ZN B 401 coo 28.44 32.05 73.53 28.64 31.12 71.24 -42.54 105.00 8.17 -43.55 106.07 6.24 coo 29.33 36.13 69.70 30.07 34.20 70.11 -40.87 100.43 6.30 -42.90 100.10 6.71 coo 38.54 36.60 66.38 37.88 34.77 67.15 -44.72 94.50 12.35 -45.14 96.41 13.13 coo 30.62 37.23 61.07 30.08 35.73 62.49 -43.07 90.96 4.68 -43.24 93.07 4.75 ULMN 4 1aj8_c02 CITRATE SYNTHASE user 4 4 # 4 A 193 SER B 289 SER.? -5.32 O1 B3P B 371s A 223 HIS B 330 HIS~? -3.52 ZN ZN B 401s A 262 HIS B 102 HIS~? 4.91 O2 B3P B 371 A 312 ASP B 48 ASP.? 7.12 ZN ZN B 401 coo 28.44 32.05 73.53 28.64 31.12 71.24 -42.54 105.00 8.17 -43.55 106.07 6.24 coo 29.33 36.13 69.70 30.07 34.20 70.11 -40.87 100.43 6.30 -42.90 100.10 6.71 coo 38.54 36.60 66.38 37.88 34.77 67.15 -49.25 96.38 11.24 -48.46 97.85 9.95 coo 30.62 37.23 61.07 30.08 35.73 62.49 -43.07 90.96 4.68 -43.24 93.07 4.75 ULMN 4 1aj8_c02 CITRATE SYNTHASE user 5 4 # 5 A 193 SER B 332 SER~? 10.87 ZN ZN B 401 A 223 HIS B 330 HIS~? -3.52 ZN ZN B 401s A 262 HIS B 102 HIS~? 4.91 O2 B3P B 371 A 312 ASP B 48 ASP.? 7.12 ZN ZN B 401 coo 28.44 32.05 73.53 28.64 31.12 71.24 -35.18 97.79 10.03 -33.17 99.10 9.80 coo 29.33 36.13 69.70 30.07 34.20 70.11 -40.87 100.43 6.30 -42.90 100.10 6.71 coo 38.54 36.60 66.38 37.88 34.77 67.15 -49.25 96.38 11.24 -48.46 97.85 9.95 coo 30.62 37.23 61.07 30.08 35.73 62.49 -43.07 90.96 4.68 -43.24 93.07 4.75 1aj8_c02 source 1aj8 CITRATE SYNTHASE : 5 hits 1aj8_c02 naa= 4 ULMN 4 1aj8_c03 CITRATE SYNTHASE user 1 4 # 1 B 193 SER A 289 SER.? -5.35 O1 B3P A 371s B 223 HIS A 330 HIS~? -3.46 ZN ZN A 402s B 262 HIS A 68 HIS.? -3.48 ZN ZN A 401s B 312 ASP A 48 ASP.? 7.07 ZN ZN A 402 coo 24.20 33.47 87.18 22.82 34.14 89.12 -41.15 110.32 -7.28 -42.46 109.97 -5.25 coo 23.86 29.50 91.20 24.12 31.58 91.00 -37.28 113.42 -5.32 -38.81 114.77 -5.81 coo 29.35 31.42 99.15 28.72 33.09 98.04 -37.46 120.39 -11.50 -38.87 119.03 -12.26 coo 20.42 28.25 99.26 20.25 29.62 97.63 -34.00 122.50 -3.86 -35.34 120.86 -3.93 ULMN 4 1aj8_c03 CITRATE SYNTHASE user 2 4 # 2 B 193 SER A 289 SER.? -5.35 O1 B3P A 371s B 223 HIS A 330 HIS~? -3.46 ZN ZN A 402s B 262 HIS A 102 HIS~? 4.84 O2 B3P A 371 B 312 ASP A 48 ASP.? 7.07 ZN ZN A 402 coo 24.20 33.47 87.18 22.82 34.14 89.12 -41.15 110.32 -7.28 -42.46 109.97 -5.25 coo 23.86 29.50 91.20 24.12 31.58 91.00 -37.28 113.42 -5.32 -38.81 114.77 -5.81 coo 29.35 31.42 99.15 28.72 33.09 98.04 -42.24 121.28 -10.34 -42.29 119.63 -9.04 coo 20.42 28.25 99.26 20.25 29.62 97.63 -34.00 122.50 -3.86 -35.34 120.86 -3.93 ULMN 4 1aj8_c03 CITRATE SYNTHASE user 3 4 # 3 B 193 SER B 289 SER.? -5.32 O1 B3P B 371s B 223 HIS B 330 HIS~? -3.52 ZN ZN B 401s B 262 HIS B 68 HIS.? -3.46 ZN ZN B 402s B 312 ASP B 48 ASP.? 7.12 ZN ZN B 401 coo 24.20 33.47 87.18 22.82 34.14 89.12 -42.54 105.00 8.17 -43.55 106.07 6.24 coo 23.86 29.50 91.20 24.12 31.58 91.00 -40.87 100.43 6.30 -42.90 100.10 6.71 coo 29.35 31.42 99.15 28.72 33.09 98.04 -44.72 94.50 12.35 -45.14 96.41 13.13 coo 20.42 28.25 99.26 20.25 29.62 97.63 -43.07 90.96 4.68 -43.24 93.07 4.75 ULMN 4 1aj8_c03 CITRATE SYNTHASE user 4 4 # 4 B 193 SER B 289 SER.? -5.32 O1 B3P B 371s B 223 HIS B 330 HIS~? -3.52 ZN ZN B 401s B 262 HIS B 102 HIS~? 4.91 O2 B3P B 371 B 312 ASP B 48 ASP.? 7.12 ZN ZN B 401 coo 24.20 33.47 87.18 22.82 34.14 89.12 -42.54 105.00 8.17 -43.55 106.07 6.24 coo 23.86 29.50 91.20 24.12 31.58 91.00 -40.87 100.43 6.30 -42.90 100.10 6.71 coo 29.35 31.42 99.15 28.72 33.09 98.04 -49.25 96.38 11.24 -48.46 97.85 9.95 coo 20.42 28.25 99.26 20.25 29.62 97.63 -43.07 90.96 4.68 -43.24 93.07 4.75 ULMN 4 1aj8_c03 CITRATE SYNTHASE user 5 4 # 5 B 193 SER B 332 SER~? 10.87 ZN ZN B 401 B 223 HIS B 330 HIS~? -3.52 ZN ZN B 401s B 262 HIS B 102 HIS~? 4.91 O2 B3P B 371 B 312 ASP B 48 ASP.? 7.12 ZN ZN B 401 coo 24.20 33.47 87.18 22.82 34.14 89.12 -35.18 97.79 10.03 -33.17 99.10 9.80 coo 23.86 29.50 91.20 24.12 31.58 91.00 -40.87 100.43 6.30 -42.90 100.10 6.71 coo 29.35 31.42 99.15 28.72 33.09 98.04 -49.25 96.38 11.24 -48.46 97.85 9.95 coo 20.42 28.25 99.26 20.25 29.62 97.63 -43.07 90.96 4.68 -43.24 93.07 4.75 1aj8_c03 source 1aj8 CITRATE SYNTHASE : 5 hits 1aj8_c03 naa= 4 ULMN 4 1ako_c01 EXONUCLEASE III user 1 4 # 1 109 TYR A 84 TYR~? 13.75 O4 B3P A 371 151 ASP B 317 ASP~? 10.65 O4 B3P A 371 229 ASP B 314 ASP~? 9.37 O5 B3P A 371 259 HIS B 313 HIS~? 5.49 ZN ZN A 402 coo 33.16 18.85 -1.53 34.64 16.76 -2.64 -39.14 126.77 2.96 -38.54 124.09 2.48 coo 35.04 17.56 3.16 36.71 16.39 2.64 -39.61 120.08 5.26 -40.74 120.57 3.54 coo 35.23 15.91 8.28 35.41 14.90 6.45 -40.38 114.62 4.43 -42.39 114.53 3.82 coo 34.93 11.62 4.24 36.26 12.70 3.02 -40.27 117.73 -1.83 -39.85 118.55 -3.71 ULMN 4 1ako_c01 EXONUCLEASE III user 2 4 # 2 109 TYR B 84 TYR~? 13.70 O4 B3P B 371 151 ASP A 317 ASP~? 10.45 O4 B3P B 371 229 ASP A 314 ASP~? 9.10 O5 B3P B 371 259 HIS A 313 HIS~? 5.54 ZN ZN B 401 coo 33.16 18.85 -1.53 34.64 16.76 -2.64 -49.86 90.29 -2.09 -47.88 92.17 -1.55 coo 35.04 17.56 3.16 36.71 16.39 2.64 -46.62 96.07 -4.20 -47.85 96.41 -2.50 coo 35.23 15.91 8.28 35.41 14.90 6.45 -44.29 101.20 -3.40 -45.94 102.37 -2.71 coo 34.93 11.62 4.24 36.26 12.70 3.02 -45.85 98.44 2.81 -45.85 97.45 4.68 1ako_c01 source 1ako EXONUCLEASE III : 2 hits 1ako_c01 naa= 4 ULMN 4 1al6_c01 CITRATE SYNTHASE user 1 4 # 1 244 SER A 289 SER.? -5.35 O1 B3P A 371s 274 HIS A 330 HIS~? -3.46 ZN ZN A 402s 320 HIS A 68 HIS.? -3.48 ZN ZN A 401s 375 ASP A 48 ASP.? 7.07 ZN ZN A 402 coo 7.28 -2.66 -2.02 9.55 -2.28 -2.78 -41.15 110.32 -7.28 -42.46 109.97 -5.25 coo 11.08 -2.90 2.00 11.09 -3.48 -0.01 -37.28 113.42 -5.32 -38.81 114.77 -5.81 coo 17.22 -10.90 1.81 16.10 -10.23 0.18 -37.46 120.39 -11.50 -38.87 119.03 -12.26 coo 20.14 -1.52 3.09 18.48 -1.53 1.77 -34.00 122.50 -3.86 -35.34 120.86 -3.93 ULMN 4 1al6_c01 CITRATE SYNTHASE user 2 4 # 2 244 SER B 289 SER.? -5.32 O1 B3P B 371s 274 HIS B 330 HIS~? -3.52 ZN ZN B 401s 320 HIS B 68 HIS.? -3.46 ZN ZN B 402s 375 ASP B 48 ASP.? 7.12 ZN ZN B 401 coo 7.28 -2.66 -2.02 9.55 -2.28 -2.78 -42.54 105.00 8.17 -43.55 106.07 6.24 coo 11.08 -2.90 2.00 11.09 -3.48 -0.01 -40.87 100.43 6.30 -42.90 100.10 6.71 coo 17.22 -10.90 1.81 16.10 -10.23 0.18 -44.72 94.50 12.35 -45.14 96.41 13.13 coo 20.14 -1.52 3.09 18.48 -1.53 1.77 -43.07 90.96 4.68 -43.24 93.07 4.75 1al6_c01 source 1al6 CITRATE SYNTHASE : 2 hits 1al6_c01 naa= 4 ULMN 4 1aq0_c00 1,3-1,4-BETA-GLUCANASE user 1 4 # 1 A 232 GLU B 203 GLU^? 37.09 O3 B3P B 371 A 280 GLU B 199 GLU^? 48.27 O3 B3P B 371 A 283 LYS B 144 LYS~? 49.27 O3 B3P B 371 A 288 GLU B 173 GLU^? 50.63 O3 B3P B 371 coo 5.76 85.47 37.35 6.76 85.56 39.24 -66.30 108.47 45.19 -65.02 110.19 45.11 coo 4.25 95.66 42.75 4.18 93.57 42.69 -77.31 110.33 51.94 -78.27 110.21 50.08 coo 9.66 95.18 46.95 8.19 90.97 44.00 -73.99 104.12 56.30 -69.99 102.62 56.83 coo 13.49 92.75 43.16 12.39 91.15 42.33 -68.84 109.86 56.27 -69.26 109.60 58.32 1aq0_c00 source 1aq0 1,3-1,4-BETA-GLUCANASE : 1 hits 1aq0_c00 naa= 4 ULMN 4 1aq0_c01 1,3-1,4-BETA-GLUCANASE user 1 4 # 1 B 232 GLU B 203 GLU^? 37.09 O3 B3P B 371 B 280 GLU B 199 GLU^? 48.27 O3 B3P B 371 B 283 LYS B 144 LYS~? 49.27 O3 B3P B 371 B 288 GLU B 173 GLU^? 50.63 O3 B3P B 371 coo -0.96 61.87 2.24 -2.27 63.48 2.70 -66.30 108.47 45.19 -65.02 110.19 45.11 coo -4.32 67.50 -7.41 -4.63 66.46 -5.59 -77.31 110.33 51.94 -78.27 110.21 50.08 coo -6.22 73.35 -4.20 -4.99 69.00 -1.28 -73.99 104.12 56.30 -69.99 102.62 56.83 coo -1.91 73.68 -0.16 -1.91 71.74 0.71 -68.84 109.86 56.27 -69.26 109.60 58.32 1aq0_c01 source 1aq0 1,3-1,4-BETA-GLUCANASE : 1 hits 1aq0_c01 naa= 4 ULMN 4 1avf_c06 GASTRICSIN user 1 4 # 1 J 32 ASP B 309 ASP.? 7.61 ZN ZN B 401 J 35 SER B 289 SER.? -5.32 O1 B3P B 371s J 75 TYR B 293 TYR~? 6.51 C11 B3P B 371 J 217 ASP B 327 ASP^? 11.42 O1 B3P B 371 coo -37.57 -17.54 20.53 -38.55 -18.66 19.00 -40.43 105.08 4.20 -40.75 103.07 3.51 coo -40.93 -20.91 21.81 -38.85 -21.36 20.65 -42.54 105.00 8.17 -43.55 106.07 6.24 coo -41.81 -30.90 17.10 -43.71 -28.85 16.83 -45.29 110.79 14.65 -47.81 109.59 14.74 coo -43.00 -16.46 14.92 -41.37 -17.71 15.28 -33.51 107.30 6.30 -34.89 106.08 5.25 1avf_c06 source 1avf GASTRICSIN : 1 hits 1avf_c06 naa= 4 ULMN 4 1bcr_c00 SERINE CARBOXYPEPTIDASE II user 1 4 # 1 A 146 SER A 332 SER~? 10.92 ZN ZN A 402 A 147 TYR A 334 TYR~? 12.18 ZN ZN A 402 B 338 ASP A 309 ASP.? 7.55 ZN ZN A 402 B 397 HIS A 330 HIS~? -3.46 ZN ZN A 402s coo 66.05 29.20 71.20 67.54 30.99 71.60 -31.12 112.57 -9.16 -30.10 110.35 -8.93 coo 69.74 28.84 76.21 71.42 27.25 77.79 -28.13 116.36 -9.51 -26.22 114.55 -10.48 coo 65.80 31.83 62.23 66.99 32.08 63.95 -39.32 109.22 -3.35 -38.59 111.09 -2.57 coo 65.11 33.35 66.77 66.04 32.32 68.30 -37.28 113.42 -5.32 -38.81 114.77 -5.81 ULMN 4 1bcr_c00 SERINE CARBOXYPEPTIDASE II user 2 4 # 2 A 146 SER B 332 SER~? 10.87 ZN ZN B 401 A 147 TYR B 334 TYR~? 12.17 ZN ZN B 401 B 338 ASP B 309 ASP.? 7.61 ZN ZN B 401 B 397 HIS B 330 HIS~? -3.52 ZN ZN B 401s coo 66.05 29.20 71.20 67.54 30.99 71.60 -35.18 97.79 10.03 -33.17 99.10 9.80 coo 69.74 28.84 76.21 71.42 27.25 77.79 -34.63 93.02 10.30 -32.01 93.55 11.20 coo 65.80 31.83 62.23 66.99 32.08 63.95 -40.43 105.08 4.20 -40.75 103.07 3.51 coo 65.11 33.35 66.77 66.04 32.32 68.30 -40.87 100.43 6.30 -42.90 100.10 6.71 1bcr_c00 source 1bcr SERINE CARBOXYPEPTIDASE II : 2 hits 1bcr_c00 naa= 4 ULMN 4 1bvz_c07 ALPHA-AMYLASE II user 1 4 # 1 B 244 HIS A 313 HIS~? 5.54 ZN ZN B 401 B 325 ASP A 317 ASP~? 10.45 O4 B3P B 371 B 354 GLU A 294 GLU~? 11.80 C9 B3P A 371 B 421 ASP A 327 ASP^? 11.36 O1 B3P A 371 coo 18.86 7.90 56.29 20.11 7.10 54.89 -45.85 98.44 2.81 -45.85 97.45 4.68 coo 25.90 8.19 53.87 25.36 6.97 52.29 -46.62 96.07 -4.20 -47.85 96.41 -2.50 coo 27.87 10.66 47.95 27.82 8.60 48.27 -44.58 100.10 -10.25 -45.30 101.55 -8.87 coo 26.02 1.87 43.38 25.90 1.97 45.49 -34.76 103.64 -5.32 -35.22 105.46 -4.31 ULMN 4 1bvz_c07 ALPHA-AMYLASE II user 2 4 # 2 B 244 HIS B 313 HIS~? 5.49 ZN ZN A 402 B 325 ASP B 314 ASP~? 9.37 O5 B3P A 371 B 354 GLU B 294 GLU~? 11.71 C9 B3P B 371 B 421 ASP B 327 ASP^? 11.42 O1 B3P B 371 coo 18.86 7.90 56.29 20.11 7.10 54.89 -40.27 117.73 -1.83 -39.85 118.55 -3.71 coo 25.90 8.19 53.87 25.36 6.97 52.29 -40.38 114.62 4.43 -42.39 114.53 3.82 coo 27.87 10.66 47.95 27.82 8.60 48.27 -39.97 115.47 11.20 -41.44 114.67 9.87 coo 26.02 1.87 43.38 25.90 1.97 45.49 -33.51 107.30 6.30 -34.89 106.08 5.25 ULMN 4 1bvz_c07 ALPHA-AMYLASE II user 3 4 # 3 B 244 HIS B 313 HIS~? 5.49 ZN ZN A 402 B 325 ASP B 317 ASP~? 10.65 O4 B3P A 371 B 354 GLU B 294 GLU~? 11.71 C9 B3P B 371 B 421 ASP B 327 ASP^? 11.42 O1 B3P B 371 coo 18.86 7.90 56.29 20.11 7.10 54.89 -40.27 117.73 -1.83 -39.85 118.55 -3.71 coo 25.90 8.19 53.87 25.36 6.97 52.29 -39.61 120.08 5.26 -40.74 120.57 3.54 coo 27.87 10.66 47.95 27.82 8.60 48.27 -39.97 115.47 11.20 -41.44 114.67 9.87 coo 26.02 1.87 43.38 25.90 1.97 45.49 -33.51 107.30 6.30 -34.89 106.08 5.25 1bvz_c07 source 1bvz ALPHA-AMYLASE II : 3 hits 1bvz_c07 naa= 4 ULMN 4 1c17_c11 ATP SYNTHASE SUBUNIT C user 1 4 # 1 A 61 ASP A 27 ASP.? 7.07 C10 B3P A 371 M 206 SER A 269 SER.? 18.75 ZN ZN A 402 M 210 ARG B 271 ARG^? 13.51 ZN ZN A 402 M 214 ASN B 329 ASN~? 12.78 ZN ZN B 401 coo 2.15 -17.14 -6.89 2.91 -15.59 -8.10 -47.69 122.20 -10.88 -45.61 122.04 -10.59 coo -2.55 -23.32 19.81 -3.48 -21.59 18.38 -26.28 104.71 -2.85 -27.39 103.46 -1.14 coo 1.98 -17.11 17.69 1.79 -15.15 15.33 -31.35 108.28 2.46 -33.78 107.49 0.72 coo 8.13 -16.73 20.92 6.75 -15.93 19.51 -34.09 101.07 5.53 -32.43 102.02 4.53 ULMN 4 1c17_c11 ATP SYNTHASE SUBUNIT C user 2 4 # 2 A 61 ASP B 9 ASP~? 27.36 ZN ZN B 402 M 206 SER B 212 SER~? 30.92 O3 B3P B 371 M 210 ARG B 213 ARG~? 34.75 O3 B3P B 371 M 214 ASN B 157 ASN~? 40.14 O3 B3P B 371 coo 2.15 -17.14 -6.89 2.91 -15.59 -8.10 -55.13 78.56 23.44 -56.66 77.19 23.76 coo -2.55 -23.32 19.81 -3.48 -21.59 18.38 -73.65 99.09 31.39 -73.40 97.15 29.92 coo 1.98 -17.11 17.69 1.79 -15.15 15.33 -71.11 92.84 34.22 -70.18 91.65 36.92 coo 8.13 -16.73 20.92 6.75 -15.93 19.51 -71.10 91.16 40.81 -72.67 89.90 41.47 ULMN 4 1c17_c11 ATP SYNTHASE SUBUNIT C user 3 4 # 3 A 61 ASP B 27 ASP.? 7.01 C10 B3P B 371 M 206 SER B 269 SER.? 18.61 ZN ZN B 401 M 210 ARG A 271 ARG^? 13.44 ZN ZN B 401 M 214 ASN A 329 ASN~? 12.75 ZN ZN A 402 coo 2.15 -17.14 -6.89 2.91 -15.59 -8.10 -54.29 98.49 11.88 -52.46 97.53 11.54 coo -2.55 -23.32 19.81 -3.48 -21.59 18.38 -26.94 101.96 3.67 -27.42 103.67 1.99 coo 1.98 -17.11 17.69 1.79 -15.15 15.33 -33.34 101.75 -1.66 -34.94 103.58 0.21 coo 8.13 -16.73 20.92 6.75 -15.93 19.51 -31.94 109.24 -4.59 -31.02 107.56 -3.63 1c17_c11 source 1c17 ATP SYNTHASE SUBUNIT C : 3 hits 1c17_c11 naa= 4 ULMN 4 1cd5_c00 GLUCOSAMINE 6-PHOSPHATE DEAMINASE user 1 4 # 1 A 72 ASP A 27 ASP.? 7.07 C10 B3P A 371 A 141 ASP A 48 ASP.? 7.07 ZN ZN A 402 A 143 HIS A 69 HIS.? -3.50 ZN ZN A 402s A 148 GLU A 333 GLU~? 2.48 ZN ZN A 401s coo 86.21 51.78 11.27 86.87 50.27 12.61 -47.69 122.20 -10.88 -45.61 122.04 -10.59 coo 77.92 48.13 25.32 78.70 49.17 23.61 -34.00 122.50 -3.86 -35.34 120.86 -3.93 coo 79.83 48.98 19.95 81.76 49.72 20.33 -38.08 120.43 -6.58 -37.62 118.38 -6.66 coo 76.11 54.71 19.44 77.75 55.81 18.59 -35.80 114.74 -10.32 -37.65 115.72 -10.06 ULMN 4 1cd5_c00 GLUCOSAMINE 6-PHOSPHATE DEAMINASE user 2 4 # 2 A 72 ASP B 27 ASP.? 7.01 C10 B3P B 371 A 141 ASP B 48 ASP.? 7.12 ZN ZN B 401 A 143 HIS B 69 HIS.? -3.44 ZN ZN B 401s A 148 GLU B 333 GLU~? 2.50 ZN ZN B 402s coo 86.21 51.78 11.27 86.87 50.27 12.61 -54.29 98.49 11.88 -52.46 97.53 11.54 coo 77.92 48.13 25.32 78.70 49.17 23.61 -43.07 90.96 4.68 -43.24 93.07 4.75 coo 79.83 48.98 19.95 81.76 49.72 20.33 -45.30 94.94 7.48 -43.81 96.41 7.64 coo 76.11 54.71 19.44 77.75 55.81 18.59 -40.33 98.40 11.28 -42.37 98.54 11.02 1cd5_c00 source 1cd5 GLUCOSAMINE 6-PHOSPHATE DEAMINASE : 2 hits 1cd5_c00 naa= 4 ULMN 4 1dco_c01 DCOH user 1 4 # 1 B 62 HIS A 69 HIS.? -3.50 ZN ZN A 402s B 63 HIS A 102 HIS~? 4.84 O2 B3P A 371 B 80 HIS A 330 HIS~? -3.46 ZN ZN A 402s B 89 ASP A 48 ASP.? 7.07 ZN ZN A 402 coo 30.13 28.91 18.82 29.78 26.89 19.27 -38.08 120.43 -6.58 -37.62 118.38 -6.66 coo 30.80 33.19 23.94 30.03 35.03 23.38 -42.24 121.28 -10.34 -42.29 119.63 -9.04 coo 25.47 25.21 25.04 27.09 24.88 26.31 -37.28 113.42 -5.32 -38.81 114.77 -5.81 coo 32.70 23.27 17.35 31.06 23.48 18.68 -34.00 122.50 -3.86 -35.34 120.86 -3.93 ULMN 4 1dco_c01 DCOH user 2 4 # 2 B 62 HIS A 102 HIS~? 4.84 O2 B3P A 371 B 63 HIS A 68 HIS.? -3.48 ZN ZN A 401s B 80 HIS B 313 HIS~? 5.49 ZN ZN A 402 B 89 ASP A 27 ASP.? 7.07 C10 B3P A 371 coo 30.13 28.91 18.82 29.78 26.89 19.27 -42.24 121.28 -10.34 -42.29 119.63 -9.04 coo 30.80 33.19 23.94 30.03 35.03 23.38 -37.46 120.39 -11.50 -38.87 119.03 -12.26 coo 25.47 25.21 25.04 27.09 24.88 26.31 -40.27 117.73 -1.83 -39.85 118.55 -3.71 coo 32.70 23.27 17.35 31.06 23.48 18.68 -47.69 122.20 -10.88 -45.61 122.04 -10.59 ULMN 4 1dco_c01 DCOH user 3 4 # 3 B 62 HIS B 69 HIS.? -3.44 ZN ZN B 401s B 63 HIS B 102 HIS~? 4.91 O2 B3P B 371 B 80 HIS B 330 HIS~? -3.52 ZN ZN B 401s B 89 ASP B 48 ASP.? 7.12 ZN ZN B 401 coo 30.13 28.91 18.82 29.78 26.89 19.27 -45.30 94.94 7.48 -43.81 96.41 7.64 coo 30.80 33.19 23.94 30.03 35.03 23.38 -49.25 96.38 11.24 -48.46 97.85 9.95 coo 25.47 25.21 25.04 27.09 24.88 26.31 -40.87 100.43 6.30 -42.90 100.10 6.71 coo 32.70 23.27 17.35 31.06 23.48 18.68 -43.07 90.96 4.68 -43.24 93.07 4.75 ULMN 4 1dco_c01 DCOH user 4 4 # 4 B 62 HIS B 102 HIS~? 4.91 O2 B3P B 371 B 63 HIS B 68 HIS.? -3.46 ZN ZN B 402s B 80 HIS A 313 HIS~? 5.54 ZN ZN B 401 B 89 ASP B 27 ASP.? 7.01 C10 B3P B 371 coo 30.13 28.91 18.82 29.78 26.89 19.27 -49.25 96.38 11.24 -48.46 97.85 9.95 coo 30.80 33.19 23.94 30.03 35.03 23.38 -44.72 94.50 12.35 -45.14 96.41 13.13 coo 25.47 25.21 25.04 27.09 24.88 26.31 -45.85 98.44 2.81 -45.85 97.45 4.68 coo 32.70 23.27 17.35 31.06 23.48 18.68 -54.29 98.49 11.88 -52.46 97.53 11.54 1dco_c01 source 1dco DCOH : 4 hits 1dco_c01 naa= 4 ULMN 4 1dco_c02 DCOH user 1 4 # 1 C 62 HIS A 102 HIS~? 4.84 O2 B3P A 371 C 63 HIS A 68 HIS.? -3.48 ZN ZN A 401s C 80 HIS B 313 HIS~? 5.49 ZN ZN A 402 C 89 ASP A 27 ASP.? 7.07 C10 B3P A 371 coo 29.60 51.54 13.33 29.70 53.54 12.79 -42.24 121.28 -10.34 -42.29 119.63 -9.04 coo 35.52 48.78 13.63 35.21 46.77 13.20 -37.46 120.39 -11.50 -38.87 119.03 -12.26 coo 33.83 55.44 5.53 34.68 55.77 3.67 -40.27 117.73 -1.83 -39.85 118.55 -3.71 coo 27.62 57.06 14.62 28.16 56.67 12.64 -47.69 122.20 -10.88 -45.61 122.04 -10.59 ULMN 4 1dco_c02 DCOH user 2 4 # 2 C 62 HIS B 102 HIS~? 4.91 O2 B3P B 371 C 63 HIS B 68 HIS.? -3.46 ZN ZN B 402s C 80 HIS A 313 HIS~? 5.54 ZN ZN B 401 C 89 ASP B 27 ASP.? 7.01 C10 B3P B 371 coo 29.60 51.54 13.33 29.70 53.54 12.79 -49.25 96.38 11.24 -48.46 97.85 9.95 coo 35.52 48.78 13.63 35.21 46.77 13.20 -44.72 94.50 12.35 -45.14 96.41 13.13 coo 33.83 55.44 5.53 34.68 55.77 3.67 -45.85 98.44 2.81 -45.85 97.45 4.68 coo 27.62 57.06 14.62 28.16 56.67 12.64 -54.29 98.49 11.88 -52.46 97.53 11.54 1dco_c02 source 1dco DCOH : 2 hits 1dco_c02 naa= 4 ULMN 4 1dco_c03 DCOH user 1 4 # 1 D 62 HIS A 102 HIS~? 4.84 O2 B3P A 371 D 63 HIS A 68 HIS.? -3.48 ZN ZN A 401s D 80 HIS B 313 HIS~? 5.49 ZN ZN A 402 D 89 ASP A 27 ASP.? 7.07 C10 B3P A 371 coo 57.14 54.52 28.76 58.02 56.20 27.93 -42.24 121.28 -10.34 -42.29 119.63 -9.04 coo 50.55 54.00 30.19 50.52 53.10 32.06 -37.46 120.39 -11.50 -38.87 119.03 -12.26 coo 55.23 64.51 29.49 55.46 66.50 28.94 -40.27 117.73 -1.83 -39.85 118.55 -3.71 coo 60.71 56.13 24.08 59.92 57.52 25.41 -47.69 122.20 -10.88 -45.61 122.04 -10.59 ULMN 4 1dco_c03 DCOH user 2 4 # 2 D 62 HIS B 102 HIS~? 4.91 O2 B3P B 371 D 63 HIS B 68 HIS.? -3.46 ZN ZN B 402s D 80 HIS A 313 HIS~? 5.54 ZN ZN B 401 D 89 ASP B 27 ASP.? 7.01 C10 B3P B 371 coo 57.14 54.52 28.76 58.02 56.20 27.93 -49.25 96.38 11.24 -48.46 97.85 9.95 coo 50.55 54.00 30.19 50.52 53.10 32.06 -44.72 94.50 12.35 -45.14 96.41 13.13 coo 55.23 64.51 29.49 55.46 66.50 28.94 -45.85 98.44 2.81 -45.85 97.45 4.68 coo 60.71 56.13 24.08 59.92 57.52 25.41 -54.29 98.49 11.88 -52.46 97.53 11.54 1dco_c03 source 1dco DCOH : 2 hits 1dco_c03 naa= 4 ULMN 4 1dco_c04 DCOH user 1 4 # 1 E 62 HIS A 68 HIS.? -3.48 ZN ZN A 401s E 63 HIS A 69 HIS.? -3.50 ZN ZN A 402s E 80 HIS A 330 HIS~? -3.46 ZN ZN A 402s E 89 ASP A 106 ASP~? 2.01 ZN ZN A 401s coo 19.60 57.21 59.85 19.08 56.80 57.88 -37.46 120.39 -11.50 -38.87 119.03 -12.26 coo 16.21 54.27 64.44 16.08 55.68 65.97 -38.08 120.43 -6.58 -37.62 118.38 -6.66 coo 11.87 56.63 56.75 11.79 54.55 56.99 -37.28 113.42 -5.32 -38.81 114.77 -5.81 coo 21.75 55.40 54.53 20.13 56.68 54.67 -41.67 116.42 -14.91 -40.59 116.67 -13.13 ULMN 4 1dco_c04 DCOH user 2 4 # 2 E 62 HIS A 69 HIS.? -3.50 ZN ZN A 402s E 63 HIS A 102 HIS~? 4.84 O2 B3P A 371 E 80 HIS A 330 HIS~? -3.46 ZN ZN A 402s E 89 ASP A 48 ASP.? 7.07 ZN ZN A 402 coo 19.60 57.21 59.85 19.08 56.80 57.88 -38.08 120.43 -6.58 -37.62 118.38 -6.66 coo 16.21 54.27 64.44 16.08 55.68 65.97 -42.24 121.28 -10.34 -42.29 119.63 -9.04 coo 11.87 56.63 56.75 11.79 54.55 56.99 -37.28 113.42 -5.32 -38.81 114.77 -5.81 coo 21.75 55.40 54.53 20.13 56.68 54.67 -34.00 122.50 -3.86 -35.34 120.86 -3.93 ULMN 4 1dco_c04 DCOH user 3 4 # 3 E 62 HIS B 68 HIS.? -3.46 ZN ZN B 402s E 63 HIS B 69 HIS.? -3.44 ZN ZN B 401s E 80 HIS B 330 HIS~? -3.52 ZN ZN B 401s E 89 ASP B 106 ASP~? 1.96 ZN ZN B 402s coo 19.60 57.21 59.85 19.08 56.80 57.88 -44.72 94.50 12.35 -45.14 96.41 13.13 coo 16.21 54.27 64.44 16.08 55.68 65.97 -45.30 94.94 7.48 -43.81 96.41 7.64 coo 11.87 56.63 56.75 11.79 54.55 56.99 -40.87 100.43 6.30 -42.90 100.10 6.71 coo 21.75 55.40 54.53 20.13 56.68 54.67 -46.09 100.09 15.88 -45.34 99.27 14.09 ULMN 4 1dco_c04 DCOH user 4 4 # 4 E 62 HIS B 69 HIS.? -3.44 ZN ZN B 401s E 63 HIS B 102 HIS~? 4.91 O2 B3P B 371 E 80 HIS B 330 HIS~? -3.52 ZN ZN B 401s E 89 ASP B 48 ASP.? 7.12 ZN ZN B 401 coo 19.60 57.21 59.85 19.08 56.80 57.88 -45.30 94.94 7.48 -43.81 96.41 7.64 coo 16.21 54.27 64.44 16.08 55.68 65.97 -49.25 96.38 11.24 -48.46 97.85 9.95 coo 11.87 56.63 56.75 11.79 54.55 56.99 -40.87 100.43 6.30 -42.90 100.10 6.71 coo 21.75 55.40 54.53 20.13 56.68 54.67 -43.07 90.96 4.68 -43.24 93.07 4.75 1dco_c04 source 1dco DCOH : 4 hits 1dco_c04 naa= 4 ULMN 4 1dco_c05 DCOH user 1 4 # 1 F 62 HIS A 102 HIS~? 4.84 O2 B3P A 371 F 63 HIS A 68 HIS.? -3.48 ZN ZN A 401s F 80 HIS B 313 HIS~? 5.49 ZN ZN A 402 F 89 ASP A 27 ASP.? 7.07 C10 B3P A 371 coo 12.05 28.43 70.32 10.75 27.97 68.79 -42.24 121.28 -10.34 -42.29 119.63 -9.04 coo 17.14 32.02 68.53 18.69 31.37 69.75 -37.46 120.39 -11.50 -38.87 119.03 -12.26 coo 14.97 24.19 61.54 16.03 23.48 59.90 -40.27 117.73 -1.83 -39.85 118.55 -3.71 coo 5.92 28.03 68.57 7.27 26.97 67.43 -47.69 122.20 -10.88 -45.61 122.04 -10.59 ULMN 4 1dco_c05 DCOH user 2 4 # 2 F 62 HIS A 312 HIS~? 6.48 ZN ZN B 401 F 63 HIS A 313 HIS~? 5.54 ZN ZN B 401 F 80 HIS B 68 HIS.? -3.46 ZN ZN B 402s F 89 ASP B 365 ASP.? 11.69 ZN ZN B 401 coo 12.05 28.43 70.32 10.75 27.97 68.79 -41.04 97.86 3.25 -41.05 95.82 3.71 coo 17.14 32.02 68.53 18.69 31.37 69.75 -45.85 98.44 2.81 -45.85 97.45 4.68 coo 14.97 24.19 61.54 16.03 23.48 59.90 -44.72 94.50 12.35 -45.14 96.41 13.13 coo 5.92 28.03 68.57 7.27 26.97 67.43 -34.85 93.86 2.40 -34.89 96.00 2.14 ULMN 4 1dco_c05 DCOH user 3 4 # 3 F 62 HIS B 102 HIS~? 4.91 O2 B3P B 371 F 63 HIS B 68 HIS.? -3.46 ZN ZN B 402s F 80 HIS A 313 HIS~? 5.54 ZN ZN B 401 F 89 ASP B 27 ASP.? 7.01 C10 B3P B 371 coo 12.05 28.43 70.32 10.75 27.97 68.79 -49.25 96.38 11.24 -48.46 97.85 9.95 coo 17.14 32.02 68.53 18.69 31.37 69.75 -44.72 94.50 12.35 -45.14 96.41 13.13 coo 14.97 24.19 61.54 16.03 23.48 59.90 -45.85 98.44 2.81 -45.85 97.45 4.68 coo 5.92 28.03 68.57 7.27 26.97 67.43 -54.29 98.49 11.88 -52.46 97.53 11.54 ULMN 4 1dco_c05 DCOH user 4 4 # 4 F 62 HIS B 312 HIS~? 6.47 ZN ZN A 402 F 63 HIS B 313 HIS~? 5.49 ZN ZN A 402 F 80 HIS A 68 HIS.? -3.48 ZN ZN A 401s F 89 ASP A 365 ASP.? 11.72 ZN ZN A 402 coo 12.05 28.43 70.32 10.75 27.97 68.79 -36.00 115.58 -2.34 -34.91 117.32 -2.81 coo 17.14 32.02 68.53 18.69 31.37 69.75 -40.27 117.73 -1.83 -39.85 118.55 -3.71 coo 14.97 24.19 61.54 16.03 23.48 59.90 -37.46 120.39 -11.50 -38.87 119.03 -12.26 coo 5.92 28.03 68.57 7.27 26.97 67.43 -28.60 115.73 -1.61 -29.73 113.97 -1.34 1dco_c05 source 1dco DCOH : 4 hits 1dco_c05 naa= 4 ULMN 4 1dco_c06 DCOH user 1 4 # 1 G 62 HIS A 102 HIS~? 4.84 O2 B3P A 371 G 63 HIS A 68 HIS.? -3.48 ZN ZN A 401s G 80 HIS B 313 HIS~? 5.49 ZN ZN A 402 G 89 ASP A 27 ASP.? 7.07 C10 B3P A 371 coo 27.23 31.17 87.27 28.54 31.18 88.89 -42.24 121.28 -10.34 -42.29 119.63 -9.04 coo 22.77 36.07 86.61 21.15 35.09 85.77 -37.46 120.39 -11.50 -38.87 119.03 -12.26 coo 24.24 31.95 96.92 23.16 32.10 98.71 -40.27 117.73 -1.83 -39.85 118.55 -3.71 coo 33.04 31.03 88.73 31.44 31.21 90.04 -47.69 122.20 -10.88 -45.61 122.04 -10.59 ULMN 4 1dco_c06 DCOH user 2 4 # 2 G 62 HIS A 312 HIS~? 6.48 ZN ZN B 401 G 63 HIS A 313 HIS~? 5.54 ZN ZN B 401 G 80 HIS B 68 HIS.? -3.46 ZN ZN B 402s G 89 ASP B 365 ASP.? 11.69 ZN ZN B 401 coo 27.23 31.17 87.27 28.54 31.18 88.89 -41.04 97.86 3.25 -41.05 95.82 3.71 coo 22.77 36.07 86.61 21.15 35.09 85.77 -45.85 98.44 2.81 -45.85 97.45 4.68 coo 24.24 31.95 96.92 23.16 32.10 98.71 -44.72 94.50 12.35 -45.14 96.41 13.13 coo 33.04 31.03 88.73 31.44 31.21 90.04 -34.85 93.86 2.40 -34.89 96.00 2.14 ULMN 4 1dco_c06 DCOH user 3 4 # 3 G 62 HIS B 102 HIS~? 4.91 O2 B3P B 371 G 63 HIS B 68 HIS.? -3.46 ZN ZN B 402s G 80 HIS A 313 HIS~? 5.54 ZN ZN B 401 G 89 ASP B 27 ASP.? 7.01 C10 B3P B 371 coo 27.23 31.17 87.27 28.54 31.18 88.89 -49.25 96.38 11.24 -48.46 97.85 9.95 coo 22.77 36.07 86.61 21.15 35.09 85.77 -44.72 94.50 12.35 -45.14 96.41 13.13 coo 24.24 31.95 96.92 23.16 32.10 98.71 -45.85 98.44 2.81 -45.85 97.45 4.68 coo 33.04 31.03 88.73 31.44 31.21 90.04 -54.29 98.49 11.88 -52.46 97.53 11.54 ULMN 4 1dco_c06 DCOH user 4 4 # 4 G 62 HIS B 312 HIS~? 6.47 ZN ZN A 402 G 63 HIS B 313 HIS~? 5.49 ZN ZN A 402 G 80 HIS A 68 HIS.? -3.48 ZN ZN A 401s G 89 ASP A 365 ASP.? 11.72 ZN ZN A 402 coo 27.23 31.17 87.27 28.54 31.18 88.89 -36.00 115.58 -2.34 -34.91 117.32 -2.81 coo 22.77 36.07 86.61 21.15 35.09 85.77 -40.27 117.73 -1.83 -39.85 118.55 -3.71 coo 24.24 31.95 96.92 23.16 32.10 98.71 -37.46 120.39 -11.50 -38.87 119.03 -12.26 coo 33.04 31.03 88.73 31.44 31.21 90.04 -28.60 115.73 -1.61 -29.73 113.97 -1.34 1dco_c06 source 1dco DCOH : 4 hits 1dco_c06 naa= 4 ULMN 4 1dco_c07 DCOH user 1 4 # 1 H 62 HIS A 69 HIS.? -3.50 ZN ZN A 402s H 63 HIS A 102 HIS~? 4.84 O2 B3P A 371 H 80 HIS A 330 HIS~? -3.46 ZN ZN A 402s H 89 ASP A 48 ASP.? 7.07 ZN ZN A 402 coo 25.41 62.31 81.97 26.41 62.87 83.70 -38.08 120.43 -6.58 -37.62 118.38 -6.66 coo 27.91 57.00 79.64 28.08 57.36 77.58 -42.24 121.28 -10.34 -42.29 119.63 -9.04 coo 32.94 62.32 86.32 31.68 60.75 86.87 -37.28 113.42 -5.32 -38.81 114.77 -5.81 coo 22.93 64.49 87.27 24.97 64.23 86.95 -34.00 122.50 -3.86 -35.34 120.86 -3.93 ULMN 4 1dco_c07 DCOH user 2 4 # 2 H 62 HIS A 313 HIS~? 5.54 ZN ZN B 401 H 63 HIS B 330 HIS~? -3.52 ZN ZN B 401s H 80 HIS B 68 HIS.? -3.46 ZN ZN B 402s H 89 ASP B 48 ASP.? 7.12 ZN ZN B 401 coo 25.41 62.31 81.97 26.41 62.87 83.70 -45.85 98.44 2.81 -45.85 97.45 4.68 coo 27.91 57.00 79.64 28.08 57.36 77.58 -40.87 100.43 6.30 -42.90 100.10 6.71 coo 32.94 62.32 86.32 31.68 60.75 86.87 -44.72 94.50 12.35 -45.14 96.41 13.13 coo 22.93 64.49 87.27 24.97 64.23 86.95 -43.07 90.96 4.68 -43.24 93.07 4.75 ULMN 4 1dco_c07 DCOH user 3 4 # 3 H 62 HIS A 313 HIS~? 5.54 ZN ZN B 401 H 63 HIS B 330 HIS~? -3.52 ZN ZN B 401s H 80 HIS B 102 HIS~? 4.91 O2 B3P B 371 H 89 ASP B 48 ASP.? 7.12 ZN ZN B 401 coo 25.41 62.31 81.97 26.41 62.87 83.70 -45.85 98.44 2.81 -45.85 97.45 4.68 coo 27.91 57.00 79.64 28.08 57.36 77.58 -40.87 100.43 6.30 -42.90 100.10 6.71 coo 32.94 62.32 86.32 31.68 60.75 86.87 -49.25 96.38 11.24 -48.46 97.85 9.95 coo 22.93 64.49 87.27 24.97 64.23 86.95 -43.07 90.96 4.68 -43.24 93.07 4.75 ULMN 4 1dco_c07 DCOH user 4 4 # 4 H 62 HIS B 69 HIS.? -3.44 ZN ZN B 401s H 63 HIS B 102 HIS~? 4.91 O2 B3P B 371 H 80 HIS B 330 HIS~? -3.52 ZN ZN B 401s H 89 ASP B 48 ASP.? 7.12 ZN ZN B 401 coo 25.41 62.31 81.97 26.41 62.87 83.70 -45.30 94.94 7.48 -43.81 96.41 7.64 coo 27.91 57.00 79.64 28.08 57.36 77.58 -49.25 96.38 11.24 -48.46 97.85 9.95 coo 32.94 62.32 86.32 31.68 60.75 86.87 -40.87 100.43 6.30 -42.90 100.10 6.71 coo 22.93 64.49 87.27 24.97 64.23 86.95 -43.07 90.96 4.68 -43.24 93.07 4.75 1dco_c07 source 1dco DCOH : 4 hits 1dco_c07 naa= 4 ULMN 4 1ddj_c04 PLASMINOGEN user 1 4 # 1 A 603 HIS A 102 HIS~? 4.84 O2 B3P A 371 A 646 ASP A 27 ASP.? 7.07 C10 B3P A 371 A 741 ALA A 100 ALA^? 10.88 ZN ZN A 401 A 742 GLY A 30 GLY^? 14.70 ZN ZN A 401 coo 17.92 60.45 -3.51 16.63 61.88 -2.68 -42.24 121.28 -10.34 -42.29 119.63 -9.04 coo 18.60 56.26 -8.31 18.53 57.26 -6.47 -47.69 122.20 -10.88 -45.61 122.04 -10.59 coo 15.76 55.12 -0.44 16.10 56.60 -0.54 -40.07 127.59 -11.35 -41.05 127.25 -10.17 coo 18.59 52.82 -1.50 17.88 52.53 -1.22 -43.79 130.44 -13.71 -43.44 130.23 -12.98 ULMN 4 1ddj_c04 PLASMINOGEN user 2 4 # 2 A 603 HIS B 102 HIS~? 4.91 O2 B3P B 371 A 646 ASP B 27 ASP.? 7.01 C10 B3P B 371 A 741 ALA B 100 ALA^? 10.75 ZN ZN B 402 A 742 GLY B 30 GLY^? 14.53 ZN ZN B 402 coo 17.92 60.45 -3.51 16.63 61.88 -2.68 -49.25 96.38 11.24 -48.46 97.85 9.95 coo 18.60 56.26 -8.31 18.53 57.26 -6.47 -54.29 98.49 11.88 -52.46 97.53 11.54 coo 15.76 55.12 -0.44 16.10 56.60 -0.54 -50.76 89.87 12.14 -51.40 90.79 11.05 coo 18.59 52.82 -1.50 17.88 52.53 -1.22 -55.27 89.43 14.51 -54.92 89.45 13.77 1ddj_c04 source 1ddj PLASMINOGEN : 2 hits 1ddj_c04 naa= 4 ULMN 4 1ddj_c05 PLASMINOGEN user 1 4 # 1 B 603 HIS A 102 HIS~? 4.84 O2 B3P A 371 B 646 ASP A 27 ASP.? 7.07 C10 B3P A 371 B 741 ALA A 100 ALA^? 10.88 ZN ZN A 401 B 742 GLY A 30 GLY^? 14.70 ZN ZN A 401 coo -28.76 37.11 -20.75 -29.48 38.32 -19.19 -42.24 121.28 -10.34 -42.29 119.63 -9.04 coo -23.42 34.83 -23.78 -25.09 36.03 -23.31 -47.69 122.20 -10.88 -45.61 122.04 -10.59 coo -27.00 42.91 -23.45 -27.89 42.02 -22.58 -40.07 127.59 -11.35 -41.05 127.25 -10.17 coo -26.52 41.43 -26.94 -26.21 42.13 -26.73 -43.79 130.44 -13.71 -43.44 130.23 -12.98 ULMN 4 1ddj_c05 PLASMINOGEN user 2 4 # 2 B 603 HIS B 102 HIS~? 4.91 O2 B3P B 371 B 646 ASP B 27 ASP.? 7.01 C10 B3P B 371 B 741 ALA B 100 ALA^? 10.75 ZN ZN B 402 B 742 GLY B 30 GLY^? 14.53 ZN ZN B 402 coo -28.76 37.11 -20.75 -29.48 38.32 -19.19 -49.25 96.38 11.24 -48.46 97.85 9.95 coo -23.42 34.83 -23.78 -25.09 36.03 -23.31 -54.29 98.49 11.88 -52.46 97.53 11.54 coo -27.00 42.91 -23.45 -27.89 42.02 -22.58 -50.76 89.87 12.14 -51.40 90.79 11.05 coo -26.52 41.43 -26.94 -26.21 42.13 -26.73 -55.27 89.43 14.51 -54.92 89.45 13.77 1ddj_c05 source 1ddj PLASMINOGEN : 2 hits 1ddj_c05 naa= 4 ULMN 4 1ddj_c06 PLASMINOGEN user 1 4 # 1 C 603 HIS A 102 HIS~? 4.84 O2 B3P A 371 C 646 ASP A 27 ASP.? 7.07 C10 B3P A 371 C 741 ALA A 100 ALA^? 10.88 ZN ZN A 401 C 742 GLY A 30 GLY^? 14.70 ZN ZN A 401 coo 15.33 59.81 59.60 13.98 60.99 60.69 -42.24 121.28 -10.34 -42.29 119.63 -9.04 coo 16.06 55.72 54.73 15.97 56.49 56.70 -47.69 122.20 -10.88 -45.61 122.04 -10.59 coo 13.55 54.01 62.74 13.86 55.50 62.79 -40.07 127.59 -11.35 -41.05 127.25 -10.17 coo 16.36 51.81 61.40 15.69 51.50 61.72 -43.79 130.44 -13.71 -43.44 130.23 -12.98 ULMN 4 1ddj_c06 PLASMINOGEN user 2 4 # 2 C 603 HIS B 102 HIS~? 4.91 O2 B3P B 371 C 646 ASP B 27 ASP.? 7.01 C10 B3P B 371 C 741 ALA B 100 ALA^? 10.75 ZN ZN B 402 C 742 GLY B 30 GLY^? 14.53 ZN ZN B 402 coo 15.33 59.81 59.60 13.98 60.99 60.69 -49.25 96.38 11.24 -48.46 97.85 9.95 coo 16.06 55.72 54.73 15.97 56.49 56.70 -54.29 98.49 11.88 -52.46 97.53 11.54 coo 13.55 54.01 62.74 13.86 55.50 62.79 -50.76 89.87 12.14 -51.40 90.79 11.05 coo 16.36 51.81 61.40 15.69 51.50 61.72 -55.27 89.43 14.51 -54.92 89.45 13.77 1ddj_c06 source 1ddj PLASMINOGEN : 2 hits 1ddj_c06 naa= 4 ULMN 4 1ddj_c07 PLASMINOGEN user 1 4 # 1 D 603 HIS A 102 HIS~? 4.84 O2 B3P A 371 D 646 ASP A 27 ASP.? 7.07 C10 B3P A 371 D 741 ALA A 100 ALA^? 10.88 ZN ZN A 401 D 742 GLY A 30 GLY^? 14.70 ZN ZN A 401 coo -30.51 33.83 43.05 -30.50 33.12 45.03 -42.24 121.28 -10.34 -42.29 119.63 -9.04 coo -25.73 33.05 39.28 -27.50 34.05 39.88 -47.69 122.20 -10.88 -45.61 122.04 -10.59 coo -29.58 40.72 40.37 -30.29 39.69 41.25 -40.07 127.59 -11.35 -41.05 127.25 -10.17 coo -29.22 39.61 36.72 -28.92 40.32 37.00 -43.79 130.44 -13.71 -43.44 130.23 -12.98 ULMN 4 1ddj_c07 PLASMINOGEN user 2 4 # 2 D 603 HIS B 102 HIS~? 4.91 O2 B3P B 371 D 646 ASP B 27 ASP.? 7.01 C10 B3P B 371 D 741 ALA B 100 ALA^? 10.75 ZN ZN B 402 D 742 GLY B 30 GLY^? 14.53 ZN ZN B 402 coo -30.51 33.83 43.05 -30.50 33.12 45.03 -49.25 96.38 11.24 -48.46 97.85 9.95 coo -25.73 33.05 39.28 -27.50 34.05 39.88 -54.29 98.49 11.88 -52.46 97.53 11.54 coo -29.58 40.72 40.37 -30.29 39.69 41.25 -50.76 89.87 12.14 -51.40 90.79 11.05 coo -29.22 39.61 36.72 -28.92 40.32 37.00 -55.27 89.43 14.51 -54.92 89.45 13.77 1ddj_c07 source 1ddj PLASMINOGEN : 2 hits 1ddj_c07 naa= 4 ULMN 4 1df9_c00 BOWMAN-BIRK TYPE TRYPSIN INHIBITOR user 1 4 # 1 A 51 HIS A 312 HIS~? 6.48 ZN ZN B 401 A 75 ASP B 365 ASP.? 11.69 ZN ZN B 401 A 135 SER B 332 SER~? 10.87 ZN ZN B 401 A 153 GLY B 308 GLY.? 7.72 O1 B3P B 371 coo 82.73 13.99 81.18 84.11 13.14 79.85 -41.04 97.86 3.25 -41.05 95.82 3.71 coo 79.95 16.88 76.33 81.62 16.87 77.62 -34.85 93.86 2.40 -34.89 96.00 2.14 coo 87.55 10.17 77.17 86.98 9.59 79.47 -35.18 97.79 10.03 -33.17 99.10 9.80 coo 79.86 4.56 77.77 79.43 4.83 78.44 -37.60 104.71 7.65 -38.14 105.31 7.82 ULMN 4 1df9_c00 BOWMAN-BIRK TYPE TRYPSIN INHIBITOR user 2 4 # 2 A 51 HIS B 312 HIS~? 6.47 ZN ZN A 402 A 75 ASP A 365 ASP.? 11.72 ZN ZN A 402 A 135 SER A 332 SER~? 10.92 ZN ZN A 402 A 153 GLY A 308 GLY.? 7.69 O1 B3P A 371 coo 82.73 13.99 81.18 84.11 13.14 79.85 -36.00 115.58 -2.34 -34.91 117.32 -2.81 coo 79.95 16.88 76.33 81.62 16.87 77.62 -28.60 115.73 -1.61 -29.73 113.97 -1.34 coo 87.55 10.17 77.17 86.98 9.59 79.47 -31.12 112.57 -9.16 -30.10 110.35 -8.93 coo 79.86 4.56 77.77 79.43 4.83 78.44 -36.78 108.02 -6.71 -37.57 107.80 -6.86 1df9_c00 source 1df9 BOWMAN-BIRK TYPE TRYPSIN INHIBITOR : 2 hits 1df9_c00 naa= 4 ULMN 4 1djo_c01 GLUTAMINASE-ASPARAGINASE user 1 4 # 1 A1294 GLU B 56 GLU~? 18.77 ZN ZN B 401 B3020 THR B 64 THR^? 20.20 ZN ZN B 402 B3034 TYR B 62 TYR.? 23.44 ZN ZN B 402 B3100 THR B 45 THR^? 14.16 ZN ZN B 402 coo 42.18 93.40 84.96 40.44 92.19 85.03 -38.44 79.17 7.21 -37.80 81.12 7.81 coo 35.69 87.89 89.88 37.41 89.09 90.33 -48.61 79.24 12.48 -49.72 79.47 14.34 coo 40.98 87.08 88.86 39.63 89.46 88.41 -42.83 75.83 12.91 -40.53 75.43 14.46 coo 33.09 94.86 90.18 34.63 94.22 91.55 -42.17 85.01 13.36 -41.21 85.38 15.27 1djo_c01 source 1djo GLUTAMINASE-ASPARAGINASE : 1 hits 1djo_c01 naa= 4 ULMN 4 1e6e_c00 ADRENODOXIN user 1 4 # 1 A 55 HIS A 17 HIS~? 19.36 ZN ZN A 401 A 159 ASP A 15 ASP~? 18.15 ZN ZN A 401 A 376 ILE A 66 ILE^? 13.53 ZN ZN A 401 A 377 THR A 45 THR^? 14.22 ZN ZN A 401 coo 17.95 58.52 112.81 17.29 59.41 111.03 -37.78 126.95 -26.45 -37.01 127.80 -28.21 coo 11.32 57.46 110.35 12.85 58.48 111.39 -44.06 130.37 -22.15 -46.01 129.61 -22.24 coo 15.00 65.23 121.40 15.42 63.95 122.00 -34.69 128.77 -14.05 -35.20 128.89 -15.40 coo 15.65 69.77 121.40 17.38 70.64 120.41 -30.23 126.99 -12.70 -29.64 126.24 -14.61 ULMN 4 1e6e_c00 ADRENODOXIN user 2 4 # 2 A 55 HIS A 94 HIS~? 26.81 ZN ZN A 402 A 159 ASP A 95 ASP.? 28.91 ZN ZN A 402 A 376 ILE A 87 ILE~? 16.82 ZN ZN A 402 A 377 THR A 50 THR~? 14.04 ZN ZN A 402 coo 17.95 58.52 112.81 17.29 59.41 111.03 -29.92 140.30 -1.80 -28.95 140.49 0.05 coo 11.32 57.46 110.35 12.85 58.48 111.39 -33.63 143.19 -6.68 -34.30 144.81 -5.56 coo 15.00 65.23 121.40 15.42 63.95 122.00 -35.16 130.86 0.97 -34.69 129.60 0.46 coo 15.65 69.77 121.40 17.38 70.64 120.41 -31.92 126.83 -1.04 -30.49 125.19 -1.17 ULMN 4 1e6e_c00 ADRENODOXIN user 3 4 # 3 A 55 HIS A 102 HIS~? 4.84 O2 B3P A 371 A 159 ASP A 27 ASP.? 7.07 C10 B3P A 371 A 376 ILE A 66 ILE^? 13.53 ZN ZN A 401 A 377 THR A 45 THR^? 14.22 ZN ZN A 401 coo 17.95 58.52 112.81 17.29 59.41 111.03 -42.24 121.28 -10.34 -42.29 119.63 -9.04 coo 11.32 57.46 110.35 12.85 58.48 111.39 -47.69 122.20 -10.88 -45.61 122.04 -10.59 coo 15.00 65.23 121.40 15.42 63.95 122.00 -34.69 128.77 -14.05 -35.20 128.89 -15.40 coo 15.65 69.77 121.40 17.38 70.64 120.41 -30.23 126.99 -12.70 -29.64 126.24 -14.61 ULMN 4 1e6e_c00 ADRENODOXIN user 4 4 # 4 A 55 HIS A 102 HIS~? 4.84 O2 B3P A 371 A 159 ASP A 27 ASP.? 7.07 C10 B3P A 371 A 376 ILE A 286 ILE.? 5.20 C9 B3P A 371 A 377 THR A 307 THR^? 6.96 O1 B3P A 371 coo 17.95 58.52 112.81 17.29 59.41 111.03 -42.24 121.28 -10.34 -42.29 119.63 -9.04 coo 11.32 57.46 110.35 12.85 58.48 111.39 -47.69 122.20 -10.88 -45.61 122.04 -10.59 coo 15.00 65.23 121.40 15.42 63.95 122.00 -41.11 108.86 -13.71 -42.57 109.18 -13.85 coo 15.65 69.77 121.40 17.38 70.64 120.41 -37.49 106.57 -10.19 -39.51 106.65 -9.34 ULMN 4 1e6e_c00 ADRENODOXIN user 5 4 # 5 A 55 HIS A 102 HIS~? 4.84 O2 B3P A 371 A 159 ASP A 106 ASP~? 2.01 ZN ZN A 401s A 376 ILE A 66 ILE^? 13.53 ZN ZN A 401 A 377 THR A 45 THR^? 14.22 ZN ZN A 401 coo 17.95 58.52 112.81 17.29 59.41 111.03 -42.24 121.28 -10.34 -42.29 119.63 -9.04 coo 11.32 57.46 110.35 12.85 58.48 111.39 -41.67 116.42 -14.91 -40.59 116.67 -13.13 coo 15.00 65.23 121.40 15.42 63.95 122.00 -34.69 128.77 -14.05 -35.20 128.89 -15.40 coo 15.65 69.77 121.40 17.38 70.64 120.41 -30.23 126.99 -12.70 -29.64 126.24 -14.61 ULMN 4 1e6e_c00 ADRENODOXIN user 6 4 # 6 A 55 HIS B 17 HIS~? 19.27 ZN ZN B 402 A 159 ASP B 15 ASP~? 18.09 ZN ZN B 402 A 376 ILE B 66 ILE^? 13.57 ZN ZN B 402 A 377 THR B 45 THR^? 14.16 ZN ZN B 402 coo 17.95 58.52 112.81 17.29 59.41 111.03 -48.32 88.94 27.24 -48.07 87.67 28.90 coo 11.32 57.46 110.35 12.85 58.48 111.39 -55.42 89.37 22.84 -56.66 91.01 23.17 coo 15.00 65.23 121.40 15.42 63.95 122.00 -46.83 85.78 14.68 -47.32 86.00 16.05 coo 15.65 69.77 121.40 17.38 70.64 120.41 -42.17 85.01 13.36 -41.21 85.38 15.27 ULMN 4 1e6e_c00 ADRENODOXIN user 7 4 # 7 A 55 HIS B 94 HIS~? 26.87 ZN ZN B 401 A 159 ASP B 95 ASP.? 28.83 ZN ZN B 401 A 376 ILE B 87 ILE~? 16.89 ZN ZN B 401 A 377 THR B 50 THR~? 13.89 ZN ZN B 401 coo 17.95 58.52 112.81 17.29 59.41 111.03 -49.13 73.87 2.20 -48.22 73.02 0.50 coo 11.32 57.46 110.35 12.85 58.48 111.39 -53.83 73.32 7.16 -55.46 72.49 6.09 coo 15.00 65.23 121.40 15.42 63.95 122.00 -48.53 84.68 -0.37 -47.47 85.49 0.15 coo 15.65 69.77 121.40 17.38 70.64 120.41 -43.67 86.36 1.73 -41.65 87.07 1.85 ULMN 4 1e6e_c00 ADRENODOXIN user 8 4 # 8 A 55 HIS B 102 HIS~? 4.91 O2 B3P B 371 A 159 ASP B 27 ASP.? 7.01 C10 B3P B 371 A 376 ILE B 66 ILE^? 13.57 ZN ZN B 402 A 377 THR B 45 THR^? 14.16 ZN ZN B 402 coo 17.95 58.52 112.81 17.29 59.41 111.03 -49.25 96.38 11.24 -48.46 97.85 9.95 coo 11.32 57.46 110.35 12.85 58.48 111.39 -54.29 98.49 11.88 -52.46 97.53 11.54 coo 15.00 65.23 121.40 15.42 63.95 122.00 -46.83 85.78 14.68 -47.32 86.00 16.05 coo 15.65 69.77 121.40 17.38 70.64 120.41 -42.17 85.01 13.36 -41.21 85.38 15.27 ULMN 4 1e6e_c00 ADRENODOXIN user 9 4 # 9 A 55 HIS B 102 HIS~? 4.91 O2 B3P B 371 A 159 ASP B 27 ASP.? 7.01 C10 B3P B 371 A 376 ILE B 286 ILE.? 5.29 C9 B3P B 371 A 377 THR B 307 THR^? 7.10 O1 B3P B 371 coo 17.95 58.52 112.81 17.29 59.41 111.03 -49.25 96.38 11.24 -48.46 97.85 9.95 coo 11.32 57.46 110.35 12.85 58.48 111.39 -54.29 98.49 11.88 -52.46 97.53 11.54 coo 15.00 65.23 121.40 15.42 63.95 122.00 -41.65 106.23 14.73 -42.98 106.75 14.93 coo 15.65 69.77 121.40 17.38 70.64 120.41 -37.32 106.26 11.14 -39.05 107.36 10.28 ULMN 4 1e6e_c00 ADRENODOXIN user 10 4 # 10 A 55 HIS B 102 HIS~? 4.91 O2 B3P B 371 A 159 ASP B 106 ASP~? 1.96 ZN ZN B 402s A 376 ILE B 66 ILE^? 13.57 ZN ZN B 402 A 377 THR B 45 THR^? 14.16 ZN ZN B 402 coo 17.95 58.52 112.81 17.29 59.41 111.03 -49.25 96.38 11.24 -48.46 97.85 9.95 coo 11.32 57.46 110.35 12.85 58.48 111.39 -46.09 100.09 15.88 -45.34 99.27 14.09 coo 15.00 65.23 121.40 15.42 63.95 122.00 -46.83 85.78 14.68 -47.32 86.00 16.05 coo 15.65 69.77 121.40 17.38 70.64 120.41 -42.17 85.01 13.36 -41.21 85.38 15.27 1e6e_c00 source 1e6e ADRENODOXIN : 10 hits 1e6e_c00 naa= 4 ULMN 4 1e6e_c01 ADRENODOXIN user 1 4 # 1 C 55 HIS A 17 HIS~? 19.36 ZN ZN A 401 C 159 ASP A 15 ASP~? 18.15 ZN ZN A 401 C 376 ILE A 66 ILE^? 13.53 ZN ZN A 401 C 377 THR A 45 THR^? 14.22 ZN ZN A 401 coo -29.07 40.56 142.27 -27.79 41.91 141.29 -37.78 126.95 -26.45 -37.01 127.80 -28.21 coo -23.44 38.39 138.46 -25.44 39.03 138.64 -44.06 130.37 -22.15 -46.01 129.61 -22.24 coo -37.08 37.01 134.95 -37.09 36.11 136.10 -34.69 128.77 -14.05 -35.20 128.89 -15.40 coo -39.65 39.67 132.35 -40.33 41.62 133.03 -30.23 126.99 -12.70 -29.64 126.24 -14.61 ULMN 4 1e6e_c01 ADRENODOXIN user 2 4 # 2 C 55 HIS A 94 HIS~? 26.81 ZN ZN A 402 C 159 ASP A 95 ASP.? 28.91 ZN ZN A 402 C 376 ILE A 87 ILE~? 16.82 ZN ZN A 402 C 377 THR A 50 THR~? 14.04 ZN ZN A 402 coo -29.07 40.56 142.27 -27.79 41.91 141.29 -29.92 140.30 -1.80 -28.95 140.49 0.05 coo -23.44 38.39 138.46 -25.44 39.03 138.64 -33.63 143.19 -6.68 -34.30 144.81 -5.56 coo -37.08 37.01 134.95 -37.09 36.11 136.10 -35.16 130.86 0.97 -34.69 129.60 0.46 coo -39.65 39.67 132.35 -40.33 41.62 133.03 -31.92 126.83 -1.04 -30.49 125.19 -1.17 ULMN 4 1e6e_c01 ADRENODOXIN user 3 4 # 3 C 55 HIS A 102 HIS~? 4.84 O2 B3P A 371 C 159 ASP A 27 ASP.? 7.07 C10 B3P A 371 C 376 ILE A 66 ILE^? 13.53 ZN ZN A 401 C 377 THR A 45 THR^? 14.22 ZN ZN A 401 coo -29.07 40.56 142.27 -27.79 41.91 141.29 -42.24 121.28 -10.34 -42.29 119.63 -9.04 coo -23.44 38.39 138.46 -25.44 39.03 138.64 -47.69 122.20 -10.88 -45.61 122.04 -10.59 coo -37.08 37.01 134.95 -37.09 36.11 136.10 -34.69 128.77 -14.05 -35.20 128.89 -15.40 coo -39.65 39.67 132.35 -40.33 41.62 133.03 -30.23 126.99 -12.70 -29.64 126.24 -14.61 ULMN 4 1e6e_c01 ADRENODOXIN user 4 4 # 4 C 55 HIS A 102 HIS~? 4.84 O2 B3P A 371 C 159 ASP A 27 ASP.? 7.07 C10 B3P A 371 C 376 ILE A 286 ILE.? 5.20 C9 B3P A 371 C 377 THR A 307 THR^? 6.96 O1 B3P A 371 coo -29.07 40.56 142.27 -27.79 41.91 141.29 -42.24 121.28 -10.34 -42.29 119.63 -9.04 coo -23.44 38.39 138.46 -25.44 39.03 138.64 -47.69 122.20 -10.88 -45.61 122.04 -10.59 coo -37.08 37.01 134.95 -37.09 36.11 136.10 -41.11 108.86 -13.71 -42.57 109.18 -13.85 coo -39.65 39.67 132.35 -40.33 41.62 133.03 -37.49 106.57 -10.19 -39.51 106.65 -9.34 ULMN 4 1e6e_c01 ADRENODOXIN user 5 4 # 5 C 55 HIS A 102 HIS~? 4.84 O2 B3P A 371 C 159 ASP A 106 ASP~? 2.01 ZN ZN A 401s C 376 ILE A 66 ILE^? 13.53 ZN ZN A 401 C 377 THR A 45 THR^? 14.22 ZN ZN A 401 coo -29.07 40.56 142.27 -27.79 41.91 141.29 -42.24 121.28 -10.34 -42.29 119.63 -9.04 coo -23.44 38.39 138.46 -25.44 39.03 138.64 -41.67 116.42 -14.91 -40.59 116.67 -13.13 coo -37.08 37.01 134.95 -37.09 36.11 136.10 -34.69 128.77 -14.05 -35.20 128.89 -15.40 coo -39.65 39.67 132.35 -40.33 41.62 133.03 -30.23 126.99 -12.70 -29.64 126.24 -14.61 ULMN 4 1e6e_c01 ADRENODOXIN user 6 4 # 6 C 55 HIS B 17 HIS~? 19.27 ZN ZN B 402 C 159 ASP B 15 ASP~? 18.09 ZN ZN B 402 C 376 ILE B 66 ILE^? 13.57 ZN ZN B 402 C 377 THR B 45 THR^? 14.16 ZN ZN B 402 coo -29.07 40.56 142.27 -27.79 41.91 141.29 -48.32 88.94 27.24 -48.07 87.67 28.90 coo -23.44 38.39 138.46 -25.44 39.03 138.64 -55.42 89.37 22.84 -56.66 91.01 23.17 coo -37.08 37.01 134.95 -37.09 36.11 136.10 -46.83 85.78 14.68 -47.32 86.00 16.05 coo -39.65 39.67 132.35 -40.33 41.62 133.03 -42.17 85.01 13.36 -41.21 85.38 15.27 ULMN 4 1e6e_c01 ADRENODOXIN user 7 4 # 7 C 55 HIS B 94 HIS~? 26.87 ZN ZN B 401 C 159 ASP B 95 ASP.? 28.83 ZN ZN B 401 C 376 ILE B 87 ILE~? 16.89 ZN ZN B 401 C 377 THR B 50 THR~? 13.89 ZN ZN B 401 coo -29.07 40.56 142.27 -27.79 41.91 141.29 -49.13 73.87 2.20 -48.22 73.02 0.50 coo -23.44 38.39 138.46 -25.44 39.03 138.64 -53.83 73.32 7.16 -55.46 72.49 6.09 coo -37.08 37.01 134.95 -37.09 36.11 136.10 -48.53 84.68 -0.37 -47.47 85.49 0.15 coo -39.65 39.67 132.35 -40.33 41.62 133.03 -43.67 86.36 1.73 -41.65 87.07 1.85 ULMN 4 1e6e_c01 ADRENODOXIN user 8 4 # 8 C 55 HIS B 102 HIS~? 4.91 O2 B3P B 371 C 159 ASP B 27 ASP.? 7.01 C10 B3P B 371 C 376 ILE B 66 ILE^? 13.57 ZN ZN B 402 C 377 THR B 45 THR^? 14.16 ZN ZN B 402 coo -29.07 40.56 142.27 -27.79 41.91 141.29 -49.25 96.38 11.24 -48.46 97.85 9.95 coo -23.44 38.39 138.46 -25.44 39.03 138.64 -54.29 98.49 11.88 -52.46 97.53 11.54 coo -37.08 37.01 134.95 -37.09 36.11 136.10 -46.83 85.78 14.68 -47.32 86.00 16.05 coo -39.65 39.67 132.35 -40.33 41.62 133.03 -42.17 85.01 13.36 -41.21 85.38 15.27 ULMN 4 1e6e_c01 ADRENODOXIN user 9 4 # 9 C 55 HIS B 102 HIS~? 4.91 O2 B3P B 371 C 159 ASP B 27 ASP.? 7.01 C10 B3P B 371 C 376 ILE B 286 ILE.? 5.29 C9 B3P B 371 C 377 THR B 307 THR^? 7.10 O1 B3P B 371 coo -29.07 40.56 142.27 -27.79 41.91 141.29 -49.25 96.38 11.24 -48.46 97.85 9.95 coo -23.44 38.39 138.46 -25.44 39.03 138.64 -54.29 98.49 11.88 -52.46 97.53 11.54 coo -37.08 37.01 134.95 -37.09 36.11 136.10 -41.65 106.23 14.73 -42.98 106.75 14.93 coo -39.65 39.67 132.35 -40.33 41.62 133.03 -37.32 106.26 11.14 -39.05 107.36 10.28 ULMN 4 1e6e_c01 ADRENODOXIN user 10 4 # 10 C 55 HIS B 102 HIS~? 4.91 O2 B3P B 371 C 159 ASP B 106 ASP~? 1.96 ZN ZN B 402s C 376 ILE B 66 ILE^? 13.57 ZN ZN B 402 C 377 THR B 45 THR^? 14.16 ZN ZN B 402 coo -29.07 40.56 142.27 -27.79 41.91 141.29 -49.25 96.38 11.24 -48.46 97.85 9.95 coo -23.44 38.39 138.46 -25.44 39.03 138.64 -46.09 100.09 15.88 -45.34 99.27 14.09 coo -37.08 37.01 134.95 -37.09 36.11 136.10 -46.83 85.78 14.68 -47.32 86.00 16.05 coo -39.65 39.67 132.35 -40.33 41.62 133.03 -42.17 85.01 13.36 -41.21 85.38 15.27 1e6e_c01 source 1e6e ADRENODOXIN : 10 hits 1e6e_c01 naa= 4 ULMN 4 1ec9_c11 GLUCARATE DEHYDRATASE user 1 4 # 1 D 207 LYS A 74 LYS.? 6.52 C5 B3P A 371 D 313 ASP A 48 ASP.? 7.07 ZN ZN A 402 D 339 HIS A 69 HIS.? -3.50 ZN ZN A 402s D 373 GLU B 294 GLU~? 11.71 C9 B3P B 371 coo 17.14 -12.99 22.96 17.50 -8.64 21.08 -48.78 125.51 -1.27 -51.17 122.94 -3.63 coo 12.06 1.87 22.99 13.29 2.38 24.60 -34.00 122.50 -3.86 -35.34 120.86 -3.93 coo 13.74 -1.84 22.10 15.79 -1.45 22.35 -38.08 120.43 -6.58 -37.62 118.38 -6.66 coo 13.94 -5.98 40.88 13.74 -7.36 42.48 -39.97 115.47 11.20 -41.44 114.67 9.87 1ec9_c11 source 1ec9 GLUCARATE DEHYDRATASE : 1 hits 1ec9_c11 naa= 4 ULMN 4 1ghs_c00 1,3-BETA-GLUCANASE (E.C.3.2.1.39) (1user 1 4 # 1 A 231 GLU B 203 GLU^? 37.09 O3 B3P B 371 A 279 GLU B 199 GLU^? 48.27 O3 B3P B 371 A 282 LYS B 144 LYS~? 49.27 O3 B3P B 371 A 288 GLU B 173 GLU^? 50.63 O3 B3P B 371 coo 56.45 0.46 86.18 56.87 -0.85 87.80 -66.30 108.47 45.19 -65.02 110.19 45.11 coo 47.04 -1.91 92.33 48.79 -2.81 91.49 -77.31 110.33 51.94 -78.27 110.21 50.08 coo 49.98 -4.05 98.00 52.40 -3.58 93.17 -73.99 104.12 56.30 -69.99 102.62 56.83 coo 54.40 -0.12 97.85 55.58 0.51 96.24 -68.84 109.86 56.27 -69.26 109.60 58.32 1ghs_c00 source 1ghs 1,3-BETA-GLUCANASE (E.C.3.2.1.39) (1,3-BETA-D-: 1 hits 1ghs_c00 naa= 4 ULMN 4 1ghs_c01 1,3-BETA-GLUCANASE (E.C.3.2.1.39) (1user 1 4 # 1 B 231 GLU B 203 GLU^? 37.09 O3 B3P B 371 B 279 GLU B 199 GLU^? 48.27 O3 B3P B 371 B 282 LYS B 144 LYS~? 49.27 O3 B3P B 371 B 288 GLU B 173 GLU^? 50.63 O3 B3P B 371 coo 47.83 -0.67 47.15 49.17 -0.90 48.81 -66.30 108.47 45.19 -65.02 110.19 45.11 coo 44.68 -9.78 53.79 46.22 -8.74 52.81 -77.31 110.33 51.94 -78.27 110.21 50.08 coo 47.92 -7.86 59.48 48.51 -6.22 53.96 -73.99 104.12 56.30 -69.99 102.62 56.83 coo 47.02 -1.91 59.02 47.41 -1.07 57.09 -68.84 109.86 56.27 -69.26 109.60 58.32 1ghs_c01 source 1ghs 1,3-BETA-GLUCANASE (E.C.3.2.1.39) (1,3-BETA-D-: 1 hits 1ghs_c01 naa= 4 ULMN 4 1grc_c01 GLYCINAMIDE RIBONUCLEOTIDE TRANSFORMuser 1 4 # 1 B 106 ASN A 329 ASN~? 12.75 ZN ZN A 402 B 108 HIS A 330 HIS~? -3.46 ZN ZN A 402s B 135 SER A 289 SER.? -5.35 O1 B3P A 371s B 144 ASP B 309 ASP.? 7.61 ZN ZN B 401 coo 36.64 101.02 13.15 38.55 101.84 12.78 -31.94 109.24 -4.59 -31.02 107.56 -3.63 coo 41.00 107.18 12.86 42.70 107.82 11.96 -37.28 113.42 -5.32 -38.81 114.77 -5.81 coo 36.51 108.90 17.50 37.10 110.80 16.19 -41.15 110.32 -7.28 -42.46 109.97 -5.25 coo 31.60 110.69 6.14 29.69 109.74 5.94 -40.43 105.08 4.20 -40.75 103.07 3.51 ULMN 4 1grc_c01 GLYCINAMIDE RIBONUCLEOTIDE TRANSFORMuser 2 4 # 2 B 106 ASN A 329 ASN~? 12.75 ZN ZN A 402 B 108 HIS A 330 HIS~? -3.46 ZN ZN A 402s B 135 SER A 289 SER.? -5.35 O1 B3P A 371s B 144 ASP B 314 ASP~? 9.37 O5 B3P A 371 coo 36.64 101.02 13.15 38.55 101.84 12.78 -31.94 109.24 -4.59 -31.02 107.56 -3.63 coo 41.00 107.18 12.86 42.70 107.82 11.96 -37.28 113.42 -5.32 -38.81 114.77 -5.81 coo 36.51 108.90 17.50 37.10 110.80 16.19 -41.15 110.32 -7.28 -42.46 109.97 -5.25 coo 31.60 110.69 6.14 29.69 109.74 5.94 -40.38 114.62 4.43 -42.39 114.53 3.82 ULMN 4 1grc_c01 GLYCINAMIDE RIBONUCLEOTIDE TRANSFORMuser 3 4 # 3 B 106 ASN B 329 ASN~? 12.78 ZN ZN B 401 B 108 HIS B 330 HIS~? -3.52 ZN ZN B 401s B 135 SER B 289 SER.? -5.32 O1 B3P B 371s B 144 ASP A 309 ASP.? 7.55 ZN ZN A 402 coo 36.64 101.02 13.15 38.55 101.84 12.78 -34.09 101.07 5.53 -32.43 102.02 4.53 coo 41.00 107.18 12.86 42.70 107.82 11.96 -40.87 100.43 6.30 -42.90 100.10 6.71 coo 36.51 108.90 17.50 37.10 110.80 16.19 -42.54 105.00 8.17 -43.55 106.07 6.24 coo 31.60 110.69 6.14 29.69 109.74 5.94 -39.32 109.22 -3.35 -38.59 111.09 -2.57 ULMN 4 1grc_c01 GLYCINAMIDE RIBONUCLEOTIDE TRANSFORMuser 4 4 # 4 B 106 ASN B 329 ASN~? 12.78 ZN ZN B 401 B 108 HIS B 330 HIS~? -3.52 ZN ZN B 401s B 135 SER B 289 SER.? -5.32 O1 B3P B 371s B 144 ASP A 314 ASP~? 9.10 O5 B3P B 371 coo 36.64 101.02 13.15 38.55 101.84 12.78 -34.09 101.07 5.53 -32.43 102.02 4.53 coo 41.00 107.18 12.86 42.70 107.82 11.96 -40.87 100.43 6.30 -42.90 100.10 6.71 coo 36.51 108.90 17.50 37.10 110.80 16.19 -42.54 105.00 8.17 -43.55 106.07 6.24 coo 31.60 110.69 6.14 29.69 109.74 5.94 -44.29 101.20 -3.40 -45.94 102.37 -2.71 1grc_c01 source 1grc GLYCINAMIDE RIBONUCLEOTIDE TRANSFORMYLASE (E.C: 4 hits 1grc_c01 naa= 4 ULMN 4 1j00_c00 THIOESTERASE I user 1 4 # 1 A 44 GLY A 308 GLY.? 7.69 O1 B3P A 371 A 73 ASN A 329 ASN~? 12.75 ZN ZN A 402 A 154 ASP B 314 ASP~? 9.37 O5 B3P A 371 A 157 HIS B 313 HIS~? 5.49 ZN ZN A 402 coo 5.31 35.31 46.19 5.56 34.58 46.17 -36.78 108.02 -6.71 -37.57 107.80 -6.86 coo 1.82 33.37 49.33 3.83 34.09 49.37 -31.94 109.24 -4.59 -31.02 107.56 -3.63 coo 8.45 43.15 56.37 9.67 41.50 55.89 -40.38 114.62 4.43 -42.39 114.53 3.82 coo 9.95 38.09 54.06 8.12 38.46 53.08 -40.27 117.73 -1.83 -39.85 118.55 -3.71 ULMN 4 1j00_c00 THIOESTERASE I user 2 4 # 2 A 44 GLY B 308 GLY.? 7.72 O1 B3P B 371 A 73 ASN B 329 ASN~? 12.78 ZN ZN B 401 A 154 ASP A 314 ASP~? 9.10 O5 B3P B 371 A 157 HIS A 313 HIS~? 5.54 ZN ZN B 401 coo 5.31 35.31 46.19 5.56 34.58 46.17 -37.60 104.71 7.65 -38.14 105.31 7.82 coo 1.82 33.37 49.33 3.83 34.09 49.37 -34.09 101.07 5.53 -32.43 102.02 4.53 coo 8.45 43.15 56.37 9.67 41.50 55.89 -44.29 101.20 -3.40 -45.94 102.37 -2.71 coo 9.95 38.09 54.06 8.12 38.46 53.08 -45.85 98.44 2.81 -45.85 97.45 4.68 1j00_c00 source 1j00 THIOESTERASE I : 2 hits 1j00_c00 naa= 4 ULMN 4 1j00_c01 THIOESTERASE I user 1 4 # 1 A 44 GLY A 308 GLY.? 7.69 O1 B3P A 371 A 73 ASN A 329 ASN~? 12.75 ZN ZN A 402 A 154 ASP B 314 ASP~? 9.37 O5 B3P A 371 A 157 HIS B 313 HIS~? 5.49 ZN ZN A 402 coo 5.31 35.31 46.19 5.56 34.58 46.17 -36.78 108.02 -6.71 -37.57 107.80 -6.86 coo 1.82 33.37 49.33 3.83 34.09 49.37 -31.94 109.24 -4.59 -31.02 107.56 -3.63 coo 8.45 43.15 56.37 9.67 41.50 55.89 -40.38 114.62 4.43 -42.39 114.53 3.82 coo 9.95 38.09 54.06 8.12 38.46 53.08 -40.27 117.73 -1.83 -39.85 118.55 -3.71 ULMN 4 1j00_c01 THIOESTERASE I user 2 4 # 2 A 44 GLY B 308 GLY.? 7.72 O1 B3P B 371 A 73 ASN B 329 ASN~? 12.78 ZN ZN B 401 A 154 ASP A 314 ASP~? 9.10 O5 B3P B 371 A 157 HIS A 313 HIS~? 5.54 ZN ZN B 401 coo 5.31 35.31 46.19 5.56 34.58 46.17 -37.60 104.71 7.65 -38.14 105.31 7.82 coo 1.82 33.37 49.33 3.83 34.09 49.37 -34.09 101.07 5.53 -32.43 102.02 4.53 coo 8.45 43.15 56.37 9.67 41.50 55.89 -44.29 101.20 -3.40 -45.94 102.37 -2.71 coo 9.95 38.09 54.06 8.12 38.46 53.08 -45.85 98.44 2.81 -45.85 97.45 4.68 1j00_c01 source 1j00 THIOESTERASE I : 2 hits 1j00_c01 naa= 4 ULMN 4 1jxa_c01 GLUCOSAMINE 6-PHOSPHATE SYNTHASE user 1 4 # 1 A 481 GLU B 199 GLU^? 48.27 O3 B3P B 371 A 485 LYS B 201 LYS^? 38.84 O3 B3P B 371 A 488 GLU B 171 GLU^? 44.83 O3 B3P B 371 A 603 LYS B 151 LYS~? 44.72 O3 B3P B 371 coo -7.79 3.39 10.29 -9.01 4.74 9.32 -77.31 110.33 51.94 -78.27 110.21 50.08 coo -9.44 10.08 8.58 -11.94 6.98 8.10 -70.79 108.75 48.84 -67.72 112.70 45.12 coo -13.30 11.40 4.76 -13.95 9.40 5.16 -66.65 104.35 51.79 -66.88 102.97 53.37 coo -21.26 6.97 3.81 -20.43 4.23 9.21 -69.89 96.96 48.64 -67.19 100.03 52.94 1jxa_c01 source 1jxa GLUCOSAMINE 6-PHOSPHATE SYNTHASE : 1 hits 1jxa_c01 naa= 4 ULMN 4 1kez_c01 ERYTHRONOLIDE SYNTHASE user 1 4 # 1 B 142 SER A 67 SER^? 10.42 ZN ZN A 402 B 143 ALA A 46 ALA^? 12.32 ZN ZN A 402 B 169 ASP A 48 ASP.? 7.07 ZN ZN A 402 B 259 HIS A 69 HIS.? -3.50 ZN ZN A 402s coo -22.50 44.77 16.45 -24.28 43.38 17.37 -35.40 126.06 -10.23 -37.10 126.61 -8.52 coo -24.61 43.93 13.40 -25.95 43.19 13.46 -31.18 124.97 -9.62 -31.44 126.01 -8.48 coo -16.98 43.09 16.07 -15.37 42.66 17.38 -34.00 122.50 -3.86 -35.34 120.86 -3.93 coo -20.12 38.81 19.97 -21.75 39.57 18.89 -38.08 120.43 -6.58 -37.62 118.38 -6.66 ULMN 4 1kez_c01 ERYTHRONOLIDE SYNTHASE user 2 4 # 2 B 142 SER B 67 SER^? 10.38 ZN ZN B 401 B 143 ALA B 46 ALA^? 12.33 ZN ZN B 401 B 169 ASP B 48 ASP.? 7.12 ZN ZN B 401 B 259 HIS B 69 HIS.? -3.44 ZN ZN B 401s coo -22.50 44.77 16.45 -24.28 43.38 17.37 -46.05 88.61 10.98 -47.75 89.13 9.26 coo -24.61 43.93 13.40 -25.95 43.19 13.46 -41.82 87.26 10.31 -42.61 86.56 9.20 coo -16.98 43.09 16.07 -15.37 42.66 17.38 -43.07 90.96 4.68 -43.24 93.07 4.75 coo -20.12 38.81 19.97 -21.75 39.57 18.89 -45.30 94.94 7.48 -43.81 96.41 7.64 1kez_c01 source 1kez ERYTHRONOLIDE SYNTHASE : 2 hits 1kez_c01 naa= 4 ULMN 4 1mdr_c00 MANDELATE RACEMASE (E.C.5.1.2.2) user 1 4 # 1 166 LYS A 337 LYS~? 13.43 ZN ZN A 402 270 ASP A 309 ASP.? 7.55 ZN ZN A 402 297 HIS A 330 HIS~? -3.46 ZN ZN A 402s 317 GLU A 333 GLU~? 2.48 ZN ZN A 401s coo 27.27 1.43 25.09 29.18 5.25 22.89 -29.31 122.02 -13.66 -26.65 121.35 -8.38 coo 29.40 9.25 9.79 31.51 9.14 10.05 -39.32 109.22 -3.35 -38.59 111.09 -2.57 coo 29.05 8.65 14.00 30.25 7.04 14.30 -37.28 113.42 -5.32 -38.81 114.77 -5.81 coo 29.25 11.66 19.43 29.42 9.79 18.51 -35.80 114.74 -10.32 -37.65 115.72 -10.06 1mdr_c00 source 1mdr MANDELATE RACEMASE (E.C.5.1.2.2) : 1 hits 1mdr_c00 naa= 4 ULMN 4 1mrq_c00 ALDO-KETO REDUCTASE FAMILY 1 MEMBER user 1 4 # 1 A 50 ASP A 314 ASP~? 9.10 O5 B3P B 371 A 55 TYR A 295 TYR~? 16.26 C9 B3P A 371 A 84 LYS A 319 LYS~? 18.09 ZN ZN B 401 A 117 HIS A 321 HIS~? 16.72 O4 B3P B 371 coo 11.09 42.89 24.44 11.32 42.06 22.49 -44.29 101.20 -3.40 -45.94 102.37 -2.71 coo 4.60 40.33 20.42 7.25 39.50 20.05 -48.13 97.91 -11.44 -47.20 97.03 -8.94 coo 9.71 44.83 15.47 10.13 41.43 19.93 -41.25 92.42 -6.09 -36.50 89.98 -5.00 coo 9.34 39.83 14.67 8.39 39.19 16.43 -47.70 92.41 -8.31 -49.45 92.40 -7.16 ULMN 4 1mrq_c00 ALDO-KETO REDUCTASE FAMILY 1 MEMBER user 2 4 # 2 A 50 ASP B 314 ASP~? 9.37 O5 B3P A 371 A 55 TYR B 295 TYR~? 16.19 C9 B3P B 371 A 84 LYS B 319 LYS~? 18.23 ZN ZN A 402 A 117 HIS B 321 HIS~? 16.92 O4 B3P A 371 coo 11.09 42.89 24.44 11.32 42.06 22.49 -40.38 114.62 4.43 -42.39 114.53 3.82 coo 4.60 40.33 20.42 7.25 39.50 20.05 -41.84 119.19 12.43 -40.61 119.57 9.93 coo 9.71 44.83 15.47 10.13 41.43 19.93 -33.05 120.28 7.11 -27.72 119.85 5.88 coo 9.34 39.83 14.67 8.39 39.19 16.43 -38.45 123.77 9.41 -39.84 124.80 8.23 1mrq_c00 source 1mrq ALDO-KETO REDUCTASE FAMILY 1 MEMBER C1 : 2 hits 1mrq_c00 naa= 4 ULMN 4 1pix_c00 GLUTACONYL-COA DECARBOXYLASE A SUBUNuser 1 4 # 1 A 151 VAL A 107 VAL~? 7.93 O3 B3P A 371 A 194 GLY A 111 GLY~? 9.12 ZN ZN A 401 A 417 ILE B 128 ILE.? 12.75 C11 B3P B 371 A 457 ALA B 284 ALA^? 12.60 C9 B3P B 371 coo 60.43 93.31 8.03 62.16 94.30 8.93 -43.11 116.21 -19.22 -45.12 116.93 -18.61 coo 59.34 89.99 13.88 59.24 89.18 13.73 -36.86 117.78 -20.05 -36.51 117.12 -20.33 coo 39.61 128.90 22.54 40.04 128.24 23.80 -42.82 109.39 22.95 -41.53 109.67 22.40 coo 43.27 124.32 20.47 43.79 125.29 21.53 -36.83 109.49 19.17 -37.78 110.64 18.83 ULMN 4 1pix_c00 GLUTACONYL-COA DECARBOXYLASE A SUBUNuser 2 4 # 2 A 151 VAL A 107 VAL~? 7.93 O3 B3P A 371 A 194 GLY A 111 GLY~? 9.12 ZN ZN A 401 A 417 ILE B 128 ILE.? 12.75 C11 B3P B 371 A 457 ALA B 297 ALA~? 12.86 C9 B3P B 371 coo 60.43 93.31 8.03 62.16 94.30 8.93 -43.11 116.21 -19.22 -45.12 116.93 -18.61 coo 59.34 89.99 13.88 59.24 89.18 13.73 -36.86 117.78 -20.05 -36.51 117.12 -20.33 coo 39.61 128.90 22.54 40.04 128.24 23.80 -42.82 109.39 22.95 -41.53 109.67 22.40 coo 43.27 124.32 20.47 43.79 125.29 21.53 -40.42 114.50 18.56 -39.73 113.50 17.66 ULMN 4 1pix_c00 GLUTACONYL-COA DECARBOXYLASE A SUBUNuser 3 4 # 3 A 151 VAL B 107 VAL~? 8.11 O3 B3P B 371 A 194 GLY B 111 GLY~? 9.03 ZN ZN B 402 A 417 ILE A 128 ILE.? 12.65 C11 B3P A 371 A 457 ALA A 284 ALA^? 12.66 C9 B3P A 371 coo 60.43 93.31 8.03 62.16 94.30 8.93 -47.18 100.87 20.21 -49.25 101.28 19.60 coo 59.34 89.99 13.88 59.24 89.18 13.73 -42.81 96.30 20.91 -42.15 96.64 21.19 coo 39.61 128.90 22.54 40.04 128.24 23.80 -43.78 106.66 -21.81 -42.86 105.74 -21.19 coo 43.27 124.32 20.47 43.79 125.29 21.53 -38.71 103.48 -18.18 -40.15 103.01 -17.91 ULMN 4 1pix_c00 GLUTACONYL-COA DECARBOXYLASE A SUBUNuser 4 4 # 4 A 151 VAL B 107 VAL~? 8.11 O3 B3P B 371 A 194 GLY B 111 GLY~? 9.03 ZN ZN B 402 A 417 ILE A 128 ILE.? 12.65 C11 B3P A 371 A 457 ALA A 297 ALA~? 12.94 C9 B3P A 371 coo 60.43 93.31 8.03 62.16 94.30 8.93 -47.18 100.87 20.21 -49.25 101.28 19.60 coo 59.34 89.99 13.88 59.24 89.18 13.73 -42.81 96.30 20.91 -42.15 96.64 21.19 coo 39.61 128.90 22.54 40.04 128.24 23.80 -43.78 106.66 -21.81 -42.86 105.74 -21.19 coo 43.27 124.32 20.47 43.79 125.29 21.53 -44.43 101.11 -17.62 -43.26 101.65 -16.76 ULMN 4 1pix_c00 GLUTACONYL-COA DECARBOXYLASE A SUBUNuser 5 4 # 5 A 151 VAL B 357 VAL^? 19.90 ZN ZN B 402 A 194 GLY B 42 GLY.? 23.56 ZN ZN B 402 A 417 ILE A 261 ILE~? 16.82 O1 B3P A 371 A 457 ALA A 258 ALA~? 19.39 O1 B3P A 371 coo 60.43 93.31 8.03 62.16 94.30 8.93 -41.00 79.44 18.27 -42.07 81.04 19.29 coo 59.34 89.99 13.88 59.24 89.18 13.73 -45.06 75.57 15.90 -45.81 75.90 15.59 coo 39.61 128.90 22.54 40.04 128.24 23.80 -27.79 104.37 -13.82 -29.08 103.66 -14.18 coo 43.27 124.32 20.47 43.79 125.29 21.53 -28.05 99.80 -11.43 -28.59 99.01 -10.27 1pix_c00 source 1pix GLUTACONYL-COA DECARBOXYLASE A SUBUNIT : 5 hits 1pix_c00 naa= 4 ULMN 4 1pix_c01 GLUTACONYL-COA DECARBOXYLASE A SUBUNuser 1 4 # 1 B 151 VAL A 107 VAL~? 7.93 O3 B3P A 371 B 194 GLY A 111 GLY~? 9.12 ZN ZN A 401 B 417 ILE B 128 ILE.? 12.75 C11 B3P B 371 B 457 ALA B 284 ALA^? 12.60 C9 B3P B 371 coo 52.95 126.71 13.21 51.34 125.24 13.19 -43.11 116.21 -19.22 -45.12 116.93 -18.61 coo 50.40 126.23 20.48 50.46 127.00 20.75 -36.86 117.78 -20.05 -36.51 117.12 -20.33 coo 68.38 85.45 19.33 67.41 85.52 20.41 -42.82 109.39 22.95 -41.53 109.67 22.40 coo 65.50 91.13 17.77 64.65 89.88 18.00 -36.83 109.49 19.17 -37.78 110.64 18.83 ULMN 4 1pix_c01 GLUTACONYL-COA DECARBOXYLASE A SUBUNuser 2 4 # 2 B 151 VAL A 107 VAL~? 7.93 O3 B3P A 371 B 194 GLY A 111 GLY~? 9.12 ZN ZN A 401 B 417 ILE B 128 ILE.? 12.75 C11 B3P B 371 B 457 ALA B 297 ALA~? 12.86 C9 B3P B 371 coo 52.95 126.71 13.21 51.34 125.24 13.19 -43.11 116.21 -19.22 -45.12 116.93 -18.61 coo 50.40 126.23 20.48 50.46 127.00 20.75 -36.86 117.78 -20.05 -36.51 117.12 -20.33 coo 68.38 85.45 19.33 67.41 85.52 20.41 -42.82 109.39 22.95 -41.53 109.67 22.40 coo 65.50 91.13 17.77 64.65 89.88 18.00 -40.42 114.50 18.56 -39.73 113.50 17.66 ULMN 4 1pix_c01 GLUTACONYL-COA DECARBOXYLASE A SUBUNuser 3 4 # 3 B 151 VAL A 119 VAL~? 15.00 ZN ZN A 401 B 194 GLY A 339 GLY~? 12.94 ZN ZN A 401 B 417 ILE B 128 ILE.? 12.75 C11 B3P B 371 B 457 ALA B 284 ALA^? 12.60 C9 B3P B 371 coo 52.95 126.71 13.21 51.34 125.24 13.19 -26.86 111.00 -18.52 -26.78 112.31 -16.82 coo 50.40 126.23 20.48 50.46 127.00 20.75 -29.42 120.06 -18.66 -29.36 120.82 -18.29 coo 68.38 85.45 19.33 67.41 85.52 20.41 -42.82 109.39 22.95 -41.53 109.67 22.40 coo 65.50 91.13 17.77 64.65 89.88 18.00 -36.83 109.49 19.17 -37.78 110.64 18.83 ULMN 4 1pix_c01 GLUTACONYL-COA DECARBOXYLASE A SUBUNuser 4 4 # 4 B 151 VAL A 119 VAL~? 15.00 ZN ZN A 401 B 194 GLY A 339 GLY~? 12.94 ZN ZN A 401 B 417 ILE B 128 ILE.? 12.75 C11 B3P B 371 B 457 ALA B 297 ALA~? 12.86 C9 B3P B 371 coo 52.95 126.71 13.21 51.34 125.24 13.19 -26.86 111.00 -18.52 -26.78 112.31 -16.82 coo 50.40 126.23 20.48 50.46 127.00 20.75 -29.42 120.06 -18.66 -29.36 120.82 -18.29 coo 68.38 85.45 19.33 67.41 85.52 20.41 -42.82 109.39 22.95 -41.53 109.67 22.40 coo 65.50 91.13 17.77 64.65 89.88 18.00 -40.42 114.50 18.56 -39.73 113.50 17.66 ULMN 4 1pix_c01 GLUTACONYL-COA DECARBOXYLASE A SUBUNuser 5 4 # 5 B 151 VAL B 107 VAL~? 8.11 O3 B3P B 371 B 194 GLY B 111 GLY~? 9.03 ZN ZN B 402 B 417 ILE A 128 ILE.? 12.65 C11 B3P A 371 B 457 ALA A 284 ALA^? 12.66 C9 B3P A 371 coo 52.95 126.71 13.21 51.34 125.24 13.19 -47.18 100.87 20.21 -49.25 101.28 19.60 coo 50.40 126.23 20.48 50.46 127.00 20.75 -42.81 96.30 20.91 -42.15 96.64 21.19 coo 68.38 85.45 19.33 67.41 85.52 20.41 -43.78 106.66 -21.81 -42.86 105.74 -21.19 coo 65.50 91.13 17.77 64.65 89.88 18.00 -38.71 103.48 -18.18 -40.15 103.01 -17.91 ULMN 4 1pix_c01 GLUTACONYL-COA DECARBOXYLASE A SUBUNuser 6 4 # 6 B 151 VAL B 107 VAL~? 8.11 O3 B3P B 371 B 194 GLY B 111 GLY~? 9.03 ZN ZN B 402 B 417 ILE A 128 ILE.? 12.65 C11 B3P A 371 B 457 ALA A 297 ALA~? 12.94 C9 B3P A 371 coo 52.95 126.71 13.21 51.34 125.24 13.19 -47.18 100.87 20.21 -49.25 101.28 19.60 coo 50.40 126.23 20.48 50.46 127.00 20.75 -42.81 96.30 20.91 -42.15 96.64 21.19 coo 68.38 85.45 19.33 67.41 85.52 20.41 -43.78 106.66 -21.81 -42.86 105.74 -21.19 coo 65.50 91.13 17.77 64.65 89.88 18.00 -44.43 101.11 -17.62 -43.26 101.65 -16.76 ULMN 4 1pix_c01 GLUTACONYL-COA DECARBOXYLASE A SUBUNuser 7 4 # 7 B 151 VAL B 357 VAL^? 19.90 ZN ZN B 402 B 194 GLY B 42 GLY.? 23.56 ZN ZN B 402 B 417 ILE A 261 ILE~? 16.82 O1 B3P A 371 B 457 ALA A 258 ALA~? 19.39 O1 B3P A 371 coo 52.95 126.71 13.21 51.34 125.24 13.19 -41.00 79.44 18.27 -42.07 81.04 19.29 coo 50.40 126.23 20.48 50.46 127.00 20.75 -45.06 75.57 15.90 -45.81 75.90 15.59 coo 68.38 85.45 19.33 67.41 85.52 20.41 -27.79 104.37 -13.82 -29.08 103.66 -14.18 coo 65.50 91.13 17.77 64.65 89.88 18.00 -28.05 99.80 -11.43 -28.59 99.01 -10.27 1pix_c01 source 1pix GLUTACONYL-COA DECARBOXYLASE A SUBUNIT : 7 hits 1pix_c01 naa= 4 ULMN 4 1pvd_c00 PYRUVATE DECARBOXYLASE (PDC) (E.C.4.user 1 4 # 1 A 28 ASP A 314 ASP~? 9.10 O5 B3P B 371 A 114 HIS A 312 HIS~? 6.48 ZN ZN B 401 A 115 HIS A 313 HIS~? 5.54 ZN ZN B 401 A 477 GLU B 233 GLU^? 23.73 O3 B3P B 371 coo -15.88 -12.55 22.80 -17.35 -11.37 23.73 -44.29 101.20 -3.40 -45.94 102.37 -2.71 coo -19.86 -7.63 20.42 -20.26 -6.94 22.43 -41.04 97.86 3.25 -41.05 95.82 3.71 coo -15.53 -7.10 20.34 -16.48 -7.70 22.11 -45.85 98.44 2.81 -45.85 97.45 4.68 coo 5.56 18.52 30.85 3.87 17.54 30.36 -64.75 110.13 30.02 -64.81 111.27 28.28 ULMN 4 1pvd_c00 PYRUVATE DECARBOXYLASE (PDC) (E.C.4.user 2 4 # 2 A 28 ASP B 314 ASP~? 9.37 O5 B3P A 371 A 114 HIS B 312 HIS~? 6.47 ZN ZN A 402 A 115 HIS B 313 HIS~? 5.49 ZN ZN A 402 A 477 GLU A 233 GLU^? 23.79 O3 B3P A 371 coo -15.88 -12.55 22.80 -17.35 -11.37 23.73 -40.38 114.62 4.43 -42.39 114.53 3.82 coo -19.86 -7.63 20.42 -20.26 -6.94 22.43 -36.00 115.58 -2.34 -34.91 117.32 -2.81 coo -15.53 -7.10 20.34 -16.48 -7.70 22.11 -40.27 117.73 -1.83 -39.85 118.55 -3.71 coo 5.56 18.52 30.85 3.87 17.54 30.36 -62.71 117.71 -29.26 -63.44 117.34 -27.30 1pvd_c00 source 1pvd PYRUVATE DECARBOXYLASE (PDC) (E.C.4.1.1.1) : 2 hits 1pvd_c00 naa= 4 ULMN 4 1pvd_c01 PYRUVATE DECARBOXYLASE (PDC) (E.C.4.user 1 4 # 1 B 28 ASP A 314 ASP~? 9.10 O5 B3P B 371 B 114 HIS A 312 HIS~? 6.48 ZN ZN B 401 B 115 HIS A 313 HIS~? 5.54 ZN ZN B 401 B 477 GLU B 233 GLU^? 23.73 O3 B3P B 371 coo 7.54 16.02 24.50 8.40 15.18 26.23 -44.29 101.20 -3.40 -45.94 102.37 -2.71 coo 12.56 11.13 24.12 12.84 11.07 26.21 -41.04 97.86 3.25 -41.05 95.82 3.71 coo 8.02 10.56 23.37 8.23 11.43 25.26 -45.85 98.44 2.81 -45.85 97.45 4.68 coo -16.37 -13.88 29.96 -14.84 -12.68 29.83 -64.75 110.13 30.02 -64.81 111.27 28.28 ULMN 4 1pvd_c01 PYRUVATE DECARBOXYLASE (PDC) (E.C.4.user 2 4 # 2 B 28 ASP B 314 ASP~? 9.37 O5 B3P A 371 B 114 HIS B 312 HIS~? 6.47 ZN ZN A 402 B 115 HIS B 313 HIS~? 5.49 ZN ZN A 402 B 477 GLU A 233 GLU^? 23.79 O3 B3P A 371 coo 7.54 16.02 24.50 8.40 15.18 26.23 -40.38 114.62 4.43 -42.39 114.53 3.82 coo 12.56 11.13 24.12 12.84 11.07 26.21 -36.00 115.58 -2.34 -34.91 117.32 -2.81 coo 8.02 10.56 23.37 8.23 11.43 25.26 -40.27 117.73 -1.83 -39.85 118.55 -3.71 coo -16.37 -13.88 29.96 -14.84 -12.68 29.83 -62.71 117.71 -29.26 -63.44 117.34 -27.30 1pvd_c01 source 1pvd PYRUVATE DECARBOXYLASE (PDC) (E.C.4.1.1.1) : 2 hits 1pvd_c01 naa= 4 ULMN 4 1qh9_c01 2-HALOACID DEHALOGENASE user 1 4 # 1 A 10 ASP A 309 ASP.? 7.55 ZN ZN A 402 A 41 ARG B 271 ARG^? 13.51 ZN ZN A 402 A 118 SER A 289 SER.? -5.35 O1 B3P A 371s A 180 ASP A 327 ASP^? 11.36 O1 B3P A 371 coo 20.70 13.03 9.13 22.27 11.81 9.81 -39.32 109.22 -3.35 -38.59 111.09 -2.57 coo 23.00 19.17 17.85 22.49 17.70 15.19 -31.35 108.28 2.46 -33.78 107.49 0.72 coo 17.70 9.25 13.10 16.68 11.30 13.99 -41.15 110.32 -7.28 -42.46 109.97 -5.25 coo 26.47 11.43 10.70 25.16 9.82 11.06 -34.76 103.64 -5.32 -35.22 105.46 -4.31 ULMN 4 1qh9_c01 2-HALOACID DEHALOGENASE user 2 4 # 2 A 10 ASP B 309 ASP.? 7.61 ZN ZN B 401 A 41 ARG A 271 ARG^? 13.44 ZN ZN B 401 A 118 SER B 289 SER.? -5.32 O1 B3P B 371s A 180 ASP B 327 ASP^? 11.42 O1 B3P B 371 coo 20.70 13.03 9.13 22.27 11.81 9.81 -40.43 105.08 4.20 -40.75 103.07 3.51 coo 23.00 19.17 17.85 22.49 17.70 15.19 -33.34 101.75 -1.66 -34.94 103.58 0.21 coo 17.70 9.25 13.10 16.68 11.30 13.99 -42.54 105.00 8.17 -43.55 106.07 6.24 coo 26.47 11.43 10.70 25.16 9.82 11.06 -33.51 107.30 6.30 -34.89 106.08 5.25 1qh9_c01 source 1qh9 2-HALOACID DEHALOGENASE : 2 hits 1qh9_c01 naa= 4 ULMN 4 1qi9_c03 VANADIUM BROMOPEROXIDASE user 1 4 # 1 B 341 LYS A 311 LYS~? 6.37 O5 B3P B 371 B 411 HIS B 330 HIS~? -3.52 ZN ZN B 401s B 418 HIS B 102 HIS~? 4.91 O2 B3P B 371 B 486 HIS B 69 HIS.? -3.44 ZN ZN B 401s coo 86.35 -0.78 12.68 84.14 3.90 10.48 -40.88 103.07 -0.16 -45.35 106.37 1.57 coo 86.78 4.06 6.95 85.81 5.85 7.39 -40.87 100.43 6.30 -42.90 100.10 6.71 coo 81.39 11.93 10.46 82.24 12.93 8.84 -49.25 96.38 11.24 -48.46 97.85 9.95 coo 78.14 5.23 9.11 80.26 5.28 9.20 -45.30 94.94 7.48 -43.81 96.41 7.64 ULMN 4 1qi9_c03 VANADIUM BROMOPEROXIDASE user 2 4 # 2 B 341 LYS B 311 LYS~? 6.90 O5 B3P A 371 B 411 HIS A 330 HIS~? -3.46 ZN ZN A 402s B 418 HIS A 102 HIS~? 4.84 O2 B3P A 371 B 486 HIS A 69 HIS.? -3.50 ZN ZN A 402s coo 86.35 -0.78 12.68 84.14 3.90 10.48 -38.57 111.14 1.14 -44.17 110.56 -0.29 coo 86.78 4.06 6.95 85.81 5.85 7.39 -37.28 113.42 -5.32 -38.81 114.77 -5.81 coo 81.39 11.93 10.46 82.24 12.93 8.84 -42.24 121.28 -10.34 -42.29 119.63 -9.04 coo 78.14 5.23 9.11 80.26 5.28 9.20 -38.08 120.43 -6.58 -37.62 118.38 -6.66 1qi9_c03 source 1qi9 VANADIUM BROMOPEROXIDASE : 2 hits 1qi9_c03 naa= 4 ULMN 4 1qrz_c00 PLASMINOGEN user 1 4 # 1 A 603 HIS B 330 HIS~? -3.52 ZN ZN B 401s A 646 ASP A 314 ASP~? 9.10 O5 B3P B 371 A 739 GLY B 292 GLY.? 9.39 N2 B3P B 371 A 741 SER B 289 SER.? -5.32 O1 B3P B 371s coo -20.72 2.99 34.37 -21.94 1.82 35.61 -40.87 100.43 6.30 -42.90 100.10 6.71 coo -18.83 7.68 26.86 -20.89 7.78 26.56 -44.29 101.20 -3.40 -45.94 102.37 -2.71 coo -13.44 -7.35 30.08 -14.24 -7.41 30.34 -45.16 113.16 10.27 -44.47 113.01 10.77 coo -16.10 -1.48 32.49 -17.38 0.37 33.40 -42.54 105.00 8.17 -43.55 106.07 6.24 1qrz_c00 source 1qrz PLASMINOGEN : 1 hits 1qrz_c00 naa= 4 ULMN 4 1qrz_c03 PLASMINOGEN user 1 4 # 1 D 603 HIS B 330 HIS~? -3.52 ZN ZN B 401s D 646 ASP A 314 ASP~? 9.10 O5 B3P B 371 D 739 GLY B 292 GLY.? 9.39 N2 B3P B 371 D 741 SER B 289 SER.? -5.32 O1 B3P B 371s coo -52.57 -8.94 46.70 -54.06 -7.64 47.39 -40.87 100.43 6.30 -42.90 100.10 6.71 coo -45.30 -14.04 46.94 -45.65 -14.15 49.00 -44.29 101.20 -3.40 -45.94 102.37 -2.71 coo -45.82 1.31 41.67 -46.38 1.39 42.31 -45.16 113.16 10.27 -44.47 113.01 10.77 coo -49.16 -4.56 43.16 -50.44 -6.45 43.96 -42.54 105.00 8.17 -43.55 106.07 6.24 1qrz_c03 source 1qrz PLASMINOGEN : 1 hits 1qrz_c03 naa= 4 ULMN 4 1qrz_c04 PLASMINOGEN user 1 4 # 1 A 603 HIS A 330 HIS~? -3.46 ZN ZN A 402s A 646 ASP A 106 ASP~? 2.01 ZN ZN A 401s A 741 SER A 289 SER.? -5.35 O1 B3P A 371s A 742 GLY A 290 GLY.? 4.67 C9 B3P A 371 coo -20.72 2.99 34.37 -21.94 1.82 35.61 -37.28 113.42 -5.32 -38.81 114.77 -5.81 coo -18.83 7.68 26.86 -20.89 7.78 26.56 -41.67 116.42 -14.91 -40.59 116.67 -13.13 coo -16.10 -1.48 32.49 -17.38 0.37 33.40 -41.15 110.32 -7.28 -42.46 109.97 -5.25 coo -13.41 0.94 31.30 -13.38 0.16 31.09 -42.81 108.30 -9.98 -42.74 107.91 -9.29 ULMN 4 1qrz_c04 PLASMINOGEN user 2 4 # 2 A 603 HIS A 330 HIS~? -3.46 ZN ZN A 402s A 646 ASP A 327 ASP^? 11.36 O1 B3P A 371 A 741 SER A 289 SER.? -5.35 O1 B3P A 371s A 742 GLY A 290 GLY.? 4.67 C9 B3P A 371 coo -20.72 2.99 34.37 -21.94 1.82 35.61 -37.28 113.42 -5.32 -38.81 114.77 -5.81 coo -18.83 7.68 26.86 -20.89 7.78 26.56 -34.76 103.64 -5.32 -35.22 105.46 -4.31 coo -16.10 -1.48 32.49 -17.38 0.37 33.40 -41.15 110.32 -7.28 -42.46 109.97 -5.25 coo -13.41 0.94 31.30 -13.38 0.16 31.09 -42.81 108.30 -9.98 -42.74 107.91 -9.29 ULMN 4 1qrz_c04 PLASMINOGEN user 3 4 # 3 A 603 HIS B 330 HIS~? -3.52 ZN ZN B 401s A 646 ASP B 106 ASP~? 1.96 ZN ZN B 402s A 741 SER B 289 SER.? -5.32 O1 B3P B 371s A 742 GLY B 290 GLY.? 4.65 C9 B3P B 371 coo -20.72 2.99 34.37 -21.94 1.82 35.61 -40.87 100.43 6.30 -42.90 100.10 6.71 coo -18.83 7.68 26.86 -20.89 7.78 26.56 -46.09 100.09 15.88 -45.34 99.27 14.09 coo -16.10 -1.48 32.49 -17.38 0.37 33.40 -42.54 105.00 8.17 -43.55 106.07 6.24 coo -13.41 0.94 31.30 -13.38 0.16 31.09 -42.85 107.65 10.92 -42.56 107.92 10.26 ULMN 4 1qrz_c04 PLASMINOGEN user 4 4 # 4 A 603 HIS B 330 HIS~? -3.52 ZN ZN B 401s A 646 ASP B 327 ASP^? 11.42 O1 B3P B 371 A 741 SER B 289 SER.? -5.32 O1 B3P B 371s A 742 GLY B 290 GLY.? 4.65 C9 B3P B 371 coo -20.72 2.99 34.37 -21.94 1.82 35.61 -40.87 100.43 6.30 -42.90 100.10 6.71 coo -18.83 7.68 26.86 -20.89 7.78 26.56 -33.51 107.30 6.30 -34.89 106.08 5.25 coo -16.10 -1.48 32.49 -17.38 0.37 33.40 -42.54 105.00 8.17 -43.55 106.07 6.24 coo -13.41 0.94 31.30 -13.38 0.16 31.09 -42.85 107.65 10.92 -42.56 107.92 10.26 1qrz_c04 source 1qrz PLASMINOGEN : 4 hits 1qrz_c04 naa= 4 ULMN 4 1qrz_c05 PLASMINOGEN user 1 4 # 1 B 603 HIS A 330 HIS~? -3.46 ZN ZN A 402s B 646 ASP A 327 ASP^? 11.36 O1 B3P A 371 B 741 SER A 289 SER.? -5.35 O1 B3P A 371s B 742 GLY A 290 GLY.? 4.67 C9 B3P A 371 coo -48.36 3.10 -3.91 -49.78 2.04 -2.80 -37.28 113.42 -5.32 -38.81 114.77 -5.81 coo -46.10 7.71 -10.96 -48.16 8.01 -11.35 -34.76 103.64 -5.32 -35.22 105.46 -4.31 coo -43.75 -1.60 -6.12 -44.85 0.33 -5.15 -41.15 110.32 -7.28 -42.46 109.97 -5.25 coo -41.03 0.89 -7.12 -41.01 0.10 -7.37 -42.81 108.30 -9.98 -42.74 107.91 -9.29 ULMN 4 1qrz_c05 PLASMINOGEN user 2 4 # 2 B 603 HIS B 330 HIS~? -3.52 ZN ZN B 401s B 646 ASP B 327 ASP^? 11.42 O1 B3P B 371 B 741 SER B 289 SER.? -5.32 O1 B3P B 371s B 742 GLY B 290 GLY.? 4.65 C9 B3P B 371 coo -48.36 3.10 -3.91 -49.78 2.04 -2.80 -40.87 100.43 6.30 -42.90 100.10 6.71 coo -46.10 7.71 -10.96 -48.16 8.01 -11.35 -33.51 107.30 6.30 -34.89 106.08 5.25 coo -43.75 -1.60 -6.12 -44.85 0.33 -5.15 -42.54 105.00 8.17 -43.55 106.07 6.24 coo -41.03 0.89 -7.12 -41.01 0.10 -7.37 -42.85 107.65 10.92 -42.56 107.92 10.26 1qrz_c05 source 1qrz PLASMINOGEN : 2 hits 1qrz_c05 naa= 4 ULMN 4 1qrz_c06 PLASMINOGEN user 1 4 # 1 C 603 HIS A 330 HIS~? -3.46 ZN ZN A 402s C 646 ASP A 327 ASP^? 11.36 O1 B3P A 371 C 741 SER A 289 SER.? -5.35 O1 B3P A 371s C 742 GLY A 290 GLY.? 4.67 C9 B3P A 371 coo 1.49 -9.23 8.48 -0.19 -8.40 9.43 -37.28 113.42 -5.32 -38.81 114.77 -5.81 coo 9.05 -13.82 8.74 8.78 -14.02 10.85 -34.76 103.64 -5.32 -35.22 105.46 -4.31 coo 4.71 -4.57 4.71 3.58 -6.49 5.69 -41.15 110.32 -7.28 -42.46 109.97 -5.25 coo 6.69 -6.98 2.53 6.88 -6.20 2.57 -42.81 108.30 -9.98 -42.74 107.91 -9.29 ULMN 4 1qrz_c06 PLASMINOGEN user 2 4 # 2 C 603 HIS B 330 HIS~? -3.52 ZN ZN B 401s C 646 ASP B 327 ASP^? 11.42 O1 B3P B 371 C 741 SER B 289 SER.? -5.32 O1 B3P B 371s C 742 GLY B 290 GLY.? 4.65 C9 B3P B 371 coo 1.49 -9.23 8.48 -0.19 -8.40 9.43 -40.87 100.43 6.30 -42.90 100.10 6.71 coo 9.05 -13.82 8.74 8.78 -14.02 10.85 -33.51 107.30 6.30 -34.89 106.08 5.25 coo 4.71 -4.57 4.71 3.58 -6.49 5.69 -42.54 105.00 8.17 -43.55 106.07 6.24 coo 6.69 -6.98 2.53 6.88 -6.20 2.57 -42.85 107.65 10.92 -42.56 107.92 10.26 1qrz_c06 source 1qrz PLASMINOGEN : 2 hits 1qrz_c06 naa= 4 ULMN 4 1qrz_c07 PLASMINOGEN user 1 4 # 1 D 603 HIS A 330 HIS~? -3.46 ZN ZN A 402s D 646 ASP A 327 ASP^? 11.36 O1 B3P A 371 D 741 SER A 289 SER.? -5.35 O1 B3P A 371s D 742 GLY A 290 GLY.? 4.67 C9 B3P A 371 coo -52.57 -8.94 46.70 -54.06 -7.64 47.39 -37.28 113.42 -5.32 -38.81 114.77 -5.81 coo -45.30 -14.04 46.94 -45.65 -14.15 49.00 -34.76 103.64 -5.32 -35.22 105.46 -4.31 coo -49.16 -4.56 43.16 -50.44 -6.45 43.96 -41.15 110.32 -7.28 -42.46 109.97 -5.25 coo -47.33 -7.05 40.93 -47.11 -6.27 40.97 -42.81 108.30 -9.98 -42.74 107.91 -9.29 ULMN 4 1qrz_c07 PLASMINOGEN user 2 4 # 2 D 603 HIS B 330 HIS~? -3.52 ZN ZN B 401s D 646 ASP B 327 ASP^? 11.42 O1 B3P B 371 D 741 SER B 289 SER.? -5.32 O1 B3P B 371s D 742 GLY B 290 GLY.? 4.65 C9 B3P B 371 coo -52.57 -8.94 46.70 -54.06 -7.64 47.39 -40.87 100.43 6.30 -42.90 100.10 6.71 coo -45.30 -14.04 46.94 -45.65 -14.15 49.00 -33.51 107.30 6.30 -34.89 106.08 5.25 coo -49.16 -4.56 43.16 -50.44 -6.45 43.96 -42.54 105.00 8.17 -43.55 106.07 6.24 coo -47.33 -7.05 40.93 -47.11 -6.27 40.97 -42.85 107.65 10.92 -42.56 107.92 10.26 1qrz_c07 source 1qrz PLASMINOGEN : 2 hits 1qrz_c07 naa= 4 ULMN 4 1r4f_c01 IAG-NUCLEOSIDE HYDROLASE user 1 4 # 1 B 10 ASP A 15 ASP~? 18.15 ZN ZN A 401 B 83 TRP A 347 TRP~? 17.32 ZN ZN A 401 B 186 ASN A 104 ASN~? 10.02 ZN ZN A 401 B 260 ALA A 100 ALA^? 10.88 ZN ZN A 401 coo 32.41 24.46 38.87 30.66 25.57 39.24 -44.06 130.37 -22.15 -46.01 129.61 -22.24 coo 21.58 23.61 33.02 20.95 24.04 36.89 -34.02 126.64 -26.71 -35.49 125.97 -23.11 coo 27.66 25.11 45.19 28.06 26.34 43.52 -44.00 122.84 -17.81 -42.86 124.34 -16.78 coo 25.52 34.62 42.47 24.97 33.24 42.72 -40.07 127.59 -11.35 -41.05 127.25 -10.17 ULMN 4 1r4f_c01 IAG-NUCLEOSIDE HYDROLASE user 2 4 # 2 B 10 ASP A 106 ASP~? 2.01 ZN ZN A 401s B 83 TRP A 26 TRP.? -3.65 C7 B3P A 371s B 186 ASN A 104 ASN~? 10.02 ZN ZN A 401 B 260 ALA A 100 ALA^? 10.88 ZN ZN A 401 coo 32.41 24.46 38.87 30.66 25.57 39.24 -41.67 116.42 -14.91 -40.59 116.67 -13.13 coo 21.58 23.61 33.02 20.95 24.04 36.89 -51.65 117.79 -9.49 -47.76 118.11 -9.04 coo 27.66 25.11 45.19 28.06 26.34 43.52 -44.00 122.84 -17.81 -42.86 124.34 -16.78 coo 25.52 34.62 42.47 24.97 33.24 42.72 -40.07 127.59 -11.35 -41.05 127.25 -10.17 ULMN 4 1r4f_c01 IAG-NUCLEOSIDE HYDROLASE user 3 4 # 3 B 10 ASP B 15 ASP~? 18.09 ZN ZN B 402 B 83 TRP B 347 TRP~? 17.27 ZN ZN B 402 B 186 ASN B 104 ASN~? 9.93 ZN ZN B 402 B 260 ALA B 100 ALA^? 10.75 ZN ZN B 402 coo 32.41 24.46 38.87 30.66 25.57 39.24 -55.42 89.37 22.84 -56.66 91.01 23.17 coo 21.58 23.61 33.02 20.95 24.04 36.89 -45.02 87.04 27.40 -45.85 88.61 23.88 coo 27.66 25.11 45.19 28.06 26.34 43.52 -51.47 95.82 18.77 -51.36 94.03 17.61 coo 25.52 34.62 42.47 24.97 33.24 42.72 -50.76 89.87 12.14 -51.40 90.79 11.05 ULMN 4 1r4f_c01 IAG-NUCLEOSIDE HYDROLASE user 4 4 # 4 B 10 ASP B 106 ASP~? 1.96 ZN ZN B 402s B 83 TRP B 26 TRP.? -3.78 C7 B3P B 371s B 186 ASN B 104 ASN~? 9.93 ZN ZN B 402 B 260 ALA B 100 ALA^? 10.75 ZN ZN B 402 coo 32.41 24.46 38.87 30.66 25.57 39.24 -46.09 100.09 15.88 -45.34 99.27 14.09 coo 21.58 23.61 33.02 20.95 24.04 36.89 -55.31 104.28 10.59 -52.19 101.94 10.03 coo 27.66 25.11 45.19 28.06 26.34 43.52 -51.47 95.82 18.77 -51.36 94.03 17.61 coo 25.52 34.62 42.47 24.97 33.24 42.72 -50.76 89.87 12.14 -51.40 90.79 11.05 1r4f_c01 source 1r4f IAG-NUCLEOSIDE HYDROLASE : 4 hits 1r4f_c01 naa= 4 ULMN 4 1rgq_c00 NS4A PEPTIDE user 1 4 # 1 A 60 HIS A 312 HIS~? 6.48 ZN ZN B 401 A 84 ASP B 48 ASP.? 7.12 ZN ZN B 401 A 140 GLY B 287 GLY.? -5.68 O1 B3P B 371s A 142 SER B 332 SER~? 10.87 ZN ZN B 401 coo -11.57 56.27 -2.56 -10.65 55.84 -4.39 -41.04 97.86 3.25 -41.05 95.82 3.71 coo -6.31 55.84 0.20 -8.34 56.18 -0.37 -43.07 90.96 4.68 -43.24 93.07 4.75 coo -14.76 51.65 -11.32 -14.03 51.78 -11.65 -39.64 102.20 13.09 -40.38 102.61 13.11 coo -9.99 51.54 -8.47 -9.82 53.92 -8.11 -35.18 97.79 10.03 -33.17 99.10 9.80 ULMN 4 1rgq_c00 NS4A PEPTIDE user 2 4 # 2 A 60 HIS A 312 HIS~? 6.48 ZN ZN B 401 A 84 ASP B 365 ASP.? 11.69 ZN ZN B 401 A 140 GLY B 287 GLY.? -5.68 O1 B3P B 371s A 142 SER B 332 SER~? 10.87 ZN ZN B 401 coo -11.57 56.27 -2.56 -10.65 55.84 -4.39 -41.04 97.86 3.25 -41.05 95.82 3.71 coo -6.31 55.84 0.20 -8.34 56.18 -0.37 -34.85 93.86 2.40 -34.89 96.00 2.14 coo -14.76 51.65 -11.32 -14.03 51.78 -11.65 -39.64 102.20 13.09 -40.38 102.61 13.11 coo -9.99 51.54 -8.47 -9.82 53.92 -8.11 -35.18 97.79 10.03 -33.17 99.10 9.80 ULMN 4 1rgq_c00 NS4A PEPTIDE user 3 4 # 3 A 60 HIS A 313 HIS~? 5.54 ZN ZN B 401 A 84 ASP A 314 ASP~? 9.10 O5 B3P B 371 A 140 GLY B 288 GLY.? -3.59 O1 B3P B 371s A 142 SER B 289 SER.? -5.32 O1 B3P B 371s coo -11.57 56.27 -2.56 -10.65 55.84 -4.39 -45.85 98.44 2.81 -45.85 97.45 4.68 coo -6.31 55.84 0.20 -8.34 56.18 -0.37 -44.29 101.20 -3.40 -45.94 102.37 -2.71 coo -14.76 51.65 -11.32 -14.03 51.78 -11.65 -41.26 101.79 9.71 -40.78 102.47 9.85 coo -9.99 51.54 -8.47 -9.82 53.92 -8.11 -42.54 105.00 8.17 -43.55 106.07 6.24 ULMN 4 1rgq_c00 NS4A PEPTIDE user 4 4 # 4 A 60 HIS A 313 HIS~? 5.54 ZN ZN B 401 A 84 ASP A 314 ASP~? 9.10 O5 B3P B 371 A 140 GLY B 308 GLY.? 7.72 O1 B3P B 371 A 142 SER B 289 SER.? -5.32 O1 B3P B 371s coo -11.57 56.27 -2.56 -10.65 55.84 -4.39 -45.85 98.44 2.81 -45.85 97.45 4.68 coo -6.31 55.84 0.20 -8.34 56.18 -0.37 -44.29 101.20 -3.40 -45.94 102.37 -2.71 coo -14.76 51.65 -11.32 -14.03 51.78 -11.65 -37.60 104.71 7.65 -38.14 105.31 7.82 coo -9.99 51.54 -8.47 -9.82 53.92 -8.11 -42.54 105.00 8.17 -43.55 106.07 6.24 ULMN 4 1rgq_c00 NS4A PEPTIDE user 5 4 # 5 A 60 HIS B 312 HIS~? 6.47 ZN ZN A 402 A 84 ASP A 48 ASP.? 7.07 ZN ZN A 402 A 140 GLY A 287 GLY.? -5.56 O1 B3P A 371s A 142 SER A 332 SER~? 10.92 ZN ZN A 402 coo -11.57 56.27 -2.56 -10.65 55.84 -4.39 -36.00 115.58 -2.34 -34.91 117.32 -2.81 coo -6.31 55.84 0.20 -8.34 56.18 -0.37 -34.00 122.50 -3.86 -35.34 120.86 -3.93 coo -14.76 51.65 -11.32 -14.03 51.78 -11.65 -37.37 111.28 -12.26 -38.18 111.28 -12.23 coo -9.99 51.54 -8.47 -9.82 53.92 -8.11 -31.12 112.57 -9.16 -30.10 110.35 -8.93 ULMN 4 1rgq_c00 NS4A PEPTIDE user 6 4 # 6 A 60 HIS B 312 HIS~? 6.47 ZN ZN A 402 A 84 ASP A 365 ASP.? 11.72 ZN ZN A 402 A 140 GLY A 287 GLY.? -5.56 O1 B3P A 371s A 142 SER A 332 SER~? 10.92 ZN ZN A 402 coo -11.57 56.27 -2.56 -10.65 55.84 -4.39 -36.00 115.58 -2.34 -34.91 117.32 -2.81 coo -6.31 55.84 0.20 -8.34 56.18 -0.37 -28.60 115.73 -1.61 -29.73 113.97 -1.34 coo -14.76 51.65 -11.32 -14.03 51.78 -11.65 -37.37 111.28 -12.26 -38.18 111.28 -12.23 coo -9.99 51.54 -8.47 -9.82 53.92 -8.11 -31.12 112.57 -9.16 -30.10 110.35 -8.93 1rgq_c00 source 1rgq NS4A PEPTIDE : 6 hits 1rgq_c00 naa= 4 ULMN 4 1v0y_c00 PHOSPHOLIPASE D user 1 4 # 1 A 170 HIS A 68 HIS.? -3.48 ZN ZN A 401s A 202 ASP A 309 ASP.? 7.55 ZN ZN A 402 A 448 HIS A 330 HIS~? -3.46 ZN ZN A 402s A 473 ASP A 106 ASP~? 2.01 ZN ZN A 401s coo 15.19 27.99 11.95 13.02 28.03 12.03 -37.46 120.39 -11.50 -38.87 119.03 -12.26 coo 4.95 34.38 14.49 6.71 33.17 14.61 -39.32 109.22 -3.35 -38.59 111.09 -2.57 coo 6.73 30.70 11.43 8.79 30.60 11.04 -37.28 113.42 -5.32 -38.81 114.77 -5.81 coo 16.78 26.00 16.74 15.90 26.28 14.86 -41.67 116.42 -14.91 -40.59 116.67 -13.13 ULMN 4 1v0y_c00 PHOSPHOLIPASE D user 2 4 # 2 A 170 HIS A 102 HIS~? 4.84 O2 B3P A 371 A 202 ASP A 309 ASP.? 7.55 ZN ZN A 402 A 448 HIS A 330 HIS~? -3.46 ZN ZN A 402s A 473 ASP A 106 ASP~? 2.01 ZN ZN A 401s coo 15.19 27.99 11.95 13.02 28.03 12.03 -42.24 121.28 -10.34 -42.29 119.63 -9.04 coo 4.95 34.38 14.49 6.71 33.17 14.61 -39.32 109.22 -3.35 -38.59 111.09 -2.57 coo 6.73 30.70 11.43 8.79 30.60 11.04 -37.28 113.42 -5.32 -38.81 114.77 -5.81 coo 16.78 26.00 16.74 15.90 26.28 14.86 -41.67 116.42 -14.91 -40.59 116.67 -13.13 ULMN 4 1v0y_c00 PHOSPHOLIPASE D user 3 4 # 3 A 170 HIS A 312 HIS~? 6.48 ZN ZN B 401 A 202 ASP B 106 ASP~? 1.96 ZN ZN B 402s A 448 HIS B 68 HIS.? -3.46 ZN ZN B 402s A 473 ASP B 309 ASP.? 7.61 ZN ZN B 401 coo 15.19 27.99 11.95 13.02 28.03 12.03 -41.04 97.86 3.25 -41.05 95.82 3.71 coo 4.95 34.38 14.49 6.71 33.17 14.61 -46.09 100.09 15.88 -45.34 99.27 14.09 coo 6.73 30.70 11.43 8.79 30.60 11.04 -44.72 94.50 12.35 -45.14 96.41 13.13 coo 16.78 26.00 16.74 15.90 26.28 14.86 -40.43 105.08 4.20 -40.75 103.07 3.51 ULMN 4 1v0y_c00 PHOSPHOLIPASE D user 4 4 # 4 A 170 HIS A 330 HIS~? -3.46 ZN ZN A 402s A 202 ASP A 106 ASP~? 2.01 ZN ZN A 401s A 448 HIS A 68 HIS.? -3.48 ZN ZN A 401s A 473 ASP A 309 ASP.? 7.55 ZN ZN A 402 coo 15.19 27.99 11.95 13.02 28.03 12.03 -37.28 113.42 -5.32 -38.81 114.77 -5.81 coo 4.95 34.38 14.49 6.71 33.17 14.61 -41.67 116.42 -14.91 -40.59 116.67 -13.13 coo 6.73 30.70 11.43 8.79 30.60 11.04 -37.46 120.39 -11.50 -38.87 119.03 -12.26 coo 16.78 26.00 16.74 15.90 26.28 14.86 -39.32 109.22 -3.35 -38.59 111.09 -2.57 ULMN 4 1v0y_c00 PHOSPHOLIPASE D user 5 4 # 5 A 170 HIS A 330 HIS~? -3.46 ZN ZN A 402s A 202 ASP A 106 ASP~? 2.01 ZN ZN A 401s A 448 HIS A 102 HIS~? 4.84 O2 B3P A 371 A 473 ASP A 309 ASP.? 7.55 ZN ZN A 402 coo 15.19 27.99 11.95 13.02 28.03 12.03 -37.28 113.42 -5.32 -38.81 114.77 -5.81 coo 4.95 34.38 14.49 6.71 33.17 14.61 -41.67 116.42 -14.91 -40.59 116.67 -13.13 coo 6.73 30.70 11.43 8.79 30.60 11.04 -42.24 121.28 -10.34 -42.29 119.63 -9.04 coo 16.78 26.00 16.74 15.90 26.28 14.86 -39.32 109.22 -3.35 -38.59 111.09 -2.57 ULMN 4 1v0y_c00 PHOSPHOLIPASE D user 6 4 # 6 A 170 HIS B 68 HIS.? -3.46 ZN ZN B 402s A 202 ASP B 309 ASP.? 7.61 ZN ZN B 401 A 448 HIS B 330 HIS~? -3.52 ZN ZN B 401s A 473 ASP B 106 ASP~? 1.96 ZN ZN B 402s coo 15.19 27.99 11.95 13.02 28.03 12.03 -44.72 94.50 12.35 -45.14 96.41 13.13 coo 4.95 34.38 14.49 6.71 33.17 14.61 -40.43 105.08 4.20 -40.75 103.07 3.51 coo 6.73 30.70 11.43 8.79 30.60 11.04 -40.87 100.43 6.30 -42.90 100.10 6.71 coo 16.78 26.00 16.74 15.90 26.28 14.86 -46.09 100.09 15.88 -45.34 99.27 14.09 ULMN 4 1v0y_c00 PHOSPHOLIPASE D user 7 4 # 7 A 170 HIS B 102 HIS~? 4.91 O2 B3P B 371 A 202 ASP B 309 ASP.? 7.61 ZN ZN B 401 A 448 HIS B 330 HIS~? -3.52 ZN ZN B 401s A 473 ASP B 106 ASP~? 1.96 ZN ZN B 402s coo 15.19 27.99 11.95 13.02 28.03 12.03 -49.25 96.38 11.24 -48.46 97.85 9.95 coo 4.95 34.38 14.49 6.71 33.17 14.61 -40.43 105.08 4.20 -40.75 103.07 3.51 coo 6.73 30.70 11.43 8.79 30.60 11.04 -40.87 100.43 6.30 -42.90 100.10 6.71 coo 16.78 26.00 16.74 15.90 26.28 14.86 -46.09 100.09 15.88 -45.34 99.27 14.09 ULMN 4 1v0y_c00 PHOSPHOLIPASE D user 8 4 # 8 A 170 HIS B 312 HIS~? 6.47 ZN ZN A 402 A 202 ASP A 106 ASP~? 2.01 ZN ZN A 401s A 448 HIS A 68 HIS.? -3.48 ZN ZN A 401s A 473 ASP A 309 ASP.? 7.55 ZN ZN A 402 coo 15.19 27.99 11.95 13.02 28.03 12.03 -36.00 115.58 -2.34 -34.91 117.32 -2.81 coo 4.95 34.38 14.49 6.71 33.17 14.61 -41.67 116.42 -14.91 -40.59 116.67 -13.13 coo 6.73 30.70 11.43 8.79 30.60 11.04 -37.46 120.39 -11.50 -38.87 119.03 -12.26 coo 16.78 26.00 16.74 15.90 26.28 14.86 -39.32 109.22 -3.35 -38.59 111.09 -2.57 ULMN 4 1v0y_c00 PHOSPHOLIPASE D user 9 4 # 9 A 170 HIS B 330 HIS~? -3.52 ZN ZN B 401s A 202 ASP B 106 ASP~? 1.96 ZN ZN B 402s A 448 HIS B 68 HIS.? -3.46 ZN ZN B 402s A 473 ASP B 309 ASP.? 7.61 ZN ZN B 401 coo 15.19 27.99 11.95 13.02 28.03 12.03 -40.87 100.43 6.30 -42.90 100.10 6.71 coo 4.95 34.38 14.49 6.71 33.17 14.61 -46.09 100.09 15.88 -45.34 99.27 14.09 coo 6.73 30.70 11.43 8.79 30.60 11.04 -44.72 94.50 12.35 -45.14 96.41 13.13 coo 16.78 26.00 16.74 15.90 26.28 14.86 -40.43 105.08 4.20 -40.75 103.07 3.51 ULMN 4 1v0y_c00 PHOSPHOLIPASE D user 10 4 # 10 A 170 HIS B 330 HIS~? -3.52 ZN ZN B 401s A 202 ASP B 106 ASP~? 1.96 ZN ZN B 402s A 448 HIS B 102 HIS~? 4.91 O2 B3P B 371 A 473 ASP B 309 ASP.? 7.61 ZN ZN B 401 coo 15.19 27.99 11.95 13.02 28.03 12.03 -40.87 100.43 6.30 -42.90 100.10 6.71 coo 4.95 34.38 14.49 6.71 33.17 14.61 -46.09 100.09 15.88 -45.34 99.27 14.09 coo 6.73 30.70 11.43 8.79 30.60 11.04 -49.25 96.38 11.24 -48.46 97.85 9.95 coo 16.78 26.00 16.74 15.90 26.28 14.86 -40.43 105.08 4.20 -40.75 103.07 3.51 1v0y_c00 source 1v0y PHOSPHOLIPASE D : 10 hits 1v0y_c00 naa= 4 ULMN 4 2alr_c00 ALDEHYDE REDUCTASE user 1 4 # 1 44 ASP A 314 ASP~? 9.10 O5 B3P B 371 49 TYR A 295 TYR~? 16.26 C9 B3P A 371 79 LYS A 319 LYS~? 18.09 ZN ZN B 401 112 HIS A 321 HIS~? 16.72 O4 B3P B 371 coo 6.17 -0.98 36.99 6.36 -2.08 35.21 -44.29 101.20 -3.40 -45.94 102.37 -2.71 coo 8.78 -8.94 37.04 9.01 -6.91 35.11 -48.13 97.91 -11.44 -47.20 97.03 -8.94 coo 1.95 -7.11 31.57 6.32 -4.48 33.65 -41.25 92.42 -6.09 -36.50 89.98 -5.00 coo 6.57 -8.25 29.17 8.05 -8.05 30.63 -47.70 92.41 -8.31 -49.45 92.40 -7.16 ULMN 4 2alr_c00 ALDEHYDE REDUCTASE user 2 4 # 2 44 ASP B 314 ASP~? 9.37 O5 B3P A 371 49 TYR B 295 TYR~? 16.19 C9 B3P B 371 79 LYS B 319 LYS~? 18.23 ZN ZN A 402 112 HIS B 321 HIS~? 16.92 O4 B3P A 371 coo 6.17 -0.98 36.99 6.36 -2.08 35.21 -40.38 114.62 4.43 -42.39 114.53 3.82 coo 8.78 -8.94 37.04 9.01 -6.91 35.11 -41.84 119.19 12.43 -40.61 119.57 9.93 coo 1.95 -7.11 31.57 6.32 -4.48 33.65 -33.05 120.28 7.11 -27.72 119.85 5.88 coo 6.57 -8.25 29.17 8.05 -8.05 30.63 -38.45 123.77 9.41 -39.84 124.80 8.23 2alr_c00 source 2alr ALDEHYDE REDUCTASE : 2 hits 2alr_c00 naa= 4 ULMN 3 12as_c00 ASPARAGINE SYNTHETASE user 1 3 # 1 A 46 ASP A 365 ASP.? 11.72 ZN ZN A 402 A 100 ARG B 271 ARG^? 13.51 ZN ZN A 402 A 116 GLN A 368 GLN^? 21.79 ZN ZN A 402 coo 32.24 20.09 5.34 30.38 19.04 5.27 -28.60 115.73 -1.61 -29.73 113.97 -1.34 coo 26.40 25.34 6.28 26.15 22.33 7.25 -31.35 108.28 2.46 -33.78 107.49 0.72 coo 26.74 21.94 13.78 27.57 20.97 12.08 -23.64 112.82 4.69 -22.27 114.10 5.71 ULMN 3 12as_c00 ASPARAGINE SYNTHETASE user 2 3 # 2 A 46 ASP B 365 ASP.? 11.69 ZN ZN B 401 A 100 ARG A 271 ARG^? 13.44 ZN ZN B 401 A 116 GLN B 368 GLN^? 21.77 ZN ZN B 401 coo 32.24 20.09 5.34 30.38 19.04 5.27 -34.85 93.86 2.40 -34.89 96.00 2.14 coo 26.40 25.34 6.28 26.15 22.33 7.25 -33.34 101.75 -1.66 -34.94 103.58 0.21 coo 26.74 21.94 13.78 27.57 20.97 12.08 -29.16 93.76 -3.85 -28.70 92.01 -5.01 12as_c00 source 12as ASPARAGINE SYNTHETASE : 2 hits 12as_c00 naa= 3 ULMN 3 12as_c01 ASPARAGINE SYNTHETASE user 1 3 # 1 B 46 ASP A 365 ASP.? 11.72 ZN ZN A 402 B 100 ARG B 271 ARG^? 13.51 ZN ZN A 402 B 116 GLN A 368 GLN^? 21.79 ZN ZN A 402 coo 32.18 48.37 12.48 33.96 49.46 12.97 -28.60 115.73 -1.61 -29.73 113.97 -1.34 coo 39.04 43.25 11.37 38.30 45.35 13.56 -31.35 108.28 2.46 -33.78 107.49 0.72 coo 37.43 42.63 19.41 36.76 44.08 17.97 -23.64 112.82 4.69 -22.27 114.10 5.71 ULMN 3 12as_c01 ASPARAGINE SYNTHETASE user 2 3 # 2 B 46 ASP B 365 ASP.? 11.69 ZN ZN B 401 B 100 ARG A 271 ARG^? 13.44 ZN ZN B 401 B 116 GLN B 368 GLN^? 21.77 ZN ZN B 401 coo 32.18 48.37 12.48 33.96 49.46 12.97 -34.85 93.86 2.40 -34.89 96.00 2.14 coo 39.04 43.25 11.37 38.30 45.35 13.56 -33.34 101.75 -1.66 -34.94 103.58 0.21 coo 37.43 42.63 19.41 36.76 44.08 17.97 -29.16 93.76 -3.85 -28.70 92.01 -5.01 12as_c01 source 12as ASPARAGINE SYNTHETASE : 2 hits 12as_c01 naa= 3 ULMN 3 1a05_c00 3-ISOPROPYLMALATE DEHYDROGENASE user 1 3 # 1 A 140 TYR A 84 TYR~? 13.75 O4 B3P A 371 B 190 LYS B 319 LYS~? 18.23 ZN ZN A 402 B 222 ASP B 314 ASP~? 9.37 O5 B3P A 371 coo 7.17 16.59 41.26 8.01 19.20 40.73 -39.14 126.77 2.96 -38.54 124.09 2.48 coo 13.38 20.00 35.06 11.43 22.49 39.53 -33.05 120.28 7.11 -27.72 119.85 5.88 coo 9.76 26.58 38.10 11.63 25.78 38.76 -40.38 114.62 4.43 -42.39 114.53 3.82 ULMN 3 1a05_c00 3-ISOPROPYLMALATE DEHYDROGENASE user 2 3 # 2 A 140 TYR A 136 TYR^? 26.70 O3 B3P A 371 B 190 LYS A 235 LYS^? 20.59 O3 B3P A 371 B 222 ASP A 133 ASP^? 16.96 O3 B3P A 371 coo 7.17 16.59 41.26 8.01 19.20 40.73 -62.12 122.60 -32.08 -63.01 122.36 -29.44 coo 13.38 20.00 35.06 11.43 22.49 39.53 -57.83 114.71 -29.98 -61.47 113.46 -24.90 coo 9.76 26.58 38.10 11.63 25.78 38.76 -52.93 118.32 -28.08 -51.05 118.45 -27.14 ULMN 3 1a05_c00 3-ISOPROPYLMALATE DEHYDROGENASE user 3 3 # 3 A 140 TYR A 295 TYR~? 16.26 C9 B3P A 371 B 190 LYS A 319 LYS~? 18.09 ZN ZN B 401 B 222 ASP A 314 ASP~? 9.10 O5 B3P B 371 coo 7.17 16.59 41.26 8.01 19.20 40.73 -48.13 97.91 -11.44 -47.20 97.03 -8.94 coo 13.38 20.00 35.06 11.43 22.49 39.53 -41.25 92.42 -6.09 -36.50 89.98 -5.00 coo 9.76 26.58 38.10 11.63 25.78 38.76 -44.29 101.20 -3.40 -45.94 102.37 -2.71 ULMN 3 1a05_c00 3-ISOPROPYLMALATE DEHYDROGENASE user 4 3 # 4 A 140 TYR B 84 TYR~? 13.70 O4 B3P B 371 B 190 LYS A 319 LYS~? 18.09 ZN ZN B 401 B 222 ASP A 314 ASP~? 9.10 O5 B3P B 371 coo 7.17 16.59 41.26 8.01 19.20 40.73 -49.86 90.29 -2.09 -47.88 92.17 -1.55 coo 13.38 20.00 35.06 11.43 22.49 39.53 -41.25 92.42 -6.09 -36.50 89.98 -5.00 coo 9.76 26.58 38.10 11.63 25.78 38.76 -44.29 101.20 -3.40 -45.94 102.37 -2.71 ULMN 3 1a05_c00 3-ISOPROPYLMALATE DEHYDROGENASE user 5 3 # 5 A 140 TYR B 136 TYR^? 26.89 O3 B3P B 371 B 190 LYS B 235 LYS^? 19.61 O3 B3P B 371 B 222 ASP B 133 ASP^? 16.46 O3 B3P B 371 coo 7.17 16.59 41.26 8.01 19.20 40.73 -67.10 105.92 32.90 -67.89 106.45 30.30 coo 13.38 20.00 35.06 11.43 22.49 39.53 -59.03 109.94 30.76 -61.23 112.02 25.19 coo 9.76 26.58 38.10 11.63 25.78 38.76 -57.12 104.20 28.48 -55.49 103.35 27.39 ULMN 3 1a05_c00 3-ISOPROPYLMALATE DEHYDROGENASE user 6 3 # 6 A 140 TYR B 295 TYR~? 16.19 C9 B3P B 371 B 190 LYS B 319 LYS~? 18.23 ZN ZN A 402 B 222 ASP B 314 ASP~? 9.37 O5 B3P A 371 coo 7.17 16.59 41.26 8.01 19.20 40.73 -41.84 119.19 12.43 -40.61 119.57 9.93 coo 13.38 20.00 35.06 11.43 22.49 39.53 -33.05 120.28 7.11 -27.72 119.85 5.88 coo 9.76 26.58 38.10 11.63 25.78 38.76 -40.38 114.62 4.43 -42.39 114.53 3.82 1a05_c00 source 1a05 3-ISOPROPYLMALATE DEHYDROGENASE : 6 hits 1a05_c00 naa= 3 ULMN 3 1a05_c01 3-ISOPROPYLMALATE DEHYDROGENASE user 1 3 # 1 A 190 LYS A 235 LYS^? 20.59 O3 B3P A 371 A 222 ASP A 133 ASP^? 16.96 O3 B3P A 371 B 140 TYR A 136 TYR^? 26.70 O3 B3P A 371 coo -4.61 20.12 30.34 -2.74 22.65 25.95 -57.83 114.71 -29.98 -61.47 113.46 -24.90 coo -1.04 26.60 27.37 -2.94 25.93 26.69 -52.93 118.32 -28.08 -51.05 118.45 -27.14 coo 1.51 16.60 24.17 0.82 19.23 24.79 -62.12 122.60 -32.08 -63.01 122.36 -29.44 ULMN 3 1a05_c01 3-ISOPROPYLMALATE DEHYDROGENASE user 2 3 # 2 A 190 LYS A 319 LYS~? 18.09 ZN ZN B 401 A 222 ASP A 314 ASP~? 9.10 O5 B3P B 371 B 140 TYR A 295 TYR~? 16.26 C9 B3P A 371 coo -4.61 20.12 30.34 -2.74 22.65 25.95 -41.25 92.42 -6.09 -36.50 89.98 -5.00 coo -1.04 26.60 27.37 -2.94 25.93 26.69 -44.29 101.20 -3.40 -45.94 102.37 -2.71 coo 1.51 16.60 24.17 0.82 19.23 24.79 -48.13 97.91 -11.44 -47.20 97.03 -8.94 ULMN 3 1a05_c01 3-ISOPROPYLMALATE DEHYDROGENASE user 3 3 # 3 A 190 LYS A 319 LYS~? 18.09 ZN ZN B 401 A 222 ASP A 314 ASP~? 9.10 O5 B3P B 371 B 140 TYR B 84 TYR~? 13.70 O4 B3P B 371 coo -4.61 20.12 30.34 -2.74 22.65 25.95 -41.25 92.42 -6.09 -36.50 89.98 -5.00 coo -1.04 26.60 27.37 -2.94 25.93 26.69 -44.29 101.20 -3.40 -45.94 102.37 -2.71 coo 1.51 16.60 24.17 0.82 19.23 24.79 -49.86 90.29 -2.09 -47.88 92.17 -1.55 ULMN 3 1a05_c01 3-ISOPROPYLMALATE DEHYDROGENASE user 4 3 # 4 A 190 LYS B 235 LYS^? 19.61 O3 B3P B 371 A 222 ASP B 133 ASP^? 16.46 O3 B3P B 371 B 140 TYR B 136 TYR^? 26.89 O3 B3P B 371 coo -4.61 20.12 30.34 -2.74 22.65 25.95 -59.03 109.94 30.76 -61.23 112.02 25.19 coo -1.04 26.60 27.37 -2.94 25.93 26.69 -57.12 104.20 28.48 -55.49 103.35 27.39 coo 1.51 16.60 24.17 0.82 19.23 24.79 -67.10 105.92 32.90 -67.89 106.45 30.30 ULMN 3 1a05_c01 3-ISOPROPYLMALATE DEHYDROGENASE user 5 3 # 5 A 190 LYS B 319 LYS~? 18.23 ZN ZN A 402 A 222 ASP B 314 ASP~? 9.37 O5 B3P A 371 B 140 TYR A 84 TYR~? 13.75 O4 B3P A 371 coo -4.61 20.12 30.34 -2.74 22.65 25.95 -33.05 120.28 7.11 -27.72 119.85 5.88 coo -1.04 26.60 27.37 -2.94 25.93 26.69 -40.38 114.62 4.43 -42.39 114.53 3.82 coo 1.51 16.60 24.17 0.82 19.23 24.79 -39.14 126.77 2.96 -38.54 124.09 2.48 ULMN 3 1a05_c01 3-ISOPROPYLMALATE DEHYDROGENASE user 6 3 # 6 A 190 LYS B 319 LYS~? 18.23 ZN ZN A 402 A 222 ASP B 314 ASP~? 9.37 O5 B3P A 371 B 140 TYR B 295 TYR~? 16.19 C9 B3P B 371 coo -4.61 20.12 30.34 -2.74 22.65 25.95 -33.05 120.28 7.11 -27.72 119.85 5.88 coo -1.04 26.60 27.37 -2.94 25.93 26.69 -40.38 114.62 4.43 -42.39 114.53 3.82 coo 1.51 16.60 24.17 0.82 19.23 24.79 -41.84 119.19 12.43 -40.61 119.57 9.93 1a05_c01 source 1a05 3-ISOPROPYLMALATE DEHYDROGENASE : 6 hits 1a05_c01 naa= 3 ULMN 3 1a0j_c00 TRYPSIN user 1 3 # 1 A 57 HIS A 69 HIS.? -3.50 ZN ZN A 402s A 102 ASP A 48 ASP.? 7.07 ZN ZN A 402 A 195 SER A 67 SER^? 10.42 ZN ZN A 402 coo 25.57 41.22 61.68 24.18 39.98 62.50 -38.08 120.43 -6.58 -37.62 118.38 -6.66 coo 22.33 45.48 59.73 23.35 43.67 60.06 -34.00 122.50 -3.86 -35.34 120.86 -3.93 coo 20.90 36.72 61.65 22.18 37.53 63.52 -35.40 126.06 -10.23 -37.10 126.61 -8.52 ULMN 3 1a0j_c00 TRYPSIN user 2 3 # 2 A 57 HIS A 330 HIS~? -3.46 ZN ZN A 402s A 102 ASP A 309 ASP.? 7.55 ZN ZN A 402 A 195 SER A 332 SER~? 10.92 ZN ZN A 402 coo 25.57 41.22 61.68 24.18 39.98 62.50 -37.28 113.42 -5.32 -38.81 114.77 -5.81 coo 22.33 45.48 59.73 23.35 43.67 60.06 -39.32 109.22 -3.35 -38.59 111.09 -2.57 coo 20.90 36.72 61.65 22.18 37.53 63.52 -31.12 112.57 -9.16 -30.10 110.35 -8.93 ULMN 3 1a0j_c00 TRYPSIN user 3 3 # 3 A 57 HIS B 69 HIS.? -3.44 ZN ZN B 401s A 102 ASP B 48 ASP.? 7.12 ZN ZN B 401 A 195 SER B 67 SER^? 10.38 ZN ZN B 401 coo 25.57 41.22 61.68 24.18 39.98 62.50 -45.30 94.94 7.48 -43.81 96.41 7.64 coo 22.33 45.48 59.73 23.35 43.67 60.06 -43.07 90.96 4.68 -43.24 93.07 4.75 coo 20.90 36.72 61.65 22.18 37.53 63.52 -46.05 88.61 10.98 -47.75 89.13 9.26 ULMN 3 1a0j_c00 TRYPSIN user 4 3 # 4 A 57 HIS B 330 HIS~? -3.52 ZN ZN B 401s A 102 ASP B 309 ASP.? 7.61 ZN ZN B 401 A 195 SER B 332 SER~? 10.87 ZN ZN B 401 coo 25.57 41.22 61.68 24.18 39.98 62.50 -40.87 100.43 6.30 -42.90 100.10 6.71 coo 22.33 45.48 59.73 23.35 43.67 60.06 -40.43 105.08 4.20 -40.75 103.07 3.51 coo 20.90 36.72 61.65 22.18 37.53 63.52 -35.18 97.79 10.03 -33.17 99.10 9.80 1a0j_c00 source 1a0j TRYPSIN : 4 hits 1a0j_c00 naa= 3 ULMN 3 1a0j_c01 TRYPSIN user 1 3 # 1 B 57 HIS A 69 HIS.? -3.50 ZN ZN A 402s B 102 ASP A 48 ASP.? 7.07 ZN ZN A 402 B 195 SER A 67 SER^? 10.42 ZN ZN A 402 coo 44.08 45.58 52.81 45.86 46.55 52.85 -38.08 120.43 -6.58 -37.62 118.38 -6.66 coo 43.04 44.75 47.18 43.31 45.51 49.13 -34.00 122.50 -3.86 -35.34 120.86 -3.93 coo 48.11 50.52 52.24 48.62 48.46 53.13 -35.40 126.06 -10.23 -37.10 126.61 -8.52 ULMN 3 1a0j_c01 TRYPSIN user 2 3 # 2 B 57 HIS A 330 HIS~? -3.46 ZN ZN A 402s B 102 ASP A 309 ASP.? 7.55 ZN ZN A 402 B 195 SER A 332 SER~? 10.92 ZN ZN A 402 coo 44.08 45.58 52.81 45.86 46.55 52.85 -37.28 113.42 -5.32 -38.81 114.77 -5.81 coo 43.04 44.75 47.18 43.31 45.51 49.13 -39.32 109.22 -3.35 -38.59 111.09 -2.57 coo 48.11 50.52 52.24 48.62 48.46 53.13 -31.12 112.57 -9.16 -30.10 110.35 -8.93 ULMN 3 1a0j_c01 TRYPSIN user 3 3 # 3 B 57 HIS B 69 HIS.? -3.44 ZN ZN B 401s B 102 ASP B 48 ASP.? 7.12 ZN ZN B 401 B 195 SER B 67 SER^? 10.38 ZN ZN B 401 coo 44.08 45.58 52.81 45.86 46.55 52.85 -45.30 94.94 7.48 -43.81 96.41 7.64 coo 43.04 44.75 47.18 43.31 45.51 49.13 -43.07 90.96 4.68 -43.24 93.07 4.75 coo 48.11 50.52 52.24 48.62 48.46 53.13 -46.05 88.61 10.98 -47.75 89.13 9.26 ULMN 3 1a0j_c01 TRYPSIN user 4 3 # 4 B 57 HIS B 330 HIS~? -3.52 ZN ZN B 401s B 102 ASP B 309 ASP.? 7.61 ZN ZN B 401 B 195 SER B 332 SER~? 10.87 ZN ZN B 401 coo 44.08 45.58 52.81 45.86 46.55 52.85 -40.87 100.43 6.30 -42.90 100.10 6.71 coo 43.04 44.75 47.18 43.31 45.51 49.13 -40.43 105.08 4.20 -40.75 103.07 3.51 coo 48.11 50.52 52.24 48.62 48.46 53.13 -35.18 97.79 10.03 -33.17 99.10 9.80 1a0j_c01 source 1a0j TRYPSIN : 4 hits 1a0j_c01 naa= 3 ULMN 3 1a0j_c02 TRYPSIN user 1 3 # 1 C 57 HIS A 69 HIS.? -3.50 ZN ZN A 402s C 102 ASP A 48 ASP.? 7.07 ZN ZN A 402 C 195 SER A 67 SER^? 10.42 ZN ZN A 402 coo 34.37 41.18 73.21 34.04 43.09 73.87 -38.08 120.43 -6.58 -37.62 118.38 -6.66 coo 34.89 38.34 78.12 35.11 39.59 76.42 -34.00 122.50 -3.86 -35.34 120.86 -3.93 coo 36.16 46.87 75.66 34.01 46.43 74.59 -35.40 126.06 -10.23 -37.10 126.61 -8.52 ULMN 3 1a0j_c02 TRYPSIN user 2 3 # 2 C 57 HIS A 330 HIS~? -3.46 ZN ZN A 402s C 102 ASP A 309 ASP.? 7.55 ZN ZN A 402 C 195 SER A 332 SER~? 10.92 ZN ZN A 402 coo 34.37 41.18 73.21 34.04 43.09 73.87 -37.28 113.42 -5.32 -38.81 114.77 -5.81 coo 34.89 38.34 78.12 35.11 39.59 76.42 -39.32 109.22 -3.35 -38.59 111.09 -2.57 coo 36.16 46.87 75.66 34.01 46.43 74.59 -31.12 112.57 -9.16 -30.10 110.35 -8.93 ULMN 3 1a0j_c02 TRYPSIN user 3 3 # 3 C 57 HIS B 69 HIS.? -3.44 ZN ZN B 401s C 102 ASP B 48 ASP.? 7.12 ZN ZN B 401 C 195 SER B 67 SER^? 10.38 ZN ZN B 401 coo 34.37 41.18 73.21 34.04 43.09 73.87 -45.30 94.94 7.48 -43.81 96.41 7.64 coo 34.89 38.34 78.12 35.11 39.59 76.42 -43.07 90.96 4.68 -43.24 93.07 4.75 coo 36.16 46.87 75.66 34.01 46.43 74.59 -46.05 88.61 10.98 -47.75 89.13 9.26 ULMN 3 1a0j_c02 TRYPSIN user 4 3 # 4 C 57 HIS B 330 HIS~? -3.52 ZN ZN B 401s C 102 ASP B 309 ASP.? 7.61 ZN ZN B 401 C 195 SER B 332 SER~? 10.87 ZN ZN B 401 coo 34.37 41.18 73.21 34.04 43.09 73.87 -40.87 100.43 6.30 -42.90 100.10 6.71 coo 34.89 38.34 78.12 35.11 39.59 76.42 -40.43 105.08 4.20 -40.75 103.07 3.51 coo 36.16 46.87 75.66 34.01 46.43 74.59 -35.18 97.79 10.03 -33.17 99.10 9.80 1a0j_c02 source 1a0j TRYPSIN : 4 hits 1a0j_c02 naa= 3 ULMN 3 1a0j_c03 TRYPSIN user 1 3 # 1 D 57 HIS A 69 HIS.? -3.50 ZN ZN A 402s D 102 ASP A 48 ASP.? 7.07 ZN ZN A 402 D 195 SER A 67 SER^? 10.42 ZN ZN A 402 coo 8.19 15.01 95.72 7.78 16.53 97.01 -38.08 120.43 -6.58 -37.62 118.38 -6.66 coo 13.53 16.28 93.98 11.45 16.21 94.40 -34.00 122.50 -3.86 -35.34 120.86 -3.93 coo 6.63 21.03 97.42 6.71 19.20 98.95 -35.40 126.06 -10.23 -37.10 126.61 -8.52 ULMN 3 1a0j_c03 TRYPSIN user 2 3 # 2 D 57 HIS A 330 HIS~? -3.46 ZN ZN A 402s D 102 ASP A 309 ASP.? 7.55 ZN ZN A 402 D 195 SER A 332 SER~? 10.92 ZN ZN A 402 coo 8.19 15.01 95.72 7.78 16.53 97.01 -37.28 113.42 -5.32 -38.81 114.77 -5.81 coo 13.53 16.28 93.98 11.45 16.21 94.40 -39.32 109.22 -3.35 -38.59 111.09 -2.57 coo 6.63 21.03 97.42 6.71 19.20 98.95 -31.12 112.57 -9.16 -30.10 110.35 -8.93 ULMN 3 1a0j_c03 TRYPSIN user 3 3 # 3 D 57 HIS B 69 HIS.? -3.44 ZN ZN B 401s D 102 ASP B 48 ASP.? 7.12 ZN ZN B 401 D 195 SER B 67 SER^? 10.38 ZN ZN B 401 coo 8.19 15.01 95.72 7.78 16.53 97.01 -45.30 94.94 7.48 -43.81 96.41 7.64 coo 13.53 16.28 93.98 11.45 16.21 94.40 -43.07 90.96 4.68 -43.24 93.07 4.75 coo 6.63 21.03 97.42 6.71 19.20 98.95 -46.05 88.61 10.98 -47.75 89.13 9.26 ULMN 3 1a0j_c03 TRYPSIN user 4 3 # 4 D 57 HIS B 330 HIS~? -3.52 ZN ZN B 401s D 102 ASP B 309 ASP.? 7.61 ZN ZN B 401 D 195 SER B 332 SER~? 10.87 ZN ZN B 401 coo 8.19 15.01 95.72 7.78 16.53 97.01 -40.87 100.43 6.30 -42.90 100.10 6.71 coo 13.53 16.28 93.98 11.45 16.21 94.40 -40.43 105.08 4.20 -40.75 103.07 3.51 coo 6.63 21.03 97.42 6.71 19.20 98.95 -35.18 97.79 10.03 -33.17 99.10 9.80 1a0j_c03 source 1a0j TRYPSIN : 4 hits 1a0j_c03 naa= 3 ULMN 3 1a0j_c12 TRYPSIN user 1 3 # 1 A 57 HIS A 68 HIS.? -3.48 ZN ZN A 401s A 102 ASP A 106 ASP~? 2.01 ZN ZN A 401s A 193 GLY A 339 GLY~? 12.94 ZN ZN A 401 coo 25.57 41.22 61.68 24.18 39.98 62.50 -37.46 120.39 -11.50 -38.87 119.03 -12.26 coo 22.33 45.48 59.73 23.35 43.67 60.06 -41.67 116.42 -14.91 -40.59 116.67 -13.13 coo 22.57 32.23 64.13 21.98 32.82 64.22 -29.42 120.06 -18.66 -29.36 120.82 -18.29 ULMN 3 1a0j_c12 TRYPSIN user 2 3 # 2 A 57 HIS A 69 HIS.? -3.50 ZN ZN A 402s A 102 ASP A 48 ASP.? 7.07 ZN ZN A 402 A 193 GLY A 287 GLY.? -5.56 O1 B3P A 371s coo 25.57 41.22 61.68 24.18 39.98 62.50 -38.08 120.43 -6.58 -37.62 118.38 -6.66 coo 22.33 45.48 59.73 23.35 43.67 60.06 -34.00 122.50 -3.86 -35.34 120.86 -3.93 coo 22.57 32.23 64.13 21.98 32.82 64.22 -37.37 111.28 -12.26 -38.18 111.28 -12.23 ULMN 3 1a0j_c12 TRYPSIN user 3 3 # 3 A 57 HIS A 69 HIS.? -3.50 ZN ZN A 402s A 102 ASP A 48 ASP.? 7.07 ZN ZN A 402 A 193 GLY A 288 GLY.? -3.58 O1 B3P A 371s coo 25.57 41.22 61.68 24.18 39.98 62.50 -38.08 120.43 -6.58 -37.62 118.38 -6.66 coo 22.33 45.48 59.73 23.35 43.67 60.06 -34.00 122.50 -3.86 -35.34 120.86 -3.93 coo 22.57 32.23 64.13 21.98 32.82 64.22 -38.32 112.40 -8.76 -38.34 111.58 -8.94 ULMN 3 1a0j_c12 TRYPSIN user 4 3 # 4 A 57 HIS A 102 HIS~? 4.84 O2 B3P A 371 A 102 ASP A 27 ASP.? 7.07 C10 B3P A 371 A 193 GLY A 111 GLY~? 9.12 ZN ZN A 401 coo 25.57 41.22 61.68 24.18 39.98 62.50 -42.24 121.28 -10.34 -42.29 119.63 -9.04 coo 22.33 45.48 59.73 23.35 43.67 60.06 -47.69 122.20 -10.88 -45.61 122.04 -10.59 coo 22.57 32.23 64.13 21.98 32.82 64.22 -36.86 117.78 -20.05 -36.51 117.12 -20.33 ULMN 3 1a0j_c12 TRYPSIN user 5 3 # 5 A 57 HIS A 102 HIS~? 4.84 O2 B3P A 371 A 102 ASP A 27 ASP.? 7.07 C10 B3P A 371 A 193 GLY A 287 GLY.? -5.56 O1 B3P A 371s coo 25.57 41.22 61.68 24.18 39.98 62.50 -42.24 121.28 -10.34 -42.29 119.63 -9.04 coo 22.33 45.48 59.73 23.35 43.67 60.06 -47.69 122.20 -10.88 -45.61 122.04 -10.59 coo 22.57 32.23 64.13 21.98 32.82 64.22 -37.37 111.28 -12.26 -38.18 111.28 -12.23 ULMN 3 1a0j_c12 TRYPSIN user 6 3 # 6 A 57 HIS A 102 HIS~? 4.84 O2 B3P A 371 A 102 ASP A 27 ASP.? 7.07 C10 B3P A 371 A 193 GLY A 288 GLY.? -3.58 O1 B3P A 371s coo 25.57 41.22 61.68 24.18 39.98 62.50 -42.24 121.28 -10.34 -42.29 119.63 -9.04 coo 22.33 45.48 59.73 23.35 43.67 60.06 -47.69 122.20 -10.88 -45.61 122.04 -10.59 coo 22.57 32.23 64.13 21.98 32.82 64.22 -38.32 112.40 -8.76 -38.34 111.58 -8.94 ULMN 3 1a0j_c12 TRYPSIN user 7 3 # 7 A 57 HIS A 102 HIS~? 4.84 O2 B3P A 371 A 102 ASP A 106 ASP~? 2.01 ZN ZN A 401s A 193 GLY A 30 GLY^? 14.70 ZN ZN A 401 coo 25.57 41.22 61.68 24.18 39.98 62.50 -42.24 121.28 -10.34 -42.29 119.63 -9.04 coo 22.33 45.48 59.73 23.35 43.67 60.06 -41.67 116.42 -14.91 -40.59 116.67 -13.13 coo 22.57 32.23 64.13 21.98 32.82 64.22 -43.79 130.44 -13.71 -43.44 130.23 -12.98 ULMN 3 1a0j_c12 TRYPSIN user 8 3 # 8 A 57 HIS A 312 HIS~? 6.48 ZN ZN B 401 A 102 ASP B 48 ASP.? 7.12 ZN ZN B 401 A 193 GLY B 287 GLY.? -5.68 O1 B3P B 371s coo 25.57 41.22 61.68 24.18 39.98 62.50 -41.04 97.86 3.25 -41.05 95.82 3.71 coo 22.33 45.48 59.73 23.35 43.67 60.06 -43.07 90.96 4.68 -43.24 93.07 4.75 coo 22.57 32.23 64.13 21.98 32.82 64.22 -39.64 102.20 13.09 -40.38 102.61 13.11 ULMN 3 1a0j_c12 TRYPSIN user 9 3 # 9 A 57 HIS A 312 HIS~? 6.48 ZN ZN B 401 A 102 ASP B 48 ASP.? 7.12 ZN ZN B 401 A 193 GLY B 308 GLY.? 7.72 O1 B3P B 371 coo 25.57 41.22 61.68 24.18 39.98 62.50 -41.04 97.86 3.25 -41.05 95.82 3.71 coo 22.33 45.48 59.73 23.35 43.67 60.06 -43.07 90.96 4.68 -43.24 93.07 4.75 coo 22.57 32.23 64.13 21.98 32.82 64.22 -37.60 104.71 7.65 -38.14 105.31 7.82 ULMN 3 1a0j_c12 TRYPSIN user 10 3 # 10 A 57 HIS A 312 HIS~? 6.48 ZN ZN B 401 A 102 ASP B 365 ASP.? 11.69 ZN ZN B 401 A 193 GLY B 287 GLY.? -5.68 O1 B3P B 371s coo 25.57 41.22 61.68 24.18 39.98 62.50 -41.04 97.86 3.25 -41.05 95.82 3.71 coo 22.33 45.48 59.73 23.35 43.67 60.06 -34.85 93.86 2.40 -34.89 96.00 2.14 coo 22.57 32.23 64.13 21.98 32.82 64.22 -39.64 102.20 13.09 -40.38 102.61 13.11 ULMN 3 1a0j_c12 TRYPSIN user 11 3 # 11 A 57 HIS A 312 HIS~? 6.48 ZN ZN B 401 A 102 ASP B 365 ASP.? 11.69 ZN ZN B 401 A 193 GLY B 308 GLY.? 7.72 O1 B3P B 371 coo 25.57 41.22 61.68 24.18 39.98 62.50 -41.04 97.86 3.25 -41.05 95.82 3.71 coo 22.33 45.48 59.73 23.35 43.67 60.06 -34.85 93.86 2.40 -34.89 96.00 2.14 coo 22.57 32.23 64.13 21.98 32.82 64.22 -37.60 104.71 7.65 -38.14 105.31 7.82 ULMN 3 1a0j_c12 TRYPSIN user 12 3 # 12 A 57 HIS A 313 HIS~? 5.54 ZN ZN B 401 A 102 ASP A 314 ASP~? 9.10 O5 B3P B 371 A 193 GLY B 288 GLY.? -3.59 O1 B3P B 371s coo 25.57 41.22 61.68 24.18 39.98 62.50 -45.85 98.44 2.81 -45.85 97.45 4.68 coo 22.33 45.48 59.73 23.35 43.67 60.06 -44.29 101.20 -3.40 -45.94 102.37 -2.71 coo 22.57 32.23 64.13 21.98 32.82 64.22 -41.26 101.79 9.71 -40.78 102.47 9.85 ULMN 3 1a0j_c12 TRYPSIN user 13 3 # 13 A 57 HIS A 313 HIS~? 5.54 ZN ZN B 401 A 102 ASP A 314 ASP~? 9.10 O5 B3P B 371 A 193 GLY B 308 GLY.? 7.72 O1 B3P B 371 coo 25.57 41.22 61.68 24.18 39.98 62.50 -45.85 98.44 2.81 -45.85 97.45 4.68 coo 22.33 45.48 59.73 23.35 43.67 60.06 -44.29 101.20 -3.40 -45.94 102.37 -2.71 coo 22.57 32.23 64.13 21.98 32.82 64.22 -37.60 104.71 7.65 -38.14 105.31 7.82 ULMN 3 1a0j_c12 TRYPSIN user 14 3 # 14 A 57 HIS A 313 HIS~? 5.54 ZN ZN B 401 A 102 ASP A 317 ASP~? 10.45 O4 B3P B 371 A 193 GLY B 288 GLY.? -3.59 O1 B3P B 371s coo 25.57 41.22 61.68 24.18 39.98 62.50 -45.85 98.44 2.81 -45.85 97.45 4.68 coo 22.33 45.48 59.73 23.35 43.67 60.06 -46.62 96.07 -4.20 -47.85 96.41 -2.50 coo 22.57 32.23 64.13 21.98 32.82 64.22 -41.26 101.79 9.71 -40.78 102.47 9.85 ULMN 3 1a0j_c12 TRYPSIN user 15 3 # 15 A 57 HIS A 321 HIS~? 16.72 O4 B3P B 371 A 102 ASP A 317 ASP~? 10.45 O4 B3P B 371 A 193 GLY B 85 GLY~? 19.76 O4 B3P B 371 coo 25.57 41.22 61.68 24.18 39.98 62.50 -47.70 92.41 -8.31 -49.45 92.40 -7.16 coo 22.33 45.48 59.73 23.35 43.67 60.06 -46.62 96.07 -4.20 -47.85 96.41 -2.50 coo 22.57 32.23 64.13 21.98 32.82 64.22 -52.96 85.52 -4.18 -52.18 85.43 -4.06 ULMN 3 1a0j_c12 TRYPSIN user 16 3 # 16 A 57 HIS B 68 HIS.? -3.46 ZN ZN B 402s A 102 ASP B 106 ASP~? 1.96 ZN ZN B 402s A 193 GLY B 339 GLY~? 13.00 ZN ZN B 402 coo 25.57 41.22 61.68 24.18 39.98 62.50 -44.72 94.50 12.35 -45.14 96.41 13.13 coo 22.33 45.48 59.73 23.35 43.67 60.06 -46.09 100.09 15.88 -45.34 99.27 14.09 coo 22.57 32.23 64.13 21.98 32.82 64.22 -37.72 90.24 19.44 -38.08 89.61 19.05 ULMN 3 1a0j_c12 TRYPSIN user 17 3 # 17 A 57 HIS B 69 HIS.? -3.44 ZN ZN B 401s A 102 ASP B 48 ASP.? 7.12 ZN ZN B 401 A 193 GLY B 287 GLY.? -5.68 O1 B3P B 371s coo 25.57 41.22 61.68 24.18 39.98 62.50 -45.30 94.94 7.48 -43.81 96.41 7.64 coo 22.33 45.48 59.73 23.35 43.67 60.06 -43.07 90.96 4.68 -43.24 93.07 4.75 coo 22.57 32.23 64.13 21.98 32.82 64.22 -39.64 102.20 13.09 -40.38 102.61 13.11 ULMN 3 1a0j_c12 TRYPSIN user 18 3 # 18 A 57 HIS B 69 HIS.? -3.44 ZN ZN B 401s A 102 ASP B 48 ASP.? 7.12 ZN ZN B 401 A 193 GLY B 288 GLY.? -3.59 O1 B3P B 371s coo 25.57 41.22 61.68 24.18 39.98 62.50 -45.30 94.94 7.48 -43.81 96.41 7.64 coo 22.33 45.48 59.73 23.35 43.67 60.06 -43.07 90.96 4.68 -43.24 93.07 4.75 coo 22.57 32.23 64.13 21.98 32.82 64.22 -41.26 101.79 9.71 -40.78 102.47 9.85 ULMN 3 1a0j_c12 TRYPSIN user 19 3 # 19 A 57 HIS B 102 HIS~? 4.91 O2 B3P B 371 A 102 ASP B 27 ASP.? 7.01 C10 B3P B 371 A 193 GLY B 111 GLY~? 9.03 ZN ZN B 402 coo 25.57 41.22 61.68 24.18 39.98 62.50 -49.25 96.38 11.24 -48.46 97.85 9.95 coo 22.33 45.48 59.73 23.35 43.67 60.06 -54.29 98.49 11.88 -52.46 97.53 11.54 coo 22.57 32.23 64.13 21.98 32.82 64.22 -42.81 96.30 20.91 -42.15 96.64 21.19 ULMN 3 1a0j_c12 TRYPSIN user 20 3 # 20 A 57 HIS B 102 HIS~? 4.91 O2 B3P B 371 A 102 ASP B 27 ASP.? 7.01 C10 B3P B 371 A 193 GLY B 287 GLY.? -5.68 O1 B3P B 371s coo 25.57 41.22 61.68 24.18 39.98 62.50 -49.25 96.38 11.24 -48.46 97.85 9.95 coo 22.33 45.48 59.73 23.35 43.67 60.06 -54.29 98.49 11.88 -52.46 97.53 11.54 coo 22.57 32.23 64.13 21.98 32.82 64.22 -39.64 102.20 13.09 -40.38 102.61 13.11 ULMN 3 1a0j_c12 TRYPSIN user 21 3 # 21 A 57 HIS B 102 HIS~? 4.91 O2 B3P B 371 A 102 ASP B 27 ASP.? 7.01 C10 B3P B 371 A 193 GLY B 288 GLY.? -3.59 O1 B3P B 371s coo 25.57 41.22 61.68 24.18 39.98 62.50 -49.25 96.38 11.24 -48.46 97.85 9.95 coo 22.33 45.48 59.73 23.35 43.67 60.06 -54.29 98.49 11.88 -52.46 97.53 11.54 coo 22.57 32.23 64.13 21.98 32.82 64.22 -41.26 101.79 9.71 -40.78 102.47 9.85 ULMN 3 1a0j_c12 TRYPSIN user 22 3 # 22 A 57 HIS B 102 HIS~? 4.91 O2 B3P B 371 A 102 ASP B 106 ASP~? 1.96 ZN ZN B 402s A 193 GLY B 30 GLY^? 14.53 ZN ZN B 402 coo 25.57 41.22 61.68 24.18 39.98 62.50 -49.25 96.38 11.24 -48.46 97.85 9.95 coo 22.33 45.48 59.73 23.35 43.67 60.06 -46.09 100.09 15.88 -45.34 99.27 14.09 coo 22.57 32.23 64.13 21.98 32.82 64.22 -55.27 89.43 14.51 -54.92 89.45 13.77 ULMN 3 1a0j_c12 TRYPSIN user 23 3 # 23 A 57 HIS B 312 HIS~? 6.47 ZN ZN A 402 A 102 ASP A 48 ASP.? 7.07 ZN ZN A 402 A 193 GLY A 287 GLY.? -5.56 O1 B3P A 371s coo 25.57 41.22 61.68 24.18 39.98 62.50 -36.00 115.58 -2.34 -34.91 117.32 -2.81 coo 22.33 45.48 59.73 23.35 43.67 60.06 -34.00 122.50 -3.86 -35.34 120.86 -3.93 coo 22.57 32.23 64.13 21.98 32.82 64.22 -37.37 111.28 -12.26 -38.18 111.28 -12.23 ULMN 3 1a0j_c12 TRYPSIN user 24 3 # 24 A 57 HIS B 312 HIS~? 6.47 ZN ZN A 402 A 102 ASP A 48 ASP.? 7.07 ZN ZN A 402 A 193 GLY A 308 GLY.? 7.69 O1 B3P A 371 coo 25.57 41.22 61.68 24.18 39.98 62.50 -36.00 115.58 -2.34 -34.91 117.32 -2.81 coo 22.33 45.48 59.73 23.35 43.67 60.06 -34.00 122.50 -3.86 -35.34 120.86 -3.93 coo 22.57 32.23 64.13 21.98 32.82 64.22 -36.78 108.02 -6.71 -37.57 107.80 -6.86 ULMN 3 1a0j_c12 TRYPSIN user 25 3 # 25 A 57 HIS B 312 HIS~? 6.47 ZN ZN A 402 A 102 ASP A 365 ASP.? 11.72 ZN ZN A 402 A 193 GLY A 287 GLY.? -5.56 O1 B3P A 371s coo 25.57 41.22 61.68 24.18 39.98 62.50 -36.00 115.58 -2.34 -34.91 117.32 -2.81 coo 22.33 45.48 59.73 23.35 43.67 60.06 -28.60 115.73 -1.61 -29.73 113.97 -1.34 coo 22.57 32.23 64.13 21.98 32.82 64.22 -37.37 111.28 -12.26 -38.18 111.28 -12.23 ULMN 3 1a0j_c12 TRYPSIN user 26 3 # 26 A 57 HIS B 312 HIS~? 6.47 ZN ZN A 402 A 102 ASP A 365 ASP.? 11.72 ZN ZN A 402 A 193 GLY A 308 GLY.? 7.69 O1 B3P A 371 coo 25.57 41.22 61.68 24.18 39.98 62.50 -36.00 115.58 -2.34 -34.91 117.32 -2.81 coo 22.33 45.48 59.73 23.35 43.67 60.06 -28.60 115.73 -1.61 -29.73 113.97 -1.34 coo 22.57 32.23 64.13 21.98 32.82 64.22 -36.78 108.02 -6.71 -37.57 107.80 -6.86 ULMN 3 1a0j_c12 TRYPSIN user 27 3 # 27 A 57 HIS B 313 HIS~? 5.49 ZN ZN A 402 A 102 ASP B 314 ASP~? 9.37 O5 B3P A 371 A 193 GLY A 288 GLY.? -3.58 O1 B3P A 371s coo 25.57 41.22 61.68 24.18 39.98 62.50 -40.27 117.73 -1.83 -39.85 118.55 -3.71 coo 22.33 45.48 59.73 23.35 43.67 60.06 -40.38 114.62 4.43 -42.39 114.53 3.82 coo 22.57 32.23 64.13 21.98 32.82 64.22 -38.32 112.40 -8.76 -38.34 111.58 -8.94 ULMN 3 1a0j_c12 TRYPSIN user 28 3 # 28 A 57 HIS B 313 HIS~? 5.49 ZN ZN A 402 A 102 ASP B 314 ASP~? 9.37 O5 B3P A 371 A 193 GLY A 308 GLY.? 7.69 O1 B3P A 371 coo 25.57 41.22 61.68 24.18 39.98 62.50 -40.27 117.73 -1.83 -39.85 118.55 -3.71 coo 22.33 45.48 59.73 23.35 43.67 60.06 -40.38 114.62 4.43 -42.39 114.53 3.82 coo 22.57 32.23 64.13 21.98 32.82 64.22 -36.78 108.02 -6.71 -37.57 107.80 -6.86 ULMN 3 1a0j_c12 TRYPSIN user 29 3 # 29 A 57 HIS B 321 HIS~? 16.92 O4 B3P A 371 A 102 ASP B 317 ASP~? 10.65 O4 B3P A 371 A 193 GLY A 85 GLY~? 19.74 O4 B3P A 371 coo 25.57 41.22 61.68 24.18 39.98 62.50 -38.45 123.77 9.41 -39.84 124.80 8.23 coo 22.33 45.48 59.73 23.35 43.67 60.06 -39.61 120.08 5.26 -40.74 120.57 3.54 coo 22.57 32.23 64.13 21.98 32.82 64.22 -39.21 132.55 4.91 -38.47 132.20 4.74 ULMN 3 1a0j_c12 TRYPSIN user 30 3 # 30 A 57 HIS B 321 HIS~? 16.92 O4 B3P A 371 A 102 ASP B 317 ASP~? 10.65 O4 B3P A 371 A 193 GLY B 274 GLY.? 20.62 ZN ZN A 402 coo 25.57 41.22 61.68 24.18 39.98 62.50 -38.45 123.77 9.41 -39.84 124.80 8.23 coo 22.33 45.48 59.73 23.35 43.67 60.06 -39.61 120.08 5.26 -40.74 120.57 3.54 coo 22.57 32.23 64.13 21.98 32.82 64.22 -28.47 117.52 9.71 -27.96 117.13 9.12 1a0j_c12 source 1a0j TRYPSIN : 30 hits 1a0j_c12 naa= 3 ULMN 3 1a0j_c13 TRYPSIN user 1 3 # 1 B 57 HIS A 68 HIS.? -3.48 ZN ZN A 401s B 102 ASP A 106 ASP~? 2.01 ZN ZN A 401s B 193 GLY A 339 GLY~? 12.94 ZN ZN A 401 coo 44.08 45.58 52.81 45.86 46.55 52.85 -37.46 120.39 -11.50 -38.87 119.03 -12.26 coo 43.04 44.75 47.18 43.31 45.51 49.13 -41.67 116.42 -14.91 -40.59 116.67 -13.13 coo 50.46 51.91 56.90 50.65 51.62 56.14 -29.42 120.06 -18.66 -29.36 120.82 -18.29 ULMN 3 1a0j_c13 TRYPSIN user 2 3 # 2 B 57 HIS A 69 HIS.? -3.50 ZN ZN A 402s B 102 ASP A 48 ASP.? 7.07 ZN ZN A 402 B 193 GLY A 287 GLY.? -5.56 O1 B3P A 371s coo 44.08 45.58 52.81 45.86 46.55 52.85 -38.08 120.43 -6.58 -37.62 118.38 -6.66 coo 43.04 44.75 47.18 43.31 45.51 49.13 -34.00 122.50 -3.86 -35.34 120.86 -3.93 coo 50.46 51.91 56.90 50.65 51.62 56.14 -37.37 111.28 -12.26 -38.18 111.28 -12.23 ULMN 3 1a0j_c13 TRYPSIN user 3 3 # 3 B 57 HIS A 102 HIS~? 4.84 O2 B3P A 371 B 102 ASP A 27 ASP.? 7.07 C10 B3P A 371 B 193 GLY A 111 GLY~? 9.12 ZN ZN A 401 coo 44.08 45.58 52.81 45.86 46.55 52.85 -42.24 121.28 -10.34 -42.29 119.63 -9.04 coo 43.04 44.75 47.18 43.31 45.51 49.13 -47.69 122.20 -10.88 -45.61 122.04 -10.59 coo 50.46 51.91 56.90 50.65 51.62 56.14 -36.86 117.78 -20.05 -36.51 117.12 -20.33 ULMN 3 1a0j_c13 TRYPSIN user 4 3 # 4 B 57 HIS A 102 HIS~? 4.84 O2 B3P A 371 B 102 ASP A 27 ASP.? 7.07 C10 B3P A 371 B 193 GLY A 287 GLY.? -5.56 O1 B3P A 371s coo 44.08 45.58 52.81 45.86 46.55 52.85 -42.24 121.28 -10.34 -42.29 119.63 -9.04 coo 43.04 44.75 47.18 43.31 45.51 49.13 -47.69 122.20 -10.88 -45.61 122.04 -10.59 coo 50.46 51.91 56.90 50.65 51.62 56.14 -37.37 111.28 -12.26 -38.18 111.28 -12.23 ULMN 3 1a0j_c13 TRYPSIN user 5 3 # 5 B 57 HIS A 102 HIS~? 4.84 O2 B3P A 371 B 102 ASP A 27 ASP.? 7.07 C10 B3P A 371 B 193 GLY A 288 GLY.? -3.58 O1 B3P A 371s coo 44.08 45.58 52.81 45.86 46.55 52.85 -42.24 121.28 -10.34 -42.29 119.63 -9.04 coo 43.04 44.75 47.18 43.31 45.51 49.13 -47.69 122.20 -10.88 -45.61 122.04 -10.59 coo 50.46 51.91 56.90 50.65 51.62 56.14 -38.32 112.40 -8.76 -38.34 111.58 -8.94 ULMN 3 1a0j_c13 TRYPSIN user 6 3 # 6 B 57 HIS A 102 HIS~? 4.84 O2 B3P A 371 B 102 ASP A 106 ASP~? 2.01 ZN ZN A 401s B 193 GLY A 30 GLY^? 14.70 ZN ZN A 401 coo 44.08 45.58 52.81 45.86 46.55 52.85 -42.24 121.28 -10.34 -42.29 119.63 -9.04 coo 43.04 44.75 47.18 43.31 45.51 49.13 -41.67 116.42 -14.91 -40.59 116.67 -13.13 coo 50.46 51.91 56.90 50.65 51.62 56.14 -43.79 130.44 -13.71 -43.44 130.23 -12.98 ULMN 3 1a0j_c13 TRYPSIN user 7 3 # 7 B 57 HIS A 312 HIS~? 6.48 ZN ZN B 401 B 102 ASP B 48 ASP.? 7.12 ZN ZN B 401 B 193 GLY B 287 GLY.? -5.68 O1 B3P B 371s coo 44.08 45.58 52.81 45.86 46.55 52.85 -41.04 97.86 3.25 -41.05 95.82 3.71 coo 43.04 44.75 47.18 43.31 45.51 49.13 -43.07 90.96 4.68 -43.24 93.07 4.75 coo 50.46 51.91 56.90 50.65 51.62 56.14 -39.64 102.20 13.09 -40.38 102.61 13.11 ULMN 3 1a0j_c13 TRYPSIN user 8 3 # 8 B 57 HIS A 312 HIS~? 6.48 ZN ZN B 401 B 102 ASP B 48 ASP.? 7.12 ZN ZN B 401 B 193 GLY B 308 GLY.? 7.72 O1 B3P B 371 coo 44.08 45.58 52.81 45.86 46.55 52.85 -41.04 97.86 3.25 -41.05 95.82 3.71 coo 43.04 44.75 47.18 43.31 45.51 49.13 -43.07 90.96 4.68 -43.24 93.07 4.75 coo 50.46 51.91 56.90 50.65 51.62 56.14 -37.60 104.71 7.65 -38.14 105.31 7.82 ULMN 3 1a0j_c13 TRYPSIN user 9 3 # 9 B 57 HIS A 312 HIS~? 6.48 ZN ZN B 401 B 102 ASP B 365 ASP.? 11.69 ZN ZN B 401 B 193 GLY B 287 GLY.? -5.68 O1 B3P B 371s coo 44.08 45.58 52.81 45.86 46.55 52.85 -41.04 97.86 3.25 -41.05 95.82 3.71 coo 43.04 44.75 47.18 43.31 45.51 49.13 -34.85 93.86 2.40 -34.89 96.00 2.14 coo 50.46 51.91 56.90 50.65 51.62 56.14 -39.64 102.20 13.09 -40.38 102.61 13.11 ULMN 3 1a0j_c13 TRYPSIN user 10 3 # 10 B 57 HIS A 312 HIS~? 6.48 ZN ZN B 401 B 102 ASP B 365 ASP.? 11.69 ZN ZN B 401 B 193 GLY B 308 GLY.? 7.72 O1 B3P B 371 coo 44.08 45.58 52.81 45.86 46.55 52.85 -41.04 97.86 3.25 -41.05 95.82 3.71 coo 43.04 44.75 47.18 43.31 45.51 49.13 -34.85 93.86 2.40 -34.89 96.00 2.14 coo 50.46 51.91 56.90 50.65 51.62 56.14 -37.60 104.71 7.65 -38.14 105.31 7.82 ULMN 3 1a0j_c13 TRYPSIN user 11 3 # 11 B 57 HIS A 313 HIS~? 5.54 ZN ZN B 401 B 102 ASP A 314 ASP~? 9.10 O5 B3P B 371 B 193 GLY B 288 GLY.? -3.59 O1 B3P B 371s coo 44.08 45.58 52.81 45.86 46.55 52.85 -45.85 98.44 2.81 -45.85 97.45 4.68 coo 43.04 44.75 47.18 43.31 45.51 49.13 -44.29 101.20 -3.40 -45.94 102.37 -2.71 coo 50.46 51.91 56.90 50.65 51.62 56.14 -41.26 101.79 9.71 -40.78 102.47 9.85 ULMN 3 1a0j_c13 TRYPSIN user 12 3 # 12 B 57 HIS A 313 HIS~? 5.54 ZN ZN B 401 B 102 ASP A 314 ASP~? 9.10 O5 B3P B 371 B 193 GLY B 308 GLY.? 7.72 O1 B3P B 371 coo 44.08 45.58 52.81 45.86 46.55 52.85 -45.85 98.44 2.81 -45.85 97.45 4.68 coo 43.04 44.75 47.18 43.31 45.51 49.13 -44.29 101.20 -3.40 -45.94 102.37 -2.71 coo 50.46 51.91 56.90 50.65 51.62 56.14 -37.60 104.71 7.65 -38.14 105.31 7.82 ULMN 3 1a0j_c13 TRYPSIN user 13 3 # 13 B 57 HIS A 313 HIS~? 5.54 ZN ZN B 401 B 102 ASP A 317 ASP~? 10.45 O4 B3P B 371 B 193 GLY B 288 GLY.? -3.59 O1 B3P B 371s coo 44.08 45.58 52.81 45.86 46.55 52.85 -45.85 98.44 2.81 -45.85 97.45 4.68 coo 43.04 44.75 47.18 43.31 45.51 49.13 -46.62 96.07 -4.20 -47.85 96.41 -2.50 coo 50.46 51.91 56.90 50.65 51.62 56.14 -41.26 101.79 9.71 -40.78 102.47 9.85 ULMN 3 1a0j_c13 TRYPSIN user 14 3 # 14 B 57 HIS A 321 HIS~? 16.72 O4 B3P B 371 B 102 ASP A 317 ASP~? 10.45 O4 B3P B 371 B 193 GLY B 85 GLY~? 19.76 O4 B3P B 371 coo 44.08 45.58 52.81 45.86 46.55 52.85 -47.70 92.41 -8.31 -49.45 92.40 -7.16 coo 43.04 44.75 47.18 43.31 45.51 49.13 -46.62 96.07 -4.20 -47.85 96.41 -2.50 coo 50.46 51.91 56.90 50.65 51.62 56.14 -52.96 85.52 -4.18 -52.18 85.43 -4.06 ULMN 3 1a0j_c13 TRYPSIN user 15 3 # 15 B 57 HIS B 68 HIS.? -3.46 ZN ZN B 402s B 102 ASP B 106 ASP~? 1.96 ZN ZN B 402s B 193 GLY B 339 GLY~? 13.00 ZN ZN B 402 coo 44.08 45.58 52.81 45.86 46.55 52.85 -44.72 94.50 12.35 -45.14 96.41 13.13 coo 43.04 44.75 47.18 43.31 45.51 49.13 -46.09 100.09 15.88 -45.34 99.27 14.09 coo 50.46 51.91 56.90 50.65 51.62 56.14 -37.72 90.24 19.44 -38.08 89.61 19.05 ULMN 3 1a0j_c13 TRYPSIN user 16 3 # 16 B 57 HIS B 69 HIS.? -3.44 ZN ZN B 401s B 102 ASP B 48 ASP.? 7.12 ZN ZN B 401 B 193 GLY B 287 GLY.? -5.68 O1 B3P B 371s coo 44.08 45.58 52.81 45.86 46.55 52.85 -45.30 94.94 7.48 -43.81 96.41 7.64 coo 43.04 44.75 47.18 43.31 45.51 49.13 -43.07 90.96 4.68 -43.24 93.07 4.75 coo 50.46 51.91 56.90 50.65 51.62 56.14 -39.64 102.20 13.09 -40.38 102.61 13.11 ULMN 3 1a0j_c13 TRYPSIN user 17 3 # 17 B 57 HIS B 102 HIS~? 4.91 O2 B3P B 371 B 102 ASP B 27 ASP.? 7.01 C10 B3P B 371 B 193 GLY B 111 GLY~? 9.03 ZN ZN B 402 coo 44.08 45.58 52.81 45.86 46.55 52.85 -49.25 96.38 11.24 -48.46 97.85 9.95 coo 43.04 44.75 47.18 43.31 45.51 49.13 -54.29 98.49 11.88 -52.46 97.53 11.54 coo 50.46 51.91 56.90 50.65 51.62 56.14 -42.81 96.30 20.91 -42.15 96.64 21.19 ULMN 3 1a0j_c13 TRYPSIN user 18 3 # 18 B 57 HIS B 102 HIS~? 4.91 O2 B3P B 371 B 102 ASP B 27 ASP.? 7.01 C10 B3P B 371 B 193 GLY B 287 GLY.? -5.68 O1 B3P B 371s coo 44.08 45.58 52.81 45.86 46.55 52.85 -49.25 96.38 11.24 -48.46 97.85 9.95 coo 43.04 44.75 47.18 43.31 45.51 49.13 -54.29 98.49 11.88 -52.46 97.53 11.54 coo 50.46 51.91 56.90 50.65 51.62 56.14 -39.64 102.20 13.09 -40.38 102.61 13.11 ULMN 3 1a0j_c13 TRYPSIN user 19 3 # 19 B 57 HIS B 102 HIS~? 4.91 O2 B3P B 371 B 102 ASP B 27 ASP.? 7.01 C10 B3P B 371 B 193 GLY B 288 GLY.? -3.59 O1 B3P B 371s coo 44.08 45.58 52.81 45.86 46.55 52.85 -49.25 96.38 11.24 -48.46 97.85 9.95 coo 43.04 44.75 47.18 43.31 45.51 49.13 -54.29 98.49 11.88 -52.46 97.53 11.54 coo 50.46 51.91 56.90 50.65 51.62 56.14 -41.26 101.79 9.71 -40.78 102.47 9.85 ULMN 3 1a0j_c13 TRYPSIN user 20 3 # 20 B 57 HIS B 102 HIS~? 4.91 O2 B3P B 371 B 102 ASP B 106 ASP~? 1.96 ZN ZN B 402s B 193 GLY B 30 GLY^? 14.53 ZN ZN B 402 coo 44.08 45.58 52.81 45.86 46.55 52.85 -49.25 96.38 11.24 -48.46 97.85 9.95 coo 43.04 44.75 47.18 43.31 45.51 49.13 -46.09 100.09 15.88 -45.34 99.27 14.09 coo 50.46 51.91 56.90 50.65 51.62 56.14 -55.27 89.43 14.51 -54.92 89.45 13.77 ULMN 3 1a0j_c13 TRYPSIN user 21 3 # 21 B 57 HIS B 312 HIS~? 6.47 ZN ZN A 402 B 102 ASP A 48 ASP.? 7.07 ZN ZN A 402 B 193 GLY A 287 GLY.? -5.56 O1 B3P A 371s coo 44.08 45.58 52.81 45.86 46.55 52.85 -36.00 115.58 -2.34 -34.91 117.32 -2.81 coo 43.04 44.75 47.18 43.31 45.51 49.13 -34.00 122.50 -3.86 -35.34 120.86 -3.93 coo 50.46 51.91 56.90 50.65 51.62 56.14 -37.37 111.28 -12.26 -38.18 111.28 -12.23 ULMN 3 1a0j_c13 TRYPSIN user 22 3 # 22 B 57 HIS B 312 HIS~? 6.47 ZN ZN A 402 B 102 ASP A 48 ASP.? 7.07 ZN ZN A 402 B 193 GLY A 308 GLY.? 7.69 O1 B3P A 371 coo 44.08 45.58 52.81 45.86 46.55 52.85 -36.00 115.58 -2.34 -34.91 117.32 -2.81 coo 43.04 44.75 47.18 43.31 45.51 49.13 -34.00 122.50 -3.86 -35.34 120.86 -3.93 coo 50.46 51.91 56.90 50.65 51.62 56.14 -36.78 108.02 -6.71 -37.57 107.80 -6.86 ULMN 3 1a0j_c13 TRYPSIN user 23 3 # 23 B 57 HIS B 312 HIS~? 6.47 ZN ZN A 402 B 102 ASP A 365 ASP.? 11.72 ZN ZN A 402 B 193 GLY A 287 GLY.? -5.56 O1 B3P A 371s coo 44.08 45.58 52.81 45.86 46.55 52.85 -36.00 115.58 -2.34 -34.91 117.32 -2.81 coo 43.04 44.75 47.18 43.31 45.51 49.13 -28.60 115.73 -1.61 -29.73 113.97 -1.34 coo 50.46 51.91 56.90 50.65 51.62 56.14 -37.37 111.28 -12.26 -38.18 111.28 -12.23 ULMN 3 1a0j_c13 TRYPSIN user 24 3 # 24 B 57 HIS B 312 HIS~? 6.47 ZN ZN A 402 B 102 ASP A 365 ASP.? 11.72 ZN ZN A 402 B 193 GLY A 308 GLY.? 7.69 O1 B3P A 371 coo 44.08 45.58 52.81 45.86 46.55 52.85 -36.00 115.58 -2.34 -34.91 117.32 -2.81 coo 43.04 44.75 47.18 43.31 45.51 49.13 -28.60 115.73 -1.61 -29.73 113.97 -1.34 coo 50.46 51.91 56.90 50.65 51.62 56.14 -36.78 108.02 -6.71 -37.57 107.80 -6.86 ULMN 3 1a0j_c13 TRYPSIN user 25 3 # 25 B 57 HIS B 313 HIS~? 5.49 ZN ZN A 402 B 102 ASP B 314 ASP~? 9.37 O5 B3P A 371 B 193 GLY A 288 GLY.? -3.58 O1 B3P A 371s coo 44.08 45.58 52.81 45.86 46.55 52.85 -40.27 117.73 -1.83 -39.85 118.55 -3.71 coo 43.04 44.75 47.18 43.31 45.51 49.13 -40.38 114.62 4.43 -42.39 114.53 3.82 coo 50.46 51.91 56.90 50.65 51.62 56.14 -38.32 112.40 -8.76 -38.34 111.58 -8.94 ULMN 3 1a0j_c13 TRYPSIN user 26 3 # 26 B 57 HIS B 313 HIS~? 5.49 ZN ZN A 402 B 102 ASP B 314 ASP~? 9.37 O5 B3P A 371 B 193 GLY A 308 GLY.? 7.69 O1 B3P A 371 coo 44.08 45.58 52.81 45.86 46.55 52.85 -40.27 117.73 -1.83 -39.85 118.55 -3.71 coo 43.04 44.75 47.18 43.31 45.51 49.13 -40.38 114.62 4.43 -42.39 114.53 3.82 coo 50.46 51.91 56.90 50.65 51.62 56.14 -36.78 108.02 -6.71 -37.57 107.80 -6.86 ULMN 3 1a0j_c13 TRYPSIN user 27 3 # 27 B 57 HIS B 313 HIS~? 5.49 ZN ZN A 402 B 102 ASP B 317 ASP~? 10.65 O4 B3P A 371 B 193 GLY A 288 GLY.? -3.58 O1 B3P A 371s coo 44.08 45.58 52.81 45.86 46.55 52.85 -40.27 117.73 -1.83 -39.85 118.55 -3.71 coo 43.04 44.75 47.18 43.31 45.51 49.13 -39.61 120.08 5.26 -40.74 120.57 3.54 coo 50.46 51.91 56.90 50.65 51.62 56.14 -38.32 112.40 -8.76 -38.34 111.58 -8.94 ULMN 3 1a0j_c13 TRYPSIN user 28 3 # 28 B 57 HIS B 321 HIS~? 16.92 O4 B3P A 371 B 102 ASP B 317 ASP~? 10.65 O4 B3P A 371 B 193 GLY A 85 GLY~? 19.74 O4 B3P A 371 coo 44.08 45.58 52.81 45.86 46.55 52.85 -38.45 123.77 9.41 -39.84 124.80 8.23 coo 43.04 44.75 47.18 43.31 45.51 49.13 -39.61 120.08 5.26 -40.74 120.57 3.54 coo 50.46 51.91 56.90 50.65 51.62 56.14 -39.21 132.55 4.91 -38.47 132.20 4.74 ULMN 3 1a0j_c13 TRYPSIN user 29 3 # 29 B 57 HIS B 321 HIS~? 16.92 O4 B3P A 371 B 102 ASP B 317 ASP~? 10.65 O4 B3P A 371 B 193 GLY B 274 GLY.? 20.62 ZN ZN A 402 coo 44.08 45.58 52.81 45.86 46.55 52.85 -38.45 123.77 9.41 -39.84 124.80 8.23 coo 43.04 44.75 47.18 43.31 45.51 49.13 -39.61 120.08 5.26 -40.74 120.57 3.54 coo 50.46 51.91 56.90 50.65 51.62 56.14 -28.47 117.52 9.71 -27.96 117.13 9.12 1a0j_c13 source 1a0j TRYPSIN : 29 hits 1a0j_c13 naa= 3 ULMN 3 1a0j_c14 TRYPSIN user 1 3 # 1 C 57 HIS A 68 HIS.? -3.48 ZN ZN A 401s C 102 ASP A 106 ASP~? 2.01 ZN ZN A 401s C 193 GLY A 339 GLY~? 12.94 ZN ZN A 401 coo 34.37 41.18 73.21 34.04 43.09 73.87 -37.46 120.39 -11.50 -38.87 119.03 -12.26 coo 34.89 38.34 78.12 35.11 39.59 76.42 -41.67 116.42 -14.91 -40.59 116.67 -13.13 coo 35.43 51.03 72.12 35.20 50.72 72.87 -29.42 120.06 -18.66 -29.36 120.82 -18.29 ULMN 3 1a0j_c14 TRYPSIN user 2 3 # 2 C 57 HIS A 69 HIS.? -3.50 ZN ZN A 402s C 102 ASP A 48 ASP.? 7.07 ZN ZN A 402 C 193 GLY A 287 GLY.? -5.56 O1 B3P A 371s coo 34.37 41.18 73.21 34.04 43.09 73.87 -38.08 120.43 -6.58 -37.62 118.38 -6.66 coo 34.89 38.34 78.12 35.11 39.59 76.42 -34.00 122.50 -3.86 -35.34 120.86 -3.93 coo 35.43 51.03 72.12 35.20 50.72 72.87 -37.37 111.28 -12.26 -38.18 111.28 -12.23 ULMN 3 1a0j_c14 TRYPSIN user 3 3 # 3 C 57 HIS A 69 HIS.? -3.50 ZN ZN A 402s C 102 ASP A 48 ASP.? 7.07 ZN ZN A 402 C 193 GLY A 288 GLY.? -3.58 O1 B3P A 371s coo 34.37 41.18 73.21 34.04 43.09 73.87 -38.08 120.43 -6.58 -37.62 118.38 -6.66 coo 34.89 38.34 78.12 35.11 39.59 76.42 -34.00 122.50 -3.86 -35.34 120.86 -3.93 coo 35.43 51.03 72.12 35.20 50.72 72.87 -38.32 112.40 -8.76 -38.34 111.58 -8.94 ULMN 3 1a0j_c14 TRYPSIN user 4 3 # 4 C 57 HIS A 102 HIS~? 4.84 O2 B3P A 371 C 102 ASP A 27 ASP.? 7.07 C10 B3P A 371 C 193 GLY A 111 GLY~? 9.12 ZN ZN A 401 coo 34.37 41.18 73.21 34.04 43.09 73.87 -42.24 121.28 -10.34 -42.29 119.63 -9.04 coo 34.89 38.34 78.12 35.11 39.59 76.42 -47.69 122.20 -10.88 -45.61 122.04 -10.59 coo 35.43 51.03 72.12 35.20 50.72 72.87 -36.86 117.78 -20.05 -36.51 117.12 -20.33 ULMN 3 1a0j_c14 TRYPSIN user 5 3 # 5 C 57 HIS A 102 HIS~? 4.84 O2 B3P A 371 C 102 ASP A 27 ASP.? 7.07 C10 B3P A 371 C 193 GLY A 287 GLY.? -5.56 O1 B3P A 371s coo 34.37 41.18 73.21 34.04 43.09 73.87 -42.24 121.28 -10.34 -42.29 119.63 -9.04 coo 34.89 38.34 78.12 35.11 39.59 76.42 -47.69 122.20 -10.88 -45.61 122.04 -10.59 coo 35.43 51.03 72.12 35.20 50.72 72.87 -37.37 111.28 -12.26 -38.18 111.28 -12.23 ULMN 3 1a0j_c14 TRYPSIN user 6 3 # 6 C 57 HIS A 102 HIS~? 4.84 O2 B3P A 371 C 102 ASP A 27 ASP.? 7.07 C10 B3P A 371 C 193 GLY A 288 GLY.? -3.58 O1 B3P A 371s coo 34.37 41.18 73.21 34.04 43.09 73.87 -42.24 121.28 -10.34 -42.29 119.63 -9.04 coo 34.89 38.34 78.12 35.11 39.59 76.42 -47.69 122.20 -10.88 -45.61 122.04 -10.59 coo 35.43 51.03 72.12 35.20 50.72 72.87 -38.32 112.40 -8.76 -38.34 111.58 -8.94 ULMN 3 1a0j_c14 TRYPSIN user 7 3 # 7 C 57 HIS A 102 HIS~? 4.84 O2 B3P A 371 C 102 ASP A 106 ASP~? 2.01 ZN ZN A 401s C 193 GLY A 30 GLY^? 14.70 ZN ZN A 401 coo 34.37 41.18 73.21 34.04 43.09 73.87 -42.24 121.28 -10.34 -42.29 119.63 -9.04 coo 34.89 38.34 78.12 35.11 39.59 76.42 -41.67 116.42 -14.91 -40.59 116.67 -13.13 coo 35.43 51.03 72.12 35.20 50.72 72.87 -43.79 130.44 -13.71 -43.44 130.23 -12.98 ULMN 3 1a0j_c14 TRYPSIN user 8 3 # 8 C 57 HIS A 312 HIS~? 6.48 ZN ZN B 401 C 102 ASP B 48 ASP.? 7.12 ZN ZN B 401 C 193 GLY B 287 GLY.? -5.68 O1 B3P B 371s coo 34.37 41.18 73.21 34.04 43.09 73.87 -41.04 97.86 3.25 -41.05 95.82 3.71 coo 34.89 38.34 78.12 35.11 39.59 76.42 -43.07 90.96 4.68 -43.24 93.07 4.75 coo 35.43 51.03 72.12 35.20 50.72 72.87 -39.64 102.20 13.09 -40.38 102.61 13.11 ULMN 3 1a0j_c14 TRYPSIN user 9 3 # 9 C 57 HIS A 312 HIS~? 6.48 ZN ZN B 401 C 102 ASP B 48 ASP.? 7.12 ZN ZN B 401 C 193 GLY B 308 GLY.? 7.72 O1 B3P B 371 coo 34.37 41.18 73.21 34.04 43.09 73.87 -41.04 97.86 3.25 -41.05 95.82 3.71 coo 34.89 38.34 78.12 35.11 39.59 76.42 -43.07 90.96 4.68 -43.24 93.07 4.75 coo 35.43 51.03 72.12 35.20 50.72 72.87 -37.60 104.71 7.65 -38.14 105.31 7.82 ULMN 3 1a0j_c14 TRYPSIN user 10 3 # 10 C 57 HIS A 312 HIS~? 6.48 ZN ZN B 401 C 102 ASP B 365 ASP.? 11.69 ZN ZN B 401 C 193 GLY B 287 GLY.? -5.68 O1 B3P B 371s coo 34.37 41.18 73.21 34.04 43.09 73.87 -41.04 97.86 3.25 -41.05 95.82 3.71 coo 34.89 38.34 78.12 35.11 39.59 76.42 -34.85 93.86 2.40 -34.89 96.00 2.14 coo 35.43 51.03 72.12 35.20 50.72 72.87 -39.64 102.20 13.09 -40.38 102.61 13.11 ULMN 3 1a0j_c14 TRYPSIN user 11 3 # 11 C 57 HIS A 312 HIS~? 6.48 ZN ZN B 401 C 102 ASP B 365 ASP.? 11.69 ZN ZN B 401 C 193 GLY B 308 GLY.? 7.72 O1 B3P B 371 coo 34.37 41.18 73.21 34.04 43.09 73.87 -41.04 97.86 3.25 -41.05 95.82 3.71 coo 34.89 38.34 78.12 35.11 39.59 76.42 -34.85 93.86 2.40 -34.89 96.00 2.14 coo 35.43 51.03 72.12 35.20 50.72 72.87 -37.60 104.71 7.65 -38.14 105.31 7.82 ULMN 3 1a0j_c14 TRYPSIN user 12 3 # 12 C 57 HIS A 313 HIS~? 5.54 ZN ZN B 401 C 102 ASP A 314 ASP~? 9.10 O5 B3P B 371 C 193 GLY B 288 GLY.? -3.59 O1 B3P B 371s coo 34.37 41.18 73.21 34.04 43.09 73.87 -45.85 98.44 2.81 -45.85 97.45 4.68 coo 34.89 38.34 78.12 35.11 39.59 76.42 -44.29 101.20 -3.40 -45.94 102.37 -2.71 coo 35.43 51.03 72.12 35.20 50.72 72.87 -41.26 101.79 9.71 -40.78 102.47 9.85 ULMN 3 1a0j_c14 TRYPSIN user 13 3 # 13 C 57 HIS A 313 HIS~? 5.54 ZN ZN B 401 C 102 ASP A 314 ASP~? 9.10 O5 B3P B 371 C 193 GLY B 308 GLY.? 7.72 O1 B3P B 371 coo 34.37 41.18 73.21 34.04 43.09 73.87 -45.85 98.44 2.81 -45.85 97.45 4.68 coo 34.89 38.34 78.12 35.11 39.59 76.42 -44.29 101.20 -3.40 -45.94 102.37 -2.71 coo 35.43 51.03 72.12 35.20 50.72 72.87 -37.60 104.71 7.65 -38.14 105.31 7.82 ULMN 3 1a0j_c14 TRYPSIN user 14 3 # 14 C 57 HIS A 313 HIS~? 5.54 ZN ZN B 401 C 102 ASP A 317 ASP~? 10.45 O4 B3P B 371 C 193 GLY B 288 GLY.? -3.59 O1 B3P B 371s coo 34.37 41.18 73.21 34.04 43.09 73.87 -45.85 98.44 2.81 -45.85 97.45 4.68 coo 34.89 38.34 78.12 35.11 39.59 76.42 -46.62 96.07 -4.20 -47.85 96.41 -2.50 coo 35.43 51.03 72.12 35.20 50.72 72.87 -41.26 101.79 9.71 -40.78 102.47 9.85 ULMN 3 1a0j_c14 TRYPSIN user 15 3 # 15 C 57 HIS A 321 HIS~? 16.72 O4 B3P B 371 C 102 ASP A 317 ASP~? 10.45 O4 B3P B 371 C 193 GLY A 274 GLY.? 20.46 ZN ZN B 401 coo 34.37 41.18 73.21 34.04 43.09 73.87 -47.70 92.41 -8.31 -49.45 92.40 -7.16 coo 34.89 38.34 78.12 35.11 39.59 76.42 -46.62 96.07 -4.20 -47.85 96.41 -2.50 coo 35.43 51.03 72.12 35.20 50.72 72.87 -35.77 92.29 -8.66 -35.12 92.40 -8.08 ULMN 3 1a0j_c14 TRYPSIN user 16 3 # 16 C 57 HIS A 321 HIS~? 16.72 O4 B3P B 371 C 102 ASP A 317 ASP~? 10.45 O4 B3P B 371 C 193 GLY B 85 GLY~? 19.76 O4 B3P B 371 coo 34.37 41.18 73.21 34.04 43.09 73.87 -47.70 92.41 -8.31 -49.45 92.40 -7.16 coo 34.89 38.34 78.12 35.11 39.59 76.42 -46.62 96.07 -4.20 -47.85 96.41 -2.50 coo 35.43 51.03 72.12 35.20 50.72 72.87 -52.96 85.52 -4.18 -52.18 85.43 -4.06 ULMN 3 1a0j_c14 TRYPSIN user 17 3 # 17 C 57 HIS B 68 HIS.? -3.46 ZN ZN B 402s C 102 ASP B 106 ASP~? 1.96 ZN ZN B 402s C 193 GLY B 30 GLY^? 14.53 ZN ZN B 402 coo 34.37 41.18 73.21 34.04 43.09 73.87 -44.72 94.50 12.35 -45.14 96.41 13.13 coo 34.89 38.34 78.12 35.11 39.59 76.42 -46.09 100.09 15.88 -45.34 99.27 14.09 coo 35.43 51.03 72.12 35.20 50.72 72.87 -55.27 89.43 14.51 -54.92 89.45 13.77 ULMN 3 1a0j_c14 TRYPSIN user 18 3 # 18 C 57 HIS B 68 HIS.? -3.46 ZN ZN B 402s C 102 ASP B 106 ASP~? 1.96 ZN ZN B 402s C 193 GLY B 339 GLY~? 13.00 ZN ZN B 402 coo 34.37 41.18 73.21 34.04 43.09 73.87 -44.72 94.50 12.35 -45.14 96.41 13.13 coo 34.89 38.34 78.12 35.11 39.59 76.42 -46.09 100.09 15.88 -45.34 99.27 14.09 coo 35.43 51.03 72.12 35.20 50.72 72.87 -37.72 90.24 19.44 -38.08 89.61 19.05 ULMN 3 1a0j_c14 TRYPSIN user 19 3 # 19 C 57 HIS B 69 HIS.? -3.44 ZN ZN B 401s C 102 ASP B 48 ASP.? 7.12 ZN ZN B 401 C 193 GLY B 287 GLY.? -5.68 O1 B3P B 371s coo 34.37 41.18 73.21 34.04 43.09 73.87 -45.30 94.94 7.48 -43.81 96.41 7.64 coo 34.89 38.34 78.12 35.11 39.59 76.42 -43.07 90.96 4.68 -43.24 93.07 4.75 coo 35.43 51.03 72.12 35.20 50.72 72.87 -39.64 102.20 13.09 -40.38 102.61 13.11 ULMN 3 1a0j_c14 TRYPSIN user 20 3 # 20 C 57 HIS B 69 HIS.? -3.44 ZN ZN B 401s C 102 ASP B 48 ASP.? 7.12 ZN ZN B 401 C 193 GLY B 288 GLY.? -3.59 O1 B3P B 371s coo 34.37 41.18 73.21 34.04 43.09 73.87 -45.30 94.94 7.48 -43.81 96.41 7.64 coo 34.89 38.34 78.12 35.11 39.59 76.42 -43.07 90.96 4.68 -43.24 93.07 4.75 coo 35.43 51.03 72.12 35.20 50.72 72.87 -41.26 101.79 9.71 -40.78 102.47 9.85 ULMN 3 1a0j_c14 TRYPSIN user 21 3 # 21 C 57 HIS B 102 HIS~? 4.91 O2 B3P B 371 C 102 ASP B 27 ASP.? 7.01 C10 B3P B 371 C 193 GLY B 111 GLY~? 9.03 ZN ZN B 402 coo 34.37 41.18 73.21 34.04 43.09 73.87 -49.25 96.38 11.24 -48.46 97.85 9.95 coo 34.89 38.34 78.12 35.11 39.59 76.42 -54.29 98.49 11.88 -52.46 97.53 11.54 coo 35.43 51.03 72.12 35.20 50.72 72.87 -42.81 96.30 20.91 -42.15 96.64 21.19 ULMN 3 1a0j_c14 TRYPSIN user 22 3 # 22 C 57 HIS B 102 HIS~? 4.91 O2 B3P B 371 C 102 ASP B 27 ASP.? 7.01 C10 B3P B 371 C 193 GLY B 287 GLY.? -5.68 O1 B3P B 371s coo 34.37 41.18 73.21 34.04 43.09 73.87 -49.25 96.38 11.24 -48.46 97.85 9.95 coo 34.89 38.34 78.12 35.11 39.59 76.42 -54.29 98.49 11.88 -52.46 97.53 11.54 coo 35.43 51.03 72.12 35.20 50.72 72.87 -39.64 102.20 13.09 -40.38 102.61 13.11 ULMN 3 1a0j_c14 TRYPSIN user 23 3 # 23 C 57 HIS B 102 HIS~? 4.91 O2 B3P B 371 C 102 ASP B 27 ASP.? 7.01 C10 B3P B 371 C 193 GLY B 288 GLY.? -3.59 O1 B3P B 371s coo 34.37 41.18 73.21 34.04 43.09 73.87 -49.25 96.38 11.24 -48.46 97.85 9.95 coo 34.89 38.34 78.12 35.11 39.59 76.42 -54.29 98.49 11.88 -52.46 97.53 11.54 coo 35.43 51.03 72.12 35.20 50.72 72.87 -41.26 101.79 9.71 -40.78 102.47 9.85 ULMN 3 1a0j_c14 TRYPSIN user 24 3 # 24 C 57 HIS B 102 HIS~? 4.91 O2 B3P B 371 C 102 ASP B 106 ASP~? 1.96 ZN ZN B 402s C 193 GLY B 30 GLY^? 14.53 ZN ZN B 402 coo 34.37 41.18 73.21 34.04 43.09 73.87 -49.25 96.38 11.24 -48.46 97.85 9.95 coo 34.89 38.34 78.12 35.11 39.59 76.42 -46.09 100.09 15.88 -45.34 99.27 14.09 coo 35.43 51.03 72.12 35.20 50.72 72.87 -55.27 89.43 14.51 -54.92 89.45 13.77 ULMN 3 1a0j_c14 TRYPSIN user 25 3 # 25 C 57 HIS B 312 HIS~? 6.47 ZN ZN A 402 C 102 ASP A 48 ASP.? 7.07 ZN ZN A 402 C 193 GLY A 287 GLY.? -5.56 O1 B3P A 371s coo 34.37 41.18 73.21 34.04 43.09 73.87 -36.00 115.58 -2.34 -34.91 117.32 -2.81 coo 34.89 38.34 78.12 35.11 39.59 76.42 -34.00 122.50 -3.86 -35.34 120.86 -3.93 coo 35.43 51.03 72.12 35.20 50.72 72.87 -37.37 111.28 -12.26 -38.18 111.28 -12.23 ULMN 3 1a0j_c14 TRYPSIN user 26 3 # 26 C 57 HIS B 312 HIS~? 6.47 ZN ZN A 402 C 102 ASP A 48 ASP.? 7.07 ZN ZN A 402 C 193 GLY A 308 GLY.? 7.69 O1 B3P A 371 coo 34.37 41.18 73.21 34.04 43.09 73.87 -36.00 115.58 -2.34 -34.91 117.32 -2.81 coo 34.89 38.34 78.12 35.11 39.59 76.42 -34.00 122.50 -3.86 -35.34 120.86 -3.93 coo 35.43 51.03 72.12 35.20 50.72 72.87 -36.78 108.02 -6.71 -37.57 107.80 -6.86 ULMN 3 1a0j_c14 TRYPSIN user 27 3 # 27 C 57 HIS B 312 HIS~? 6.47 ZN ZN A 402 C 102 ASP A 365 ASP.? 11.72 ZN ZN A 402 C 193 GLY A 287 GLY.? -5.56 O1 B3P A 371s coo 34.37 41.18 73.21 34.04 43.09 73.87 -36.00 115.58 -2.34 -34.91 117.32 -2.81 coo 34.89 38.34 78.12 35.11 39.59 76.42 -28.60 115.73 -1.61 -29.73 113.97 -1.34 coo 35.43 51.03 72.12 35.20 50.72 72.87 -37.37 111.28 -12.26 -38.18 111.28 -12.23 ULMN 3 1a0j_c14 TRYPSIN user 28 3 # 28 C 57 HIS B 312 HIS~? 6.47 ZN ZN A 402 C 102 ASP A 365 ASP.? 11.72 ZN ZN A 402 C 193 GLY A 308 GLY.? 7.69 O1 B3P A 371 coo 34.37 41.18 73.21 34.04 43.09 73.87 -36.00 115.58 -2.34 -34.91 117.32 -2.81 coo 34.89 38.34 78.12 35.11 39.59 76.42 -28.60 115.73 -1.61 -29.73 113.97 -1.34 coo 35.43 51.03 72.12 35.20 50.72 72.87 -36.78 108.02 -6.71 -37.57 107.80 -6.86 ULMN 3 1a0j_c14 TRYPSIN user 29 3 # 29 C 57 HIS B 313 HIS~? 5.49 ZN ZN A 402 C 102 ASP B 314 ASP~? 9.37 O5 B3P A 371 C 193 GLY A 288 GLY.? -3.58 O1 B3P A 371s coo 34.37 41.18 73.21 34.04 43.09 73.87 -40.27 117.73 -1.83 -39.85 118.55 -3.71 coo 34.89 38.34 78.12 35.11 39.59 76.42 -40.38 114.62 4.43 -42.39 114.53 3.82 coo 35.43 51.03 72.12 35.20 50.72 72.87 -38.32 112.40 -8.76 -38.34 111.58 -8.94 ULMN 3 1a0j_c14 TRYPSIN user 30 3 # 30 C 57 HIS B 313 HIS~? 5.49 ZN ZN A 402 C 102 ASP B 314 ASP~? 9.37 O5 B3P A 371 C 193 GLY A 308 GLY.? 7.69 O1 B3P A 371 coo 34.37 41.18 73.21 34.04 43.09 73.87 -40.27 117.73 -1.83 -39.85 118.55 -3.71 coo 34.89 38.34 78.12 35.11 39.59 76.42 -40.38 114.62 4.43 -42.39 114.53 3.82 coo 35.43 51.03 72.12 35.20 50.72 72.87 -36.78 108.02 -6.71 -37.57 107.80 -6.86 ULMN 3 1a0j_c14 TRYPSIN user 31 3 # 31 C 57 HIS B 321 HIS~? 16.92 O4 B3P A 371 C 102 ASP B 317 ASP~? 10.65 O4 B3P A 371 C 193 GLY A 85 GLY~? 19.74 O4 B3P A 371 coo 34.37 41.18 73.21 34.04 43.09 73.87 -38.45 123.77 9.41 -39.84 124.80 8.23 coo 34.89 38.34 78.12 35.11 39.59 76.42 -39.61 120.08 5.26 -40.74 120.57 3.54 coo 35.43 51.03 72.12 35.20 50.72 72.87 -39.21 132.55 4.91 -38.47 132.20 4.74 ULMN 3 1a0j_c14 TRYPSIN user 32 3 # 32 C 57 HIS B 321 HIS~? 16.92 O4 B3P A 371 C 102 ASP B 317 ASP~? 10.65 O4 B3P A 371 C 193 GLY B 274 GLY.? 20.62 ZN ZN A 402 coo 34.37 41.18 73.21 34.04 43.09 73.87 -38.45 123.77 9.41 -39.84 124.80 8.23 coo 34.89 38.34 78.12 35.11 39.59 76.42 -39.61 120.08 5.26 -40.74 120.57 3.54 coo 35.43 51.03 72.12 35.20 50.72 72.87 -28.47 117.52 9.71 -27.96 117.13 9.12 1a0j_c14 source 1a0j TRYPSIN : 32 hits 1a0j_c14 naa= 3 ULMN 3 1a0j_c15 TRYPSIN user 1 3 # 1 D 57 HIS A 68 HIS.? -3.48 ZN ZN A 401s D 102 ASP A 106 ASP~? 2.01 ZN ZN A 401s D 193 GLY A 339 GLY~? 12.94 ZN ZN A 401 coo 8.19 15.01 95.72 7.78 16.53 97.01 -37.46 120.39 -11.50 -38.87 119.03 -12.26 coo 13.53 16.28 93.98 11.45 16.21 94.40 -41.67 116.42 -14.91 -40.59 116.67 -13.13 coo 1.80 21.25 100.04 2.61 21.42 100.18 -29.42 120.06 -18.66 -29.36 120.82 -18.29 ULMN 3 1a0j_c15 TRYPSIN user 2 3 # 2 D 57 HIS A 69 HIS.? -3.50 ZN ZN A 402s D 102 ASP A 48 ASP.? 7.07 ZN ZN A 402 D 193 GLY A 287 GLY.? -5.56 O1 B3P A 371s coo 8.19 15.01 95.72 7.78 16.53 97.01 -38.08 120.43 -6.58 -37.62 118.38 -6.66 coo 13.53 16.28 93.98 11.45 16.21 94.40 -34.00 122.50 -3.86 -35.34 120.86 -3.93 coo 1.80 21.25 100.04 2.61 21.42 100.18 -37.37 111.28 -12.26 -38.18 111.28 -12.23 ULMN 3 1a0j_c15 TRYPSIN user 3 3 # 3 D 57 HIS A 102 HIS~? 4.84 O2 B3P A 371 D 102 ASP A 27 ASP.? 7.07 C10 B3P A 371 D 193 GLY A 111 GLY~? 9.12 ZN ZN A 401 coo 8.19 15.01 95.72 7.78 16.53 97.01 -42.24 121.28 -10.34 -42.29 119.63 -9.04 coo 13.53 16.28 93.98 11.45 16.21 94.40 -47.69 122.20 -10.88 -45.61 122.04 -10.59 coo 1.80 21.25 100.04 2.61 21.42 100.18 -36.86 117.78 -20.05 -36.51 117.12 -20.33 ULMN 3 1a0j_c15 TRYPSIN user 4 3 # 4 D 57 HIS A 102 HIS~? 4.84 O2 B3P A 371 D 102 ASP A 27 ASP.? 7.07 C10 B3P A 371 D 193 GLY A 287 GLY.? -5.56 O1 B3P A 371s coo 8.19 15.01 95.72 7.78 16.53 97.01 -42.24 121.28 -10.34 -42.29 119.63 -9.04 coo 13.53 16.28 93.98 11.45 16.21 94.40 -47.69 122.20 -10.88 -45.61 122.04 -10.59 coo 1.80 21.25 100.04 2.61 21.42 100.18 -37.37 111.28 -12.26 -38.18 111.28 -12.23 ULMN 3 1a0j_c15 TRYPSIN user 5 3 # 5 D 57 HIS A 102 HIS~? 4.84 O2 B3P A 371 D 102 ASP A 27 ASP.? 7.07 C10 B3P A 371 D 193 GLY A 288 GLY.? -3.58 O1 B3P A 371s coo 8.19 15.01 95.72 7.78 16.53 97.01 -42.24 121.28 -10.34 -42.29 119.63 -9.04 coo 13.53 16.28 93.98 11.45 16.21 94.40 -47.69 122.20 -10.88 -45.61 122.04 -10.59 coo 1.80 21.25 100.04 2.61 21.42 100.18 -38.32 112.40 -8.76 -38.34 111.58 -8.94 ULMN 3 1a0j_c15 TRYPSIN user 6 3 # 6 D 57 HIS A 102 HIS~? 4.84 O2 B3P A 371 D 102 ASP A 106 ASP~? 2.01 ZN ZN A 401s D 193 GLY A 30 GLY^? 14.70 ZN ZN A 401 coo 8.19 15.01 95.72 7.78 16.53 97.01 -42.24 121.28 -10.34 -42.29 119.63 -9.04 coo 13.53 16.28 93.98 11.45 16.21 94.40 -41.67 116.42 -14.91 -40.59 116.67 -13.13 coo 1.80 21.25 100.04 2.61 21.42 100.18 -43.79 130.44 -13.71 -43.44 130.23 -12.98 ULMN 3 1a0j_c15 TRYPSIN user 7 3 # 7 D 57 HIS A 312 HIS~? 6.48 ZN ZN B 401 D 102 ASP B 48 ASP.? 7.12 ZN ZN B 401 D 193 GLY B 287 GLY.? -5.68 O1 B3P B 371s coo 8.19 15.01 95.72 7.78 16.53 97.01 -41.04 97.86 3.25 -41.05 95.82 3.71 coo 13.53 16.28 93.98 11.45 16.21 94.40 -43.07 90.96 4.68 -43.24 93.07 4.75 coo 1.80 21.25 100.04 2.61 21.42 100.18 -39.64 102.20 13.09 -40.38 102.61 13.11 ULMN 3 1a0j_c15 TRYPSIN user 8 3 # 8 D 57 HIS A 312 HIS~? 6.48 ZN ZN B 401 D 102 ASP B 48 ASP.? 7.12 ZN ZN B 401 D 193 GLY B 308 GLY.? 7.72 O1 B3P B 371 coo 8.19 15.01 95.72 7.78 16.53 97.01 -41.04 97.86 3.25 -41.05 95.82 3.71 coo 13.53 16.28 93.98 11.45 16.21 94.40 -43.07 90.96 4.68 -43.24 93.07 4.75 coo 1.80 21.25 100.04 2.61 21.42 100.18 -37.60 104.71 7.65 -38.14 105.31 7.82 ULMN 3 1a0j_c15 TRYPSIN user 9 3 # 9 D 57 HIS A 312 HIS~? 6.48 ZN ZN B 401 D 102 ASP B 365 ASP.? 11.69 ZN ZN B 401 D 193 GLY B 287 GLY.? -5.68 O1 B3P B 371s coo 8.19 15.01 95.72 7.78 16.53 97.01 -41.04 97.86 3.25 -41.05 95.82 3.71 coo 13.53 16.28 93.98 11.45 16.21 94.40 -34.85 93.86 2.40 -34.89 96.00 2.14 coo 1.80 21.25 100.04 2.61 21.42 100.18 -39.64 102.20 13.09 -40.38 102.61 13.11 ULMN 3 1a0j_c15 TRYPSIN user 10 3 # 10 D 57 HIS A 312 HIS~? 6.48 ZN ZN B 401 D 102 ASP B 365 ASP.? 11.69 ZN ZN B 401 D 193 GLY B 308 GLY.? 7.72 O1 B3P B 371 coo 8.19 15.01 95.72 7.78 16.53 97.01 -41.04 97.86 3.25 -41.05 95.82 3.71 coo 13.53 16.28 93.98 11.45 16.21 94.40 -34.85 93.86 2.40 -34.89 96.00 2.14 coo 1.80 21.25 100.04 2.61 21.42 100.18 -37.60 104.71 7.65 -38.14 105.31 7.82 ULMN 3 1a0j_c15 TRYPSIN user 11 3 # 11 D 57 HIS A 313 HIS~? 5.54 ZN ZN B 401 D 102 ASP A 314 ASP~? 9.10 O5 B3P B 371 D 193 GLY B 288 GLY.? -3.59 O1 B3P B 371s coo 8.19 15.01 95.72 7.78 16.53 97.01 -45.85 98.44 2.81 -45.85 97.45 4.68 coo 13.53 16.28 93.98 11.45 16.21 94.40 -44.29 101.20 -3.40 -45.94 102.37 -2.71 coo 1.80 21.25 100.04 2.61 21.42 100.18 -41.26 101.79 9.71 -40.78 102.47 9.85 ULMN 3 1a0j_c15 TRYPSIN user 12 3 # 12 D 57 HIS A 313 HIS~? 5.54 ZN ZN B 401 D 102 ASP A 314 ASP~? 9.10 O5 B3P B 371 D 193 GLY B 308 GLY.? 7.72 O1 B3P B 371 coo 8.19 15.01 95.72 7.78 16.53 97.01 -45.85 98.44 2.81 -45.85 97.45 4.68 coo 13.53 16.28 93.98 11.45 16.21 94.40 -44.29 101.20 -3.40 -45.94 102.37 -2.71 coo 1.80 21.25 100.04 2.61 21.42 100.18 -37.60 104.71 7.65 -38.14 105.31 7.82 ULMN 3 1a0j_c15 TRYPSIN user 13 3 # 13 D 57 HIS A 313 HIS~? 5.54 ZN ZN B 401 D 102 ASP A 317 ASP~? 10.45 O4 B3P B 371 D 193 GLY B 288 GLY.? -3.59 O1 B3P B 371s coo 8.19 15.01 95.72 7.78 16.53 97.01 -45.85 98.44 2.81 -45.85 97.45 4.68 coo 13.53 16.28 93.98 11.45 16.21 94.40 -46.62 96.07 -4.20 -47.85 96.41 -2.50 coo 1.80 21.25 100.04 2.61 21.42 100.18 -41.26 101.79 9.71 -40.78 102.47 9.85 ULMN 3 1a0j_c15 TRYPSIN user 14 3 # 14 D 57 HIS A 321 HIS~? 16.72 O4 B3P B 371 D 102 ASP A 317 ASP~? 10.45 O4 B3P B 371 D 193 GLY B 85 GLY~? 19.76 O4 B3P B 371 coo 8.19 15.01 95.72 7.78 16.53 97.01 -47.70 92.41 -8.31 -49.45 92.40 -7.16 coo 13.53 16.28 93.98 11.45 16.21 94.40 -46.62 96.07 -4.20 -47.85 96.41 -2.50 coo 1.80 21.25 100.04 2.61 21.42 100.18 -52.96 85.52 -4.18 -52.18 85.43 -4.06 ULMN 3 1a0j_c15 TRYPSIN user 15 3 # 15 D 57 HIS B 68 HIS.? -3.46 ZN ZN B 402s D 102 ASP B 106 ASP~? 1.96 ZN ZN B 402s D 193 GLY B 339 GLY~? 13.00 ZN ZN B 402 coo 8.19 15.01 95.72 7.78 16.53 97.01 -44.72 94.50 12.35 -45.14 96.41 13.13 coo 13.53 16.28 93.98 11.45 16.21 94.40 -46.09 100.09 15.88 -45.34 99.27 14.09 coo 1.80 21.25 100.04 2.61 21.42 100.18 -37.72 90.24 19.44 -38.08 89.61 19.05 ULMN 3 1a0j_c15 TRYPSIN user 16 3 # 16 D 57 HIS B 69 HIS.? -3.44 ZN ZN B 401s D 102 ASP B 48 ASP.? 7.12 ZN ZN B 401 D 193 GLY B 287 GLY.? -5.68 O1 B3P B 371s coo 8.19 15.01 95.72 7.78 16.53 97.01 -45.30 94.94 7.48 -43.81 96.41 7.64 coo 13.53 16.28 93.98 11.45 16.21 94.40 -43.07 90.96 4.68 -43.24 93.07 4.75 coo 1.80 21.25 100.04 2.61 21.42 100.18 -39.64 102.20 13.09 -40.38 102.61 13.11 ULMN 3 1a0j_c15 TRYPSIN user 17 3 # 17 D 57 HIS B 102 HIS~? 4.91 O2 B3P B 371 D 102 ASP B 27 ASP.? 7.01 C10 B3P B 371 D 193 GLY B 111 GLY~? 9.03 ZN ZN B 402 coo 8.19 15.01 95.72 7.78 16.53 97.01 -49.25 96.38 11.24 -48.46 97.85 9.95 coo 13.53 16.28 93.98 11.45 16.21 94.40 -54.29 98.49 11.88 -52.46 97.53 11.54 coo 1.80 21.25 100.04 2.61 21.42 100.18 -42.81 96.30 20.91 -42.15 96.64 21.19 ULMN 3 1a0j_c15 TRYPSIN user 18 3 # 18 D 57 HIS B 102 HIS~? 4.91 O2 B3P B 371 D 102 ASP B 27 ASP.? 7.01 C10 B3P B 371 D 193 GLY B 287 GLY.? -5.68 O1 B3P B 371s coo 8.19 15.01 95.72 7.78 16.53 97.01 -49.25 96.38 11.24 -48.46 97.85 9.95 coo 13.53 16.28 93.98 11.45 16.21 94.40 -54.29 98.49 11.88 -52.46 97.53 11.54 coo 1.80 21.25 100.04 2.61 21.42 100.18 -39.64 102.20 13.09 -40.38 102.61 13.11 ULMN 3 1a0j_c15 TRYPSIN user 19 3 # 19 D 57 HIS B 102 HIS~? 4.91 O2 B3P B 371 D 102 ASP B 27 ASP.? 7.01 C10 B3P B 371 D 193 GLY B 288 GLY.? -3.59 O1 B3P B 371s coo 8.19 15.01 95.72 7.78 16.53 97.01 -49.25 96.38 11.24 -48.46 97.85 9.95 coo 13.53 16.28 93.98 11.45 16.21 94.40 -54.29 98.49 11.88 -52.46 97.53 11.54 coo 1.80 21.25 100.04 2.61 21.42 100.18 -41.26 101.79 9.71 -40.78 102.47 9.85 ULMN 3 1a0j_c15 TRYPSIN user 20 3 # 20 D 57 HIS B 102 HIS~? 4.91 O2 B3P B 371 D 102 ASP B 106 ASP~? 1.96 ZN ZN B 402s D 193 GLY B 30 GLY^? 14.53 ZN ZN B 402 coo 8.19 15.01 95.72 7.78 16.53 97.01 -49.25 96.38 11.24 -48.46 97.85 9.95 coo 13.53 16.28 93.98 11.45 16.21 94.40 -46.09 100.09 15.88 -45.34 99.27 14.09 coo 1.80 21.25 100.04 2.61 21.42 100.18 -55.27 89.43 14.51 -54.92 89.45 13.77 ULMN 3 1a0j_c15 TRYPSIN user 21 3 # 21 D 57 HIS B 312 HIS~? 6.47 ZN ZN A 402 D 102 ASP A 48 ASP.? 7.07 ZN ZN A 402 D 193 GLY A 287 GLY.? -5.56 O1 B3P A 371s coo 8.19 15.01 95.72 7.78 16.53 97.01 -36.00 115.58 -2.34 -34.91 117.32 -2.81 coo 13.53 16.28 93.98 11.45 16.21 94.40 -34.00 122.50 -3.86 -35.34 120.86 -3.93 coo 1.80 21.25 100.04 2.61 21.42 100.18 -37.37 111.28 -12.26 -38.18 111.28 -12.23 ULMN 3 1a0j_c15 TRYPSIN user 22 3 # 22 D 57 HIS B 312 HIS~? 6.47 ZN ZN A 402 D 102 ASP A 48 ASP.? 7.07 ZN ZN A 402 D 193 GLY A 308 GLY.? 7.69 O1 B3P A 371 coo 8.19 15.01 95.72 7.78 16.53 97.01 -36.00 115.58 -2.34 -34.91 117.32 -2.81 coo 13.53 16.28 93.98 11.45 16.21 94.40 -34.00 122.50 -3.86 -35.34 120.86 -3.93 coo 1.80 21.25 100.04 2.61 21.42 100.18 -36.78 108.02 -6.71 -37.57 107.80 -6.86 ULMN 3 1a0j_c15 TRYPSIN user 23 3 # 23 D 57 HIS B 312 HIS~? 6.47 ZN ZN A 402 D 102 ASP A 365 ASP.? 11.72 ZN ZN A 402 D 193 GLY A 287 GLY.? -5.56 O1 B3P A 371s coo 8.19 15.01 95.72 7.78 16.53 97.01 -36.00 115.58 -2.34 -34.91 117.32 -2.81 coo 13.53 16.28 93.98 11.45 16.21 94.40 -28.60 115.73 -1.61 -29.73 113.97 -1.34 coo 1.80 21.25 100.04 2.61 21.42 100.18 -37.37 111.28 -12.26 -38.18 111.28 -12.23 ULMN 3 1a0j_c15 TRYPSIN user 24 3 # 24 D 57 HIS B 312 HIS~? 6.47 ZN ZN A 402 D 102 ASP A 365 ASP.? 11.72 ZN ZN A 402 D 193 GLY A 308 GLY.? 7.69 O1 B3P A 371 coo 8.19 15.01 95.72 7.78 16.53 97.01 -36.00 115.58 -2.34 -34.91 117.32 -2.81 coo 13.53 16.28 93.98 11.45 16.21 94.40 -28.60 115.73 -1.61 -29.73 113.97 -1.34 coo 1.80 21.25 100.04 2.61 21.42 100.18 -36.78 108.02 -6.71 -37.57 107.80 -6.86 ULMN 3 1a0j_c15 TRYPSIN user 25 3 # 25 D 57 HIS B 313 HIS~? 5.49 ZN ZN A 402 D 102 ASP B 314 ASP~? 9.37 O5 B3P A 371 D 193 GLY A 288 GLY.? -3.58 O1 B3P A 371s coo 8.19 15.01 95.72 7.78 16.53 97.01 -40.27 117.73 -1.83 -39.85 118.55 -3.71 coo 13.53 16.28 93.98 11.45 16.21 94.40 -40.38 114.62 4.43 -42.39 114.53 3.82 coo 1.80 21.25 100.04 2.61 21.42 100.18 -38.32 112.40 -8.76 -38.34 111.58 -8.94 ULMN 3 1a0j_c15 TRYPSIN user 26 3 # 26 D 57 HIS B 313 HIS~? 5.49 ZN ZN A 402 D 102 ASP B 314 ASP~? 9.37 O5 B3P A 371 D 193 GLY A 308 GLY.? 7.69 O1 B3P A 371 coo 8.19 15.01 95.72 7.78 16.53 97.01 -40.27 117.73 -1.83 -39.85 118.55 -3.71 coo 13.53 16.28 93.98 11.45 16.21 94.40 -40.38 114.62 4.43 -42.39 114.53 3.82 coo 1.80 21.25 100.04 2.61 21.42 100.18 -36.78 108.02 -6.71 -37.57 107.80 -6.86 ULMN 3 1a0j_c15 TRYPSIN user 27 3 # 27 D 57 HIS B 313 HIS~? 5.49 ZN ZN A 402 D 102 ASP B 317 ASP~? 10.65 O4 B3P A 371 D 193 GLY A 288 GLY.? -3.58 O1 B3P A 371s coo 8.19 15.01 95.72 7.78 16.53 97.01 -40.27 117.73 -1.83 -39.85 118.55 -3.71 coo 13.53 16.28 93.98 11.45 16.21 94.40 -39.61 120.08 5.26 -40.74 120.57 3.54 coo 1.80 21.25 100.04 2.61 21.42 100.18 -38.32 112.40 -8.76 -38.34 111.58 -8.94 ULMN 3 1a0j_c15 TRYPSIN user 28 3 # 28 D 57 HIS B 321 HIS~? 16.92 O4 B3P A 371 D 102 ASP B 317 ASP~? 10.65 O4 B3P A 371 D 193 GLY A 85 GLY~? 19.74 O4 B3P A 371 coo 8.19 15.01 95.72 7.78 16.53 97.01 -38.45 123.77 9.41 -39.84 124.80 8.23 coo 13.53 16.28 93.98 11.45 16.21 94.40 -39.61 120.08 5.26 -40.74 120.57 3.54 coo 1.80 21.25 100.04 2.61 21.42 100.18 -39.21 132.55 4.91 -38.47 132.20 4.74 ULMN 3 1a0j_c15 TRYPSIN user 29 3 # 29 D 57 HIS B 321 HIS~? 16.92 O4 B3P A 371 D 102 ASP B 317 ASP~? 10.65 O4 B3P A 371 D 193 GLY B 274 GLY.? 20.62 ZN ZN A 402 coo 8.19 15.01 95.72 7.78 16.53 97.01 -38.45 123.77 9.41 -39.84 124.80 8.23 coo 13.53 16.28 93.98 11.45 16.21 94.40 -39.61 120.08 5.26 -40.74 120.57 3.54 coo 1.80 21.25 100.04 2.61 21.42 100.18 -28.47 117.52 9.71 -27.96 117.13 9.12 1a0j_c15 source 1a0j TRYPSIN : 29 hits 1a0j_c15 naa= 3 ULMN 3 1a41_c01 TOPOISOMERASE I user 1 3 # 1 223 ARG A 271 ARG^? 13.44 ZN ZN B 401 265 HIS A 312 HIS~? 6.48 ZN ZN B 401 274 TYR A 295 TYR~? 16.26 C9 B3P A 371 coo -15.18 55.46 8.55 -14.82 52.98 10.38 -33.34 101.75 -1.66 -34.94 103.58 0.21 coo -14.48 45.59 11.18 -14.02 47.49 10.42 -41.04 97.86 3.25 -41.05 95.82 3.71 coo 0.94 52.26 9.16 1.95 54.78 9.91 -48.13 97.91 -11.44 -47.20 97.03 -8.94 ULMN 3 1a41_c01 TOPOISOMERASE I user 2 3 # 2 223 ARG B 271 ARG^? 13.51 ZN ZN A 402 265 HIS B 312 HIS~? 6.47 ZN ZN A 402 274 TYR B 295 TYR~? 16.19 C9 B3P B 371 coo -15.18 55.46 8.55 -14.82 52.98 10.38 -31.35 108.28 2.46 -33.78 107.49 0.72 coo -14.48 45.59 11.18 -14.02 47.49 10.42 -36.00 115.58 -2.34 -34.91 117.32 -2.81 coo 0.94 52.26 9.16 1.95 54.78 9.91 -41.84 119.19 12.43 -40.61 119.57 9.93 1a41_c01 source 1a41 TOPOISOMERASE I : 2 hits 1a41_c01 naa= 3 ULMN 3 1a4y_c00 RIBONUCLEASE INHIBITOR user 1 3 # 1 B 13 HIS A 69 HIS.? -3.50 ZN ZN A 402s B 40 LYS A 74 LYS.? 6.52 C5 B3P A 371 B 114 HIS B 312 HIS~? 6.47 ZN ZN A 402 coo 1.80 -13.66 41.28 2.01 -11.61 41.71 -38.08 120.43 -6.58 -37.62 118.38 -6.66 coo 8.72 -5.06 38.24 5.16 -8.30 41.14 -48.78 125.51 -1.27 -51.17 122.94 -3.63 coo -3.17 -9.07 46.16 -1.65 -8.08 47.22 -36.00 115.58 -2.34 -34.91 117.32 -2.81 ULMN 3 1a4y_c00 RIBONUCLEASE INHIBITOR user 2 3 # 2 B 13 HIS A 69 HIS.? -3.50 ZN ZN A 402s B 40 LYS A 337 LYS~? 13.43 ZN ZN A 402 B 114 HIS A 330 HIS~? -3.46 ZN ZN A 402s coo 1.80 -13.66 41.28 2.01 -11.61 41.71 -38.08 120.43 -6.58 -37.62 118.38 -6.66 coo 8.72 -5.06 38.24 5.16 -8.30 41.14 -29.31 122.02 -13.66 -26.65 121.35 -8.38 coo -3.17 -9.07 46.16 -1.65 -8.08 47.22 -37.28 113.42 -5.32 -38.81 114.77 -5.81 ULMN 3 1a4y_c00 RIBONUCLEASE INHIBITOR user 3 3 # 3 B 13 HIS A 69 HIS.? -3.50 ZN ZN A 402s B 40 LYS A 337 LYS~? 13.43 ZN ZN A 402 B 114 HIS B 312 HIS~? 6.47 ZN ZN A 402 coo 1.80 -13.66 41.28 2.01 -11.61 41.71 -38.08 120.43 -6.58 -37.62 118.38 -6.66 coo 8.72 -5.06 38.24 5.16 -8.30 41.14 -29.31 122.02 -13.66 -26.65 121.35 -8.38 coo -3.17 -9.07 46.16 -1.65 -8.08 47.22 -36.00 115.58 -2.34 -34.91 117.32 -2.81 ULMN 3 1a4y_c00 RIBONUCLEASE INHIBITOR user 4 3 # 4 B 13 HIS A 102 HIS~? 4.84 O2 B3P A 371 B 40 LYS A 337 LYS~? 13.43 ZN ZN A 402 B 114 HIS B 313 HIS~? 5.49 ZN ZN A 402 coo 1.80 -13.66 41.28 2.01 -11.61 41.71 -42.24 121.28 -10.34 -42.29 119.63 -9.04 coo 8.72 -5.06 38.24 5.16 -8.30 41.14 -29.31 122.02 -13.66 -26.65 121.35 -8.38 coo -3.17 -9.07 46.16 -1.65 -8.08 47.22 -40.27 117.73 -1.83 -39.85 118.55 -3.71 ULMN 3 1a4y_c00 RIBONUCLEASE INHIBITOR user 5 3 # 5 B 13 HIS A 312 HIS~? 6.48 ZN ZN B 401 B 40 LYS A 319 LYS~? 18.09 ZN ZN B 401 B 114 HIS B 69 HIS.? -3.44 ZN ZN B 401s coo 1.80 -13.66 41.28 2.01 -11.61 41.71 -41.04 97.86 3.25 -41.05 95.82 3.71 coo 8.72 -5.06 38.24 5.16 -8.30 41.14 -41.25 92.42 -6.09 -36.50 89.98 -5.00 coo -3.17 -9.07 46.16 -1.65 -8.08 47.22 -45.30 94.94 7.48 -43.81 96.41 7.64 ULMN 3 1a4y_c00 RIBONUCLEASE INHIBITOR user 6 3 # 6 B 13 HIS A 313 HIS~? 5.54 ZN ZN B 401 B 40 LYS A 319 LYS~? 18.09 ZN ZN B 401 B 114 HIS B 330 HIS~? -3.52 ZN ZN B 401s coo 1.80 -13.66 41.28 2.01 -11.61 41.71 -45.85 98.44 2.81 -45.85 97.45 4.68 coo 8.72 -5.06 38.24 5.16 -8.30 41.14 -41.25 92.42 -6.09 -36.50 89.98 -5.00 coo -3.17 -9.07 46.16 -1.65 -8.08 47.22 -40.87 100.43 6.30 -42.90 100.10 6.71 ULMN 3 1a4y_c00 RIBONUCLEASE INHIBITOR user 7 3 # 7 B 13 HIS A 330 HIS~? -3.46 ZN ZN A 402s B 40 LYS A 311 LYS~? 6.37 O5 B3P B 371 B 114 HIS B 313 HIS~? 5.49 ZN ZN A 402 coo 1.80 -13.66 41.28 2.01 -11.61 41.71 -37.28 113.42 -5.32 -38.81 114.77 -5.81 coo 8.72 -5.06 38.24 5.16 -8.30 41.14 -40.88 103.07 -0.16 -45.35 106.37 1.57 coo -3.17 -9.07 46.16 -1.65 -8.08 47.22 -40.27 117.73 -1.83 -39.85 118.55 -3.71 ULMN 3 1a4y_c00 RIBONUCLEASE INHIBITOR user 8 3 # 8 B 13 HIS B 69 HIS.? -3.44 ZN ZN B 401s B 40 LYS B 74 LYS.? 4.72 C5 B3P B 371 B 114 HIS A 312 HIS~? 6.48 ZN ZN B 401 coo 1.80 -13.66 41.28 2.01 -11.61 41.71 -45.30 94.94 7.48 -43.81 96.41 7.64 coo 8.72 -5.06 38.24 5.16 -8.30 41.14 -57.07 96.46 2.17 -55.04 101.69 2.44 coo -3.17 -9.07 46.16 -1.65 -8.08 47.22 -41.04 97.86 3.25 -41.05 95.82 3.71 ULMN 3 1a4y_c00 RIBONUCLEASE INHIBITOR user 9 3 # 9 B 13 HIS B 69 HIS.? -3.44 ZN ZN B 401s B 40 LYS B 337 LYS~? 13.35 ZN ZN B 401 B 114 HIS A 312 HIS~? 6.48 ZN ZN B 401 coo 1.80 -13.66 41.28 2.01 -11.61 41.71 -45.30 94.94 7.48 -43.81 96.41 7.64 coo 8.72 -5.06 38.24 5.16 -8.30 41.14 -38.72 88.65 14.37 -36.15 88.00 9.08 coo -3.17 -9.07 46.16 -1.65 -8.08 47.22 -41.04 97.86 3.25 -41.05 95.82 3.71 ULMN 3 1a4y_c00 RIBONUCLEASE INHIBITOR user 10 3 # 10 B 13 HIS B 69 HIS.? -3.44 ZN ZN B 401s B 40 LYS B 337 LYS~? 13.35 ZN ZN B 401 B 114 HIS B 330 HIS~? -3.52 ZN ZN B 401s coo 1.80 -13.66 41.28 2.01 -11.61 41.71 -45.30 94.94 7.48 -43.81 96.41 7.64 coo 8.72 -5.06 38.24 5.16 -8.30 41.14 -38.72 88.65 14.37 -36.15 88.00 9.08 coo -3.17 -9.07 46.16 -1.65 -8.08 47.22 -40.87 100.43 6.30 -42.90 100.10 6.71 ULMN 3 1a4y_c00 RIBONUCLEASE INHIBITOR user 11 3 # 11 B 13 HIS B 312 HIS~? 6.47 ZN ZN A 402 B 40 LYS B 319 LYS~? 18.23 ZN ZN A 402 B 114 HIS A 69 HIS.? -3.50 ZN ZN A 402s coo 1.80 -13.66 41.28 2.01 -11.61 41.71 -36.00 115.58 -2.34 -34.91 117.32 -2.81 coo 8.72 -5.06 38.24 5.16 -8.30 41.14 -33.05 120.28 7.11 -27.72 119.85 5.88 coo -3.17 -9.07 46.16 -1.65 -8.08 47.22 -38.08 120.43 -6.58 -37.62 118.38 -6.66 ULMN 3 1a4y_c00 RIBONUCLEASE INHIBITOR user 12 3 # 12 B 13 HIS B 313 HIS~? 5.49 ZN ZN A 402 B 40 LYS B 319 LYS~? 18.23 ZN ZN A 402 B 114 HIS A 330 HIS~? -3.46 ZN ZN A 402s coo 1.80 -13.66 41.28 2.01 -11.61 41.71 -40.27 117.73 -1.83 -39.85 118.55 -3.71 coo 8.72 -5.06 38.24 5.16 -8.30 41.14 -33.05 120.28 7.11 -27.72 119.85 5.88 coo -3.17 -9.07 46.16 -1.65 -8.08 47.22 -37.28 113.42 -5.32 -38.81 114.77 -5.81 ULMN 3 1a4y_c00 RIBONUCLEASE INHIBITOR user 13 3 # 13 B 13 HIS B 330 HIS~? -3.52 ZN ZN B 401s B 40 LYS B 311 LYS~? 6.90 O5 B3P A 371 B 114 HIS A 313 HIS~? 5.54 ZN ZN B 401 coo 1.80 -13.66 41.28 2.01 -11.61 41.71 -40.87 100.43 6.30 -42.90 100.10 6.71 coo 8.72 -5.06 38.24 5.16 -8.30 41.14 -38.57 111.14 1.14 -44.17 110.56 -0.29 coo -3.17 -9.07 46.16 -1.65 -8.08 47.22 -45.85 98.44 2.81 -45.85 97.45 4.68 1a4y_c00 source 1a4y RIBONUCLEASE INHIBITOR : 13 hits 1a4y_c00 naa= 3 ULMN 3 1a4y_c01 RIBONUCLEASE INHIBITOR user 1 3 # 1 E 13 HIS A 69 HIS.? -3.50 ZN ZN A 402s E 40 LYS A 74 LYS.? 6.52 C5 B3P A 371 E 114 HIS B 312 HIS~? 6.47 ZN ZN A 402 coo 22.66 18.80 -11.81 23.81 19.26 -10.13 -38.08 120.43 -6.58 -37.62 118.38 -6.66 coo 21.57 20.13 -0.45 23.62 20.29 -5.74 -48.78 125.51 -1.27 -51.17 122.94 -3.63 coo 30.88 19.38 -11.95 31.04 21.06 -10.71 -36.00 115.58 -2.34 -34.91 117.32 -2.81 ULMN 3 1a4y_c01 RIBONUCLEASE INHIBITOR user 2 3 # 2 E 13 HIS A 69 HIS.? -3.50 ZN ZN A 402s E 40 LYS A 337 LYS~? 13.43 ZN ZN A 402 E 114 HIS A 330 HIS~? -3.46 ZN ZN A 402s coo 22.66 18.80 -11.81 23.81 19.26 -10.13 -38.08 120.43 -6.58 -37.62 118.38 -6.66 coo 21.57 20.13 -0.45 23.62 20.29 -5.74 -29.31 122.02 -13.66 -26.65 121.35 -8.38 coo 30.88 19.38 -11.95 31.04 21.06 -10.71 -37.28 113.42 -5.32 -38.81 114.77 -5.81 ULMN 3 1a4y_c01 RIBONUCLEASE INHIBITOR user 3 3 # 3 E 13 HIS A 69 HIS.? -3.50 ZN ZN A 402s E 40 LYS A 337 LYS~? 13.43 ZN ZN A 402 E 114 HIS B 312 HIS~? 6.47 ZN ZN A 402 coo 22.66 18.80 -11.81 23.81 19.26 -10.13 -38.08 120.43 -6.58 -37.62 118.38 -6.66 coo 21.57 20.13 -0.45 23.62 20.29 -5.74 -29.31 122.02 -13.66 -26.65 121.35 -8.38 coo 30.88 19.38 -11.95 31.04 21.06 -10.71 -36.00 115.58 -2.34 -34.91 117.32 -2.81 ULMN 3 1a4y_c01 RIBONUCLEASE INHIBITOR user 4 3 # 4 E 13 HIS A 102 HIS~? 4.84 O2 B3P A 371 E 40 LYS A 337 LYS~? 13.43 ZN ZN A 402 E 114 HIS B 313 HIS~? 5.49 ZN ZN A 402 coo 22.66 18.80 -11.81 23.81 19.26 -10.13 -42.24 121.28 -10.34 -42.29 119.63 -9.04 coo 21.57 20.13 -0.45 23.62 20.29 -5.74 -29.31 122.02 -13.66 -26.65 121.35 -8.38 coo 30.88 19.38 -11.95 31.04 21.06 -10.71 -40.27 117.73 -1.83 -39.85 118.55 -3.71 ULMN 3 1a4y_c01 RIBONUCLEASE INHIBITOR user 5 3 # 5 E 13 HIS A 312 HIS~? 6.48 ZN ZN B 401 E 40 LYS A 319 LYS~? 18.09 ZN ZN B 401 E 114 HIS B 69 HIS.? -3.44 ZN ZN B 401s coo 22.66 18.80 -11.81 23.81 19.26 -10.13 -41.04 97.86 3.25 -41.05 95.82 3.71 coo 21.57 20.13 -0.45 23.62 20.29 -5.74 -41.25 92.42 -6.09 -36.50 89.98 -5.00 coo 30.88 19.38 -11.95 31.04 21.06 -10.71 -45.30 94.94 7.48 -43.81 96.41 7.64 ULMN 3 1a4y_c01 RIBONUCLEASE INHIBITOR user 6 3 # 6 E 13 HIS A 313 HIS~? 5.54 ZN ZN B 401 E 40 LYS A 319 LYS~? 18.09 ZN ZN B 401 E 114 HIS B 330 HIS~? -3.52 ZN ZN B 401s coo 22.66 18.80 -11.81 23.81 19.26 -10.13 -45.85 98.44 2.81 -45.85 97.45 4.68 coo 21.57 20.13 -0.45 23.62 20.29 -5.74 -41.25 92.42 -6.09 -36.50 89.98 -5.00 coo 30.88 19.38 -11.95 31.04 21.06 -10.71 -40.87 100.43 6.30 -42.90 100.10 6.71 ULMN 3 1a4y_c01 RIBONUCLEASE INHIBITOR user 7 3 # 7 E 13 HIS A 330 HIS~? -3.46 ZN ZN A 402s E 40 LYS A 311 LYS~? 6.37 O5 B3P B 371 E 114 HIS B 313 HIS~? 5.49 ZN ZN A 402 coo 22.66 18.80 -11.81 23.81 19.26 -10.13 -37.28 113.42 -5.32 -38.81 114.77 -5.81 coo 21.57 20.13 -0.45 23.62 20.29 -5.74 -40.88 103.07 -0.16 -45.35 106.37 1.57 coo 30.88 19.38 -11.95 31.04 21.06 -10.71 -40.27 117.73 -1.83 -39.85 118.55 -3.71 ULMN 3 1a4y_c01 RIBONUCLEASE INHIBITOR user 8 3 # 8 E 13 HIS B 69 HIS.? -3.44 ZN ZN B 401s E 40 LYS B 74 LYS.? 4.72 C5 B3P B 371 E 114 HIS A 312 HIS~? 6.48 ZN ZN B 401 coo 22.66 18.80 -11.81 23.81 19.26 -10.13 -45.30 94.94 7.48 -43.81 96.41 7.64 coo 21.57 20.13 -0.45 23.62 20.29 -5.74 -57.07 96.46 2.17 -55.04 101.69 2.44 coo 30.88 19.38 -11.95 31.04 21.06 -10.71 -41.04 97.86 3.25 -41.05 95.82 3.71 ULMN 3 1a4y_c01 RIBONUCLEASE INHIBITOR user 9 3 # 9 E 13 HIS B 69 HIS.? -3.44 ZN ZN B 401s E 40 LYS B 337 LYS~? 13.35 ZN ZN B 401 E 114 HIS A 312 HIS~? 6.48 ZN ZN B 401 coo 22.66 18.80 -11.81 23.81 19.26 -10.13 -45.30 94.94 7.48 -43.81 96.41 7.64 coo 21.57 20.13 -0.45 23.62 20.29 -5.74 -38.72 88.65 14.37 -36.15 88.00 9.08 coo 30.88 19.38 -11.95 31.04 21.06 -10.71 -41.04 97.86 3.25 -41.05 95.82 3.71 ULMN 3 1a4y_c01 RIBONUCLEASE INHIBITOR user 10 3 # 10 E 13 HIS B 69 HIS.? -3.44 ZN ZN B 401s E 40 LYS B 337 LYS~? 13.35 ZN ZN B 401 E 114 HIS B 330 HIS~? -3.52 ZN ZN B 401s coo 22.66 18.80 -11.81 23.81 19.26 -10.13 -45.30 94.94 7.48 -43.81 96.41 7.64 coo 21.57 20.13 -0.45 23.62 20.29 -5.74 -38.72 88.65 14.37 -36.15 88.00 9.08 coo 30.88 19.38 -11.95 31.04 21.06 -10.71 -40.87 100.43 6.30 -42.90 100.10 6.71 ULMN 3 1a4y_c01 RIBONUCLEASE INHIBITOR user 11 3 # 11 E 13 HIS B 102 HIS~? 4.91 O2 B3P B 371 E 40 LYS B 337 LYS~? 13.35 ZN ZN B 401 E 114 HIS A 313 HIS~? 5.54 ZN ZN B 401 coo 22.66 18.80 -11.81 23.81 19.26 -10.13 -49.25 96.38 11.24 -48.46 97.85 9.95 coo 21.57 20.13 -0.45 23.62 20.29 -5.74 -38.72 88.65 14.37 -36.15 88.00 9.08 coo 30.88 19.38 -11.95 31.04 21.06 -10.71 -45.85 98.44 2.81 -45.85 97.45 4.68 ULMN 3 1a4y_c01 RIBONUCLEASE INHIBITOR user 12 3 # 12 E 13 HIS B 312 HIS~? 6.47 ZN ZN A 402 E 40 LYS B 319 LYS~? 18.23 ZN ZN A 402 E 114 HIS A 69 HIS.? -3.50 ZN ZN A 402s coo 22.66 18.80 -11.81 23.81 19.26 -10.13 -36.00 115.58 -2.34 -34.91 117.32 -2.81 coo 21.57 20.13 -0.45 23.62 20.29 -5.74 -33.05 120.28 7.11 -27.72 119.85 5.88 coo 30.88 19.38 -11.95 31.04 21.06 -10.71 -38.08 120.43 -6.58 -37.62 118.38 -6.66 ULMN 3 1a4y_c01 RIBONUCLEASE INHIBITOR user 13 3 # 13 E 13 HIS B 313 HIS~? 5.49 ZN ZN A 402 E 40 LYS B 319 LYS~? 18.23 ZN ZN A 402 E 114 HIS A 330 HIS~? -3.46 ZN ZN A 402s coo 22.66 18.80 -11.81 23.81 19.26 -10.13 -40.27 117.73 -1.83 -39.85 118.55 -3.71 coo 21.57 20.13 -0.45 23.62 20.29 -5.74 -33.05 120.28 7.11 -27.72 119.85 5.88 coo 30.88 19.38 -11.95 31.04 21.06 -10.71 -37.28 113.42 -5.32 -38.81 114.77 -5.81 ULMN 3 1a4y_c01 RIBONUCLEASE INHIBITOR user 14 3 # 14 E 13 HIS B 330 HIS~? -3.52 ZN ZN B 401s E 40 LYS B 311 LYS~? 6.90 O5 B3P A 371 E 114 HIS A 313 HIS~? 5.54 ZN ZN B 401 coo 22.66 18.80 -11.81 23.81 19.26 -10.13 -40.87 100.43 6.30 -42.90 100.10 6.71 coo 21.57 20.13 -0.45 23.62 20.29 -5.74 -38.57 111.14 1.14 -44.17 110.56 -0.29 coo 30.88 19.38 -11.95 31.04 21.06 -10.71 -45.85 98.44 2.81 -45.85 97.45 4.68 1a4y_c01 source 1a4y RIBONUCLEASE INHIBITOR : 14 hits 1a4y_c01 naa= 3 ULMN 3 1a50_c03 TRYPTOPHAN SYNTHASE user 1 3 # 1 A 49 GLU A 233 GLU^? 23.79 O3 B3P A 371 A 60 ASP A 230 ASP^? 38.04 O3 B3P A 371 A 175 TYR A 135 TYR^? 22.72 O3 B3P A 371 coo 46.10 28.27 19.27 45.48 26.99 20.84 -62.71 117.71 -29.26 -63.44 117.34 -27.30 coo 56.42 28.06 12.93 55.01 27.92 14.50 -69.05 121.76 -38.15 -70.74 121.65 -39.40 coo 45.02 22.04 15.38 46.16 24.00 13.76 -55.36 120.20 -32.34 -52.69 120.16 -31.50 ULMN 3 1a50_c03 TRYPTOPHAN SYNTHASE user 2 3 # 2 A 49 GLU A 294 GLU~? 11.80 C9 B3P A 371 A 60 ASP A 309 ASP.? 7.55 ZN ZN A 402 A 175 TYR A 293 TYR~? 6.46 C11 B3P A 371 coo 46.10 28.27 19.27 45.48 26.99 20.84 -44.58 100.10 -10.25 -45.30 101.55 -8.87 coo 56.42 28.06 12.93 55.01 27.92 14.50 -39.32 109.22 -3.35 -38.59 111.09 -2.57 coo 45.02 22.04 15.38 46.16 24.00 13.76 -46.61 106.89 -13.57 -48.15 109.22 -13.70 ULMN 3 1a50_c03 TRYPTOPHAN SYNTHASE user 3 3 # 3 A 49 GLU A 294 GLU~? 11.80 C9 B3P A 371 A 60 ASP A 327 ASP^? 11.36 O1 B3P A 371 A 175 TYR A 293 TYR~? 6.46 C11 B3P A 371 coo 46.10 28.27 19.27 45.48 26.99 20.84 -44.58 100.10 -10.25 -45.30 101.55 -8.87 coo 56.42 28.06 12.93 55.01 27.92 14.50 -34.76 103.64 -5.32 -35.22 105.46 -4.31 coo 45.02 22.04 15.38 46.16 24.00 13.76 -46.61 106.89 -13.57 -48.15 109.22 -13.70 ULMN 3 1a50_c03 TRYPTOPHAN SYNTHASE user 4 3 # 4 A 49 GLU A 333 GLU~? 2.48 ZN ZN A 401s A 60 ASP A 327 ASP^? 11.36 O1 B3P A 371 A 175 TYR A 331 TYR~? 10.26 ZN ZN A 402 coo 46.10 28.27 19.27 45.48 26.99 20.84 -35.80 114.74 -10.32 -37.65 115.72 -10.06 coo 56.42 28.06 12.93 55.01 27.92 14.50 -34.76 103.64 -5.32 -35.22 105.46 -4.31 coo 45.02 22.04 15.38 46.16 24.00 13.76 -30.16 115.06 -4.86 -28.37 117.16 -5.34 ULMN 3 1a50_c03 TRYPTOPHAN SYNTHASE user 5 3 # 5 A 49 GLU A 333 GLU~? 2.48 ZN ZN A 401s A 60 ASP A 327 ASP^? 11.36 O1 B3P A 371 A 175 TYR A 334 TYR~? 12.18 ZN ZN A 402 coo 46.10 28.27 19.27 45.48 26.99 20.84 -35.80 114.74 -10.32 -37.65 115.72 -10.06 coo 56.42 28.06 12.93 55.01 27.92 14.50 -34.76 103.64 -5.32 -35.22 105.46 -4.31 coo 45.02 22.04 15.38 46.16 24.00 13.76 -28.13 116.36 -9.51 -26.22 114.55 -10.48 ULMN 3 1a50_c03 TRYPTOPHAN SYNTHASE user 6 3 # 6 A 49 GLU B 199 GLU^? 48.27 O3 B3P B 371 A 60 ASP B 145 ASP~? 55.34 O3 B3P B 371 A 175 TYR B 224 TYR.? 49.72 O3 B3P B 371 coo 46.10 28.27 19.27 45.48 26.99 20.84 -77.31 110.33 51.94 -78.27 110.21 50.08 coo 56.42 28.06 12.93 55.01 27.92 14.50 -76.73 100.72 58.46 -76.44 101.76 60.27 coo 45.02 22.04 15.38 46.16 24.00 13.76 -83.24 105.70 47.06 -84.73 107.98 47.79 ULMN 3 1a50_c03 TRYPTOPHAN SYNTHASE user 7 3 # 7 A 49 GLU B 199 GLU^? 48.27 O3 B3P B 371 A 60 ASP B 230 ASP^? 38.13 O3 B3P B 371 A 175 TYR B 224 TYR.? 49.72 O3 B3P B 371 coo 46.10 28.27 19.27 45.48 26.99 20.84 -77.31 110.33 51.94 -78.27 110.21 50.08 coo 56.42 28.06 12.93 55.01 27.92 14.50 -72.67 110.26 38.86 -74.22 111.29 39.84 coo 45.02 22.04 15.38 46.16 24.00 13.76 -83.24 105.70 47.06 -84.73 107.98 47.79 ULMN 3 1a50_c03 TRYPTOPHAN SYNTHASE user 8 3 # 8 A 49 GLU B 233 GLU^? 23.73 O3 B3P B 371 A 60 ASP B 230 ASP^? 38.13 O3 B3P B 371 A 175 TYR B 135 TYR^? 22.73 O3 B3P B 371 coo 46.10 28.27 19.27 45.48 26.99 20.84 -64.75 110.13 30.02 -64.81 111.27 28.28 coo 56.42 28.06 12.93 55.01 27.92 14.50 -72.67 110.26 38.86 -74.22 111.29 39.84 coo 45.02 22.04 15.38 46.16 24.00 13.76 -60.04 104.36 33.10 -57.67 103.06 32.39 ULMN 3 1a50_c03 TRYPTOPHAN SYNTHASE user 9 3 # 9 A 49 GLU B 294 GLU~? 11.71 C9 B3P B 371 A 60 ASP B 309 ASP.? 7.61 ZN ZN B 401 A 175 TYR B 293 TYR~? 6.51 C11 B3P B 371 coo 46.10 28.27 19.27 45.48 26.99 20.84 -39.97 115.47 11.20 -41.44 114.67 9.87 coo 56.42 28.06 12.93 55.01 27.92 14.50 -40.43 105.08 4.20 -40.75 103.07 3.51 coo 45.02 22.04 15.38 46.16 24.00 13.76 -45.29 110.79 14.65 -47.81 109.59 14.74 ULMN 3 1a50_c03 TRYPTOPHAN SYNTHASE user 10 3 # 10 A 49 GLU B 294 GLU~? 11.71 C9 B3P B 371 A 60 ASP B 327 ASP^? 11.42 O1 B3P B 371 A 175 TYR B 293 TYR~? 6.51 C11 B3P B 371 coo 46.10 28.27 19.27 45.48 26.99 20.84 -39.97 115.47 11.20 -41.44 114.67 9.87 coo 56.42 28.06 12.93 55.01 27.92 14.50 -33.51 107.30 6.30 -34.89 106.08 5.25 coo 45.02 22.04 15.38 46.16 24.00 13.76 -45.29 110.79 14.65 -47.81 109.59 14.74 ULMN 3 1a50_c03 TRYPTOPHAN SYNTHASE user 11 3 # 11 A 49 GLU B 333 GLU~? 2.50 ZN ZN B 402s A 60 ASP B 327 ASP^? 11.42 O1 B3P B 371 A 175 TYR B 331 TYR~? 10.21 ZN ZN B 401 coo 46.10 28.27 19.27 45.48 26.99 20.84 -40.33 98.40 11.28 -42.37 98.54 11.02 coo 56.42 28.06 12.93 55.01 27.92 14.50 -33.51 107.30 6.30 -34.89 106.08 5.25 coo 45.02 22.04 15.38 46.16 24.00 13.76 -35.74 95.21 5.65 -35.48 92.47 6.11 ULMN 3 1a50_c03 TRYPTOPHAN SYNTHASE user 12 3 # 12 A 49 GLU B 333 GLU~? 2.50 ZN ZN B 402s A 60 ASP B 327 ASP^? 11.42 O1 B3P B 371 A 175 TYR B 334 TYR~? 12.17 ZN ZN B 401 coo 46.10 28.27 19.27 45.48 26.99 20.84 -40.33 98.40 11.28 -42.37 98.54 11.02 coo 56.42 28.06 12.93 55.01 27.92 14.50 -33.51 107.30 6.30 -34.89 106.08 5.25 coo 45.02 22.04 15.38 46.16 24.00 13.76 -34.63 93.02 10.30 -32.01 93.55 11.20 1a50_c03 source 1a50 TRYPTOPHAN SYNTHASE : 12 hits 1a50_c03 naa= 3 ULMN 3 1a79_c00 TRNA ENDONUCLEASE user 1 3 # 1 A 115 TYR A 331 TYR~? 10.26 ZN ZN A 402 A 125 HIS A 69 HIS.? -3.50 ZN ZN A 402s A 156 LYS A 337 LYS~? 13.43 ZN ZN A 402 coo 37.11 -19.03 58.81 39.12 -18.07 60.48 -30.16 115.06 -4.86 -28.37 117.16 -5.34 coo 44.53 -22.25 60.75 45.90 -22.66 62.28 -38.08 120.43 -6.58 -37.62 118.38 -6.66 coo 46.42 -20.06 51.80 44.79 -19.05 56.86 -29.31 122.02 -13.66 -26.65 121.35 -8.38 ULMN 3 1a79_c00 TRNA ENDONUCLEASE user 2 3 # 2 A 115 TYR A 331 TYR~? 10.26 ZN ZN A 402 A 125 HIS B 312 HIS~? 6.47 ZN ZN A 402 A 156 LYS B 319 LYS~? 18.23 ZN ZN A 402 coo 37.11 -19.03 58.81 39.12 -18.07 60.48 -30.16 115.06 -4.86 -28.37 117.16 -5.34 coo 44.53 -22.25 60.75 45.90 -22.66 62.28 -36.00 115.58 -2.34 -34.91 117.32 -2.81 coo 46.42 -20.06 51.80 44.79 -19.05 56.86 -33.05 120.28 7.11 -27.72 119.85 5.88 ULMN 3 1a79_c00 TRNA ENDONUCLEASE user 3 3 # 3 A 115 TYR B 331 TYR~? 10.21 ZN ZN B 401 A 125 HIS A 312 HIS~? 6.48 ZN ZN B 401 A 156 LYS A 319 LYS~? 18.09 ZN ZN B 401 coo 37.11 -19.03 58.81 39.12 -18.07 60.48 -35.74 95.21 5.65 -35.48 92.47 6.11 coo 44.53 -22.25 60.75 45.90 -22.66 62.28 -41.04 97.86 3.25 -41.05 95.82 3.71 coo 46.42 -20.06 51.80 44.79 -19.05 56.86 -41.25 92.42 -6.09 -36.50 89.98 -5.00 1a79_c00 source 1a79 TRNA ENDONUCLEASE : 3 hits 1a79_c00 naa= 3 ULMN 3 1a79_c01 TRNA ENDONUCLEASE user 1 3 # 1 B 115 TYR A 331 TYR~? 10.26 ZN ZN A 402 B 125 HIS A 69 HIS.? -3.50 ZN ZN A 402s B 156 LYS A 337 LYS~? 13.43 ZN ZN A 402 coo 52.78 -23.08 19.46 51.79 -21.72 17.22 -30.16 115.06 -4.86 -28.37 117.16 -5.34 coo 45.10 -24.12 17.42 43.96 -24.36 15.67 -38.08 120.43 -6.58 -37.62 118.38 -6.66 coo 43.97 -19.59 26.02 45.10 -20.27 21.16 -29.31 122.02 -13.66 -26.65 121.35 -8.38 ULMN 3 1a79_c01 TRNA ENDONUCLEASE user 2 3 # 2 B 115 TYR A 331 TYR~? 10.26 ZN ZN A 402 B 125 HIS B 312 HIS~? 6.47 ZN ZN A 402 B 156 LYS B 319 LYS~? 18.23 ZN ZN A 402 coo 52.78 -23.08 19.46 51.79 -21.72 17.22 -30.16 115.06 -4.86 -28.37 117.16 -5.34 coo 45.10 -24.12 17.42 43.96 -24.36 15.67 -36.00 115.58 -2.34 -34.91 117.32 -2.81 coo 43.97 -19.59 26.02 45.10 -20.27 21.16 -33.05 120.28 7.11 -27.72 119.85 5.88 ULMN 3 1a79_c01 TRNA ENDONUCLEASE user 3 3 # 3 B 115 TYR B 84 TYR~? 13.70 O4 B3P B 371 B 125 HIS A 321 HIS~? 16.72 O4 B3P B 371 B 156 LYS B 80 LYS.? 22.96 O4 B3P B 371 coo 52.78 -23.08 19.46 51.79 -21.72 17.22 -49.86 90.29 -2.09 -47.88 92.17 -1.55 coo 45.10 -24.12 17.42 43.96 -24.36 15.67 -47.70 92.41 -8.31 -49.45 92.40 -7.16 coo 43.97 -19.59 26.02 45.10 -20.27 21.16 -55.71 83.86 -8.01 -56.90 88.35 -11.71 ULMN 3 1a79_c01 TRNA ENDONUCLEASE user 4 3 # 4 B 115 TYR B 224 TYR.? 49.72 O3 B3P B 371 B 125 HIS B 222 HIS~? 44.73 O3 B3P B 371 B 156 LYS B 201 LYS^? 38.84 O3 B3P B 371 coo 52.78 -23.08 19.46 51.79 -21.72 17.22 -83.24 105.70 47.06 -84.73 107.98 47.79 coo 45.10 -24.12 17.42 43.96 -24.36 15.67 -78.49 101.96 45.58 -77.98 103.75 46.55 coo 43.97 -19.59 26.02 45.10 -20.27 21.16 -70.79 108.75 48.84 -67.72 112.70 45.12 ULMN 3 1a79_c01 TRNA ENDONUCLEASE user 5 3 # 5 B 115 TYR B 331 TYR~? 10.21 ZN ZN B 401 B 125 HIS A 312 HIS~? 6.48 ZN ZN B 401 B 156 LYS A 319 LYS~? 18.09 ZN ZN B 401 coo 52.78 -23.08 19.46 51.79 -21.72 17.22 -35.74 95.21 5.65 -35.48 92.47 6.11 coo 45.10 -24.12 17.42 43.96 -24.36 15.67 -41.04 97.86 3.25 -41.05 95.82 3.71 coo 43.97 -19.59 26.02 45.10 -20.27 21.16 -41.25 92.42 -6.09 -36.50 89.98 -5.00 ULMN 3 1a79_c01 TRNA ENDONUCLEASE user 6 3 # 6 B 115 TYR B 331 TYR~? 10.21 ZN ZN B 401 B 125 HIS B 69 HIS.? -3.44 ZN ZN B 401s B 156 LYS B 337 LYS~? 13.35 ZN ZN B 401 coo 52.78 -23.08 19.46 51.79 -21.72 17.22 -35.74 95.21 5.65 -35.48 92.47 6.11 coo 45.10 -24.12 17.42 43.96 -24.36 15.67 -45.30 94.94 7.48 -43.81 96.41 7.64 coo 43.97 -19.59 26.02 45.10 -20.27 21.16 -38.72 88.65 14.37 -36.15 88.00 9.08 1a79_c01 source 1a79 TRNA ENDONUCLEASE : 6 hits 1a79_c01 naa= 3 ULMN 3 1a79_c03 TRNA ENDONUCLEASE user 1 3 # 1 D 115 TYR A 331 TYR~? 10.26 ZN ZN A 402 D 125 HIS A 69 HIS.? -3.50 ZN ZN A 402s D 156 LYS A 337 LYS~? 13.43 ZN ZN A 402 coo 54.10 1.42 85.16 54.14 4.17 85.62 -30.16 115.06 -4.86 -28.37 117.16 -5.34 coo 61.27 5.43 85.32 62.73 6.38 86.49 -38.08 120.43 -6.58 -37.62 118.38 -6.66 coo 60.28 4.62 76.00 58.35 6.41 80.65 -29.31 122.02 -13.66 -26.65 121.35 -8.38 ULMN 3 1a79_c03 TRNA ENDONUCLEASE user 2 3 # 2 D 115 TYR A 331 TYR~? 10.26 ZN ZN A 402 D 125 HIS B 312 HIS~? 6.47 ZN ZN A 402 D 156 LYS B 319 LYS~? 18.23 ZN ZN A 402 coo 54.10 1.42 85.16 54.14 4.17 85.62 -30.16 115.06 -4.86 -28.37 117.16 -5.34 coo 61.27 5.43 85.32 62.73 6.38 86.49 -36.00 115.58 -2.34 -34.91 117.32 -2.81 coo 60.28 4.62 76.00 58.35 6.41 80.65 -33.05 120.28 7.11 -27.72 119.85 5.88 ULMN 3 1a79_c03 TRNA ENDONUCLEASE user 3 3 # 3 D 115 TYR B 224 TYR.? 49.72 O3 B3P B 371 D 125 HIS B 222 HIS~? 44.73 O3 B3P B 371 D 156 LYS B 201 LYS^? 38.84 O3 B3P B 371 coo 54.10 1.42 85.16 54.14 4.17 85.62 -83.24 105.70 47.06 -84.73 107.98 47.79 coo 61.27 5.43 85.32 62.73 6.38 86.49 -78.49 101.96 45.58 -77.98 103.75 46.55 coo 60.28 4.62 76.00 58.35 6.41 80.65 -70.79 108.75 48.84 -67.72 112.70 45.12 ULMN 3 1a79_c03 TRNA ENDONUCLEASE user 4 3 # 4 D 115 TYR B 331 TYR~? 10.21 ZN ZN B 401 D 125 HIS A 312 HIS~? 6.48 ZN ZN B 401 D 156 LYS A 319 LYS~? 18.09 ZN ZN B 401 coo 54.10 1.42 85.16 54.14 4.17 85.62 -35.74 95.21 5.65 -35.48 92.47 6.11 coo 61.27 5.43 85.32 62.73 6.38 86.49 -41.04 97.86 3.25 -41.05 95.82 3.71 coo 60.28 4.62 76.00 58.35 6.41 80.65 -41.25 92.42 -6.09 -36.50 89.98 -5.00 1a79_c03 source 1a79 TRNA ENDONUCLEASE : 4 hits 1a79_c03 naa= 3 ULMN 3 1a7u_c02 CHLOROPEROXIDASE T user 1 3 # 1 A 98 SER A 332 SER~? 10.92 ZN ZN A 402 A 228 ASP A 309 ASP.? 7.55 ZN ZN A 402 A 257 HIS A 330 HIS~? -3.46 ZN ZN A 402s coo 9.47 41.64 34.15 9.10 39.28 33.93 -31.12 112.57 -9.16 -30.10 110.35 -8.93 coo 2.03 38.95 28.44 3.60 38.60 29.83 -39.32 109.22 -3.35 -38.59 111.09 -2.57 coo 6.85 37.62 29.99 7.50 38.47 31.78 -37.28 113.42 -5.32 -38.81 114.77 -5.81 ULMN 3 1a7u_c02 CHLOROPEROXIDASE T user 2 3 # 2 A 98 SER B 332 SER~? 10.87 ZN ZN B 401 A 228 ASP B 309 ASP.? 7.61 ZN ZN B 401 A 257 HIS B 330 HIS~? -3.52 ZN ZN B 401s coo 9.47 41.64 34.15 9.10 39.28 33.93 -35.18 97.79 10.03 -33.17 99.10 9.80 coo 2.03 38.95 28.44 3.60 38.60 29.83 -40.43 105.08 4.20 -40.75 103.07 3.51 coo 6.85 37.62 29.99 7.50 38.47 31.78 -40.87 100.43 6.30 -42.90 100.10 6.71 1a7u_c02 source 1a7u CHLOROPEROXIDASE T : 2 hits 1a7u_c02 naa= 3 ULMN 3 1a7u_c03 CHLOROPEROXIDASE T user 1 3 # 1 B 98 SER A 332 SER~? 10.92 ZN ZN A 402 B 228 ASP A 309 ASP.? 7.55 ZN ZN A 402 B 257 HIS A 330 HIS~? -3.46 ZN ZN A 402s coo 28.35 71.07 3.94 30.08 69.46 4.49 -31.12 112.57 -9.16 -30.10 110.35 -8.93 coo 31.11 65.98 -3.92 31.07 66.41 -1.82 -39.32 109.22 -3.35 -38.59 111.09 -2.57 coo 32.76 68.02 0.70 31.21 68.44 2.05 -37.28 113.42 -5.32 -38.81 114.77 -5.81 ULMN 3 1a7u_c03 CHLOROPEROXIDASE T user 2 3 # 2 B 98 SER B 332 SER~? 10.87 ZN ZN B 401 B 228 ASP B 309 ASP.? 7.61 ZN ZN B 401 B 257 HIS B 330 HIS~? -3.52 ZN ZN B 401s coo 28.35 71.07 3.94 30.08 69.46 4.49 -35.18 97.79 10.03 -33.17 99.10 9.80 coo 31.11 65.98 -3.92 31.07 66.41 -1.82 -40.43 105.08 4.20 -40.75 103.07 3.51 coo 32.76 68.02 0.70 31.21 68.44 2.05 -40.87 100.43 6.30 -42.90 100.10 6.71 1a7u_c03 source 1a7u CHLOROPEROXIDASE T : 2 hits 1a7u_c03 naa= 3 ULMN 3 1a8h_c02 METHIONYL-TRNA SYNTHETASE user 1 3 # 1 16 ALA A 46 ALA^? 12.32 ZN ZN A 402 19 HIS A 68 HIS.? -3.48 ZN ZN A 401s 22 HIS A 69 HIS.? -3.50 ZN ZN A 402s coo 53.27 36.51 45.29 51.98 36.45 44.47 -31.18 124.97 -9.62 -31.44 126.01 -8.48 coo 46.88 33.59 48.26 46.24 34.32 46.40 -37.46 120.39 -11.50 -38.87 119.03 -12.26 coo 48.05 31.12 44.60 48.20 33.05 43.77 -38.08 120.43 -6.58 -37.62 118.38 -6.66 ULMN 3 1a8h_c02 METHIONYL-TRNA SYNTHETASE user 2 3 # 2 16 ALA A 46 ALA^? 12.32 ZN ZN A 402 19 HIS A 69 HIS.? -3.50 ZN ZN A 402s 22 HIS A 68 HIS.? -3.48 ZN ZN A 401s coo 53.27 36.51 45.29 51.98 36.45 44.47 -31.18 124.97 -9.62 -31.44 126.01 -8.48 coo 46.88 33.59 48.26 46.24 34.32 46.40 -38.08 120.43 -6.58 -37.62 118.38 -6.66 coo 48.05 31.12 44.60 48.20 33.05 43.77 -37.46 120.39 -11.50 -38.87 119.03 -12.26 ULMN 3 1a8h_c02 METHIONYL-TRNA SYNTHETASE user 3 3 # 3 16 ALA A 100 ALA^? 10.88 ZN ZN A 401 19 HIS A 68 HIS.? -3.48 ZN ZN A 401s 22 HIS A 69 HIS.? -3.50 ZN ZN A 402s coo 53.27 36.51 45.29 51.98 36.45 44.47 -40.07 127.59 -11.35 -41.05 127.25 -10.17 coo 46.88 33.59 48.26 46.24 34.32 46.40 -37.46 120.39 -11.50 -38.87 119.03 -12.26 coo 48.05 31.12 44.60 48.20 33.05 43.77 -38.08 120.43 -6.58 -37.62 118.38 -6.66 ULMN 3 1a8h_c02 METHIONYL-TRNA SYNTHETASE user 4 3 # 4 16 ALA A 100 ALA^? 10.88 ZN ZN A 401 19 HIS A 68 HIS.? -3.48 ZN ZN A 401s 22 HIS A 102 HIS~? 4.84 O2 B3P A 371 coo 53.27 36.51 45.29 51.98 36.45 44.47 -40.07 127.59 -11.35 -41.05 127.25 -10.17 coo 46.88 33.59 48.26 46.24 34.32 46.40 -37.46 120.39 -11.50 -38.87 119.03 -12.26 coo 48.05 31.12 44.60 48.20 33.05 43.77 -42.24 121.28 -10.34 -42.29 119.63 -9.04 ULMN 3 1a8h_c02 METHIONYL-TRNA SYNTHETASE user 5 3 # 5 16 ALA A 100 ALA^? 10.88 ZN ZN A 401 19 HIS A 69 HIS.? -3.50 ZN ZN A 402s 22 HIS A 68 HIS.? -3.48 ZN ZN A 401s coo 53.27 36.51 45.29 51.98 36.45 44.47 -40.07 127.59 -11.35 -41.05 127.25 -10.17 coo 46.88 33.59 48.26 46.24 34.32 46.40 -38.08 120.43 -6.58 -37.62 118.38 -6.66 coo 48.05 31.12 44.60 48.20 33.05 43.77 -37.46 120.39 -11.50 -38.87 119.03 -12.26 ULMN 3 1a8h_c02 METHIONYL-TRNA SYNTHETASE user 6 3 # 6 16 ALA A 100 ALA^? 10.88 ZN ZN A 401 19 HIS A 69 HIS.? -3.50 ZN ZN A 402s 22 HIS A 102 HIS~? 4.84 O2 B3P A 371 coo 53.27 36.51 45.29 51.98 36.45 44.47 -40.07 127.59 -11.35 -41.05 127.25 -10.17 coo 46.88 33.59 48.26 46.24 34.32 46.40 -38.08 120.43 -6.58 -37.62 118.38 -6.66 coo 48.05 31.12 44.60 48.20 33.05 43.77 -42.24 121.28 -10.34 -42.29 119.63 -9.04 ULMN 3 1a8h_c02 METHIONYL-TRNA SYNTHETASE user 7 3 # 7 16 ALA A 100 ALA^? 10.88 ZN ZN A 401 19 HIS A 102 HIS~? 4.84 O2 B3P A 371 22 HIS A 68 HIS.? -3.48 ZN ZN A 401s coo 53.27 36.51 45.29 51.98 36.45 44.47 -40.07 127.59 -11.35 -41.05 127.25 -10.17 coo 46.88 33.59 48.26 46.24 34.32 46.40 -42.24 121.28 -10.34 -42.29 119.63 -9.04 coo 48.05 31.12 44.60 48.20 33.05 43.77 -37.46 120.39 -11.50 -38.87 119.03 -12.26 ULMN 3 1a8h_c02 METHIONYL-TRNA SYNTHETASE user 8 3 # 8 16 ALA A 100 ALA^? 10.88 ZN ZN A 401 19 HIS A 102 HIS~? 4.84 O2 B3P A 371 22 HIS A 69 HIS.? -3.50 ZN ZN A 402s coo 53.27 36.51 45.29 51.98 36.45 44.47 -40.07 127.59 -11.35 -41.05 127.25 -10.17 coo 46.88 33.59 48.26 46.24 34.32 46.40 -42.24 121.28 -10.34 -42.29 119.63 -9.04 coo 48.05 31.12 44.60 48.20 33.05 43.77 -38.08 120.43 -6.58 -37.62 118.38 -6.66 ULMN 3 1a8h_c02 METHIONYL-TRNA SYNTHETASE user 9 3 # 9 16 ALA A 315 ALA~? 12.41 ZN ZN B 401 19 HIS A 312 HIS~? 6.48 ZN ZN B 401 22 HIS A 313 HIS~? 5.54 ZN ZN B 401 coo 53.27 36.51 45.29 51.98 36.45 44.47 -41.15 97.94 -3.49 -39.77 98.25 -2.75 coo 46.88 33.59 48.26 46.24 34.32 46.40 -41.04 97.86 3.25 -41.05 95.82 3.71 coo 48.05 31.12 44.60 48.20 33.05 43.77 -45.85 98.44 2.81 -45.85 97.45 4.68 ULMN 3 1a8h_c02 METHIONYL-TRNA SYNTHETASE user 10 3 # 10 16 ALA A 315 ALA~? 12.41 ZN ZN B 401 19 HIS A 313 HIS~? 5.54 ZN ZN B 401 22 HIS A 312 HIS~? 6.48 ZN ZN B 401 coo 53.27 36.51 45.29 51.98 36.45 44.47 -41.15 97.94 -3.49 -39.77 98.25 -2.75 coo 46.88 33.59 48.26 46.24 34.32 46.40 -45.85 98.44 2.81 -45.85 97.45 4.68 coo 48.05 31.12 44.60 48.20 33.05 43.77 -41.04 97.86 3.25 -41.05 95.82 3.71 ULMN 3 1a8h_c02 METHIONYL-TRNA SYNTHETASE user 11 3 # 11 16 ALA B 46 ALA^? 12.33 ZN ZN B 401 19 HIS B 68 HIS.? -3.46 ZN ZN B 402s 22 HIS B 69 HIS.? -3.44 ZN ZN B 401s coo 53.27 36.51 45.29 51.98 36.45 44.47 -41.82 87.26 10.31 -42.61 86.56 9.20 coo 46.88 33.59 48.26 46.24 34.32 46.40 -44.72 94.50 12.35 -45.14 96.41 13.13 coo 48.05 31.12 44.60 48.20 33.05 43.77 -45.30 94.94 7.48 -43.81 96.41 7.64 ULMN 3 1a8h_c02 METHIONYL-TRNA SYNTHETASE user 12 3 # 12 16 ALA B 46 ALA^? 12.33 ZN ZN B 401 19 HIS B 69 HIS.? -3.44 ZN ZN B 401s 22 HIS B 68 HIS.? -3.46 ZN ZN B 402s coo 53.27 36.51 45.29 51.98 36.45 44.47 -41.82 87.26 10.31 -42.61 86.56 9.20 coo 46.88 33.59 48.26 46.24 34.32 46.40 -45.30 94.94 7.48 -43.81 96.41 7.64 coo 48.05 31.12 44.60 48.20 33.05 43.77 -44.72 94.50 12.35 -45.14 96.41 13.13 ULMN 3 1a8h_c02 METHIONYL-TRNA SYNTHETASE user 13 3 # 13 16 ALA B 100 ALA^? 10.75 ZN ZN B 402 19 HIS B 68 HIS.? -3.46 ZN ZN B 402s 22 HIS B 69 HIS.? -3.44 ZN ZN B 401s coo 53.27 36.51 45.29 51.98 36.45 44.47 -50.76 89.87 12.14 -51.40 90.79 11.05 coo 46.88 33.59 48.26 46.24 34.32 46.40 -44.72 94.50 12.35 -45.14 96.41 13.13 coo 48.05 31.12 44.60 48.20 33.05 43.77 -45.30 94.94 7.48 -43.81 96.41 7.64 ULMN 3 1a8h_c02 METHIONYL-TRNA SYNTHETASE user 14 3 # 14 16 ALA B 100 ALA^? 10.75 ZN ZN B 402 19 HIS B 68 HIS.? -3.46 ZN ZN B 402s 22 HIS B 102 HIS~? 4.91 O2 B3P B 371 coo 53.27 36.51 45.29 51.98 36.45 44.47 -50.76 89.87 12.14 -51.40 90.79 11.05 coo 46.88 33.59 48.26 46.24 34.32 46.40 -44.72 94.50 12.35 -45.14 96.41 13.13 coo 48.05 31.12 44.60 48.20 33.05 43.77 -49.25 96.38 11.24 -48.46 97.85 9.95 ULMN 3 1a8h_c02 METHIONYL-TRNA SYNTHETASE user 15 3 # 15 16 ALA B 100 ALA^? 10.75 ZN ZN B 402 19 HIS B 69 HIS.? -3.44 ZN ZN B 401s 22 HIS B 68 HIS.? -3.46 ZN ZN B 402s coo 53.27 36.51 45.29 51.98 36.45 44.47 -50.76 89.87 12.14 -51.40 90.79 11.05 coo 46.88 33.59 48.26 46.24 34.32 46.40 -45.30 94.94 7.48 -43.81 96.41 7.64 coo 48.05 31.12 44.60 48.20 33.05 43.77 -44.72 94.50 12.35 -45.14 96.41 13.13 ULMN 3 1a8h_c02 METHIONYL-TRNA SYNTHETASE user 16 3 # 16 16 ALA B 100 ALA^? 10.75 ZN ZN B 402 19 HIS B 69 HIS.? -3.44 ZN ZN B 401s 22 HIS B 102 HIS~? 4.91 O2 B3P B 371 coo 53.27 36.51 45.29 51.98 36.45 44.47 -50.76 89.87 12.14 -51.40 90.79 11.05 coo 46.88 33.59 48.26 46.24 34.32 46.40 -45.30 94.94 7.48 -43.81 96.41 7.64 coo 48.05 31.12 44.60 48.20 33.05 43.77 -49.25 96.38 11.24 -48.46 97.85 9.95 ULMN 3 1a8h_c02 METHIONYL-TRNA SYNTHETASE user 17 3 # 17 16 ALA B 100 ALA^? 10.75 ZN ZN B 402 19 HIS B 102 HIS~? 4.91 O2 B3P B 371 22 HIS B 68 HIS.? -3.46 ZN ZN B 402s coo 53.27 36.51 45.29 51.98 36.45 44.47 -50.76 89.87 12.14 -51.40 90.79 11.05 coo 46.88 33.59 48.26 46.24 34.32 46.40 -49.25 96.38 11.24 -48.46 97.85 9.95 coo 48.05 31.12 44.60 48.20 33.05 43.77 -44.72 94.50 12.35 -45.14 96.41 13.13 ULMN 3 1a8h_c02 METHIONYL-TRNA SYNTHETASE user 18 3 # 18 16 ALA B 100 ALA^? 10.75 ZN ZN B 402 19 HIS B 102 HIS~? 4.91 O2 B3P B 371 22 HIS B 69 HIS.? -3.44 ZN ZN B 401s coo 53.27 36.51 45.29 51.98 36.45 44.47 -50.76 89.87 12.14 -51.40 90.79 11.05 coo 46.88 33.59 48.26 46.24 34.32 46.40 -49.25 96.38 11.24 -48.46 97.85 9.95 coo 48.05 31.12 44.60 48.20 33.05 43.77 -45.30 94.94 7.48 -43.81 96.41 7.64 ULMN 3 1a8h_c02 METHIONYL-TRNA SYNTHETASE user 19 3 # 19 16 ALA B 315 ALA~? 12.42 ZN ZN A 402 19 HIS B 312 HIS~? 6.47 ZN ZN A 402 22 HIS B 313 HIS~? 5.49 ZN ZN A 402 coo 53.27 36.51 45.29 51.98 36.45 44.47 -35.93 115.64 4.42 -34.97 114.71 3.67 coo 46.88 33.59 48.26 46.24 34.32 46.40 -36.00 115.58 -2.34 -34.91 117.32 -2.81 coo 48.05 31.12 44.60 48.20 33.05 43.77 -40.27 117.73 -1.83 -39.85 118.55 -3.71 ULMN 3 1a8h_c02 METHIONYL-TRNA SYNTHETASE user 20 3 # 20 16 ALA B 315 ALA~? 12.42 ZN ZN A 402 19 HIS B 313 HIS~? 5.49 ZN ZN A 402 22 HIS B 312 HIS~? 6.47 ZN ZN A 402 coo 53.27 36.51 45.29 51.98 36.45 44.47 -35.93 115.64 4.42 -34.97 114.71 3.67 coo 46.88 33.59 48.26 46.24 34.32 46.40 -40.27 117.73 -1.83 -39.85 118.55 -3.71 coo 48.05 31.12 44.60 48.20 33.05 43.77 -36.00 115.58 -2.34 -34.91 117.32 -2.81 1a8h_c02 source 1a8h METHIONYL-TRNA SYNTHETASE : 20 hits 1a8h_c02 naa= 3 ULMN 3 1a8q_c00 BROMOPEROXIDASE A1 user 1 3 # 1 94 SER A 67 SER^? 10.42 ZN ZN A 402 223 ASP A 48 ASP.? 7.07 ZN ZN A 402 252 HIS A 69 HIS.? -3.50 ZN ZN A 402s coo 40.95 0.07 3.20 39.54 1.39 4.66 -35.40 126.06 -10.23 -37.10 126.61 -8.52 coo 42.66 -2.61 12.07 41.85 -1.47 10.53 -34.00 122.50 -3.86 -35.34 120.86 -3.93 coo 41.54 1.64 9.09 40.82 1.05 7.19 -38.08 120.43 -6.58 -37.62 118.38 -6.66 ULMN 3 1a8q_c00 BROMOPEROXIDASE A1 user 2 3 # 2 94 SER A 332 SER~? 10.92 ZN ZN A 402 223 ASP A 309 ASP.? 7.55 ZN ZN A 402 252 HIS A 330 HIS~? -3.46 ZN ZN A 402s coo 40.95 0.07 3.20 39.54 1.39 4.66 -31.12 112.57 -9.16 -30.10 110.35 -8.93 coo 42.66 -2.61 12.07 41.85 -1.47 10.53 -39.32 109.22 -3.35 -38.59 111.09 -2.57 coo 41.54 1.64 9.09 40.82 1.05 7.19 -37.28 113.42 -5.32 -38.81 114.77 -5.81 ULMN 3 1a8q_c00 BROMOPEROXIDASE A1 user 3 3 # 3 94 SER B 332 SER~? 10.87 ZN ZN B 401 223 ASP B 309 ASP.? 7.61 ZN ZN B 401 252 HIS B 330 HIS~? -3.52 ZN ZN B 401s coo 40.95 0.07 3.20 39.54 1.39 4.66 -35.18 97.79 10.03 -33.17 99.10 9.80 coo 42.66 -2.61 12.07 41.85 -1.47 10.53 -40.43 105.08 4.20 -40.75 103.07 3.51 coo 41.54 1.64 9.09 40.82 1.05 7.19 -40.87 100.43 6.30 -42.90 100.10 6.71 1a8q_c00 source 1a8q BROMOPEROXIDASE A1 : 3 hits 1a8q_c00 naa= 3 ULMN 3 1a8s_c00 CHLOROPEROXIDASE F user 1 3 # 1 94 SER A 332 SER~? 10.92 ZN ZN A 402 224 ASP A 309 ASP.? 7.55 ZN ZN A 402 253 HIS A 330 HIS~? -3.46 ZN ZN A 402s coo 16.00 80.13 58.60 16.16 82.12 59.96 -31.12 112.57 -9.16 -30.10 110.35 -8.93 coo 8.47 84.84 62.27 10.52 84.40 62.08 -39.32 109.22 -3.35 -38.59 111.09 -2.57 coo 13.14 83.03 63.68 14.37 82.62 62.02 -37.28 113.42 -5.32 -38.81 114.77 -5.81 ULMN 3 1a8s_c00 CHLOROPEROXIDASE F user 2 3 # 2 94 SER B 332 SER~? 10.87 ZN ZN B 401 224 ASP B 309 ASP.? 7.61 ZN ZN B 401 253 HIS B 330 HIS~? -3.52 ZN ZN B 401s coo 16.00 80.13 58.60 16.16 82.12 59.96 -35.18 97.79 10.03 -33.17 99.10 9.80 coo 8.47 84.84 62.27 10.52 84.40 62.08 -40.43 105.08 4.20 -40.75 103.07 3.51 coo 13.14 83.03 63.68 14.37 82.62 62.02 -40.87 100.43 6.30 -42.90 100.10 6.71 1a8s_c00 source 1a8s CHLOROPEROXIDASE F : 2 hits 1a8s_c00 naa= 3 ULMN 3 1aj8_c00 CITRATE SYNTHASE user 1 3 # 1 A 223 HIS A 68 HIS.? -3.48 ZN ZN A 401s A 262 HIS A 330 HIS~? -3.46 ZN ZN A 402s A 312 ASP A 48 ASP.? 7.07 ZN ZN A 402 coo 29.33 36.13 69.70 30.07 34.20 70.11 -37.46 120.39 -11.50 -38.87 119.03 -12.26 coo 38.54 36.60 66.38 37.88 34.77 67.15 -37.28 113.42 -5.32 -38.81 114.77 -5.81 coo 30.62 37.23 61.07 30.08 35.73 62.49 -34.00 122.50 -3.86 -35.34 120.86 -3.93 ULMN 3 1aj8_c00 CITRATE SYNTHASE user 2 3 # 2 A 223 HIS A 68 HIS.? -3.48 ZN ZN A 401s A 262 HIS B 313 HIS~? 5.49 ZN ZN A 402 A 312 ASP A 48 ASP.? 7.07 ZN ZN A 402 coo 29.33 36.13 69.70 30.07 34.20 70.11 -37.46 120.39 -11.50 -38.87 119.03 -12.26 coo 38.54 36.60 66.38 37.88 34.77 67.15 -40.27 117.73 -1.83 -39.85 118.55 -3.71 coo 30.62 37.23 61.07 30.08 35.73 62.49 -34.00 122.50 -3.86 -35.34 120.86 -3.93 ULMN 3 1aj8_c00 CITRATE SYNTHASE user 3 3 # 3 A 223 HIS A 102 HIS~? 4.84 O2 B3P A 371 A 262 HIS A 330 HIS~? -3.46 ZN ZN A 402s A 312 ASP A 48 ASP.? 7.07 ZN ZN A 402 coo 29.33 36.13 69.70 30.07 34.20 70.11 -42.24 121.28 -10.34 -42.29 119.63 -9.04 coo 38.54 36.60 66.38 37.88 34.77 67.15 -37.28 113.42 -5.32 -38.81 114.77 -5.81 coo 30.62 37.23 61.07 30.08 35.73 62.49 -34.00 122.50 -3.86 -35.34 120.86 -3.93 ULMN 3 1aj8_c00 CITRATE SYNTHASE user 4 3 # 4 A 223 HIS A 102 HIS~? 4.84 O2 B3P A 371 A 262 HIS B 313 HIS~? 5.49 ZN ZN A 402 A 312 ASP A 48 ASP.? 7.07 ZN ZN A 402 coo 29.33 36.13 69.70 30.07 34.20 70.11 -42.24 121.28 -10.34 -42.29 119.63 -9.04 coo 38.54 36.60 66.38 37.88 34.77 67.15 -40.27 117.73 -1.83 -39.85 118.55 -3.71 coo 30.62 37.23 61.07 30.08 35.73 62.49 -34.00 122.50 -3.86 -35.34 120.86 -3.93 ULMN 3 1aj8_c00 CITRATE SYNTHASE user 5 3 # 5 A 223 HIS A 312 HIS~? 6.48 ZN ZN B 401 A 262 HIS B 68 HIS.? -3.46 ZN ZN B 402s A 312 ASP B 48 ASP.? 7.12 ZN ZN B 401 coo 29.33 36.13 69.70 30.07 34.20 70.11 -41.04 97.86 3.25 -41.05 95.82 3.71 coo 38.54 36.60 66.38 37.88 34.77 67.15 -44.72 94.50 12.35 -45.14 96.41 13.13 coo 30.62 37.23 61.07 30.08 35.73 62.49 -43.07 90.96 4.68 -43.24 93.07 4.75 ULMN 3 1aj8_c00 CITRATE SYNTHASE user 6 3 # 6 A 223 HIS A 312 HIS~? 6.48 ZN ZN B 401 A 262 HIS B 102 HIS~? 4.91 O2 B3P B 371 A 312 ASP B 48 ASP.? 7.12 ZN ZN B 401 coo 29.33 36.13 69.70 30.07 34.20 70.11 -41.04 97.86 3.25 -41.05 95.82 3.71 coo 38.54 36.60 66.38 37.88 34.77 67.15 -49.25 96.38 11.24 -48.46 97.85 9.95 coo 30.62 37.23 61.07 30.08 35.73 62.49 -43.07 90.96 4.68 -43.24 93.07 4.75 ULMN 3 1aj8_c00 CITRATE SYNTHASE user 7 3 # 7 A 223 HIS A 313 HIS~? 5.54 ZN ZN B 401 A 262 HIS B 68 HIS.? -3.46 ZN ZN B 402s A 312 ASP B 48 ASP.? 7.12 ZN ZN B 401 coo 29.33 36.13 69.70 30.07 34.20 70.11 -45.85 98.44 2.81 -45.85 97.45 4.68 coo 38.54 36.60 66.38 37.88 34.77 67.15 -44.72 94.50 12.35 -45.14 96.41 13.13 coo 30.62 37.23 61.07 30.08 35.73 62.49 -43.07 90.96 4.68 -43.24 93.07 4.75 ULMN 3 1aj8_c00 CITRATE SYNTHASE user 8 3 # 8 A 223 HIS A 313 HIS~? 5.54 ZN ZN B 401 A 262 HIS B 102 HIS~? 4.91 O2 B3P B 371 A 312 ASP B 48 ASP.? 7.12 ZN ZN B 401 coo 29.33 36.13 69.70 30.07 34.20 70.11 -45.85 98.44 2.81 -45.85 97.45 4.68 coo 38.54 36.60 66.38 37.88 34.77 67.15 -49.25 96.38 11.24 -48.46 97.85 9.95 coo 30.62 37.23 61.07 30.08 35.73 62.49 -43.07 90.96 4.68 -43.24 93.07 4.75 ULMN 3 1aj8_c00 CITRATE SYNTHASE user 9 3 # 9 A 223 HIS A 330 HIS~? -3.46 ZN ZN A 402s A 262 HIS A 68 HIS.? -3.48 ZN ZN A 401s A 312 ASP A 48 ASP.? 7.07 ZN ZN A 402 coo 29.33 36.13 69.70 30.07 34.20 70.11 -37.28 113.42 -5.32 -38.81 114.77 -5.81 coo 38.54 36.60 66.38 37.88 34.77 67.15 -37.46 120.39 -11.50 -38.87 119.03 -12.26 coo 30.62 37.23 61.07 30.08 35.73 62.49 -34.00 122.50 -3.86 -35.34 120.86 -3.93 ULMN 3 1aj8_c00 CITRATE SYNTHASE user 10 3 # 10 A 223 HIS A 330 HIS~? -3.46 ZN ZN A 402s A 262 HIS A 102 HIS~? 4.84 O2 B3P A 371 A 312 ASP A 48 ASP.? 7.07 ZN ZN A 402 coo 29.33 36.13 69.70 30.07 34.20 70.11 -37.28 113.42 -5.32 -38.81 114.77 -5.81 coo 38.54 36.60 66.38 37.88 34.77 67.15 -42.24 121.28 -10.34 -42.29 119.63 -9.04 coo 30.62 37.23 61.07 30.08 35.73 62.49 -34.00 122.50 -3.86 -35.34 120.86 -3.93 ULMN 3 1aj8_c00 CITRATE SYNTHASE user 11 3 # 11 A 223 HIS B 68 HIS.? -3.46 ZN ZN B 402s A 262 HIS A 313 HIS~? 5.54 ZN ZN B 401 A 312 ASP B 48 ASP.? 7.12 ZN ZN B 401 coo 29.33 36.13 69.70 30.07 34.20 70.11 -44.72 94.50 12.35 -45.14 96.41 13.13 coo 38.54 36.60 66.38 37.88 34.77 67.15 -45.85 98.44 2.81 -45.85 97.45 4.68 coo 30.62 37.23 61.07 30.08 35.73 62.49 -43.07 90.96 4.68 -43.24 93.07 4.75 ULMN 3 1aj8_c00 CITRATE SYNTHASE user 12 3 # 12 A 223 HIS B 68 HIS.? -3.46 ZN ZN B 402s A 262 HIS B 330 HIS~? -3.52 ZN ZN B 401s A 312 ASP B 48 ASP.? 7.12 ZN ZN B 401 coo 29.33 36.13 69.70 30.07 34.20 70.11 -44.72 94.50 12.35 -45.14 96.41 13.13 coo 38.54 36.60 66.38 37.88 34.77 67.15 -40.87 100.43 6.30 -42.90 100.10 6.71 coo 30.62 37.23 61.07 30.08 35.73 62.49 -43.07 90.96 4.68 -43.24 93.07 4.75 ULMN 3 1aj8_c00 CITRATE SYNTHASE user 13 3 # 13 A 223 HIS B 102 HIS~? 4.91 O2 B3P B 371 A 262 HIS A 313 HIS~? 5.54 ZN ZN B 401 A 312 ASP B 48 ASP.? 7.12 ZN ZN B 401 coo 29.33 36.13 69.70 30.07 34.20 70.11 -49.25 96.38 11.24 -48.46 97.85 9.95 coo 38.54 36.60 66.38 37.88 34.77 67.15 -45.85 98.44 2.81 -45.85 97.45 4.68 coo 30.62 37.23 61.07 30.08 35.73 62.49 -43.07 90.96 4.68 -43.24 93.07 4.75 ULMN 3 1aj8_c00 CITRATE SYNTHASE user 14 3 # 14 A 223 HIS B 102 HIS~? 4.91 O2 B3P B 371 A 262 HIS B 330 HIS~? -3.52 ZN ZN B 401s A 312 ASP B 48 ASP.? 7.12 ZN ZN B 401 coo 29.33 36.13 69.70 30.07 34.20 70.11 -49.25 96.38 11.24 -48.46 97.85 9.95 coo 38.54 36.60 66.38 37.88 34.77 67.15 -40.87 100.43 6.30 -42.90 100.10 6.71 coo 30.62 37.23 61.07 30.08 35.73 62.49 -43.07 90.96 4.68 -43.24 93.07 4.75 ULMN 3 1aj8_c00 CITRATE SYNTHASE user 15 3 # 15 A 223 HIS B 312 HIS~? 6.47 ZN ZN A 402 A 262 HIS A 68 HIS.? -3.48 ZN ZN A 401s A 312 ASP A 48 ASP.? 7.07 ZN ZN A 402 coo 29.33 36.13 69.70 30.07 34.20 70.11 -36.00 115.58 -2.34 -34.91 117.32 -2.81 coo 38.54 36.60 66.38 37.88 34.77 67.15 -37.46 120.39 -11.50 -38.87 119.03 -12.26 coo 30.62 37.23 61.07 30.08 35.73 62.49 -34.00 122.50 -3.86 -35.34 120.86 -3.93 ULMN 3 1aj8_c00 CITRATE SYNTHASE user 16 3 # 16 A 223 HIS B 312 HIS~? 6.47 ZN ZN A 402 A 262 HIS A 102 HIS~? 4.84 O2 B3P A 371 A 312 ASP A 48 ASP.? 7.07 ZN ZN A 402 coo 29.33 36.13 69.70 30.07 34.20 70.11 -36.00 115.58 -2.34 -34.91 117.32 -2.81 coo 38.54 36.60 66.38 37.88 34.77 67.15 -42.24 121.28 -10.34 -42.29 119.63 -9.04 coo 30.62 37.23 61.07 30.08 35.73 62.49 -34.00 122.50 -3.86 -35.34 120.86 -3.93 ULMN 3 1aj8_c00 CITRATE SYNTHASE user 17 3 # 17 A 223 HIS B 313 HIS~? 5.49 ZN ZN A 402 A 262 HIS A 68 HIS.? -3.48 ZN ZN A 401s A 312 ASP A 48 ASP.? 7.07 ZN ZN A 402 coo 29.33 36.13 69.70 30.07 34.20 70.11 -40.27 117.73 -1.83 -39.85 118.55 -3.71 coo 38.54 36.60 66.38 37.88 34.77 67.15 -37.46 120.39 -11.50 -38.87 119.03 -12.26 coo 30.62 37.23 61.07 30.08 35.73 62.49 -34.00 122.50 -3.86 -35.34 120.86 -3.93 ULMN 3 1aj8_c00 CITRATE SYNTHASE user 18 3 # 18 A 223 HIS B 313 HIS~? 5.49 ZN ZN A 402 A 262 HIS A 102 HIS~? 4.84 O2 B3P A 371 A 312 ASP A 48 ASP.? 7.07 ZN ZN A 402 coo 29.33 36.13 69.70 30.07 34.20 70.11 -40.27 117.73 -1.83 -39.85 118.55 -3.71 coo 38.54 36.60 66.38 37.88 34.77 67.15 -42.24 121.28 -10.34 -42.29 119.63 -9.04 coo 30.62 37.23 61.07 30.08 35.73 62.49 -34.00 122.50 -3.86 -35.34 120.86 -3.93 ULMN 3 1aj8_c00 CITRATE SYNTHASE user 19 3 # 19 A 223 HIS B 330 HIS~? -3.52 ZN ZN B 401s A 262 HIS B 68 HIS.? -3.46 ZN ZN B 402s A 312 ASP B 48 ASP.? 7.12 ZN ZN B 401 coo 29.33 36.13 69.70 30.07 34.20 70.11 -40.87 100.43 6.30 -42.90 100.10 6.71 coo 38.54 36.60 66.38 37.88 34.77 67.15 -44.72 94.50 12.35 -45.14 96.41 13.13 coo 30.62 37.23 61.07 30.08 35.73 62.49 -43.07 90.96 4.68 -43.24 93.07 4.75 ULMN 3 1aj8_c00 CITRATE SYNTHASE user 20 3 # 20 A 223 HIS B 330 HIS~? -3.52 ZN ZN B 401s A 262 HIS B 102 HIS~? 4.91 O2 B3P B 371 A 312 ASP B 48 ASP.? 7.12 ZN ZN B 401 coo 29.33 36.13 69.70 30.07 34.20 70.11 -40.87 100.43 6.30 -42.90 100.10 6.71 coo 38.54 36.60 66.38 37.88 34.77 67.15 -49.25 96.38 11.24 -48.46 97.85 9.95 coo 30.62 37.23 61.07 30.08 35.73 62.49 -43.07 90.96 4.68 -43.24 93.07 4.75 1aj8_c00 source 1aj8 CITRATE SYNTHASE : 20 hits 1aj8_c00 naa= 3 ULMN 3 1aj8_c01 CITRATE SYNTHASE user 1 3 # 1 B 223 HIS A 68 HIS.? -3.48 ZN ZN A 401s B 262 HIS A 330 HIS~? -3.46 ZN ZN A 402s B 312 ASP A 48 ASP.? 7.07 ZN ZN A 402 coo 23.86 29.50 91.20 24.12 31.58 91.00 -37.46 120.39 -11.50 -38.87 119.03 -12.26 coo 29.35 31.42 99.15 28.72 33.09 98.04 -37.28 113.42 -5.32 -38.81 114.77 -5.81 coo 20.42 28.25 99.26 20.25 29.62 97.63 -34.00 122.50 -3.86 -35.34 120.86 -3.93 ULMN 3 1aj8_c01 CITRATE SYNTHASE user 2 3 # 2 B 223 HIS A 68 HIS.? -3.48 ZN ZN A 401s B 262 HIS B 313 HIS~? 5.49 ZN ZN A 402 B 312 ASP A 48 ASP.? 7.07 ZN ZN A 402 coo 23.86 29.50 91.20 24.12 31.58 91.00 -37.46 120.39 -11.50 -38.87 119.03 -12.26 coo 29.35 31.42 99.15 28.72 33.09 98.04 -40.27 117.73 -1.83 -39.85 118.55 -3.71 coo 20.42 28.25 99.26 20.25 29.62 97.63 -34.00 122.50 -3.86 -35.34 120.86 -3.93 ULMN 3 1aj8_c01 CITRATE SYNTHASE user 3 3 # 3 B 223 HIS A 102 HIS~? 4.84 O2 B3P A 371 B 262 HIS A 330 HIS~? -3.46 ZN ZN A 402s B 312 ASP A 48 ASP.? 7.07 ZN ZN A 402 coo 23.86 29.50 91.20 24.12 31.58 91.00 -42.24 121.28 -10.34 -42.29 119.63 -9.04 coo 29.35 31.42 99.15 28.72 33.09 98.04 -37.28 113.42 -5.32 -38.81 114.77 -5.81 coo 20.42 28.25 99.26 20.25 29.62 97.63 -34.00 122.50 -3.86 -35.34 120.86 -3.93 ULMN 3 1aj8_c01 CITRATE SYNTHASE user 4 3 # 4 B 223 HIS A 102 HIS~? 4.84 O2 B3P A 371 B 262 HIS B 313 HIS~? 5.49 ZN ZN A 402 B 312 ASP A 48 ASP.? 7.07 ZN ZN A 402 coo 23.86 29.50 91.20 24.12 31.58 91.00 -42.24 121.28 -10.34 -42.29 119.63 -9.04 coo 29.35 31.42 99.15 28.72 33.09 98.04 -40.27 117.73 -1.83 -39.85 118.55 -3.71 coo 20.42 28.25 99.26 20.25 29.62 97.63 -34.00 122.50 -3.86 -35.34 120.86 -3.93 ULMN 3 1aj8_c01 CITRATE SYNTHASE user 5 3 # 5 B 223 HIS A 312 HIS~? 6.48 ZN ZN B 401 B 262 HIS B 68 HIS.? -3.46 ZN ZN B 402s B 312 ASP B 48 ASP.? 7.12 ZN ZN B 401 coo 23.86 29.50 91.20 24.12 31.58 91.00 -41.04 97.86 3.25 -41.05 95.82 3.71 coo 29.35 31.42 99.15 28.72 33.09 98.04 -44.72 94.50 12.35 -45.14 96.41 13.13 coo 20.42 28.25 99.26 20.25 29.62 97.63 -43.07 90.96 4.68 -43.24 93.07 4.75 ULMN 3 1aj8_c01 CITRATE SYNTHASE user 6 3 # 6 B 223 HIS A 312 HIS~? 6.48 ZN ZN B 401 B 262 HIS B 102 HIS~? 4.91 O2 B3P B 371 B 312 ASP B 48 ASP.? 7.12 ZN ZN B 401 coo 23.86 29.50 91.20 24.12 31.58 91.00 -41.04 97.86 3.25 -41.05 95.82 3.71 coo 29.35 31.42 99.15 28.72 33.09 98.04 -49.25 96.38 11.24 -48.46 97.85 9.95 coo 20.42 28.25 99.26 20.25 29.62 97.63 -43.07 90.96 4.68 -43.24 93.07 4.75 ULMN 3 1aj8_c01 CITRATE SYNTHASE user 7 3 # 7 B 223 HIS A 313 HIS~? 5.54 ZN ZN B 401 B 262 HIS B 68 HIS.? -3.46 ZN ZN B 402s B 312 ASP B 48 ASP.? 7.12 ZN ZN B 401 coo 23.86 29.50 91.20 24.12 31.58 91.00 -45.85 98.44 2.81 -45.85 97.45 4.68 coo 29.35 31.42 99.15 28.72 33.09 98.04 -44.72 94.50 12.35 -45.14 96.41 13.13 coo 20.42 28.25 99.26 20.25 29.62 97.63 -43.07 90.96 4.68 -43.24 93.07 4.75 ULMN 3 1aj8_c01 CITRATE SYNTHASE user 8 3 # 8 B 223 HIS A 313 HIS~? 5.54 ZN ZN B 401 B 262 HIS B 102 HIS~? 4.91 O2 B3P B 371 B 312 ASP B 48 ASP.? 7.12 ZN ZN B 401 coo 23.86 29.50 91.20 24.12 31.58 91.00 -45.85 98.44 2.81 -45.85 97.45 4.68 coo 29.35 31.42 99.15 28.72 33.09 98.04 -49.25 96.38 11.24 -48.46 97.85 9.95 coo 20.42 28.25 99.26 20.25 29.62 97.63 -43.07 90.96 4.68 -43.24 93.07 4.75 ULMN 3 1aj8_c01 CITRATE SYNTHASE user 9 3 # 9 B 223 HIS A 330 HIS~? -3.46 ZN ZN A 402s B 262 HIS A 68 HIS.? -3.48 ZN ZN A 401s B 312 ASP A 48 ASP.? 7.07 ZN ZN A 402 coo 23.86 29.50 91.20 24.12 31.58 91.00 -37.28 113.42 -5.32 -38.81 114.77 -5.81 coo 29.35 31.42 99.15 28.72 33.09 98.04 -37.46 120.39 -11.50 -38.87 119.03 -12.26 coo 20.42 28.25 99.26 20.25 29.62 97.63 -34.00 122.50 -3.86 -35.34 120.86 -3.93 ULMN 3 1aj8_c01 CITRATE SYNTHASE user 10 3 # 10 B 223 HIS A 330 HIS~? -3.46 ZN ZN A 402s B 262 HIS A 102 HIS~? 4.84 O2 B3P A 371 B 312 ASP A 48 ASP.? 7.07 ZN ZN A 402 coo 23.86 29.50 91.20 24.12 31.58 91.00 -37.28 113.42 -5.32 -38.81 114.77 -5.81 coo 29.35 31.42 99.15 28.72 33.09 98.04 -42.24 121.28 -10.34 -42.29 119.63 -9.04 coo 20.42 28.25 99.26 20.25 29.62 97.63 -34.00 122.50 -3.86 -35.34 120.86 -3.93 ULMN 3 1aj8_c01 CITRATE SYNTHASE user 11 3 # 11 B 223 HIS B 68 HIS.? -3.46 ZN ZN B 402s B 262 HIS A 313 HIS~? 5.54 ZN ZN B 401 B 312 ASP B 48 ASP.? 7.12 ZN ZN B 401 coo 23.86 29.50 91.20 24.12 31.58 91.00 -44.72 94.50 12.35 -45.14 96.41 13.13 coo 29.35 31.42 99.15 28.72 33.09 98.04 -45.85 98.44 2.81 -45.85 97.45 4.68 coo 20.42 28.25 99.26 20.25 29.62 97.63 -43.07 90.96 4.68 -43.24 93.07 4.75 ULMN 3 1aj8_c01 CITRATE SYNTHASE user 12 3 # 12 B 223 HIS B 68 HIS.? -3.46 ZN ZN B 402s B 262 HIS B 330 HIS~? -3.52 ZN ZN B 401s B 312 ASP B 48 ASP.? 7.12 ZN ZN B 401 coo 23.86 29.50 91.20 24.12 31.58 91.00 -44.72 94.50 12.35 -45.14 96.41 13.13 coo 29.35 31.42 99.15 28.72 33.09 98.04 -40.87 100.43 6.30 -42.90 100.10 6.71 coo 20.42 28.25 99.26 20.25 29.62 97.63 -43.07 90.96 4.68 -43.24 93.07 4.75 ULMN 3 1aj8_c01 CITRATE SYNTHASE user 13 3 # 13 B 223 HIS B 102 HIS~? 4.91 O2 B3P B 371 B 262 HIS A 313 HIS~? 5.54 ZN ZN B 401 B 312 ASP B 48 ASP.? 7.12 ZN ZN B 401 coo 23.86 29.50 91.20 24.12 31.58 91.00 -49.25 96.38 11.24 -48.46 97.85 9.95 coo 29.35 31.42 99.15 28.72 33.09 98.04 -45.85 98.44 2.81 -45.85 97.45 4.68 coo 20.42 28.25 99.26 20.25 29.62 97.63 -43.07 90.96 4.68 -43.24 93.07 4.75 ULMN 3 1aj8_c01 CITRATE SYNTHASE user 14 3 # 14 B 223 HIS B 102 HIS~? 4.91 O2 B3P B 371 B 262 HIS B 330 HIS~? -3.52 ZN ZN B 401s B 312 ASP B 48 ASP.? 7.12 ZN ZN B 401 coo 23.86 29.50 91.20 24.12 31.58 91.00 -49.25 96.38 11.24 -48.46 97.85 9.95 coo 29.35 31.42 99.15 28.72 33.09 98.04 -40.87 100.43 6.30 -42.90 100.10 6.71 coo 20.42 28.25 99.26 20.25 29.62 97.63 -43.07 90.96 4.68 -43.24 93.07 4.75 ULMN 3 1aj8_c01 CITRATE SYNTHASE user 15 3 # 15 B 223 HIS B 312 HIS~? 6.47 ZN ZN A 402 B 262 HIS A 68 HIS.? -3.48 ZN ZN A 401s B 312 ASP A 48 ASP.? 7.07 ZN ZN A 402 coo 23.86 29.50 91.20 24.12 31.58 91.00 -36.00 115.58 -2.34 -34.91 117.32 -2.81 coo 29.35 31.42 99.15 28.72 33.09 98.04 -37.46 120.39 -11.50 -38.87 119.03 -12.26 coo 20.42 28.25 99.26 20.25 29.62 97.63 -34.00 122.50 -3.86 -35.34 120.86 -3.93 ULMN 3 1aj8_c01 CITRATE SYNTHASE user 16 3 # 16 B 223 HIS B 312 HIS~? 6.47 ZN ZN A 402 B 262 HIS A 102 HIS~? 4.84 O2 B3P A 371 B 312 ASP A 48 ASP.? 7.07 ZN ZN A 402 coo 23.86 29.50 91.20 24.12 31.58 91.00 -36.00 115.58 -2.34 -34.91 117.32 -2.81 coo 29.35 31.42 99.15 28.72 33.09 98.04 -42.24 121.28 -10.34 -42.29 119.63 -9.04 coo 20.42 28.25 99.26 20.25 29.62 97.63 -34.00 122.50 -3.86 -35.34 120.86 -3.93 ULMN 3 1aj8_c01 CITRATE SYNTHASE user 17 3 # 17 B 223 HIS B 313 HIS~? 5.49 ZN ZN A 402 B 262 HIS A 68 HIS.? -3.48 ZN ZN A 401s B 312 ASP A 48 ASP.? 7.07 ZN ZN A 402 coo 23.86 29.50 91.20 24.12 31.58 91.00 -40.27 117.73 -1.83 -39.85 118.55 -3.71 coo 29.35 31.42 99.15 28.72 33.09 98.04 -37.46 120.39 -11.50 -38.87 119.03 -12.26 coo 20.42 28.25 99.26 20.25 29.62 97.63 -34.00 122.50 -3.86 -35.34 120.86 -3.93 ULMN 3 1aj8_c01 CITRATE SYNTHASE user 18 3 # 18 B 223 HIS B 313 HIS~? 5.49 ZN ZN A 402 B 262 HIS A 102 HIS~? 4.84 O2 B3P A 371 B 312 ASP A 48 ASP.? 7.07 ZN ZN A 402 coo 23.86 29.50 91.20 24.12 31.58 91.00 -40.27 117.73 -1.83 -39.85 118.55 -3.71 coo 29.35 31.42 99.15 28.72 33.09 98.04 -42.24 121.28 -10.34 -42.29 119.63 -9.04 coo 20.42 28.25 99.26 20.25 29.62 97.63 -34.00 122.50 -3.86 -35.34 120.86 -3.93 ULMN 3 1aj8_c01 CITRATE SYNTHASE user 19 3 # 19 B 223 HIS B 330 HIS~? -3.52 ZN ZN B 401s B 262 HIS B 68 HIS.? -3.46 ZN ZN B 402s B 312 ASP B 48 ASP.? 7.12 ZN ZN B 401 coo 23.86 29.50 91.20 24.12 31.58 91.00 -40.87 100.43 6.30 -42.90 100.10 6.71 coo 29.35 31.42 99.15 28.72 33.09 98.04 -44.72 94.50 12.35 -45.14 96.41 13.13 coo 20.42 28.25 99.26 20.25 29.62 97.63 -43.07 90.96 4.68 -43.24 93.07 4.75 ULMN 3 1aj8_c01 CITRATE SYNTHASE user 20 3 # 20 B 223 HIS B 330 HIS~? -3.52 ZN ZN B 401s B 262 HIS B 102 HIS~? 4.91 O2 B3P B 371 B 312 ASP B 48 ASP.? 7.12 ZN ZN B 401 coo 23.86 29.50 91.20 24.12 31.58 91.00 -40.87 100.43 6.30 -42.90 100.10 6.71 coo 29.35 31.42 99.15 28.72 33.09 98.04 -49.25 96.38 11.24 -48.46 97.85 9.95 coo 20.42 28.25 99.26 20.25 29.62 97.63 -43.07 90.96 4.68 -43.24 93.07 4.75 1aj8_c01 source 1aj8 CITRATE SYNTHASE : 20 hits 1aj8_c01 naa= 3 ULMN 3 1al6_c00 CITRATE SYNTHASE user 1 3 # 1 274 HIS A 68 HIS.? -3.48 ZN ZN A 401s 320 HIS A 330 HIS~? -3.46 ZN ZN A 402s 375 ASP A 48 ASP.? 7.07 ZN ZN A 402 coo 11.08 -2.90 2.00 11.09 -3.48 -0.01 -37.46 120.39 -11.50 -38.87 119.03 -12.26 coo 17.22 -10.90 1.81 16.10 -10.23 0.18 -37.28 113.42 -5.32 -38.81 114.77 -5.81 coo 20.14 -1.52 3.09 18.48 -1.53 1.77 -34.00 122.50 -3.86 -35.34 120.86 -3.93 ULMN 3 1al6_c00 CITRATE SYNTHASE user 2 3 # 2 274 HIS A 68 HIS.? -3.48 ZN ZN A 401s 320 HIS B 313 HIS~? 5.49 ZN ZN A 402 375 ASP A 48 ASP.? 7.07 ZN ZN A 402 coo 11.08 -2.90 2.00 11.09 -3.48 -0.01 -37.46 120.39 -11.50 -38.87 119.03 -12.26 coo 17.22 -10.90 1.81 16.10 -10.23 0.18 -40.27 117.73 -1.83 -39.85 118.55 -3.71 coo 20.14 -1.52 3.09 18.48 -1.53 1.77 -34.00 122.50 -3.86 -35.34 120.86 -3.93 ULMN 3 1al6_c00 CITRATE SYNTHASE user 3 3 # 3 274 HIS A 102 HIS~? 4.84 O2 B3P A 371 320 HIS A 330 HIS~? -3.46 ZN ZN A 402s 375 ASP A 48 ASP.? 7.07 ZN ZN A 402 coo 11.08 -2.90 2.00 11.09 -3.48 -0.01 -42.24 121.28 -10.34 -42.29 119.63 -9.04 coo 17.22 -10.90 1.81 16.10 -10.23 0.18 -37.28 113.42 -5.32 -38.81 114.77 -5.81 coo 20.14 -1.52 3.09 18.48 -1.53 1.77 -34.00 122.50 -3.86 -35.34 120.86 -3.93 ULMN 3 1al6_c00 CITRATE SYNTHASE user 4 3 # 4 274 HIS A 102 HIS~? 4.84 O2 B3P A 371 320 HIS B 313 HIS~? 5.49 ZN ZN A 402 375 ASP A 48 ASP.? 7.07 ZN ZN A 402 coo 11.08 -2.90 2.00 11.09 -3.48 -0.01 -42.24 121.28 -10.34 -42.29 119.63 -9.04 coo 17.22 -10.90 1.81 16.10 -10.23 0.18 -40.27 117.73 -1.83 -39.85 118.55 -3.71 coo 20.14 -1.52 3.09 18.48 -1.53 1.77 -34.00 122.50 -3.86 -35.34 120.86 -3.93 ULMN 3 1al6_c00 CITRATE SYNTHASE user 5 3 # 5 274 HIS A 312 HIS~? 6.48 ZN ZN B 401 320 HIS B 68 HIS.? -3.46 ZN ZN B 402s 375 ASP B 48 ASP.? 7.12 ZN ZN B 401 coo 11.08 -2.90 2.00 11.09 -3.48 -0.01 -41.04 97.86 3.25 -41.05 95.82 3.71 coo 17.22 -10.90 1.81 16.10 -10.23 0.18 -44.72 94.50 12.35 -45.14 96.41 13.13 coo 20.14 -1.52 3.09 18.48 -1.53 1.77 -43.07 90.96 4.68 -43.24 93.07 4.75 ULMN 3 1al6_c00 CITRATE SYNTHASE user 6 3 # 6 274 HIS A 312 HIS~? 6.48 ZN ZN B 401 320 HIS B 102 HIS~? 4.91 O2 B3P B 371 375 ASP B 48 ASP.? 7.12 ZN ZN B 401 coo 11.08 -2.90 2.00 11.09 -3.48 -0.01 -41.04 97.86 3.25 -41.05 95.82 3.71 coo 17.22 -10.90 1.81 16.10 -10.23 0.18 -49.25 96.38 11.24 -48.46 97.85 9.95 coo 20.14 -1.52 3.09 18.48 -1.53 1.77 -43.07 90.96 4.68 -43.24 93.07 4.75 ULMN 3 1al6_c00 CITRATE SYNTHASE user 7 3 # 7 274 HIS A 313 HIS~? 5.54 ZN ZN B 401 320 HIS B 68 HIS.? -3.46 ZN ZN B 402s 375 ASP B 48 ASP.? 7.12 ZN ZN B 401 coo 11.08 -2.90 2.00 11.09 -3.48 -0.01 -45.85 98.44 2.81 -45.85 97.45 4.68 coo 17.22 -10.90 1.81 16.10 -10.23 0.18 -44.72 94.50 12.35 -45.14 96.41 13.13 coo 20.14 -1.52 3.09 18.48 -1.53 1.77 -43.07 90.96 4.68 -43.24 93.07 4.75 ULMN 3 1al6_c00 CITRATE SYNTHASE user 8 3 # 8 274 HIS A 313 HIS~? 5.54 ZN ZN B 401 320 HIS B 102 HIS~? 4.91 O2 B3P B 371 375 ASP B 48 ASP.? 7.12 ZN ZN B 401 coo 11.08 -2.90 2.00 11.09 -3.48 -0.01 -45.85 98.44 2.81 -45.85 97.45 4.68 coo 17.22 -10.90 1.81 16.10 -10.23 0.18 -49.25 96.38 11.24 -48.46 97.85 9.95 coo 20.14 -1.52 3.09 18.48 -1.53 1.77 -43.07 90.96 4.68 -43.24 93.07 4.75 ULMN 3 1al6_c00 CITRATE SYNTHASE user 9 3 # 9 274 HIS A 330 HIS~? -3.46 ZN ZN A 402s 320 HIS A 68 HIS.? -3.48 ZN ZN A 401s 375 ASP A 48 ASP.? 7.07 ZN ZN A 402 coo 11.08 -2.90 2.00 11.09 -3.48 -0.01 -37.28 113.42 -5.32 -38.81 114.77 -5.81 coo 17.22 -10.90 1.81 16.10 -10.23 0.18 -37.46 120.39 -11.50 -38.87 119.03 -12.26 coo 20.14 -1.52 3.09 18.48 -1.53 1.77 -34.00 122.50 -3.86 -35.34 120.86 -3.93 ULMN 3 1al6_c00 CITRATE SYNTHASE user 10 3 # 10 274 HIS A 330 HIS~? -3.46 ZN ZN A 402s 320 HIS A 102 HIS~? 4.84 O2 B3P A 371 375 ASP A 48 ASP.? 7.07 ZN ZN A 402 coo 11.08 -2.90 2.00 11.09 -3.48 -0.01 -37.28 113.42 -5.32 -38.81 114.77 -5.81 coo 17.22 -10.90 1.81 16.10 -10.23 0.18 -42.24 121.28 -10.34 -42.29 119.63 -9.04 coo 20.14 -1.52 3.09 18.48 -1.53 1.77 -34.00 122.50 -3.86 -35.34 120.86 -3.93 ULMN 3 1al6_c00 CITRATE SYNTHASE user 11 3 # 11 274 HIS B 68 HIS.? -3.46 ZN ZN B 402s 320 HIS A 313 HIS~? 5.54 ZN ZN B 401 375 ASP B 48 ASP.? 7.12 ZN ZN B 401 coo 11.08 -2.90 2.00 11.09 -3.48 -0.01 -44.72 94.50 12.35 -45.14 96.41 13.13 coo 17.22 -10.90 1.81 16.10 -10.23 0.18 -45.85 98.44 2.81 -45.85 97.45 4.68 coo 20.14 -1.52 3.09 18.48 -1.53 1.77 -43.07 90.96 4.68 -43.24 93.07 4.75 ULMN 3 1al6_c00 CITRATE SYNTHASE user 12 3 # 12 274 HIS B 68 HIS.? -3.46 ZN ZN B 402s 320 HIS B 330 HIS~? -3.52 ZN ZN B 401s 375 ASP B 48 ASP.? 7.12 ZN ZN B 401 coo 11.08 -2.90 2.00 11.09 -3.48 -0.01 -44.72 94.50 12.35 -45.14 96.41 13.13 coo 17.22 -10.90 1.81 16.10 -10.23 0.18 -40.87 100.43 6.30 -42.90 100.10 6.71 coo 20.14 -1.52 3.09 18.48 -1.53 1.77 -43.07 90.96 4.68 -43.24 93.07 4.75 ULMN 3 1al6_c00 CITRATE SYNTHASE user 13 3 # 13 274 HIS B 102 HIS~? 4.91 O2 B3P B 371 320 HIS A 313 HIS~? 5.54 ZN ZN B 401 375 ASP B 48 ASP.? 7.12 ZN ZN B 401 coo 11.08 -2.90 2.00 11.09 -3.48 -0.01 -49.25 96.38 11.24 -48.46 97.85 9.95 coo 17.22 -10.90 1.81 16.10 -10.23 0.18 -45.85 98.44 2.81 -45.85 97.45 4.68 coo 20.14 -1.52 3.09 18.48 -1.53 1.77 -43.07 90.96 4.68 -43.24 93.07 4.75 ULMN 3 1al6_c00 CITRATE SYNTHASE user 14 3 # 14 274 HIS B 102 HIS~? 4.91 O2 B3P B 371 320 HIS B 330 HIS~? -3.52 ZN ZN B 401s 375 ASP B 48 ASP.? 7.12 ZN ZN B 401 coo 11.08 -2.90 2.00 11.09 -3.48 -0.01 -49.25 96.38 11.24 -48.46 97.85 9.95 coo 17.22 -10.90 1.81 16.10 -10.23 0.18 -40.87 100.43 6.30 -42.90 100.10 6.71 coo 20.14 -1.52 3.09 18.48 -1.53 1.77 -43.07 90.96 4.68 -43.24 93.07 4.75 ULMN 3 1al6_c00 CITRATE SYNTHASE user 15 3 # 15 274 HIS B 312 HIS~? 6.47 ZN ZN A 402 320 HIS A 68 HIS.? -3.48 ZN ZN A 401s 375 ASP A 48 ASP.? 7.07 ZN ZN A 402 coo 11.08 -2.90 2.00 11.09 -3.48 -0.01 -36.00 115.58 -2.34 -34.91 117.32 -2.81 coo 17.22 -10.90 1.81 16.10 -10.23 0.18 -37.46 120.39 -11.50 -38.87 119.03 -12.26 coo 20.14 -1.52 3.09 18.48 -1.53 1.77 -34.00 122.50 -3.86 -35.34 120.86 -3.93 ULMN 3 1al6_c00 CITRATE SYNTHASE user 16 3 # 16 274 HIS B 312 HIS~? 6.47 ZN ZN A 402 320 HIS A 102 HIS~? 4.84 O2 B3P A 371 375 ASP A 48 ASP.? 7.07 ZN ZN A 402 coo 11.08 -2.90 2.00 11.09 -3.48 -0.01 -36.00 115.58 -2.34 -34.91 117.32 -2.81 coo 17.22 -10.90 1.81 16.10 -10.23 0.18 -42.24 121.28 -10.34 -42.29 119.63 -9.04 coo 20.14 -1.52 3.09 18.48 -1.53 1.77 -34.00 122.50 -3.86 -35.34 120.86 -3.93 ULMN 3 1al6_c00 CITRATE SYNTHASE user 17 3 # 17 274 HIS B 313 HIS~? 5.49 ZN ZN A 402 320 HIS A 68 HIS.? -3.48 ZN ZN A 401s 375 ASP A 48 ASP.? 7.07 ZN ZN A 402 coo 11.08 -2.90 2.00 11.09 -3.48 -0.01 -40.27 117.73 -1.83 -39.85 118.55 -3.71 coo 17.22 -10.90 1.81 16.10 -10.23 0.18 -37.46 120.39 -11.50 -38.87 119.03 -12.26 coo 20.14 -1.52 3.09 18.48 -1.53 1.77 -34.00 122.50 -3.86 -35.34 120.86 -3.93 ULMN 3 1al6_c00 CITRATE SYNTHASE user 18 3 # 18 274 HIS B 313 HIS~? 5.49 ZN ZN A 402 320 HIS A 102 HIS~? 4.84 O2 B3P A 371 375 ASP A 48 ASP.? 7.07 ZN ZN A 402 coo 11.08 -2.90 2.00 11.09 -3.48 -0.01 -40.27 117.73 -1.83 -39.85 118.55 -3.71 coo 17.22 -10.90 1.81 16.10 -10.23 0.18 -42.24 121.28 -10.34 -42.29 119.63 -9.04 coo 20.14 -1.52 3.09 18.48 -1.53 1.77 -34.00 122.50 -3.86 -35.34 120.86 -3.93 ULMN 3 1al6_c00 CITRATE SYNTHASE user 19 3 # 19 274 HIS B 330 HIS~? -3.52 ZN ZN B 401s 320 HIS B 68 HIS.? -3.46 ZN ZN B 402s 375 ASP B 48 ASP.? 7.12 ZN ZN B 401 coo 11.08 -2.90 2.00 11.09 -3.48 -0.01 -40.87 100.43 6.30 -42.90 100.10 6.71 coo 17.22 -10.90 1.81 16.10 -10.23 0.18 -44.72 94.50 12.35 -45.14 96.41 13.13 coo 20.14 -1.52 3.09 18.48 -1.53 1.77 -43.07 90.96 4.68 -43.24 93.07 4.75 ULMN 3 1al6_c00 CITRATE SYNTHASE user 20 3 # 20 274 HIS B 330 HIS~? -3.52 ZN ZN B 401s 320 HIS B 102 HIS~? 4.91 O2 B3P B 371 375 ASP B 48 ASP.? 7.12 ZN ZN B 401 coo 11.08 -2.90 2.00 11.09 -3.48 -0.01 -40.87 100.43 6.30 -42.90 100.10 6.71 coo 17.22 -10.90 1.81 16.10 -10.23 0.18 -49.25 96.38 11.24 -48.46 97.85 9.95 coo 20.14 -1.52 3.09 18.48 -1.53 1.77 -43.07 90.96 4.68 -43.24 93.07 4.75 1al6_c00 source 1al6 CITRATE SYNTHASE : 20 hits 1al6_c00 naa= 3 ULMN 3 1ald_c00 ALDOLASE A (E.C.4.1.2.13) user 1 3 # 1 33 ASP A 95 ASP.? 28.91 ZN ZN A 402 187 GLU A 39 GLU.? 32.31 ZN ZN A 401 229 LYS A 6 LYS~? 31.92 ZN ZN A 401 coo -52.57 56.60 47.75 -51.52 54.87 46.95 -33.63 143.19 -6.68 -34.30 144.81 -5.56 coo -45.08 48.37 46.81 -46.53 49.74 45.96 -33.47 145.49 -18.26 -32.32 147.14 -18.91 coo -47.40 44.36 48.48 -50.80 49.18 46.20 -36.49 141.54 -19.20 -38.95 147.30 -19.94 ULMN 3 1ald_c00 ALDOLASE A (E.C.4.1.2.13) user 2 3 # 2 33 ASP A 207 ASP^? 23.29 O3 B3P A 371 187 GLU A 233 GLU^? 23.79 O3 B3P A 371 229 LYS A 235 LYS^? 20.59 O3 B3P A 371 coo -52.57 56.60 47.75 -51.52 54.87 46.95 -54.72 125.86 -30.99 -52.82 124.98 -31.10 coo -45.08 48.37 46.81 -46.53 49.74 45.96 -62.71 117.71 -29.26 -63.44 117.34 -27.30 coo -47.40 44.36 48.48 -50.80 49.18 46.20 -57.83 114.71 -29.98 -61.47 113.46 -24.90 ULMN 3 1ald_c00 ALDOLASE A (E.C.4.1.2.13) user 3 3 # 3 33 ASP A 303 ASP.? 22.13 C9 B3P A 371 187 GLU A 247 GLU^? 23.56 C9 B3P A 371 229 LYS A 123 LYS^? 25.39 ZN ZN A 401 coo -52.57 56.60 47.75 -51.52 54.87 46.95 -36.59 95.18 -18.70 -36.77 94.15 -20.55 coo -45.08 48.37 46.81 -46.53 49.74 45.96 -33.22 100.96 -26.56 -34.10 99.82 -28.06 coo -47.40 44.36 48.48 -50.80 49.18 46.20 -30.65 105.03 -26.89 -25.62 104.03 -28.57 ULMN 3 1ald_c00 ALDOLASE A (E.C.4.1.2.13) user 4 3 # 4 33 ASP B 3 ASP.? 33.04 ZN ZN B 402 187 GLU B 351 GLU~? 25.76 ZN ZN B 402 229 LYS B 352 LYS.? 32.29 ZN ZN B 402 coo -52.57 56.60 47.75 -51.52 54.87 46.95 -55.84 71.65 27.35 -54.41 72.00 28.83 coo -45.08 48.37 46.81 -46.53 49.74 45.96 -49.00 81.10 29.39 -50.54 81.73 30.63 coo -47.40 44.36 48.48 -50.80 49.18 46.20 -45.85 76.08 30.61 -43.31 76.30 35.48 ULMN 3 1ald_c00 ALDOLASE A (E.C.4.1.2.13) user 5 3 # 5 33 ASP B 95 ASP.? 28.83 ZN ZN B 401 187 GLU B 39 GLU.? 31.52 ZN ZN B 402 229 LYS B 6 LYS~? 31.78 ZN ZN B 402 coo -52.57 56.60 47.75 -51.52 54.87 46.95 -53.83 73.32 7.16 -55.46 72.49 6.09 coo -45.08 48.37 46.81 -46.53 49.74 45.96 -52.63 71.11 18.36 -52.53 69.16 19.13 coo -47.40 44.36 48.48 -50.80 49.18 46.20 -55.26 75.90 19.68 -60.58 72.50 19.75 ULMN 3 1ald_c00 ALDOLASE A (E.C.4.1.2.13) user 6 3 # 6 33 ASP B 145 ASP~? 55.34 O3 B3P B 371 187 GLU B 171 GLU^? 44.83 O3 B3P B 371 229 LYS B 201 LYS^? 38.84 O3 B3P B 371 coo -52.57 56.60 47.75 -51.52 54.87 46.95 -76.73 100.72 58.46 -76.44 101.76 60.27 coo -45.08 48.37 46.81 -46.53 49.74 45.96 -66.65 104.35 51.79 -66.88 102.97 53.37 coo -47.40 44.36 48.48 -50.80 49.18 46.20 -70.79 108.75 48.84 -67.72 112.70 45.12 ULMN 3 1ald_c00 ALDOLASE A (E.C.4.1.2.13) user 7 3 # 7 33 ASP B 230 ASP^? 38.13 O3 B3P B 371 187 GLU B 215 GLU~? 35.29 O3 B3P B 371 229 LYS B 211 LYS~? 29.87 O3 B3P B 371 coo -52.57 56.60 47.75 -51.52 54.87 46.95 -72.67 110.26 38.86 -74.22 111.29 39.84 coo -45.08 48.37 46.81 -46.53 49.74 45.96 -75.77 102.17 34.30 -77.34 103.06 33.18 coo -47.40 44.36 48.48 -50.80 49.18 46.20 -70.54 101.08 32.38 -72.03 107.21 30.92 ULMN 3 1ald_c00 ALDOLASE A (E.C.4.1.2.13) user 8 3 # 8 33 ASP B 303 ASP.? 21.91 C9 B3P B 371 187 GLU B 247 GLU^? 23.94 C9 B3P B 371 229 LYS B 123 LYS^? 26.96 ZN ZN B 402 coo -52.57 56.60 47.75 -51.52 54.87 46.95 -30.67 115.41 19.76 -30.51 116.22 21.72 coo -45.08 48.37 46.81 -46.53 49.74 45.96 -31.22 109.21 27.34 -30.40 110.15 29.06 coo -47.40 44.36 48.48 -50.80 49.18 46.20 -30.72 103.65 27.68 -26.65 107.35 30.80 ULMN 3 1ald_c00 ALDOLASE A (E.C.4.1.2.13) user 9 3 # 9 33 ASP B 356 ASP.? 26.91 ZN ZN B 402 187 GLU B 39 GLU.? 31.52 ZN ZN B 402 229 LYS B 6 LYS~? 31.78 ZN ZN B 402 coo -52.57 56.60 47.75 -51.52 54.87 46.95 -40.77 75.04 18.31 -40.20 73.11 18.93 coo -45.08 48.37 46.81 -46.53 49.74 45.96 -52.63 71.11 18.36 -52.53 69.16 19.13 coo -47.40 44.36 48.48 -50.80 49.18 46.20 -55.26 75.90 19.68 -60.58 72.50 19.75 1ald_c00 source 1ald ALDOLASE A (E.C.4.1.2.13) : 9 hits 1ald_c00 naa= 3 ULMN 3 1am5_c04 PEPSIN user 1 3 # 1 32 ASP A 309 ASP.? 7.55 ZN ZN A 402 35 SER A 289 SER.? -5.35 O1 B3P A 371s 215 ASP A 314 ASP~? 9.10 O5 B3P B 371 coo -7.18 8.92 145.10 -8.77 8.81 143.59 -39.32 109.22 -3.35 -38.59 111.09 -2.57 coo -12.30 10.35 145.24 -10.75 8.55 145.88 -41.15 110.32 -7.28 -42.46 109.97 -5.25 coo -8.20 12.64 138.30 -8.86 10.97 139.38 -44.29 101.20 -3.40 -45.94 102.37 -2.71 ULMN 3 1am5_c04 PEPSIN user 2 3 # 2 32 ASP A 309 ASP.? 7.55 ZN ZN A 402 35 SER A 289 SER.? -5.35 O1 B3P A 371s 215 ASP A 327 ASP^? 11.36 O1 B3P A 371 coo -7.18 8.92 145.10 -8.77 8.81 143.59 -39.32 109.22 -3.35 -38.59 111.09 -2.57 coo -12.30 10.35 145.24 -10.75 8.55 145.88 -41.15 110.32 -7.28 -42.46 109.97 -5.25 coo -8.20 12.64 138.30 -8.86 10.97 139.38 -34.76 103.64 -5.32 -35.22 105.46 -4.31 ULMN 3 1am5_c04 PEPSIN user 3 3 # 3 32 ASP B 309 ASP.? 7.61 ZN ZN B 401 35 SER B 289 SER.? -5.32 O1 B3P B 371s 215 ASP B 327 ASP^? 11.42 O1 B3P B 371 coo -7.18 8.92 145.10 -8.77 8.81 143.59 -40.43 105.08 4.20 -40.75 103.07 3.51 coo -12.30 10.35 145.24 -10.75 8.55 145.88 -42.54 105.00 8.17 -43.55 106.07 6.24 coo -8.20 12.64 138.30 -8.86 10.97 139.38 -33.51 107.30 6.30 -34.89 106.08 5.25 1am5_c04 source 1am5 PEPSIN : 3 hits 1am5_c04 naa= 3 ULMN 3 1amy_c01 ALPHA-1,4 GLYCAN-4-GLUCANOHYDROLASE user 1 3 # 1 179 ASP A 27 ASP.? 7.07 C10 B3P A 371 214 ASP A 260 ASP~? 22.40 ZN ZN A 401 289 ASP A 106 ASP~? 2.01 ZN ZN A 401s coo -0.62 65.95 29.97 0.31 67.47 31.05 -47.69 122.20 -10.88 -45.61 122.04 -10.59 coo 26.86 59.76 46.36 25.42 58.23 45.92 -24.22 101.11 -15.48 -23.38 102.12 -17.10 coo 9.42 68.07 30.27 7.35 68.27 30.10 -41.67 116.42 -14.91 -40.59 116.67 -13.13 ULMN 3 1amy_c01 ALPHA-1,4 GLYCAN-4-GLUCANOHYDROLASE user 2 3 # 2 179 ASP A 37 ASP.? 31.35 ZN ZN A 401 214 ASP A 133 ASP^? 16.96 O3 B3P A 371 289 ASP A 9 ASP~? 27.30 ZN ZN A 401 coo -0.62 65.95 29.97 0.31 67.47 31.05 -40.71 145.86 -15.24 -40.04 147.48 -16.47 coo 26.86 59.76 46.36 25.42 58.23 45.92 -52.93 118.32 -28.08 -51.05 118.45 -27.14 coo 9.42 68.07 30.27 7.35 68.27 30.10 -38.14 139.21 -22.93 -38.85 141.15 -23.22 ULMN 3 1amy_c01 ALPHA-1,4 GLYCAN-4-GLUCANOHYDROLASE user 3 3 # 3 179 ASP A 37 ASP.? 31.35 ZN ZN A 401 214 ASP B 317 ASP~? 10.65 O4 B3P A 371 289 ASP A 95 ASP.? 28.91 ZN ZN A 402 coo -0.62 65.95 29.97 0.31 67.47 31.05 -40.71 145.86 -15.24 -40.04 147.48 -16.47 coo 26.86 59.76 46.36 25.42 58.23 45.92 -39.61 120.08 5.26 -40.74 120.57 3.54 coo 9.42 68.07 30.27 7.35 68.27 30.10 -33.63 143.19 -6.68 -34.30 144.81 -5.56 ULMN 3 1amy_c01 ALPHA-1,4 GLYCAN-4-GLUCANOHYDROLASE user 4 3 # 4 179 ASP A 48 ASP.? 7.07 ZN ZN A 402 214 ASP A 256 ASP~? 27.59 O1 B3P A 371 289 ASP A 365 ASP.? 11.72 ZN ZN A 402 coo -0.62 65.95 29.97 0.31 67.47 31.05 -34.00 122.50 -3.86 -35.34 120.86 -3.93 coo 26.86 59.76 46.36 25.42 58.23 45.92 -24.42 95.00 -14.74 -23.18 93.38 -14.15 coo 9.42 68.07 30.27 7.35 68.27 30.10 -28.60 115.73 -1.61 -29.73 113.97 -1.34 ULMN 3 1amy_c01 ALPHA-1,4 GLYCAN-4-GLUCANOHYDROLASE user 5 3 # 5 179 ASP A 48 ASP.? 7.07 ZN ZN A 402 214 ASP B 106 ASP~? 1.96 ZN ZN B 402s 289 ASP B 317 ASP~? 10.65 O4 B3P A 371 coo -0.62 65.95 29.97 0.31 67.47 31.05 -34.00 122.50 -3.86 -35.34 120.86 -3.93 coo 26.86 59.76 46.36 25.42 58.23 45.92 -46.09 100.09 15.88 -45.34 99.27 14.09 coo 9.42 68.07 30.27 7.35 68.27 30.10 -39.61 120.08 5.26 -40.74 120.57 3.54 ULMN 3 1amy_c01 ALPHA-1,4 GLYCAN-4-GLUCANOHYDROLASE user 6 3 # 6 179 ASP A 249 ASP^? 25.66 ZN ZN A 401 214 ASP A 48 ASP.? 7.07 ZN ZN A 402 289 ASP A 260 ASP~? 22.40 ZN ZN A 401 coo -0.62 65.95 29.97 0.31 67.47 31.05 -25.63 99.58 -26.54 -25.45 101.65 -26.85 coo 26.86 59.76 46.36 25.42 58.23 45.92 -34.00 122.50 -3.86 -35.34 120.86 -3.93 coo 9.42 68.07 30.27 7.35 68.27 30.10 -24.22 101.11 -15.48 -23.38 102.12 -17.10 ULMN 3 1amy_c01 ALPHA-1,4 GLYCAN-4-GLUCANOHYDROLASE user 7 3 # 7 179 ASP A 249 ASP^? 25.66 ZN ZN A 401 214 ASP A 317 ASP~? 10.45 O4 B3P B 371 289 ASP A 260 ASP~? 22.40 ZN ZN A 401 coo -0.62 65.95 29.97 0.31 67.47 31.05 -25.63 99.58 -26.54 -25.45 101.65 -26.85 coo 26.86 59.76 46.36 25.42 58.23 45.92 -46.62 96.07 -4.20 -47.85 96.41 -2.50 coo 9.42 68.07 30.27 7.35 68.27 30.10 -24.22 101.11 -15.48 -23.38 102.12 -17.10 ULMN 3 1amy_c01 ALPHA-1,4 GLYCAN-4-GLUCANOHYDROLASE user 8 3 # 8 179 ASP A 249 ASP^? 25.66 ZN ZN A 401 214 ASP B 309 ASP.? 7.61 ZN ZN B 401 289 ASP A 260 ASP~? 22.40 ZN ZN A 401 coo -0.62 65.95 29.97 0.31 67.47 31.05 -25.63 99.58 -26.54 -25.45 101.65 -26.85 coo 26.86 59.76 46.36 25.42 58.23 45.92 -40.43 105.08 4.20 -40.75 103.07 3.51 coo 9.42 68.07 30.27 7.35 68.27 30.10 -24.22 101.11 -15.48 -23.38 102.12 -17.10 ULMN 3 1amy_c01 ALPHA-1,4 GLYCAN-4-GLUCANOHYDROLASE user 9 3 # 9 179 ASP A 314 ASP~? 9.10 O5 B3P B 371 214 ASP B 256 ASP~? 27.54 O1 B3P B 371 289 ASP A 309 ASP.? 7.55 ZN ZN A 402 coo -0.62 65.95 29.97 0.31 67.47 31.05 -44.29 101.20 -3.40 -45.94 102.37 -2.71 coo 26.86 59.76 46.36 25.42 58.23 45.92 -20.30 109.27 15.70 -18.39 109.99 15.10 coo 9.42 68.07 30.27 7.35 68.27 30.10 -39.32 109.22 -3.35 -38.59 111.09 -2.57 ULMN 3 1amy_c01 ALPHA-1,4 GLYCAN-4-GLUCANOHYDROLASE user 10 3 # 10 179 ASP A 314 ASP~? 9.10 O5 B3P B 371 214 ASP B 256 ASP~? 27.54 O1 B3P B 371 289 ASP A 327 ASP^? 11.36 O1 B3P A 371 coo -0.62 65.95 29.97 0.31 67.47 31.05 -44.29 101.20 -3.40 -45.94 102.37 -2.71 coo 26.86 59.76 46.36 25.42 58.23 45.92 -20.30 109.27 15.70 -18.39 109.99 15.10 coo 9.42 68.07 30.27 7.35 68.27 30.10 -34.76 103.64 -5.32 -35.22 105.46 -4.31 ULMN 3 1amy_c01 ALPHA-1,4 GLYCAN-4-GLUCANOHYDROLASE user 11 3 # 11 179 ASP A 314 ASP~? 9.10 O5 B3P B 371 214 ASP B 256 ASP~? 27.54 O1 B3P B 371 289 ASP B 309 ASP.? 7.61 ZN ZN B 401 coo -0.62 65.95 29.97 0.31 67.47 31.05 -44.29 101.20 -3.40 -45.94 102.37 -2.71 coo 26.86 59.76 46.36 25.42 58.23 45.92 -20.30 109.27 15.70 -18.39 109.99 15.10 coo 9.42 68.07 30.27 7.35 68.27 30.10 -40.43 105.08 4.20 -40.75 103.07 3.51 ULMN 3 1amy_c01 ALPHA-1,4 GLYCAN-4-GLUCANOHYDROLASE user 12 3 # 12 179 ASP A 317 ASP~? 10.45 O4 B3P B 371 214 ASP B 9 ASP~? 27.36 ZN ZN B 402 289 ASP B 48 ASP.? 7.12 ZN ZN B 401 coo -0.62 65.95 29.97 0.31 67.47 31.05 -46.62 96.07 -4.20 -47.85 96.41 -2.50 coo 26.86 59.76 46.36 25.42 58.23 45.92 -55.13 78.56 23.44 -56.66 77.19 23.76 coo 9.42 68.07 30.27 7.35 68.27 30.10 -43.07 90.96 4.68 -43.24 93.07 4.75 ULMN 3 1amy_c01 ALPHA-1,4 GLYCAN-4-GLUCANOHYDROLASE user 13 3 # 13 179 ASP A 317 ASP~? 10.45 O4 B3P B 371 214 ASP B 37 ASP.? 31.37 ZN ZN B 402 289 ASP B 48 ASP.? 7.12 ZN ZN B 401 coo -0.62 65.95 29.97 0.31 67.47 31.05 -46.62 96.07 -4.20 -47.85 96.41 -2.50 coo 26.86 59.76 46.36 25.42 58.23 45.92 -61.16 74.73 15.87 -61.47 72.93 16.97 coo 9.42 68.07 30.27 7.35 68.27 30.10 -43.07 90.96 4.68 -43.24 93.07 4.75 ULMN 3 1amy_c01 ALPHA-1,4 GLYCAN-4-GLUCANOHYDROLASE user 14 3 # 14 179 ASP A 317 ASP~? 10.45 O4 B3P B 371 214 ASP B 260 ASP~? 22.46 ZN ZN B 402 289 ASP B 48 ASP.? 7.12 ZN ZN B 401 coo -0.62 65.95 29.97 0.31 67.47 31.05 -46.62 96.07 -4.20 -47.85 96.41 -2.50 coo 26.86 59.76 46.36 25.42 58.23 45.92 -23.14 103.74 16.35 -22.94 102.41 17.89 coo 9.42 68.07 30.27 7.35 68.27 30.10 -43.07 90.96 4.68 -43.24 93.07 4.75 ULMN 3 1amy_c01 ALPHA-1,4 GLYCAN-4-GLUCANOHYDROLASE user 15 3 # 15 179 ASP A 365 ASP.? 11.72 ZN ZN A 402 214 ASP A 9 ASP~? 27.30 ZN ZN A 401 289 ASP A 48 ASP.? 7.07 ZN ZN A 402 coo -0.62 65.95 29.97 0.31 67.47 31.05 -28.60 115.73 -1.61 -29.73 113.97 -1.34 coo 26.86 59.76 46.36 25.42 58.23 45.92 -38.14 139.21 -22.93 -38.85 141.15 -23.22 coo 9.42 68.07 30.27 7.35 68.27 30.10 -34.00 122.50 -3.86 -35.34 120.86 -3.93 ULMN 3 1amy_c01 ALPHA-1,4 GLYCAN-4-GLUCANOHYDROLASE user 16 3 # 16 179 ASP B 27 ASP.? 7.01 C10 B3P B 371 214 ASP B 260 ASP~? 22.46 ZN ZN B 402 289 ASP B 106 ASP~? 1.96 ZN ZN B 402s coo -0.62 65.95 29.97 0.31 67.47 31.05 -54.29 98.49 11.88 -52.46 97.53 11.54 coo 26.86 59.76 46.36 25.42 58.23 45.92 -23.14 103.74 16.35 -22.94 102.41 17.89 coo 9.42 68.07 30.27 7.35 68.27 30.10 -46.09 100.09 15.88 -45.34 99.27 14.09 ULMN 3 1amy_c01 ALPHA-1,4 GLYCAN-4-GLUCANOHYDROLASE user 17 3 # 17 179 ASP B 37 ASP.? 31.37 ZN ZN B 402 214 ASP A 317 ASP~? 10.45 O4 B3P B 371 289 ASP B 95 ASP.? 28.83 ZN ZN B 401 coo -0.62 65.95 29.97 0.31 67.47 31.05 -61.16 74.73 15.87 -61.47 72.93 16.97 coo 26.86 59.76 46.36 25.42 58.23 45.92 -46.62 96.07 -4.20 -47.85 96.41 -2.50 coo 9.42 68.07 30.27 7.35 68.27 30.10 -53.83 73.32 7.16 -55.46 72.49 6.09 ULMN 3 1amy_c01 ALPHA-1,4 GLYCAN-4-GLUCANOHYDROLASE user 18 3 # 18 179 ASP B 37 ASP.? 31.37 ZN ZN B 402 214 ASP B 133 ASP^? 16.46 O3 B3P B 371 289 ASP B 9 ASP~? 27.36 ZN ZN B 402 coo -0.62 65.95 29.97 0.31 67.47 31.05 -61.16 74.73 15.87 -61.47 72.93 16.97 coo 26.86 59.76 46.36 25.42 58.23 45.92 -57.12 104.20 28.48 -55.49 103.35 27.39 coo 9.42 68.07 30.27 7.35 68.27 30.10 -55.13 78.56 23.44 -56.66 77.19 23.76 ULMN 3 1amy_c01 ALPHA-1,4 GLYCAN-4-GLUCANOHYDROLASE user 19 3 # 19 179 ASP B 48 ASP.? 7.12 ZN ZN B 401 214 ASP A 106 ASP~? 2.01 ZN ZN A 401s 289 ASP A 317 ASP~? 10.45 O4 B3P B 371 coo -0.62 65.95 29.97 0.31 67.47 31.05 -43.07 90.96 4.68 -43.24 93.07 4.75 coo 26.86 59.76 46.36 25.42 58.23 45.92 -41.67 116.42 -14.91 -40.59 116.67 -13.13 coo 9.42 68.07 30.27 7.35 68.27 30.10 -46.62 96.07 -4.20 -47.85 96.41 -2.50 ULMN 3 1amy_c01 ALPHA-1,4 GLYCAN-4-GLUCANOHYDROLASE user 20 3 # 20 179 ASP B 48 ASP.? 7.12 ZN ZN B 401 214 ASP B 256 ASP~? 27.54 O1 B3P B 371 289 ASP B 365 ASP.? 11.69 ZN ZN B 401 coo -0.62 65.95 29.97 0.31 67.47 31.05 -43.07 90.96 4.68 -43.24 93.07 4.75 coo 26.86 59.76 46.36 25.42 58.23 45.92 -20.30 109.27 15.70 -18.39 109.99 15.10 coo 9.42 68.07 30.27 7.35 68.27 30.10 -34.85 93.86 2.40 -34.89 96.00 2.14 ULMN 3 1amy_c01 ALPHA-1,4 GLYCAN-4-GLUCANOHYDROLASE user 21 3 # 21 179 ASP B 249 ASP^? 25.00 ZN ZN B 402 214 ASP A 309 ASP.? 7.55 ZN ZN A 402 289 ASP B 260 ASP~? 22.46 ZN ZN B 402 coo -0.62 65.95 29.97 0.31 67.47 31.05 -23.79 105.17 26.81 -24.71 103.27 27.11 coo 26.86 59.76 46.36 25.42 58.23 45.92 -39.32 109.22 -3.35 -38.59 111.09 -2.57 coo 9.42 68.07 30.27 7.35 68.27 30.10 -23.14 103.74 16.35 -22.94 102.41 17.89 ULMN 3 1amy_c01 ALPHA-1,4 GLYCAN-4-GLUCANOHYDROLASE user 22 3 # 22 179 ASP B 249 ASP^? 25.00 ZN ZN B 402 214 ASP A 327 ASP^? 11.36 O1 B3P A 371 289 ASP B 260 ASP~? 22.46 ZN ZN B 402 coo -0.62 65.95 29.97 0.31 67.47 31.05 -23.79 105.17 26.81 -24.71 103.27 27.11 coo 26.86 59.76 46.36 25.42 58.23 45.92 -34.76 103.64 -5.32 -35.22 105.46 -4.31 coo 9.42 68.07 30.27 7.35 68.27 30.10 -23.14 103.74 16.35 -22.94 102.41 17.89 ULMN 3 1amy_c01 ALPHA-1,4 GLYCAN-4-GLUCANOHYDROLASE user 23 3 # 23 179 ASP B 249 ASP^? 25.00 ZN ZN B 402 214 ASP B 48 ASP.? 7.12 ZN ZN B 401 289 ASP B 260 ASP~? 22.46 ZN ZN B 402 coo -0.62 65.95 29.97 0.31 67.47 31.05 -23.79 105.17 26.81 -24.71 103.27 27.11 coo 26.86 59.76 46.36 25.42 58.23 45.92 -43.07 90.96 4.68 -43.24 93.07 4.75 coo 9.42 68.07 30.27 7.35 68.27 30.10 -23.14 103.74 16.35 -22.94 102.41 17.89 ULMN 3 1amy_c01 ALPHA-1,4 GLYCAN-4-GLUCANOHYDROLASE user 24 3 # 24 179 ASP B 249 ASP^? 25.00 ZN ZN B 402 214 ASP B 317 ASP~? 10.65 O4 B3P A 371 289 ASP B 260 ASP~? 22.46 ZN ZN B 402 coo -0.62 65.95 29.97 0.31 67.47 31.05 -23.79 105.17 26.81 -24.71 103.27 27.11 coo 26.86 59.76 46.36 25.42 58.23 45.92 -39.61 120.08 5.26 -40.74 120.57 3.54 coo 9.42 68.07 30.27 7.35 68.27 30.10 -23.14 103.74 16.35 -22.94 102.41 17.89 ULMN 3 1amy_c01 ALPHA-1,4 GLYCAN-4-GLUCANOHYDROLASE user 25 3 # 25 179 ASP B 309 ASP.? 7.61 ZN ZN B 401 214 ASP A 249 ASP^? 25.66 ZN ZN A 401 289 ASP A 327 ASP^? 11.36 O1 B3P A 371 coo -0.62 65.95 29.97 0.31 67.47 31.05 -40.43 105.08 4.20 -40.75 103.07 3.51 coo 26.86 59.76 46.36 25.42 58.23 45.92 -25.63 99.58 -26.54 -25.45 101.65 -26.85 coo 9.42 68.07 30.27 7.35 68.27 30.10 -34.76 103.64 -5.32 -35.22 105.46 -4.31 ULMN 3 1amy_c01 ALPHA-1,4 GLYCAN-4-GLUCANOHYDROLASE user 26 3 # 26 179 ASP B 314 ASP~? 9.37 O5 B3P A 371 214 ASP A 256 ASP~? 27.59 O1 B3P A 371 289 ASP A 309 ASP.? 7.55 ZN ZN A 402 coo -0.62 65.95 29.97 0.31 67.47 31.05 -40.38 114.62 4.43 -42.39 114.53 3.82 coo 26.86 59.76 46.36 25.42 58.23 45.92 -24.42 95.00 -14.74 -23.18 93.38 -14.15 coo 9.42 68.07 30.27 7.35 68.27 30.10 -39.32 109.22 -3.35 -38.59 111.09 -2.57 ULMN 3 1amy_c01 ALPHA-1,4 GLYCAN-4-GLUCANOHYDROLASE user 27 3 # 27 179 ASP B 314 ASP~? 9.37 O5 B3P A 371 214 ASP A 256 ASP~? 27.59 O1 B3P A 371 289 ASP B 309 ASP.? 7.61 ZN ZN B 401 coo -0.62 65.95 29.97 0.31 67.47 31.05 -40.38 114.62 4.43 -42.39 114.53 3.82 coo 26.86 59.76 46.36 25.42 58.23 45.92 -24.42 95.00 -14.74 -23.18 93.38 -14.15 coo 9.42 68.07 30.27 7.35 68.27 30.10 -40.43 105.08 4.20 -40.75 103.07 3.51 ULMN 3 1amy_c01 ALPHA-1,4 GLYCAN-4-GLUCANOHYDROLASE user 28 3 # 28 179 ASP B 314 ASP~? 9.37 O5 B3P A 371 214 ASP A 256 ASP~? 27.59 O1 B3P A 371 289 ASP B 327 ASP^? 11.42 O1 B3P B 371 coo -0.62 65.95 29.97 0.31 67.47 31.05 -40.38 114.62 4.43 -42.39 114.53 3.82 coo 26.86 59.76 46.36 25.42 58.23 45.92 -24.42 95.00 -14.74 -23.18 93.38 -14.15 coo 9.42 68.07 30.27 7.35 68.27 30.10 -33.51 107.30 6.30 -34.89 106.08 5.25 ULMN 3 1amy_c01 ALPHA-1,4 GLYCAN-4-GLUCANOHYDROLASE user 29 3 # 29 179 ASP B 317 ASP~? 10.65 O4 B3P A 371 214 ASP A 9 ASP~? 27.30 ZN ZN A 401 289 ASP A 48 ASP.? 7.07 ZN ZN A 402 coo -0.62 65.95 29.97 0.31 67.47 31.05 -39.61 120.08 5.26 -40.74 120.57 3.54 coo 26.86 59.76 46.36 25.42 58.23 45.92 -38.14 139.21 -22.93 -38.85 141.15 -23.22 coo 9.42 68.07 30.27 7.35 68.27 30.10 -34.00 122.50 -3.86 -35.34 120.86 -3.93 ULMN 3 1amy_c01 ALPHA-1,4 GLYCAN-4-GLUCANOHYDROLASE user 30 3 # 30 179 ASP B 317 ASP~? 10.65 O4 B3P A 371 214 ASP A 37 ASP.? 31.35 ZN ZN A 401 289 ASP A 48 ASP.? 7.07 ZN ZN A 402 coo -0.62 65.95 29.97 0.31 67.47 31.05 -39.61 120.08 5.26 -40.74 120.57 3.54 coo 26.86 59.76 46.36 25.42 58.23 45.92 -40.71 145.86 -15.24 -40.04 147.48 -16.47 coo 9.42 68.07 30.27 7.35 68.27 30.10 -34.00 122.50 -3.86 -35.34 120.86 -3.93 ULMN 3 1amy_c01 ALPHA-1,4 GLYCAN-4-GLUCANOHYDROLASE user 31 3 # 31 179 ASP B 317 ASP~? 10.65 O4 B3P A 371 214 ASP A 260 ASP~? 22.40 ZN ZN A 401 289 ASP A 48 ASP.? 7.07 ZN ZN A 402 coo -0.62 65.95 29.97 0.31 67.47 31.05 -39.61 120.08 5.26 -40.74 120.57 3.54 coo 26.86 59.76 46.36 25.42 58.23 45.92 -24.22 101.11 -15.48 -23.38 102.12 -17.10 coo 9.42 68.07 30.27 7.35 68.27 30.10 -34.00 122.50 -3.86 -35.34 120.86 -3.93 ULMN 3 1amy_c01 ALPHA-1,4 GLYCAN-4-GLUCANOHYDROLASE user 32 3 # 32 179 ASP B 365 ASP.? 11.69 ZN ZN B 401 214 ASP B 9 ASP~? 27.36 ZN ZN B 402 289 ASP B 48 ASP.? 7.12 ZN ZN B 401 coo -0.62 65.95 29.97 0.31 67.47 31.05 -34.85 93.86 2.40 -34.89 96.00 2.14 coo 26.86 59.76 46.36 25.42 58.23 45.92 -55.13 78.56 23.44 -56.66 77.19 23.76 coo 9.42 68.07 30.27 7.35 68.27 30.10 -43.07 90.96 4.68 -43.24 93.07 4.75 1amy_c01 source 1amy ALPHA-1,4 GLYCAN-4-GLUCANOHYDROLASE (ALPHA-AMY: 32 hits 1amy_c01 naa= 3 ULMN 3 1amy_c05 ALPHA-1,4 GLYCAN-4-GLUCANOHYDROLASE user 1 3 # 1 179 ASP A 27 ASP.? 7.07 C10 B3P A 371 204 GLU A 24 GLU.? 5.45 O3 B3P A 371 289 ASP A 106 ASP~? 2.01 ZN ZN A 401s coo -0.62 65.95 29.97 0.31 67.47 31.05 -47.69 122.20 -10.88 -45.61 122.04 -10.59 coo 4.34 62.44 32.05 4.22 64.48 32.53 -48.98 117.43 -13.22 -50.25 116.20 -14.32 coo 9.42 68.07 30.27 7.35 68.27 30.10 -41.67 116.42 -14.91 -40.59 116.67 -13.13 ULMN 3 1amy_c05 ALPHA-1,4 GLYCAN-4-GLUCANOHYDROLASE user 2 3 # 2 179 ASP A 37 ASP.? 31.35 ZN ZN A 401 204 GLU A 36 GLU.? 25.91 ZN ZN A 401 289 ASP A 9 ASP~? 27.30 ZN ZN A 401 coo -0.62 65.95 29.97 0.31 67.47 31.05 -40.71 145.86 -15.24 -40.04 147.48 -16.47 coo 4.34 62.44 32.05 4.22 64.48 32.53 -43.67 141.83 -15.53 -45.30 141.25 -16.70 coo 9.42 68.07 30.27 7.35 68.27 30.10 -38.14 139.21 -22.93 -38.85 141.15 -23.22 ULMN 3 1amy_c05 ALPHA-1,4 GLYCAN-4-GLUCANOHYDROLASE user 3 3 # 3 179 ASP A 37 ASP.? 31.35 ZN ZN A 401 204 GLU A 39 GLU.? 32.31 ZN ZN A 401 289 ASP A 9 ASP~? 27.30 ZN ZN A 401 coo -0.62 65.95 29.97 0.31 67.47 31.05 -40.71 145.86 -15.24 -40.04 147.48 -16.47 coo 4.34 62.44 32.05 4.22 64.48 32.53 -33.47 145.49 -18.26 -32.32 147.14 -18.91 coo 9.42 68.07 30.27 7.35 68.27 30.10 -38.14 139.21 -22.93 -38.85 141.15 -23.22 ULMN 3 1amy_c05 ALPHA-1,4 GLYCAN-4-GLUCANOHYDROLASE user 4 3 # 4 179 ASP B 27 ASP.? 7.01 C10 B3P B 371 204 GLU B 24 GLU.? 5.23 O3 B3P B 371 289 ASP B 106 ASP~? 1.96 ZN ZN B 402s coo -0.62 65.95 29.97 0.31 67.47 31.05 -54.29 98.49 11.88 -52.46 97.53 11.54 coo 4.34 62.44 32.05 4.22 64.48 32.53 -52.79 103.05 14.35 -52.89 104.73 15.57 coo 9.42 68.07 30.27 7.35 68.27 30.10 -46.09 100.09 15.88 -45.34 99.27 14.09 ULMN 3 1amy_c05 ALPHA-1,4 GLYCAN-4-GLUCANOHYDROLASE user 5 3 # 5 179 ASP B 196 ASP.? 57.24 O3 B3P B 371 204 GLU B 195 GLU.? 55.28 O3 B3P B 371 289 ASP B 198 ASP^? 55.09 O3 B3P B 371 coo -0.62 65.95 29.97 0.31 67.47 31.05 -83.66 115.23 54.46 -85.42 116.48 54.55 coo 4.34 62.44 32.05 4.22 64.48 32.53 -77.32 118.44 56.03 -77.24 120.43 56.79 coo 9.42 68.07 30.27 7.35 68.27 30.10 -76.58 110.78 57.59 -76.81 112.28 59.06 ULMN 3 1amy_c05 ALPHA-1,4 GLYCAN-4-GLUCANOHYDROLASE user 6 3 # 6 179 ASP B 198 ASP^? 55.09 O3 B3P B 371 204 GLU B 195 GLU.? 55.28 O3 B3P B 371 289 ASP B 196 ASP.? 57.24 O3 B3P B 371 coo -0.62 65.95 29.97 0.31 67.47 31.05 -76.58 110.78 57.59 -76.81 112.28 59.06 coo 4.34 62.44 32.05 4.22 64.48 32.53 -77.32 118.44 56.03 -77.24 120.43 56.79 coo 9.42 68.07 30.27 7.35 68.27 30.10 -83.66 115.23 54.46 -85.42 116.48 54.55 ULMN 3 1amy_c05 ALPHA-1,4 GLYCAN-4-GLUCANOHYDROLASE user 7 3 # 7 179 ASP B 198 ASP^? 55.09 O3 B3P B 371 204 GLU B 199 GLU^? 48.27 O3 B3P B 371 289 ASP B 196 ASP.? 57.24 O3 B3P B 371 coo -0.62 65.95 29.97 0.31 67.47 31.05 -76.58 110.78 57.59 -76.81 112.28 59.06 coo 4.34 62.44 32.05 4.22 64.48 32.53 -77.31 110.33 51.94 -78.27 110.21 50.08 coo 9.42 68.07 30.27 7.35 68.27 30.10 -83.66 115.23 54.46 -85.42 116.48 54.55 1amy_c05 source 1amy ALPHA-1,4 GLYCAN-4-GLUCANOHYDROLASE (ALPHA-AMY: 7 hits 1amy_c05 naa= 3 ULMN 3 1amy_c06 ALPHA-1,4 GLYCAN-4-GLUCANOHYDROLASE user 1 3 # 1 179 ASP A 48 ASP.? 7.07 ZN ZN A 402 227 GLU B 275 GLU.? 25.80 ZN ZN A 402 289 ASP B 317 ASP~? 10.65 O4 B3P A 371 coo -0.62 65.95 29.97 0.31 67.47 31.05 -34.00 122.50 -3.86 -35.34 120.86 -3.93 coo 3.96 55.76 41.24 4.83 57.69 41.17 -25.20 121.46 10.93 -24.62 123.07 12.36 coo 9.42 68.07 30.27 7.35 68.27 30.10 -39.61 120.08 5.26 -40.74 120.57 3.54 ULMN 3 1amy_c06 ALPHA-1,4 GLYCAN-4-GLUCANOHYDROLASE user 2 3 # 2 179 ASP A 48 ASP.? 7.07 ZN ZN A 402 227 GLU B 294 GLU~? 11.71 C9 B3P B 371 289 ASP A 365 ASP.? 11.72 ZN ZN A 402 coo -0.62 65.95 29.97 0.31 67.47 31.05 -34.00 122.50 -3.86 -35.34 120.86 -3.93 coo 3.96 55.76 41.24 4.83 57.69 41.17 -39.97 115.47 11.20 -41.44 114.67 9.87 coo 9.42 68.07 30.27 7.35 68.27 30.10 -28.60 115.73 -1.61 -29.73 113.97 -1.34 ULMN 3 1amy_c06 ALPHA-1,4 GLYCAN-4-GLUCANOHYDROLASE user 3 3 # 3 179 ASP A 314 ASP~? 9.10 O5 B3P B 371 227 GLU A 275 GLU.? 22.22 ZN ZN B 401 289 ASP A 327 ASP^? 11.36 O1 B3P A 371 coo -0.62 65.95 29.97 0.31 67.47 31.05 -44.29 101.20 -3.40 -45.94 102.37 -2.71 coo 3.96 55.76 41.24 4.83 57.69 41.17 -34.78 87.37 -9.37 -34.61 86.91 -7.36 coo 9.42 68.07 30.27 7.35 68.27 30.10 -34.76 103.64 -5.32 -35.22 105.46 -4.31 ULMN 3 1amy_c06 ALPHA-1,4 GLYCAN-4-GLUCANOHYDROLASE user 4 3 # 4 179 ASP A 314 ASP~? 9.10 O5 B3P B 371 227 GLU A 333 GLU~? 2.48 ZN ZN A 401s 289 ASP B 309 ASP.? 7.61 ZN ZN B 401 coo -0.62 65.95 29.97 0.31 67.47 31.05 -44.29 101.20 -3.40 -45.94 102.37 -2.71 coo 3.96 55.76 41.24 4.83 57.69 41.17 -35.80 114.74 -10.32 -37.65 115.72 -10.06 coo 9.42 68.07 30.27 7.35 68.27 30.10 -40.43 105.08 4.20 -40.75 103.07 3.51 ULMN 3 1amy_c06 ALPHA-1,4 GLYCAN-4-GLUCANOHYDROLASE user 5 3 # 5 179 ASP A 314 ASP~? 9.10 O5 B3P B 371 227 GLU B 333 GLU~? 2.50 ZN ZN B 402s 289 ASP A 309 ASP.? 7.55 ZN ZN A 402 coo -0.62 65.95 29.97 0.31 67.47 31.05 -44.29 101.20 -3.40 -45.94 102.37 -2.71 coo 3.96 55.76 41.24 4.83 57.69 41.17 -40.33 98.40 11.28 -42.37 98.54 11.02 coo 9.42 68.07 30.27 7.35 68.27 30.10 -39.32 109.22 -3.35 -38.59 111.09 -2.57 ULMN 3 1amy_c06 ALPHA-1,4 GLYCAN-4-GLUCANOHYDROLASE user 6 3 # 6 179 ASP A 314 ASP~? 9.10 O5 B3P B 371 227 GLU B 333 GLU~? 2.50 ZN ZN B 402s 289 ASP A 327 ASP^? 11.36 O1 B3P A 371 coo -0.62 65.95 29.97 0.31 67.47 31.05 -44.29 101.20 -3.40 -45.94 102.37 -2.71 coo 3.96 55.76 41.24 4.83 57.69 41.17 -40.33 98.40 11.28 -42.37 98.54 11.02 coo 9.42 68.07 30.27 7.35 68.27 30.10 -34.76 103.64 -5.32 -35.22 105.46 -4.31 ULMN 3 1amy_c06 ALPHA-1,4 GLYCAN-4-GLUCANOHYDROLASE user 7 3 # 7 179 ASP A 317 ASP~? 10.45 O4 B3P B 371 227 GLU A 275 GLU.? 22.22 ZN ZN B 401 289 ASP B 48 ASP.? 7.12 ZN ZN B 401 coo -0.62 65.95 29.97 0.31 67.47 31.05 -46.62 96.07 -4.20 -47.85 96.41 -2.50 coo 3.96 55.76 41.24 4.83 57.69 41.17 -34.78 87.37 -9.37 -34.61 86.91 -7.36 coo 9.42 68.07 30.27 7.35 68.27 30.10 -43.07 90.96 4.68 -43.24 93.07 4.75 ULMN 3 1amy_c06 ALPHA-1,4 GLYCAN-4-GLUCANOHYDROLASE user 8 3 # 8 179 ASP A 327 ASP^? 11.36 O1 B3P A 371 227 GLU A 275 GLU.? 22.22 ZN ZN B 401 289 ASP A 314 ASP~? 9.10 O5 B3P B 371 coo -0.62 65.95 29.97 0.31 67.47 31.05 -34.76 103.64 -5.32 -35.22 105.46 -4.31 coo 3.96 55.76 41.24 4.83 57.69 41.17 -34.78 87.37 -9.37 -34.61 86.91 -7.36 coo 9.42 68.07 30.27 7.35 68.27 30.10 -44.29 101.20 -3.40 -45.94 102.37 -2.71 ULMN 3 1amy_c06 ALPHA-1,4 GLYCAN-4-GLUCANOHYDROLASE user 9 3 # 9 179 ASP A 365 ASP.? 11.72 ZN ZN A 402 227 GLU B 275 GLU.? 25.80 ZN ZN A 402 289 ASP A 48 ASP.? 7.07 ZN ZN A 402 coo -0.62 65.95 29.97 0.31 67.47 31.05 -28.60 115.73 -1.61 -29.73 113.97 -1.34 coo 3.96 55.76 41.24 4.83 57.69 41.17 -25.20 121.46 10.93 -24.62 123.07 12.36 coo 9.42 68.07 30.27 7.35 68.27 30.10 -34.00 122.50 -3.86 -35.34 120.86 -3.93 ULMN 3 1amy_c06 ALPHA-1,4 GLYCAN-4-GLUCANOHYDROLASE user 10 3 # 10 179 ASP A 365 ASP.? 11.72 ZN ZN A 402 227 GLU B 294 GLU~? 11.71 C9 B3P B 371 289 ASP A 48 ASP.? 7.07 ZN ZN A 402 coo -0.62 65.95 29.97 0.31 67.47 31.05 -28.60 115.73 -1.61 -29.73 113.97 -1.34 coo 3.96 55.76 41.24 4.83 57.69 41.17 -39.97 115.47 11.20 -41.44 114.67 9.87 coo 9.42 68.07 30.27 7.35 68.27 30.10 -34.00 122.50 -3.86 -35.34 120.86 -3.93 ULMN 3 1amy_c06 ALPHA-1,4 GLYCAN-4-GLUCANOHYDROLASE user 11 3 # 11 179 ASP B 48 ASP.? 7.12 ZN ZN B 401 227 GLU A 275 GLU.? 22.22 ZN ZN B 401 289 ASP A 317 ASP~? 10.45 O4 B3P B 371 coo -0.62 65.95 29.97 0.31 67.47 31.05 -43.07 90.96 4.68 -43.24 93.07 4.75 coo 3.96 55.76 41.24 4.83 57.69 41.17 -34.78 87.37 -9.37 -34.61 86.91 -7.36 coo 9.42 68.07 30.27 7.35 68.27 30.10 -46.62 96.07 -4.20 -47.85 96.41 -2.50 ULMN 3 1amy_c06 ALPHA-1,4 GLYCAN-4-GLUCANOHYDROLASE user 12 3 # 12 179 ASP B 48 ASP.? 7.12 ZN ZN B 401 227 GLU A 294 GLU~? 11.80 C9 B3P A 371 289 ASP B 365 ASP.? 11.69 ZN ZN B 401 coo -0.62 65.95 29.97 0.31 67.47 31.05 -43.07 90.96 4.68 -43.24 93.07 4.75 coo 3.96 55.76 41.24 4.83 57.69 41.17 -44.58 100.10 -10.25 -45.30 101.55 -8.87 coo 9.42 68.07 30.27 7.35 68.27 30.10 -34.85 93.86 2.40 -34.89 96.00 2.14 ULMN 3 1amy_c06 ALPHA-1,4 GLYCAN-4-GLUCANOHYDROLASE user 13 3 # 13 179 ASP B 198 ASP^? 55.09 O3 B3P B 371 227 GLU B 203 GLU^? 37.09 O3 B3P B 371 289 ASP B 145 ASP~? 55.34 O3 B3P B 371 coo -0.62 65.95 29.97 0.31 67.47 31.05 -76.58 110.78 57.59 -76.81 112.28 59.06 coo 3.96 55.76 41.24 4.83 57.69 41.17 -66.30 108.47 45.19 -65.02 110.19 45.11 coo 9.42 68.07 30.27 7.35 68.27 30.10 -76.73 100.72 58.46 -76.44 101.76 60.27 ULMN 3 1amy_c06 ALPHA-1,4 GLYCAN-4-GLUCANOHYDROLASE user 14 3 # 14 179 ASP B 314 ASP~? 9.37 O5 B3P A 371 227 GLU A 333 GLU~? 2.48 ZN ZN A 401s 289 ASP B 309 ASP.? 7.61 ZN ZN B 401 coo -0.62 65.95 29.97 0.31 67.47 31.05 -40.38 114.62 4.43 -42.39 114.53 3.82 coo 3.96 55.76 41.24 4.83 57.69 41.17 -35.80 114.74 -10.32 -37.65 115.72 -10.06 coo 9.42 68.07 30.27 7.35 68.27 30.10 -40.43 105.08 4.20 -40.75 103.07 3.51 ULMN 3 1amy_c06 ALPHA-1,4 GLYCAN-4-GLUCANOHYDROLASE user 15 3 # 15 179 ASP B 314 ASP~? 9.37 O5 B3P A 371 227 GLU A 333 GLU~? 2.48 ZN ZN A 401s 289 ASP B 327 ASP^? 11.42 O1 B3P B 371 coo -0.62 65.95 29.97 0.31 67.47 31.05 -40.38 114.62 4.43 -42.39 114.53 3.82 coo 3.96 55.76 41.24 4.83 57.69 41.17 -35.80 114.74 -10.32 -37.65 115.72 -10.06 coo 9.42 68.07 30.27 7.35 68.27 30.10 -33.51 107.30 6.30 -34.89 106.08 5.25 ULMN 3 1amy_c06 ALPHA-1,4 GLYCAN-4-GLUCANOHYDROLASE user 16 3 # 16 179 ASP B 314 ASP~? 9.37 O5 B3P A 371 227 GLU B 275 GLU.? 25.80 ZN ZN A 402 289 ASP B 327 ASP^? 11.42 O1 B3P B 371 coo -0.62 65.95 29.97 0.31 67.47 31.05 -40.38 114.62 4.43 -42.39 114.53 3.82 coo 3.96 55.76 41.24 4.83 57.69 41.17 -25.20 121.46 10.93 -24.62 123.07 12.36 coo 9.42 68.07 30.27 7.35 68.27 30.10 -33.51 107.30 6.30 -34.89 106.08 5.25 ULMN 3 1amy_c06 ALPHA-1,4 GLYCAN-4-GLUCANOHYDROLASE user 17 3 # 17 179 ASP B 314 ASP~? 9.37 O5 B3P A 371 227 GLU B 333 GLU~? 2.50 ZN ZN B 402s 289 ASP A 309 ASP.? 7.55 ZN ZN A 402 coo -0.62 65.95 29.97 0.31 67.47 31.05 -40.38 114.62 4.43 -42.39 114.53 3.82 coo 3.96 55.76 41.24 4.83 57.69 41.17 -40.33 98.40 11.28 -42.37 98.54 11.02 coo 9.42 68.07 30.27 7.35 68.27 30.10 -39.32 109.22 -3.35 -38.59 111.09 -2.57 ULMN 3 1amy_c06 ALPHA-1,4 GLYCAN-4-GLUCANOHYDROLASE user 18 3 # 18 179 ASP B 317 ASP~? 10.65 O4 B3P A 371 227 GLU B 275 GLU.? 25.80 ZN ZN A 402 289 ASP A 48 ASP.? 7.07 ZN ZN A 402 coo -0.62 65.95 29.97 0.31 67.47 31.05 -39.61 120.08 5.26 -40.74 120.57 3.54 coo 3.96 55.76 41.24 4.83 57.69 41.17 -25.20 121.46 10.93 -24.62 123.07 12.36 coo 9.42 68.07 30.27 7.35 68.27 30.10 -34.00 122.50 -3.86 -35.34 120.86 -3.93 ULMN 3 1amy_c06 ALPHA-1,4 GLYCAN-4-GLUCANOHYDROLASE user 19 3 # 19 179 ASP B 327 ASP^? 11.42 O1 B3P B 371 227 GLU B 275 GLU.? 25.80 ZN ZN A 402 289 ASP B 314 ASP~? 9.37 O5 B3P A 371 coo -0.62 65.95 29.97 0.31 67.47 31.05 -33.51 107.30 6.30 -34.89 106.08 5.25 coo 3.96 55.76 41.24 4.83 57.69 41.17 -25.20 121.46 10.93 -24.62 123.07 12.36 coo 9.42 68.07 30.27 7.35 68.27 30.10 -40.38 114.62 4.43 -42.39 114.53 3.82 ULMN 3 1amy_c06 ALPHA-1,4 GLYCAN-4-GLUCANOHYDROLASE user 20 3 # 20 179 ASP B 365 ASP.? 11.69 ZN ZN B 401 227 GLU A 294 GLU~? 11.80 C9 B3P A 371 289 ASP B 48 ASP.? 7.12 ZN ZN B 401 coo -0.62 65.95 29.97 0.31 67.47 31.05 -34.85 93.86 2.40 -34.89 96.00 2.14 coo 3.96 55.76 41.24 4.83 57.69 41.17 -44.58 100.10 -10.25 -45.30 101.55 -8.87 coo 9.42 68.07 30.27 7.35 68.27 30.10 -43.07 90.96 4.68 -43.24 93.07 4.75 1amy_c06 source 1amy ALPHA-1,4 GLYCAN-4-GLUCANOHYDROLASE (ALPHA-AMY: 20 hits 1amy_c06 naa= 3 ULMN 3 1apt_c04 ISOVALERYL (IVA)-VAL-VAL-LYSTA-O-ET user 1 3 # 1 E 33 ASP A 309 ASP.? 7.55 ZN ZN A 402 E 36 SER A 289 SER.? -5.35 O1 B3P A 371s E 213 ASP A 314 ASP~? 9.10 O5 B3P B 371 coo 26.30 12.96 16.78 25.46 12.99 18.72 -39.32 109.22 -3.35 -38.59 111.09 -2.57 coo 28.33 15.15 21.27 28.70 13.12 19.97 -41.15 110.32 -7.28 -42.46 109.97 -5.25 coo 20.15 16.04 19.79 21.65 14.49 19.86 -44.29 101.20 -3.40 -45.94 102.37 -2.71 ULMN 3 1apt_c04 ISOVALERYL (IVA)-VAL-VAL-LYSTA-O-ET user 2 3 # 2 E 33 ASP A 309 ASP.? 7.55 ZN ZN A 402 E 36 SER A 289 SER.? -5.35 O1 B3P A 371s E 213 ASP A 327 ASP^? 11.36 O1 B3P A 371 coo 26.30 12.96 16.78 25.46 12.99 18.72 -39.32 109.22 -3.35 -38.59 111.09 -2.57 coo 28.33 15.15 21.27 28.70 13.12 19.97 -41.15 110.32 -7.28 -42.46 109.97 -5.25 coo 20.15 16.04 19.79 21.65 14.49 19.86 -34.76 103.64 -5.32 -35.22 105.46 -4.31 ULMN 3 1apt_c04 ISOVALERYL (IVA)-VAL-VAL-LYSTA-O-ET user 3 3 # 3 E 33 ASP B 309 ASP.? 7.61 ZN ZN B 401 E 36 SER B 289 SER.? -5.32 O1 B3P B 371s E 213 ASP B 327 ASP^? 11.42 O1 B3P B 371 coo 26.30 12.96 16.78 25.46 12.99 18.72 -40.43 105.08 4.20 -40.75 103.07 3.51 coo 28.33 15.15 21.27 28.70 13.12 19.97 -42.54 105.00 8.17 -43.55 106.07 6.24 coo 20.15 16.04 19.79 21.65 14.49 19.86 -33.51 107.30 6.30 -34.89 106.08 5.25 1apt_c04 source 1apt ISOVALERYL (IVA)-VAL-VAL-LYSTA-O-ET (LYSTA IS : 3 hits 1apt_c04 naa= 3 ULMN 3 1aq2_c00 PHOSPHOENOLPYRUVATE CARBOXYKINASE user 1 3 # 1 232 HIS A 330 HIS~? -3.46 ZN ZN A 402s 254 LYS B 311 LYS~? 6.90 O5 B3P A 371 333 ARG A 271 ARG^? 13.44 ZN ZN B 401 coo 28.11 -1.15 8.51 29.21 0.63 8.34 -37.28 113.42 -5.32 -38.81 114.77 -5.81 coo 26.09 4.87 14.60 27.89 3.33 10.26 -38.57 111.14 1.14 -44.17 110.56 -0.29 coo 37.35 7.47 11.84 34.90 6.11 10.60 -33.34 101.75 -1.66 -34.94 103.58 0.21 ULMN 3 1aq2_c00 PHOSPHOENOLPYRUVATE CARBOXYKINASE user 2 3 # 2 232 HIS B 330 HIS~? -3.52 ZN ZN B 401s 254 LYS A 311 LYS~? 6.37 O5 B3P B 371 333 ARG B 271 ARG^? 13.51 ZN ZN A 402 coo 28.11 -1.15 8.51 29.21 0.63 8.34 -40.87 100.43 6.30 -42.90 100.10 6.71 coo 26.09 4.87 14.60 27.89 3.33 10.26 -40.88 103.07 -0.16 -45.35 106.37 1.57 coo 37.35 7.47 11.84 34.90 6.11 10.60 -31.35 108.28 2.46 -33.78 107.49 0.72 1aq2_c00 source 1aq2 PHOSPHOENOLPYRUVATE CARBOXYKINASE : 2 hits 1aq2_c00 naa= 3 ULMN 3 1aql_c02 BILE-SALT ACTIVATED LIPASE user 1 3 # 1 A 194 SER A 67 SER^? 10.42 ZN ZN A 402 A 292 ASP A 37 ASP.? 31.35 ZN ZN A 401 A 322 HIS A 330 HIS~? -3.46 ZN ZN A 402s coo 36.34 32.23 39.60 36.43 34.62 39.93 -35.40 126.06 -10.23 -37.10 126.61 -8.52 coo 19.73 19.18 41.39 21.50 18.65 40.34 -40.71 145.86 -15.24 -40.04 147.48 -16.47 coo 41.69 45.14 46.60 41.78 47.19 46.18 -37.28 113.42 -5.32 -38.81 114.77 -5.81 ULMN 3 1aql_c02 BILE-SALT ACTIVATED LIPASE user 2 3 # 2 A 194 SER A 67 SER^? 10.42 ZN ZN A 402 A 292 ASP B 314 ASP~? 9.37 O5 B3P A 371 A 322 HIS A 17 HIS~? 19.36 ZN ZN A 401 coo 36.34 32.23 39.60 36.43 34.62 39.93 -35.40 126.06 -10.23 -37.10 126.61 -8.52 coo 19.73 19.18 41.39 21.50 18.65 40.34 -40.38 114.62 4.43 -42.39 114.53 3.82 coo 41.69 45.14 46.60 41.78 47.19 46.18 -37.78 126.95 -26.45 -37.01 127.80 -28.21 ULMN 3 1aql_c02 BILE-SALT ACTIVATED LIPASE user 3 3 # 3 A 194 SER A 360 SER.? 15.92 ZN ZN A 402 A 292 ASP A 309 ASP.? 7.55 ZN ZN A 402 A 322 HIS A 94 HIS~? 26.81 ZN ZN A 402 coo 36.34 32.23 39.60 36.43 34.62 39.93 -25.64 125.99 -9.62 -26.39 125.93 -7.32 coo 19.73 19.18 41.39 21.50 18.65 40.34 -39.32 109.22 -3.35 -38.59 111.09 -2.57 coo 41.69 45.14 46.60 41.78 47.19 46.18 -29.92 140.30 -1.80 -28.95 140.49 0.05 ULMN 3 1aql_c02 BILE-SALT ACTIVATED LIPASE user 4 3 # 4 A 194 SER B 67 SER^? 10.38 ZN ZN B 401 A 292 ASP B 37 ASP.? 31.37 ZN ZN B 402 A 322 HIS B 330 HIS~? -3.52 ZN ZN B 401s coo 36.34 32.23 39.60 36.43 34.62 39.93 -46.05 88.61 10.98 -47.75 89.13 9.26 coo 19.73 19.18 41.39 21.50 18.65 40.34 -61.16 74.73 15.87 -61.47 72.93 16.97 coo 41.69 45.14 46.60 41.78 47.19 46.18 -40.87 100.43 6.30 -42.90 100.10 6.71 ULMN 3 1aql_c02 BILE-SALT ACTIVATED LIPASE user 5 3 # 5 A 194 SER B 212 SER~? 30.92 O3 B3P B 371 A 292 ASP B 15 ASP~? 18.09 ZN ZN B 402 A 322 HIS B 222 HIS~? 44.73 O3 B3P B 371 coo 36.34 32.23 39.60 36.43 34.62 39.93 -73.65 99.09 31.39 -73.40 97.15 29.92 coo 19.73 19.18 41.39 21.50 18.65 40.34 -55.42 89.37 22.84 -56.66 91.01 23.17 coo 41.69 45.14 46.60 41.78 47.19 46.18 -78.49 101.96 45.58 -77.98 103.75 46.55 ULMN 3 1aql_c02 BILE-SALT ACTIVATED LIPASE user 6 3 # 6 A 194 SER B 360 SER.? 15.98 ZN ZN B 401 A 292 ASP B 309 ASP.? 7.61 ZN ZN B 401 A 322 HIS B 94 HIS~? 26.87 ZN ZN B 401 coo 36.34 32.23 39.60 36.43 34.62 39.93 -37.68 83.46 10.19 -38.22 83.94 7.84 coo 19.73 19.18 41.39 21.50 18.65 40.34 -40.43 105.08 4.20 -40.75 103.07 3.51 coo 41.69 45.14 46.60 41.78 47.19 46.18 -49.13 73.87 2.20 -48.22 73.02 0.50 1aql_c02 source 1aql BILE-SALT ACTIVATED LIPASE : 6 hits 1aql_c02 naa= 3 ULMN 3 1aql_c03 BILE-SALT ACTIVATED LIPASE user 1 3 # 1 B 194 SER A 67 SER^? 10.42 ZN ZN A 402 B 292 ASP A 37 ASP.? 31.35 ZN ZN A 401 B 322 HIS A 330 HIS~? -3.46 ZN ZN A 402s coo 35.42 71.28 22.94 36.24 69.06 22.37 -35.40 126.06 -10.23 -37.10 126.61 -8.52 coo 24.74 78.07 5.59 24.32 79.03 7.46 -40.71 145.86 -15.24 -40.04 147.48 -16.47 coo 48.81 64.16 26.34 49.30 62.16 26.73 -37.28 113.42 -5.32 -38.81 114.77 -5.81 ULMN 3 1aql_c03 BILE-SALT ACTIVATED LIPASE user 2 3 # 2 B 194 SER B 67 SER^? 10.38 ZN ZN B 401 B 292 ASP B 37 ASP.? 31.37 ZN ZN B 402 B 322 HIS B 330 HIS~? -3.52 ZN ZN B 401s coo 35.42 71.28 22.94 36.24 69.06 22.37 -46.05 88.61 10.98 -47.75 89.13 9.26 coo 24.74 78.07 5.59 24.32 79.03 7.46 -61.16 74.73 15.87 -61.47 72.93 16.97 coo 48.81 64.16 26.34 49.30 62.16 26.73 -40.87 100.43 6.30 -42.90 100.10 6.71 ULMN 3 1aql_c03 BILE-SALT ACTIVATED LIPASE user 3 3 # 3 B 194 SER B 212 SER~? 30.92 O3 B3P B 371 B 292 ASP B 15 ASP~? 18.09 ZN ZN B 402 B 322 HIS B 222 HIS~? 44.73 O3 B3P B 371 coo 35.42 71.28 22.94 36.24 69.06 22.37 -73.65 99.09 31.39 -73.40 97.15 29.92 coo 24.74 78.07 5.59 24.32 79.03 7.46 -55.42 89.37 22.84 -56.66 91.01 23.17 coo 48.81 64.16 26.34 49.30 62.16 26.73 -78.49 101.96 45.58 -77.98 103.75 46.55 1aql_c03 source 1aql BILE-SALT ACTIVATED LIPASE : 3 hits 1aql_c03 naa= 3 ULMN 3 1avf_c04 GASTRICSIN user 1 3 # 1 A 32 ASP A 309 ASP.? 7.55 ZN ZN A 402 A 35 SER A 289 SER.? -5.35 O1 B3P A 371s A 217 ASP A 314 ASP~? 9.10 O5 B3P B 371 coo -10.06 2.54 49.69 -8.83 3.73 50.96 -39.32 109.22 -3.35 -38.59 111.09 -2.57 coo -11.96 5.74 52.90 -10.55 6.74 51.22 -41.15 110.32 -7.28 -42.46 109.97 -5.25 coo -5.22 1.43 56.08 -5.36 2.84 54.49 -44.29 101.20 -3.40 -45.94 102.37 -2.71 ULMN 3 1avf_c04 GASTRICSIN user 2 3 # 2 A 32 ASP A 309 ASP.? 7.55 ZN ZN A 402 A 35 SER A 289 SER.? -5.35 O1 B3P A 371s A 217 ASP A 327 ASP^? 11.36 O1 B3P A 371 coo -10.06 2.54 49.69 -8.83 3.73 50.96 -39.32 109.22 -3.35 -38.59 111.09 -2.57 coo -11.96 5.74 52.90 -10.55 6.74 51.22 -41.15 110.32 -7.28 -42.46 109.97 -5.25 coo -5.22 1.43 56.08 -5.36 2.84 54.49 -34.76 103.64 -5.32 -35.22 105.46 -4.31 ULMN 3 1avf_c04 GASTRICSIN user 3 3 # 3 A 32 ASP B 309 ASP.? 7.61 ZN ZN B 401 A 35 SER B 289 SER.? -5.32 O1 B3P B 371s A 217 ASP B 314 ASP~? 9.37 O5 B3P A 371 coo -10.06 2.54 49.69 -8.83 3.73 50.96 -40.43 105.08 4.20 -40.75 103.07 3.51 coo -11.96 5.74 52.90 -10.55 6.74 51.22 -42.54 105.00 8.17 -43.55 106.07 6.24 coo -5.22 1.43 56.08 -5.36 2.84 54.49 -40.38 114.62 4.43 -42.39 114.53 3.82 ULMN 3 1avf_c04 GASTRICSIN user 4 3 # 4 A 32 ASP B 309 ASP.? 7.61 ZN ZN B 401 A 35 SER B 289 SER.? -5.32 O1 B3P B 371s A 217 ASP B 327 ASP^? 11.42 O1 B3P B 371 coo -10.06 2.54 49.69 -8.83 3.73 50.96 -40.43 105.08 4.20 -40.75 103.07 3.51 coo -11.96 5.74 52.90 -10.55 6.74 51.22 -42.54 105.00 8.17 -43.55 106.07 6.24 coo -5.22 1.43 56.08 -5.36 2.84 54.49 -33.51 107.30 6.30 -34.89 106.08 5.25 1avf_c04 source 1avf GASTRICSIN : 4 hits 1avf_c04 naa= 3 ULMN 3 1avf_c05 GASTRICSIN user 1 3 # 1 J 32 ASP A 309 ASP.? 7.55 ZN ZN A 402 J 35 SER A 289 SER.? -5.35 O1 B3P A 371s J 217 ASP A 314 ASP~? 9.10 O5 B3P B 371 coo -37.57 -17.54 20.53 -38.55 -18.66 19.00 -39.32 109.22 -3.35 -38.59 111.09 -2.57 coo -40.93 -20.91 21.81 -38.85 -21.36 20.65 -41.15 110.32 -7.28 -42.46 109.97 -5.25 coo -43.00 -16.46 14.92 -41.37 -17.71 15.28 -44.29 101.20 -3.40 -45.94 102.37 -2.71 ULMN 3 1avf_c05 GASTRICSIN user 2 3 # 2 J 32 ASP A 309 ASP.? 7.55 ZN ZN A 402 J 35 SER A 289 SER.? -5.35 O1 B3P A 371s J 217 ASP A 327 ASP^? 11.36 O1 B3P A 371 coo -37.57 -17.54 20.53 -38.55 -18.66 19.00 -39.32 109.22 -3.35 -38.59 111.09 -2.57 coo -40.93 -20.91 21.81 -38.85 -21.36 20.65 -41.15 110.32 -7.28 -42.46 109.97 -5.25 coo -43.00 -16.46 14.92 -41.37 -17.71 15.28 -34.76 103.64 -5.32 -35.22 105.46 -4.31 ULMN 3 1avf_c05 GASTRICSIN user 3 3 # 3 J 32 ASP B 309 ASP.? 7.61 ZN ZN B 401 J 35 SER B 289 SER.? -5.32 O1 B3P B 371s J 217 ASP B 327 ASP^? 11.42 O1 B3P B 371 coo -37.57 -17.54 20.53 -38.55 -18.66 19.00 -40.43 105.08 4.20 -40.75 103.07 3.51 coo -40.93 -20.91 21.81 -38.85 -21.36 20.65 -42.54 105.00 8.17 -43.55 106.07 6.24 coo -43.00 -16.46 14.92 -41.37 -17.71 15.28 -33.51 107.30 6.30 -34.89 106.08 5.25 1avf_c05 source 1avf GASTRICSIN : 3 hits 1avf_c05 naa= 3 ULMN 3 1ax4_c04 TRYPTOPHANASE user 1 3 # 1 A 130 PHE A 272 PHE^? 21.34 O1 B3P A 371 A 223 ASP A 260 ASP~? 22.40 ZN ZN A 401 A 265 LYS A 118 LYS~? 19.88 ZN ZN A 401 coo 39.74 52.86 65.74 41.15 55.14 66.52 -31.27 96.31 -7.79 -29.42 94.26 -7.46 coo 30.70 47.50 67.53 29.83 49.47 67.39 -24.22 101.11 -15.48 -23.38 102.12 -17.10 coo 19.99 54.53 64.11 20.55 58.78 68.33 -28.99 110.87 -21.74 -28.14 111.12 -26.78 ULMN 3 1ax4_c04 TRYPTOPHANASE user 2 3 # 2 A 130 PHE A 272 PHE^? 21.34 O1 B3P A 371 A 223 ASP A 260 ASP~? 22.40 ZN ZN A 401 A 265 LYS A 123 LYS^? 25.39 ZN ZN A 401 coo 39.74 52.86 65.74 41.15 55.14 66.52 -31.27 96.31 -7.79 -29.42 94.26 -7.46 coo 30.70 47.50 67.53 29.83 49.47 67.39 -24.22 101.11 -15.48 -23.38 102.12 -17.10 coo 19.99 54.53 64.11 20.55 58.78 68.33 -30.65 105.03 -26.89 -25.62 104.03 -28.57 ULMN 3 1ax4_c04 TRYPTOPHANASE user 3 3 # 3 A 130 PHE A 272 PHE^? 21.34 O1 B3P A 371 A 223 ASP A 303 ASP.? 22.13 C9 B3P A 371 A 265 LYS A 123 LYS^? 25.39 ZN ZN A 401 coo 39.74 52.86 65.74 41.15 55.14 66.52 -31.27 96.31 -7.79 -29.42 94.26 -7.46 coo 30.70 47.50 67.53 29.83 49.47 67.39 -36.59 95.18 -18.70 -36.77 94.15 -20.55 coo 19.99 54.53 64.11 20.55 58.78 68.33 -30.65 105.03 -26.89 -25.62 104.03 -28.57 ULMN 3 1ax4_c04 TRYPTOPHANASE user 4 3 # 4 A 130 PHE A 272 PHE^? 21.34 O1 B3P A 371 A 223 ASP B 365 ASP.? 11.69 ZN ZN B 401 A 265 LYS B 262 LYS~? 21.77 ZN ZN B 401 coo 39.74 52.86 65.74 41.15 55.14 66.52 -31.27 96.31 -7.79 -29.42 94.26 -7.46 coo 30.70 47.50 67.53 29.83 49.47 67.39 -34.85 93.86 2.40 -34.89 96.00 2.14 coo 19.99 54.53 64.11 20.55 58.78 68.33 -25.92 101.11 10.73 -22.76 101.80 5.19 ULMN 3 1ax4_c04 TRYPTOPHANASE user 5 3 # 5 A 130 PHE B 272 PHE^? 21.32 O1 B3P B 371 A 223 ASP A 365 ASP.? 11.72 ZN ZN A 402 A 265 LYS A 262 LYS~? 21.84 ZN ZN A 402 coo 39.74 52.86 65.74 41.15 55.14 66.52 -26.75 111.69 8.68 -24.14 112.55 8.35 coo 30.70 47.50 67.53 29.83 49.47 67.39 -28.60 115.73 -1.61 -29.73 113.97 -1.34 coo 19.99 54.53 64.11 20.55 58.78 68.33 -25.04 104.85 -9.90 -22.55 102.62 -4.48 ULMN 3 1ax4_c04 TRYPTOPHANASE user 6 3 # 6 A 130 PHE B 272 PHE^? 21.32 O1 B3P B 371 A 223 ASP B 260 ASP~? 22.46 ZN ZN B 402 A 265 LYS B 118 LYS~? 19.45 ZN ZN B 402 coo 39.74 52.86 65.74 41.15 55.14 66.52 -26.75 111.69 8.68 -24.14 112.55 8.35 coo 30.70 47.50 67.53 29.83 49.47 67.39 -23.14 103.74 16.35 -22.94 102.41 17.89 coo 19.99 54.53 64.11 20.55 58.78 68.33 -32.38 97.99 22.65 -32.90 97.89 28.03 ULMN 3 1ax4_c04 TRYPTOPHANASE user 7 3 # 7 A 130 PHE B 272 PHE^? 21.32 O1 B3P B 371 A 223 ASP B 260 ASP~? 22.46 ZN ZN B 402 A 265 LYS B 123 LYS^? 26.96 ZN ZN B 402 coo 39.74 52.86 65.74 41.15 55.14 66.52 -26.75 111.69 8.68 -24.14 112.55 8.35 coo 30.70 47.50 67.53 29.83 49.47 67.39 -23.14 103.74 16.35 -22.94 102.41 17.89 coo 19.99 54.53 64.11 20.55 58.78 68.33 -30.72 103.65 27.68 -26.65 107.35 30.80 ULMN 3 1ax4_c04 TRYPTOPHANASE user 8 3 # 8 A 130 PHE B 272 PHE^? 21.32 O1 B3P B 371 A 223 ASP B 303 ASP.? 21.91 C9 B3P B 371 A 265 LYS B 123 LYS^? 26.96 ZN ZN B 402 coo 39.74 52.86 65.74 41.15 55.14 66.52 -26.75 111.69 8.68 -24.14 112.55 8.35 coo 30.70 47.50 67.53 29.83 49.47 67.39 -30.67 115.41 19.76 -30.51 116.22 21.72 coo 19.99 54.53 64.11 20.55 58.78 68.33 -30.72 103.65 27.68 -26.65 107.35 30.80 1ax4_c04 source 1ax4 TRYPTOPHANASE : 8 hits 1ax4_c04 naa= 3 ULMN 3 1ax4_c05 TRYPTOPHANASE user 1 3 # 1 B 130 PHE A 272 PHE^? 21.34 O1 B3P A 371 B 223 ASP A 260 ASP~? 22.40 ZN ZN A 401 B 265 LYS A 118 LYS~? 19.88 ZN ZN A 401 coo 7.48 54.94 99.62 7.67 52.27 100.42 -31.27 96.31 -7.79 -29.42 94.26 -7.46 coo 10.43 61.66 91.81 9.80 60.04 90.61 -24.22 101.11 -15.48 -23.38 102.12 -17.10 coo 5.43 58.06 80.08 8.57 53.00 79.37 -28.99 110.87 -21.74 -28.14 111.12 -26.78 ULMN 3 1ax4_c05 TRYPTOPHANASE user 2 3 # 2 B 130 PHE A 272 PHE^? 21.34 O1 B3P A 371 B 223 ASP A 260 ASP~? 22.40 ZN ZN A 401 B 265 LYS A 123 LYS^? 25.39 ZN ZN A 401 coo 7.48 54.94 99.62 7.67 52.27 100.42 -31.27 96.31 -7.79 -29.42 94.26 -7.46 coo 10.43 61.66 91.81 9.80 60.04 90.61 -24.22 101.11 -15.48 -23.38 102.12 -17.10 coo 5.43 58.06 80.08 8.57 53.00 79.37 -30.65 105.03 -26.89 -25.62 104.03 -28.57 ULMN 3 1ax4_c05 TRYPTOPHANASE user 3 3 # 3 B 130 PHE A 272 PHE^? 21.34 O1 B3P A 371 B 223 ASP A 303 ASP.? 22.13 C9 B3P A 371 B 265 LYS A 123 LYS^? 25.39 ZN ZN A 401 coo 7.48 54.94 99.62 7.67 52.27 100.42 -31.27 96.31 -7.79 -29.42 94.26 -7.46 coo 10.43 61.66 91.81 9.80 60.04 90.61 -36.59 95.18 -18.70 -36.77 94.15 -20.55 coo 5.43 58.06 80.08 8.57 53.00 79.37 -30.65 105.03 -26.89 -25.62 104.03 -28.57 ULMN 3 1ax4_c05 TRYPTOPHANASE user 4 3 # 4 B 130 PHE A 272 PHE^? 21.34 O1 B3P A 371 B 223 ASP B 365 ASP.? 11.69 ZN ZN B 401 B 265 LYS B 262 LYS~? 21.77 ZN ZN B 401 coo 7.48 54.94 99.62 7.67 52.27 100.42 -31.27 96.31 -7.79 -29.42 94.26 -7.46 coo 10.43 61.66 91.81 9.80 60.04 90.61 -34.85 93.86 2.40 -34.89 96.00 2.14 coo 5.43 58.06 80.08 8.57 53.00 79.37 -25.92 101.11 10.73 -22.76 101.80 5.19 ULMN 3 1ax4_c05 TRYPTOPHANASE user 5 3 # 5 B 130 PHE B 272 PHE^? 21.32 O1 B3P B 371 B 223 ASP A 365 ASP.? 11.72 ZN ZN A 402 B 265 LYS A 262 LYS~? 21.84 ZN ZN A 402 coo 7.48 54.94 99.62 7.67 52.27 100.42 -26.75 111.69 8.68 -24.14 112.55 8.35 coo 10.43 61.66 91.81 9.80 60.04 90.61 -28.60 115.73 -1.61 -29.73 113.97 -1.34 coo 5.43 58.06 80.08 8.57 53.00 79.37 -25.04 104.85 -9.90 -22.55 102.62 -4.48 ULMN 3 1ax4_c05 TRYPTOPHANASE user 6 3 # 6 B 130 PHE B 272 PHE^? 21.32 O1 B3P B 371 B 223 ASP B 260 ASP~? 22.46 ZN ZN B 402 B 265 LYS B 118 LYS~? 19.45 ZN ZN B 402 coo 7.48 54.94 99.62 7.67 52.27 100.42 -26.75 111.69 8.68 -24.14 112.55 8.35 coo 10.43 61.66 91.81 9.80 60.04 90.61 -23.14 103.74 16.35 -22.94 102.41 17.89 coo 5.43 58.06 80.08 8.57 53.00 79.37 -32.38 97.99 22.65 -32.90 97.89 28.03 ULMN 3 1ax4_c05 TRYPTOPHANASE user 7 3 # 7 B 130 PHE B 272 PHE^? 21.32 O1 B3P B 371 B 223 ASP B 260 ASP~? 22.46 ZN ZN B 402 B 265 LYS B 123 LYS^? 26.96 ZN ZN B 402 coo 7.48 54.94 99.62 7.67 52.27 100.42 -26.75 111.69 8.68 -24.14 112.55 8.35 coo 10.43 61.66 91.81 9.80 60.04 90.61 -23.14 103.74 16.35 -22.94 102.41 17.89 coo 5.43 58.06 80.08 8.57 53.00 79.37 -30.72 103.65 27.68 -26.65 107.35 30.80 ULMN 3 1ax4_c05 TRYPTOPHANASE user 8 3 # 8 B 130 PHE B 272 PHE^? 21.32 O1 B3P B 371 B 223 ASP B 303 ASP.? 21.91 C9 B3P B 371 B 265 LYS B 123 LYS^? 26.96 ZN ZN B 402 coo 7.48 54.94 99.62 7.67 52.27 100.42 -26.75 111.69 8.68 -24.14 112.55 8.35 coo 10.43 61.66 91.81 9.80 60.04 90.61 -30.67 115.41 19.76 -30.51 116.22 21.72 coo 5.43 58.06 80.08 8.57 53.00 79.37 -30.72 103.65 27.68 -26.65 107.35 30.80 1ax4_c05 source 1ax4 TRYPTOPHANASE : 8 hits 1ax4_c05 naa= 3 ULMN 3 1ax4_c06 TRYPTOPHANASE user 1 3 # 1 C 130 PHE A 272 PHE^? 21.34 O1 B3P A 371 C 223 ASP A 260 ASP~? 22.40 ZN ZN A 401 C 265 LYS A 118 LYS~? 19.88 ZN ZN A 401 coo -6.55 73.45 23.60 -6.77 71.48 21.66 -31.27 96.31 -7.79 -29.42 94.26 -7.46 coo -9.52 75.74 33.62 -8.85 73.74 33.93 -24.22 101.11 -15.48 -23.38 102.12 -17.10 coo -4.44 67.20 42.32 -7.50 62.41 40.49 -28.99 110.87 -21.74 -28.14 111.12 -26.78 ULMN 3 1ax4_c06 TRYPTOPHANASE user 2 3 # 2 C 130 PHE A 272 PHE^? 21.34 O1 B3P A 371 C 223 ASP A 260 ASP~? 22.40 ZN ZN A 401 C 265 LYS A 123 LYS^? 25.39 ZN ZN A 401 coo -6.55 73.45 23.60 -6.77 71.48 21.66 -31.27 96.31 -7.79 -29.42 94.26 -7.46 coo -9.52 75.74 33.62 -8.85 73.74 33.93 -24.22 101.11 -15.48 -23.38 102.12 -17.10 coo -4.44 67.20 42.32 -7.50 62.41 40.49 -30.65 105.03 -26.89 -25.62 104.03 -28.57 ULMN 3 1ax4_c06 TRYPTOPHANASE user 3 3 # 3 C 130 PHE A 272 PHE^? 21.34 O1 B3P A 371 C 223 ASP A 303 ASP.? 22.13 C9 B3P A 371 C 265 LYS A 123 LYS^? 25.39 ZN ZN A 401 coo -6.55 73.45 23.60 -6.77 71.48 21.66 -31.27 96.31 -7.79 -29.42 94.26 -7.46 coo -9.52 75.74 33.62 -8.85 73.74 33.93 -36.59 95.18 -18.70 -36.77 94.15 -20.55 coo -4.44 67.20 42.32 -7.50 62.41 40.49 -30.65 105.03 -26.89 -25.62 104.03 -28.57 ULMN 3 1ax4_c06 TRYPTOPHANASE user 4 3 # 4 C 130 PHE A 272 PHE^? 21.34 O1 B3P A 371 C 223 ASP B 365 ASP.? 11.69 ZN ZN B 401 C 265 LYS B 262 LYS~? 21.77 ZN ZN B 401 coo -6.55 73.45 23.60 -6.77 71.48 21.66 -31.27 96.31 -7.79 -29.42 94.26 -7.46 coo -9.52 75.74 33.62 -8.85 73.74 33.93 -34.85 93.86 2.40 -34.89 96.00 2.14 coo -4.44 67.20 42.32 -7.50 62.41 40.49 -25.92 101.11 10.73 -22.76 101.80 5.19 ULMN 3 1ax4_c06 TRYPTOPHANASE user 5 3 # 5 C 130 PHE B 272 PHE^? 21.32 O1 B3P B 371 C 223 ASP A 365 ASP.? 11.72 ZN ZN A 402 C 265 LYS A 262 LYS~? 21.84 ZN ZN A 402 coo -6.55 73.45 23.60 -6.77 71.48 21.66 -26.75 111.69 8.68 -24.14 112.55 8.35 coo -9.52 75.74 33.62 -8.85 73.74 33.93 -28.60 115.73 -1.61 -29.73 113.97 -1.34 coo -4.44 67.20 42.32 -7.50 62.41 40.49 -25.04 104.85 -9.90 -22.55 102.62 -4.48 ULMN 3 1ax4_c06 TRYPTOPHANASE user 6 3 # 6 C 130 PHE B 272 PHE^? 21.32 O1 B3P B 371 C 223 ASP B 260 ASP~? 22.46 ZN ZN B 402 C 265 LYS B 118 LYS~? 19.45 ZN ZN B 402 coo -6.55 73.45 23.60 -6.77 71.48 21.66 -26.75 111.69 8.68 -24.14 112.55 8.35 coo -9.52 75.74 33.62 -8.85 73.74 33.93 -23.14 103.74 16.35 -22.94 102.41 17.89 coo -4.44 67.20 42.32 -7.50 62.41 40.49 -32.38 97.99 22.65 -32.90 97.89 28.03 ULMN 3 1ax4_c06 TRYPTOPHANASE user 7 3 # 7 C 130 PHE B 272 PHE^? 21.32 O1 B3P B 371 C 223 ASP B 260 ASP~? 22.46 ZN ZN B 402 C 265 LYS B 123 LYS^? 26.96 ZN ZN B 402 coo -6.55 73.45 23.60 -6.77 71.48 21.66 -26.75 111.69 8.68 -24.14 112.55 8.35 coo -9.52 75.74 33.62 -8.85 73.74 33.93 -23.14 103.74 16.35 -22.94 102.41 17.89 coo -4.44 67.20 42.32 -7.50 62.41 40.49 -30.72 103.65 27.68 -26.65 107.35 30.80 ULMN 3 1ax4_c06 TRYPTOPHANASE user 8 3 # 8 C 130 PHE B 272 PHE^? 21.32 O1 B3P B 371 C 223 ASP B 303 ASP.? 21.91 C9 B3P B 371 C 265 LYS B 123 LYS^? 26.96 ZN ZN B 402 coo -6.55 73.45 23.60 -6.77 71.48 21.66 -26.75 111.69 8.68 -24.14 112.55 8.35 coo -9.52 75.74 33.62 -8.85 73.74 33.93 -30.67 115.41 19.76 -30.51 116.22 21.72 coo -4.44 67.20 42.32 -7.50 62.41 40.49 -30.72 103.65 27.68 -26.65 107.35 30.80 1ax4_c06 source 1ax4 TRYPTOPHANASE : 8 hits 1ax4_c06 naa= 3 ULMN 3 1ax4_c07 TRYPTOPHANASE user 1 3 # 1 D 130 PHE A 272 PHE^? 21.34 O1 B3P A 371 D 223 ASP A 260 ASP~? 22.40 ZN ZN A 401 D 265 LYS A 118 LYS~? 19.88 ZN ZN A 401 coo -38.60 55.38 52.70 -40.06 57.72 53.04 -31.27 96.31 -7.79 -29.42 94.26 -7.46 coo -29.46 51.67 48.51 -28.63 53.31 49.56 -24.22 101.11 -15.48 -23.38 102.12 -17.10 coo -18.87 56.53 54.79 -19.47 62.22 53.03 -28.99 110.87 -21.74 -28.14 111.12 -26.78 ULMN 3 1ax4_c07 TRYPTOPHANASE user 2 3 # 2 D 130 PHE A 272 PHE^? 21.34 O1 B3P A 371 D 223 ASP A 260 ASP~? 22.40 ZN ZN A 401 D 265 LYS A 123 LYS^? 25.39 ZN ZN A 401 coo -38.60 55.38 52.70 -40.06 57.72 53.04 -31.27 96.31 -7.79 -29.42 94.26 -7.46 coo -29.46 51.67 48.51 -28.63 53.31 49.56 -24.22 101.11 -15.48 -23.38 102.12 -17.10 coo -18.87 56.53 54.79 -19.47 62.22 53.03 -30.65 105.03 -26.89 -25.62 104.03 -28.57 ULMN 3 1ax4_c07 TRYPTOPHANASE user 3 3 # 3 D 130 PHE A 272 PHE^? 21.34 O1 B3P A 371 D 223 ASP A 303 ASP.? 22.13 C9 B3P A 371 D 265 LYS A 123 LYS^? 25.39 ZN ZN A 401 coo -38.60 55.38 52.70 -40.06 57.72 53.04 -31.27 96.31 -7.79 -29.42 94.26 -7.46 coo -29.46 51.67 48.51 -28.63 53.31 49.56 -36.59 95.18 -18.70 -36.77 94.15 -20.55 coo -18.87 56.53 54.79 -19.47 62.22 53.03 -30.65 105.03 -26.89 -25.62 104.03 -28.57 ULMN 3 1ax4_c07 TRYPTOPHANASE user 4 3 # 4 D 130 PHE A 272 PHE^? 21.34 O1 B3P A 371 D 223 ASP B 365 ASP.? 11.69 ZN ZN B 401 D 265 LYS B 262 LYS~? 21.77 ZN ZN B 401 coo -38.60 55.38 52.70 -40.06 57.72 53.04 -31.27 96.31 -7.79 -29.42 94.26 -7.46 coo -29.46 51.67 48.51 -28.63 53.31 49.56 -34.85 93.86 2.40 -34.89 96.00 2.14 coo -18.87 56.53 54.79 -19.47 62.22 53.03 -25.92 101.11 10.73 -22.76 101.80 5.19 ULMN 3 1ax4_c07 TRYPTOPHANASE user 5 3 # 5 D 130 PHE B 272 PHE^? 21.32 O1 B3P B 371 D 223 ASP A 365 ASP.? 11.72 ZN ZN A 402 D 265 LYS A 262 LYS~? 21.84 ZN ZN A 402 coo -38.60 55.38 52.70 -40.06 57.72 53.04 -26.75 111.69 8.68 -24.14 112.55 8.35 coo -29.46 51.67 48.51 -28.63 53.31 49.56 -28.60 115.73 -1.61 -29.73 113.97 -1.34 coo -18.87 56.53 54.79 -19.47 62.22 53.03 -25.04 104.85 -9.90 -22.55 102.62 -4.48 ULMN 3 1ax4_c07 TRYPTOPHANASE user 6 3 # 6 D 130 PHE B 272 PHE^? 21.32 O1 B3P B 371 D 223 ASP B 260 ASP~? 22.46 ZN ZN B 402 D 265 LYS B 118 LYS~? 19.45 ZN ZN B 402 coo -38.60 55.38 52.70 -40.06 57.72 53.04 -26.75 111.69 8.68 -24.14 112.55 8.35 coo -29.46 51.67 48.51 -28.63 53.31 49.56 -23.14 103.74 16.35 -22.94 102.41 17.89 coo -18.87 56.53 54.79 -19.47 62.22 53.03 -32.38 97.99 22.65 -32.90 97.89 28.03 ULMN 3 1ax4_c07 TRYPTOPHANASE user 7 3 # 7 D 130 PHE B 272 PHE^? 21.32 O1 B3P B 371 D 223 ASP B 260 ASP~? 22.46 ZN ZN B 402 D 265 LYS B 123 LYS^? 26.96 ZN ZN B 402 coo -38.60 55.38 52.70 -40.06 57.72 53.04 -26.75 111.69 8.68 -24.14 112.55 8.35 coo -29.46 51.67 48.51 -28.63 53.31 49.56 -23.14 103.74 16.35 -22.94 102.41 17.89 coo -18.87 56.53 54.79 -19.47 62.22 53.03 -30.72 103.65 27.68 -26.65 107.35 30.80 ULMN 3 1ax4_c07 TRYPTOPHANASE user 8 3 # 8 D 130 PHE B 272 PHE^? 21.32 O1 B3P B 371 D 223 ASP B 303 ASP.? 21.91 C9 B3P B 371 D 265 LYS B 123 LYS^? 26.96 ZN ZN B 402 coo -38.60 55.38 52.70 -40.06 57.72 53.04 -26.75 111.69 8.68 -24.14 112.55 8.35 coo -29.46 51.67 48.51 -28.63 53.31 49.56 -30.67 115.41 19.76 -30.51 116.22 21.72 coo -18.87 56.53 54.79 -19.47 62.22 53.03 -30.72 103.65 27.68 -26.65 107.35 30.80 1ax4_c07 source 1ax4 TRYPTOPHANASE : 8 hits 1ax4_c07 naa= 3 ULMN 3 1azw_c00 PROLINE IMINOPEPTIDASE user 1 3 # 1 A 110 SER A 332 SER~? 10.92 ZN ZN A 402 A 266 ASP A 309 ASP.? 7.55 ZN ZN A 402 A 294 HIS A 330 HIS~? -3.46 ZN ZN A 402s coo 32.07 25.76 77.83 34.46 26.05 77.46 -31.12 112.57 -9.16 -30.10 110.35 -8.93 coo 33.07 35.01 79.81 33.39 33.02 79.13 -39.32 109.22 -3.35 -38.59 111.09 -2.57 coo 35.53 30.26 79.89 34.62 28.71 78.80 -37.28 113.42 -5.32 -38.81 114.77 -5.81 ULMN 3 1azw_c00 PROLINE IMINOPEPTIDASE user 2 3 # 2 A 110 SER B 332 SER~? 10.87 ZN ZN B 401 A 266 ASP B 309 ASP.? 7.61 ZN ZN B 401 A 294 HIS B 330 HIS~? -3.52 ZN ZN B 401s coo 32.07 25.76 77.83 34.46 26.05 77.46 -35.18 97.79 10.03 -33.17 99.10 9.80 coo 33.07 35.01 79.81 33.39 33.02 79.13 -40.43 105.08 4.20 -40.75 103.07 3.51 coo 35.53 30.26 79.89 34.62 28.71 78.80 -40.87 100.43 6.30 -42.90 100.10 6.71 1azw_c00 source 1azw PROLINE IMINOPEPTIDASE : 2 hits 1azw_c00 naa= 3 ULMN 3 1azw_c01 PROLINE IMINOPEPTIDASE user 1 3 # 1 B 110 SER A 332 SER~? 10.92 ZN ZN A 402 B 266 ASP A 309 ASP.? 7.55 ZN ZN A 402 B 294 HIS A 330 HIS~? -3.46 ZN ZN A 402s coo 51.18 33.22 36.61 49.29 31.79 37.02 -31.12 112.57 -9.16 -30.10 110.35 -8.93 coo 44.19 39.32 34.54 45.21 37.66 35.38 -39.32 109.22 -3.35 -38.59 111.09 -2.57 coo 45.79 34.26 34.63 47.54 33.80 35.70 -37.28 113.42 -5.32 -38.81 114.77 -5.81 ULMN 3 1azw_c01 PROLINE IMINOPEPTIDASE user 2 3 # 2 B 110 SER B 332 SER~? 10.87 ZN ZN B 401 B 266 ASP B 309 ASP.? 7.61 ZN ZN B 401 B 294 HIS B 330 HIS~? -3.52 ZN ZN B 401s coo 51.18 33.22 36.61 49.29 31.79 37.02 -35.18 97.79 10.03 -33.17 99.10 9.80 coo 44.19 39.32 34.54 45.21 37.66 35.38 -40.43 105.08 4.20 -40.75 103.07 3.51 coo 45.79 34.26 34.63 47.54 33.80 35.70 -40.87 100.43 6.30 -42.90 100.10 6.71 1azw_c01 source 1azw PROLINE IMINOPEPTIDASE : 2 hits 1azw_c01 naa= 3 ULMN 3 1azy_c00 THYMIDINE PHOSPHORYLASE user 1 3 # 1 A 85 HIS A 321 HIS~? 16.72 O4 B3P B 371 A 171 ARG A 271 ARG^? 13.44 ZN ZN B 401 A 190 LYS A 319 LYS~? 18.09 ZN ZN B 401 coo 22.59 2.26 43.22 21.17 3.47 42.27 -47.70 92.41 -8.31 -49.45 92.40 -7.16